Skip to main content
LIPID MAPS®
menu
Databases
LMSD
LMPD
COMP_DB
LMISSD
Ion Mobility
Partial Spectra DB
Standards Spectra DB
Oxidized Phospholipid DB
Shorthand DB
Pathways
Reactions Explorer
LIPID MAPS® Pathways
SphinGOMAP©
Cayman Pathway Maps
Tools
Lipidomics
Tool Guide
MS Analysis
Structure
Drawing
Statistical
Analysis
Nomenclature
Tools
Lipid Analysis
Software
Education
Webinars
Podcasts
Tutorials
Resources
Classification
Nomenclature
Structure
Methods and
Protocols
Training
School
Community
Lipid of the
Month
Lipid Matters
Blog
Highlights
LipidWeb
Newsletters
External
Resources
Events Calendar
About
About Us
About Our
Partners
About Our
Sponsors
Sponsor Us
Contact Us
Archive
Downloads
Downloads Hub (All)
Experimental Data
REST
SPARQL
LMSD
LMPD
COMP_DB
PARTIAL_DB
Standards Spectra DB
login
Login
Microarray analysis of bone marrow-derived macrophage cells treated with Kdo
2
-lipid A (KLA) and ATP
Search by fold change ratio
|
Search by KEGG pathway
|
Search by LIPID MAPS lipid pathway
Kdo
2
-Lipid A / ATP gene array data - treatment:control ratios
KEGG pathway: Metabolic pathways (mmu01100)
Legend:
: View data/graphs for replicates
Gene symbol  
Time course plot
Accession
Description
Treatment
15min
30min
1hr
2hr
4hr
8hr
20hr
1-Sep
KLA
ATP
ATP+KLA
NM_017461
septin 1 (Sept1), mRNA [NM_017461]
KLA
.98
1.02
.97
.97
.98
1.13
1.08
ATP
.94
1.02
1.05
1.09
.97
.95
1.08
KLA/ATP
1.02
.90
.97
1.04
.95
.98
1.01
1110020P
15Rik
KLA
ATP
ATP+KLA
NM_197979
RIKEN cDNA 1110020P15 gene (1110020P15Rik), mRNA [NM_197979]
KLA
.86
.91
.84
.87
.81
.87
1.00
ATP
.95
.99
1.12
1.12
1.07
.94
.94
KLA/ATP
.88
.87
1.02
1.02
1.06
1.02
1.01
1190003J
15Rik
KLA
ATP
ATP+KLA
AK004470
18-day embryo whole body cDNA, RIKEN full-length enriched library, clone:1190003J15 product:hypothetical Transthyretin/Transthyretin-related containing protein, full insert sequence. [AK004470]
KLA
3.70
2.84
3.15
4.56
4.81
4.07
1.29
ATP
.99
.87
1.37
1.71
5.17
19.64
3.47
KLA/ATP
3.00
3.08
3.34
3.61
9.32
19.35
12.86
1190003J
15Rik
KLA
ATP
ATP+KLA
NM_029821
RIKEN cDNA 1190003J15 gene (1190003J15Rik), mRNA [NM_029821]
KLA
4.65
3.78
3.57
5.26
6.06
5.74
1.52
ATP
1.00
.90
1.22
1.65
5.73
15.98
4.64
KLA/ATP
3.93
3.75
3.62
4.09
10.51
18.55
15.36
1500032D
16Rik
KLA
ATP
ATP+KLA
NM_030087
RIKEN cDNA 1500032D16 gene (1500032D16Rik), transcript variant 1, mRNA [NM_030087]
KLA
.91
1.00
.92
.91
.84
.80
.69
ATP
.97
1.03
1.16
1.31
1.13
.94
.69
KLA/ATP
.98
1.03
1.11
1.34
1.12
.83
.50
1500032O
14Rik
KLA
ATP
ATP+KLA
AK005350
adult male cerebellum cDNA, RIKEN full-length enriched library, clone:1500032O14 product:succinate dehydrogenase complex, subunit A, flavoprotein (Fp), full insert sequence. [AK005350]
KLA
1.01
.97
.97
.98
1.01
1.05
1.04
ATP
.61
.42
.41
.55
1.05
1.12
.96
KLA/ATP
.62
.53
.54
.68
1.10
1.02
.88
1700012G
19Rik
KLA
ATP
ATP+KLA
AK012010
10 days embryo whole body cDNA, RIKEN full-length enriched library, clone:2610311O05 product:hypothetical HAD-like structure containing protein, full insert sequence [AK012010]
KLA
.45
.39
.37
.43
.48
.64
.62
ATP
.93
1.05
.88
.90
.63
.67
.56
KLA/ATP
.43
.42
.42
.46
.49
.50
.37
1700012G
19Rik
KLA
ATP
ATP+KLA
NM_025954
RIKEN cDNA 1700012G19 gene (1700012G19Rik), mRNA [NM_025954]
KLA
.34
.35
.28
.34
.42
.59
.70
ATP
.92
.91
.88
.79
.70
1.27
.92
KLA/ATP
.35
.33
.34
.32
.47
.80
.66
1700055N
04Rik
KLA
ATP
ATP+KLA
AK081788
16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130077J09 product:weakly similar to ALDEHYDE DEHYDROGENASE 7 (EC 1.2.1.5) [Homo sapiens], full insert sequence [AK081788]
KLA
.96
.98
.95
.97
.97
.96
1.06
ATP
1.01
1.00
.97
1.10
.95
.99
1.02
KLA/ATP
.99
1.00
.97
1.00
1.00
.96
.97
2010204N
08Rik
KLA
ATP
ATP+KLA
NM_001081137
RIKEN cDNA 2010204N08 gene (2010204N08Rik), mRNA [NM_001081137]
KLA
.99
.98
1.00
.96
.98
.98
.99
ATP
.96
.98
1.06
1.14
.98
.97
.99
KLA/ATP
.98
1.05
1.06
1.04
.99
.98
1.94
2010209O
12Rik
KLA
ATP
ATP+KLA
NM_133913
RIKEN cDNA 2010209O12 gene (2010209O12Rik), mRNA [NM_133913]
KLA
.68
.70
.69
.66
.96
1.31
1.28
ATP
1.04
1.16
.86
.85
.97
2.50
2.50
KLA/ATP
.76
.73
.51
.58
.55
1.46
2.34
2310005E
10Rik
KLA
ATP
ATP+KLA
BC026843
RIKEN cDNA 2310005E10 gene, mRNA (cDNA clone IMAGE:4487182), complete cds. [BC026843]
KLA
.70
.65
.65
.65
.83
.90
.89
ATP
1.00
.95
.75
.31
.29
.58
.80
KLA/ATP
.69
.54
.49
.28
.36
.56
.53
2310005E
10Rik
KLA
ATP
ATP+KLA
NM_172398
RIKEN cDNA 2310005E10 gene (2310005E10Rik), mRNA [NM_172398]
KLA
.78
.71
.71
.71
.69
.90
.82
ATP
1.01
.95
1.18
.89
.68
.44
.62
KLA/ATP
.71
.70
.88
.67
.60
.59
.63
2310079N
02Rik
KLA
ATP
ATP+KLA
AK086714
15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930047C07 product:RIKEN cDNA 2310079N02 gene, full insert sequence [AK086714]
KLA
.68
.70
.62
.74
.82
1.21
1.66
ATP
.90
.87
.95
.89
.69
.60
1.58
KLA/ATP
.63
.63
.70
.68
.56
.66
1.25
2310079N
02Rik
KLA
ATP
ATP+KLA
NM_025636
RIKEN cDNA 2310079N02 gene (2310079N02Rik), mRNA [NM_025636]
KLA
.62
.65
.64
.62
.70
.99
1.32
ATP
1.04
.99
.98
1.14
.85
.36
.77
KLA/ATP
.70
.70
.56
.74
.56
.47
.90
2410015N
17Rik
KLA
ATP
ATP+KLA
NM_023203
RIKEN cDNA 2410015N17 gene (2410015N17Rik), mRNA [NM_023203]
KLA
.70
.71
.68
.57
.49
.39
.52
ATP
.98
1.00
1.30
1.28
1.02
.65
.49
KLA/ATP
.69
.71
.86
.84
.70
.52
.39
2410018C
20Rik
KLA
ATP
ATP+KLA
NM_026423
RIKEN cDNA 2410018C20 gene (2410018C20Rik), mRNA [NM_026423]
KLA
.59
.58
.51
.47
.41
.42
.60
ATP
1.01
1.04
.99
1.04
.68
.47
.83
KLA/ATP
.60
.61
.53
.56
.44
.42
.38
2610209A
20Rik
KLA
ATP
ATP+KLA
NM_026010
RIKEN cDNA 2610209A20 gene (2610209A20Rik), mRNA [NM_026010]
KLA
.25
.25
.25
.28
.29
.40
.84
ATP
.93
.93
.89
.56
.32
.33
.63
KLA/ATP
.24
.25
.30
.26
.30
.29
.26
2810405K
02Rik
KLA
ATP
ATP+KLA
NM_025582
RIKEN cDNA 2810405K02 gene (2810405K02Rik), mRNA [NM_025582]
KLA
.77
.68
.61
.70
.71
1.04
1.22
ATP
.88
.87
1.16
1.24
1.07
.64
.92
KLA/ATP
.65
.74
.89
.88
.88
.58
.54
2810423A
18Rik
KLA
ATP
ATP+KLA
AK013141
10, 11 days embryo whole body cDNA, RIKEN full-length enriched library, clone:2810423A18 product:unclassifiable, full insert sequence [AK013141]
KLA
1.03
.97
1.07
.95
1.09
1.26
1.38
ATP
.96
.98
1.09
1.02
2.18
2.30
1.52
KLA/ATP
.99
.97
.94
.75
1.93
3.39
2.34
4930431L
04Rik
KLA
ATP
ATP+KLA
NM_175032
RIKEN cDNA 4930431L04 gene (4930431L04Rik), mRNA [NM_175032]
KLA
.96
1.04
1.08
1.08
1.11
.98
.98
ATP
.96
1.02
1.02
1.00
1.07
.98
.99
KLA/ATP
.99
1.01
1.05
.93
1.02
1.11
.97
4930438A
08Rik
KLA
ATP
ATP+KLA
XM_001477470
gb|PREDICTED: Mus musculus RIKEN cDNA 4930438A08 gene (4930438A08Rik), mRNA [XM_001477470]
KLA
1.78
1.45
1.69
1.62
1.69
1.48
1.31
ATP
1.07
1.04
1.24
1.13
1.13
1.61
1.67
KLA/ATP
1.83
1.46
1.58
1.30
1.43
1.36
1.95
4933405O
20Rik
KLA
ATP
ATP+KLA
NM_172901
RIKEN cDNA 4933405O20 gene (4933405O20Rik), mRNA [NM_172901]
KLA
.98
.99
1.01
1.07
1.03
1.01
1.03
ATP
.95
.97
.99
.96
.99
1.01
1.02
KLA/ATP
.93
1.01
.99
.98
.98
.92
.96
4933434I
20Rik
KLA
ATP
ATP+KLA
NM_026233
RIKEN cDNA 4933434I20 gene (4933434I20Rik), mRNA [NM_026233]
KLA
1.00
1.02
1.00
.99
1.00
1.02
1.02
ATP
.99
.99
1.02
.99
1.05
1.01
.99
KLA/ATP
1.03
.95
.95
1.02
.99
.97
1.00
6720408I
04Rik
KLA
ATP
ATP+KLA
AK020107
12 days embryo male wolffian duct includes surrounding region cDNA, RIKEN full-length enriched library, clone:6720408I04 product:hypothetical protein, full insert sequence. [AK020107]
KLA
.92
1.01
1.02
.96
.93
1.00
.99
ATP
1.00
.94
.90
.94
1.01
1.01
.98
KLA/ATP
1.00
.95
.92
.94
1.01
.97
.95
9130409I
23Rik
KLA
ATP
ATP+KLA
NM_001033819
RIKEN cDNA 9130409I23 gene (9130409I23Rik), mRNA [NM_001033819]
KLA
1.04
.98
1.00
1.04
1.05
1.07
1.00
ATP
.98
1.01
1.05
1.06
.99
.98
1.01
KLA/ATP
.98
1.03
.93
1.07
1.00
1.11
.96
A530057A
03Rik
KLA
ATP
ATP+KLA
NM_001081089
RIKEN cDNA A530057A03 gene (A530057A03Rik), mRNA [NM_001081089]
KLA
1.06
1.10
1.05
1.03
1.12
1.14
1.27
ATP
1.04
1.11
1.07
1.01
.97
.99
1.06
KLA/ATP
1.10
1.19
1.14
.96
1.11
.91
1.09
AK016943
KLA
ATP
ATP+KLA
AK016943
adult male testis cDNA, RIKEN full-length enriched library, clone:4933427C01 product:hypothetical Arginine-rich region containing protein, full insert sequence. [AK016943]
KLA
.94
1.00
.99
.94
.99
1.07
1.06
ATP
1.08
1.03
1.07
1.05
1.00
.98
.99
KLA/ATP
1.02
.95
1.03
1.02
1.08
1.00
1.04
AK031343
KLA
ATP
ATP+KLA
AK031343
13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030410A06 product:unclassifiable, full insert sequence [AK031343]
KLA
1.03
.97
.92
1.01
.97
.90
.94
ATP
1.00
1.00
.92
.95
.97
.99
.98
KLA/ATP
.98
1.01
.86
.99
.91
.93
1.00
AK046580
KLA
ATP
ATP+KLA
AK046580
4 days neonate male adipose cDNA, RIKEN full-length enriched library, clone:B430108N21 product:similar to CYTOCHROME C OXIDASE POLYPEPTIDE VA, MITOCHONDRIAL PRECURSOR (EC 1.9.3.1) [Rattus norvegicus], full insert sequence. [AK046580]
KLA
.94
.93
.98
1.02
1.13
1.13
1.01
ATP
.84
.93
.87
.91
1.14
1.02
.98
KLA/ATP
.88
.89
.99
.92
1.05
1.05
.95
AK047274
KLA
ATP
ATP+KLA
AK047274
10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930044L01 product:unclassifiable, full insert sequence. [AK047274]
KLA
.92
.85
.90
.92
.98
.93
.92
ATP
1.03
1.11
1.07
.90
.89
.93
.94
KLA/ATP
.89
.96
.94
.84
.93
.92
.92
AK077927
KLA
ATP
ATP+KLA
AK077927
13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030447B09 product:unclassifiable, full insert sequence. [AK077927]
KLA
3.15
2.64
2.14
1.56
1.86
1.87
1.23
ATP
.91
.63
.45
.45
1.18
1.41
.90
KLA/ATP
2.53
2.04
1.88
.94
1.59
1.96
1.21
AK085608
KLA
ATP
ATP+KLA
AK085608
0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630046G10 product:unclassifiable, full insert sequence. [AK085608]
KLA
.89
.96
1.01
1.03
.96
.98
1.07
ATP
1.03
1.00
.96
1.01
1.05
1.04
1.00
KLA/ATP
1.00
1.00
.99
1.04
1.01
.99
1.00
AK085642
KLA
ATP
ATP+KLA
AK085642
0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630050A03 product:unclassifiable, full insert sequence [AK085642]
KLA
1.09
1.00
.97
1.00
1.05
1.05
1.04
ATP
1.01
.95
.99
1.01
1.03
1.03
.98
KLA/ATP
.98
1.03
.99
1.02
1.08
1.03
1.02
AK086155
KLA
ATP
ATP+KLA
AK086155
15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930008J19 product:unclassifiable, full insert sequence. [AK086155]
KLA
1.02
1.05
1.02
1.02
.99
1.08
.93
ATP
.98
1.06
1.35
1.04
.94
1.11
1.08
KLA/ATP
.98
.94
1.11
1.03
1.04
1.04
1.13
AK087183
KLA
ATP
ATP+KLA
AK087183
0 day neonate lung cDNA, RIKEN full-length enriched library, clone:E030032L18 product:unclassifiable, full insert sequence. [AK087183]
KLA
.96
.95
.94
.93
.94
.89
.96
ATP
1.05
.94
.92
.90
.93
.84
.93
KLA/ATP
1.01
.97
.89
.91
.96
.87
.84
AK087232
KLA
ATP
ATP+KLA
AK087232
0 day neonate lung cDNA, RIKEN full-length enriched library, clone:E030037J19 product:unclassifiable, full insert sequence. [AK087232]
KLA
.99
1.12
1.03
1.03
1.01
.89
1.05
ATP
1.01
1.00
1.04
1.06
1.01
1.01
.92
KLA/ATP
1.02
1.05
.97
1.00
1.05
.84
.98
AK165218
KLA
ATP
ATP+KLA
AK165218
6 days neonate spleen cDNA, RIKEN full-length enriched library, clone:F420008K05 product:lipin 2, full insert sequence. [AK165218]
KLA
.96
.94
.83
1.03
1.08
.97
1.07
ATP
1.20
1.84
1.52
2.12
1.12
1.23
1.14
KLA/ATP
.97
1.03
1.17
1.13
.98
1.07
1.21
AK169742
KLA
ATP
ATP+KLA
AK169742
2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:E430016M08 product:glyceraldehyde-3-phosphate dehydrogenase, full insert sequence. [AK169742]
KLA
.82
.94
.91
.90
1.13
.93
1.79
ATP
.59
.66
.72
.89
1.88
1.96
1.26
KLA/ATP
.75
.69
.70
.84
1.00
1.13
1.46
AK209324
KLA
ATP
ATP+KLA
AK209324
cDNA, clone:Y2G0114L23, strand:plus, reference:ENSEMBL:Mouse-Transcript-ENST:ENSMUST00000060207, based on BLAT search. [AK209324]
KLA
.48
.51
.55
.57
.80
.90
1.17
ATP
1.01
.96
.73
.60
.76
.78
1.24
KLA/ATP
.54
.46
.42
.54
.76
.76
.73
AU021838
KLA
ATP
ATP+KLA
AK032842
12 days embryo male wolffian duct includes surrounding region cDNA, RIKEN full-length enriched library, clone:6720461H18 product:unclassifiable, full insert sequence [AK032842]
KLA
.87
.74
.81
.58
.51
.52
.55
ATP
1.00
1.03
1.09
.76
.43
.45
.42
KLA/ATP
.81
.82
.68
.56
.38
.37
.31
Aadat
KLA
ATP
ATP+KLA
NM_011834
aminoadipate aminotransferase (Aadat), mRNA [NM_011834]
KLA
1.05
1.06
1.04
.98
1.00
1.04
.98
ATP
.98
.99
1.10
1.03
1.00
1.04
1.03
KLA/ATP
1.05
1.09
1.07
1.04
.97
1.06
1.05
Aanat
KLA
ATP
ATP+KLA
NM_009591
arylalkylamine N-acetyltransferase (Aanat), mRNA [NM_009591]
KLA
1.04
1.01
1.17
1.06
.96
1.09
.99
ATP
.99
1.02
1.01
.99
1.01
.92
.99
KLA/ATP
1.01
1.06
1.01
1.04
.99
.99
1.02
Aass
KLA
ATP
ATP+KLA
NM_013930
aminoadipate-semialdehyde synthase (Aass), nuclear gene encoding mitochondrial protein, mRNA [NM_013930]
KLA
1.03
1.08
1.01
1.13
1.04
1.04
.99
ATP
1.00
.91
1.06
.99
.97
.95
1.01
KLA/ATP
.98
1.00
1.01
.91
.96
.94
.91
Abat
KLA
ATP
ATP+KLA
AK083062
12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530041H11 product:hypothetical protein, full insert sequence. [AK083062]
KLA
1.01
1.09
.97
.99
1.03
1.02
1.06
ATP
.96
.99
1.00
1.11
1.04
.98
1.06
KLA/ATP
1.06
1.03
.96
1.06
1.10
1.06
.96
Abat
KLA
ATP
ATP+KLA
NM_172961
4-aminobutyrate aminotransferase (Abat), nuclear gene encoding mitochondrial protein, mRNA [NM_172961]
KLA
1.03
.96
.97
1.00
.92
.97
.96
ATP
.97
.93
1.07
1.04
.97
.99
.98
KLA/ATP
1.03
1.01
1.00
.98
.94
.89
.97
Abo
KLA
ATP
ATP+KLA
NM_030718
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase, transferase B, alpha 1-3-galactosyltransferase) (Abo), mRNA [NM_030718]
KLA
1.07
.93
.95
1.01
1.00
.97
.92
ATP
.96
.95
.98
1.03
1.02
1.00
1.06
KLA/ATP
1.00
.96
1.05
1.07
1.04
.94
.99
Acaa1a
KLA
ATP
ATP+KLA
NM_130864
acetyl-Coenzyme A acyltransferase 1A (Acaa1a), mRNA [NM_130864]
KLA
1.53
1.60
1.88
2.07
2.41
2.64
1.82
ATP
1.07
.99
.98
1.10
.94
.83
1.58
KLA/ATP
1.64
1.64
1.73
1.75
1.61
1.39
1.85
Acaa1b
KLA
ATP
ATP+KLA
NM_146230
acetyl-Coenzyme A acyltransferase 1B (Acaa1b), mRNA [NM_146230]
KLA
1.52
1.66
1.93
2.04
2.32
2.51
1.83
ATP
1.04
.95
1.06
1.12
1.03
.93
1.59
KLA/ATP
1.76
1.72
1.76
1.95
1.76
1.51
1.86
Acaa2
KLA
ATP
ATP+KLA
NM_177470
acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase) (Acaa2), nuclear gene encoding mitochondrial protein, mRNA [NM_177470]
KLA
.98
.94
1.00
1.00
.90
.81
.60
ATP
1.03
1.00
1.12
1.10
.84
.48
.50
KLA/ATP
.98
.98
1.03
1.05
.99
.85
.40
Acaca
KLA
ATP
ATP+KLA
NM_133360
acetyl-Coenzyme A carboxylase alpha (Acaca), mRNA [NM_133360]
KLA
.99
.94
.95
.93
.95
1.00
1.00
ATP
.98
.97
.96
.93
.92
.96
.99
KLA/ATP
1.01
.96
.99
.92
.93
.94
.91
Acacb
KLA
ATP
ATP+KLA
NM_133904
acetyl-Coenzyme A carboxylase beta (Acacb), mRNA [NM_133904]
KLA
1.01
.93
1.00
.99
.95
1.03
.92
ATP
.96
1.04
1.05
.98
1.04
1.11
1.05
KLA/ATP
.90
1.01
1.05
1.03
.97
.96
1.08
Acad8
KLA
ATP
ATP+KLA
NM_025862
acyl-Coenzyme A dehydrogenase family, member 8 (Acad8), mRNA [NM_025862]
KLA
.89
.84
.95
.94
.84
.78
.82
ATP
1.07
.98
.99
.74
.53
.57
.69
KLA/ATP
.89
.88
.85
.65
.52
.60
.60
Acadl
KLA
ATP
ATP+KLA
NM_007381
acyl-Coenzyme A dehydrogenase, long-chain (Acadl), nuclear gene encoding mitochondrial protein, mRNA [NM_007381]
KLA
1.67
1.61
2.27
1.98
1.98
1.62
.89
ATP
1.24
1.19
1.25
1.30
1.36
1.15
.69
KLA/ATP
1.83
1.95
2.01
2.22
1.71
1.18
.84
Acadm
KLA
ATP
ATP+KLA
NM_007382
acyl-Coenzyme A dehydrogenase, medium chain (Acadm), nuclear gene encoding mitochondrial protein, mRNA [NM_007382]
KLA
.57
.50
.50
.37
.34
.34
.54
ATP
1.09
1.08
1.16
.92
.67
.43
.51
KLA/ATP
.55
.56
.57
.46
.41
.36
.29
Acads
KLA
ATP
ATP+KLA
NM_007383
acyl-Coenzyme A dehydrogenase, short chain (Acads), nuclear gene encoding mitochondrial protein, mRNA [NM_007383]
KLA
.76
.78
.76
.69
.71
.71
.70
ATP
1.02
1.11
1.01
1.28
.75
.58
.79
KLA/ATP
.80
.76
.66
.82
.56
.56
.53
Acadsb
KLA
ATP
ATP+KLA
NM_025826
acyl-Coenzyme A dehydrogenase, short/branched chain (Acadsb), nuclear gene encoding mitochondrial protein, mRNA [NM_025826]
KLA
1.30
1.38
1.39
1.23
1.50
1.35
1.26
ATP
1.18
1.36
1.31
1.24
.91
.73
1.18
KLA/ATP
1.44
1.26
1.22
1.41
.78
.68
1.19
Acadvl
KLA
ATP
ATP+KLA
NM_017366
acyl-Coenzyme A dehydrogenase, very long chain (Acadvl), nuclear gene encoding mitochondrial protein, mRNA [NM_017366]
KLA
.88
.79
.75
.87
.66
.63
.90
ATP
1.07
.89
1.24
1.04
.91
.76
.88
KLA/ATP
.78
.84
1.16
.90
.81
.64
.62
Acat1
KLA
ATP
ATP+KLA
NM_144784
acetyl-Coenzyme A acetyltransferase 1 (Acat1), nuclear gene encoding mitochondrial protein, mRNA [NM_144784]
KLA
1.04
.99
.95
.99
.81
.83
.51
ATP
.89
.88
1.21
.99
.67
.36
.47
KLA/ATP
.86
.97
1.18
.90
.64
.42
.35
Acat2
KLA
ATP
ATP+KLA
NM_009338
acetyl-Coenzyme A acetyltransferase 2 (Acat2), mRNA [NM_009338]
KLA
1.14
1.13
1.22
1.29
1.10
.93
.81
ATP
1.04
1.05
1.16
1.35
1.20
1.53
1.16
KLA/ATP
1.19
1.19
1.41
1.29
1.13
.92
.71
Acly
KLA
ATP
ATP+KLA
AK043466
7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730098H14 product:unclassifiable, full insert sequence. [AK043466]
KLA
.99
.97
.93
.93
.97
.98
.94
ATP
1.01
1.00
.93
.98
1.00
.95
1.00
KLA/ATP
.99
1.01
.91
.94
.97
.95
1.02
Acly
KLA
ATP
ATP+KLA
NM_134037
ATP citrate lyase (Acly), mRNA [NM_134037]
KLA
1.03
1.18
1.07
.98
.99
.92
.97
ATP
1.04
1.26
1.05
1.29
.98
.91
1.07
KLA/ATP
1.19
1.12
.98
1.46
.88
.94
.81
Acmsd
KLA
ATP
ATP+KLA
NM_001033041
amino carboxymuconate semialdehyde decarboxylase (Acmsd), mRNA [NM_001033041]
KLA
1.03
1.05
.97
1.03
1.06
.95
.88
ATP
.93
.99
1.03
1.00
.95
1.04
1.00
KLA/ATP
.97
.89
1.07
1.03
.95
.91
.95
Aco1
KLA
ATP
ATP+KLA
NM_007386
aconitase 1 (Aco1), mRNA [NM_007386]
KLA
.82
.85
.80
.78
.73
.74
.84
ATP
1.02
1.07
1.04
.96
.95
.88
.83
KLA/ATP
.83
.86
.81
.80
.76
.73
.62
Aco2
KLA
ATP
ATP+KLA
AK029122
10 days neonate skin cDNA, RIKEN full-length enriched library, clone:4732494K09 product:hypothetical protein, full insert sequence [AK029122]
KLA
1.02
1.02
.99
.98
.97
1.04
.83
ATP
.98
1.04
1.05
.95
.95
1.02
1.00
KLA/ATP
.96
.95
1.00
1.04
1.06
1.03
.99
Aco2
KLA
ATP
ATP+KLA
NM_080633
aconitase 2, mitochondrial (Aco2), nuclear gene encoding mitochondrial protein, mRNA [NM_080633]
KLA
.93
.96
.97
.91
.97
.99
1.07
ATP
1.05
1.04
.98
.92
.90
.83
.99
KLA/ATP
1.01
1.06
.86
.89
.83
.93
.93
Acot1
KLA
ATP
ATP+KLA
NM_012006
acyl-CoA thioesterase 1 (Acot1), mRNA [NM_012006]
KLA
.40
.34
.32
.29
.23
.17
.16
ATP
1.01
.95
1.14
1.10
.64
.26
.53
KLA/ATP
.37
.37
.42
.42
.32
.20
.22
Acot2
KLA
ATP
ATP+KLA
NM_134188
acyl-CoA thioesterase 2 (Acot2), nuclear gene encoding mitochondrial protein, mRNA [NM_134188]
KLA
.46
.49
.37
.43
.34
.37
.53
ATP
1.02
1.15
.87
.99
.54
.37
.96
KLA/ATP
.51
.46
.44
.49
.36
.34
.49
Acot3
KLA
ATP
ATP+KLA
NM_134246
acyl-CoA thioesterase 3 (Acot3), mRNA [NM_134246]
KLA
.95
.95
1.04
.99
1.01
.97
.98
ATP
1.03
.97
1.01
.92
1.02
.99
.99
KLA/ATP
.98
1.00
1.07
.96
1.01
1.00
1.01
Acot4
KLA
ATP
ATP+KLA
NM_134247
acyl-CoA thioesterase 4 (Acot4), mRNA [NM_134247]
KLA
.77
.77
.72
.74
.68
.81
.85
ATP
.95
.96
.97
.83
.79
.84
.99
KLA/ATP
.79
.78
.76
.75
.76
.76
.84
Acot5
KLA
ATP
ATP+KLA
NM_145444
acyl-CoA thioesterase 5 (Acot5), mRNA [NM_145444]
KLA
1.03
1.07
1.00
1.02
1.05
1.06
1.07
ATP
.99
.97
1.06
1.05
1.00
1.01
1.06
KLA/ATP
.98
.96
1.07
1.09
1.08
1.00
1.01
Acot7
KLA
ATP
ATP+KLA
NM_133348
acyl-CoA thioesterase 7 (Acot7), mRNA [NM_133348]
KLA
1.60
1.80
1.91
1.81
1.85
1.55
1.30
ATP
.99
1.08
1.07
1.46
1.32
1.25
.99
KLA/ATP
1.81
1.84
1.79
2.42
2.08
1.68
.82
Acot8
KLA
ATP
ATP+KLA
NM_133240
acyl-CoA thioesterase 8 (Acot8), mRNA [NM_133240]
KLA
1.03
1.01
.85
1.11
1.32
1.56
1.41
ATP
.98
1.02
1.00
1.07
.85
.95
1.38
KLA/ATP
1.04
.89
1.01
1.18
1.03
.96
1.70
Acox1
KLA
ATP
ATP+KLA
NM_015729
acyl-Coenzyme A oxidase 1, palmitoyl (Acox1), mRNA [NM_015729]
KLA
.79
.81
.78
.68
.66
.69
.82
ATP
.97
1.09
.93
.90
.81
.78
1.22
KLA/ATP
.81
.82
.69
.68
.59
.70
.88
Acox2
KLA
ATP
ATP+KLA
NM_053115
acyl-Coenzyme A oxidase 2, branched chain (Acox2), mRNA [NM_053115]
KLA
.99
1.04
1.04
1.06
1.01
1.01
.99
ATP
1.06
1.08
.97
1.04
1.02
1.00
1.02
KLA/ATP
1.07
1.05
1.03
1.01
1.01
1.04
1.02
Acox3
KLA
ATP
ATP+KLA
NM_030721
acyl-Coenzyme A oxidase 3, pristanoyl (Acox3), mRNA [NM_030721]
KLA
.56
.56
.63
.55
.50
.48
.68
ATP
1.10
1.00
.85
.76
.87
.44
.73
KLA/ATP
.61
.66
.57
.49
.57
.48
.47
Acsbg1
KLA
ATP
ATP+KLA
NM_053178
acyl-CoA synthetase bubblegum family member 1 (Acsbg1), mRNA [NM_053178]
KLA
.54
.60
.46
.48
.43
.54
.84
ATP
.93
.86
.66
.53
.41
.96
1.25
KLA/ATP
.60
.52
.44
.39
.38
.67
1.36
Acsbg2
KLA
ATP
ATP+KLA
NM_001039114
acyl-CoA synthetase bubblegum family member 2 (Acsbg2), mRNA [NM_001039114]
KLA
.96
.99
1.05
1.00
.98
1.02
1.03
ATP
1.03
1.02
1.04
.97
1.00
1.03
.96
KLA/ATP
1.02
.98
.99
1.00
.92
1.00
.98
Acsl1
KLA
ATP
ATP+KLA
NM_007981
acyl-CoA synthetase long-chain family member 1 (Acsl1), mRNA [NM_007981]
KLA
6.45
6.43
6.31
6.46
7.76
10.38
13.72
ATP
1.02
1.14
1.04
1.69
2.56
4.02
2.69
KLA/ATP
6.36
6.25
5.41
6.54
4.81
4.79
9.93
Acsl3
KLA
ATP
ATP+KLA
NM_001033606
acyl-CoA synthetase long-chain family member 3 (Acsl3), transcript variant 2, mRNA [NM_001033606]
KLA
.29
.27
.29
.29
.30
.32
.39
ATP
1.06
.98
1.19
1.92
2.34
.67
.75
KLA/ATP
.27
.26
.39
.88
1.31
.50
.24
Acsl4
KLA
ATP
ATP+KLA
NM_207625
acyl-CoA synthetase long-chain family member 4 (Acsl4), transcript variant 1, mRNA [NM_207625]
KLA
1.16
1.03
1.01
1.21
1.21
1.51
1.70
ATP
.89
.88
1.64
1.60
2.24
5.91
2.42
KLA/ATP
.92
1.00
1.90
1.71
1.83
3.23
3.56
Acsl5
KLA
ATP
ATP+KLA
NM_027976
acyl-CoA synthetase long-chain family member 5 (Acsl5), mRNA [NM_027976]
KLA
1.32
1.46
1.54
1.51
2.04
2.20
2.31
ATP
1.02
1.10
.89
1.03
.92
.84
.99
KLA/ATP
1.42
1.54
1.17
1.29
.97
1.11
1.35
Acsl6
KLA
ATP
ATP+KLA
AK147421
adult male brain UNDEFINED_CELL_LINE cDNA, RIKEN full-length enriched library, clone:M5C1038B08 product:acyl-CoA synthetase long-chain family member 6, full insert sequence [AK147421]
KLA
1.00
.97
1.02
.99
.97
1.02
1.03
ATP
.97
.96
.95
.97
1.00
1.03
1.04
KLA/ATP
.99
.96
1.08
.96
1.01
.96
1.00
Acsl6
KLA
ATP
ATP+KLA
NM_001033599
acyl-CoA synthetase long-chain family member 6 (Acsl6), transcript variant 4, mRNA [NM_001033599]
KLA
.97
.99
1.02
1.02
1.00
1.01
.99
ATP
1.01
1.01
1.02
1.00
1.00
1.01
1.04
KLA/ATP
.97
1.06
1.00
1.02
.94
1.00
1.02
Acsm1
KLA
ATP
ATP+KLA
NM_054094
acyl-CoA synthetase medium-chain family member 1 (Acsm1), mRNA [NM_054094]
KLA
.98
1.04
.95
1.00
1.04
.99
.97
ATP
1.04
1.04
1.03
.94
1.00
1.00
.97
KLA/ATP
.98
.99
1.04
.98
.95
.95
.98
Acsm2
KLA
ATP
ATP+KLA
AK165449
adult male kidney cDNA, RIKEN full-length enriched library, clone:F530004J10 product:unclassifiable, full insert sequence [AK165449]
KLA
1.00
.98
.96
1.04
1.06
.98
.97
ATP
1.02
.98
1.01
1.07
.94
.99
1.02
KLA/ATP
1.07
1.06
1.05
1.03
1.01
.97
1.00
Acsm2
KLA
ATP
ATP+KLA
NM_146197
acyl-CoA synthetase medium-chain family member 2 (Acsm2), mRNA [NM_146197]
KLA
.99
.98
.95
.99
.99
1.02
1.02
ATP
.99
.95
1.03
.99
.99
1.02
1.03
KLA/ATP
1.01
1.03
.98
.99
.97
.95
1.00
Acsm3
KLA
ATP
ATP+KLA
NM_212441
acyl-CoA synthetase medium-chain family member 3 (Acsm3), transcript variant 2, mRNA [NM_212441]
KLA
1.02
.99
.98
.96
1.00
1.00
.96
ATP
.96
1.01
.98
.87
.95
.98
.93
KLA/ATP
1.00
1.01
.92
.98
.89
.95
1.06
Acsm4
KLA
ATP
ATP+KLA
NM_178414
acyl-CoA synthetase medium-chain family member 4 (Acsm4), mRNA [NM_178414]
KLA
1.09
1.03
.95
1.05
1.01
1.00
.96
ATP
.91
1.05
.92
.96
.93
1.05
1.04
KLA/ATP
.95
.95
1.00
.97
.98
.99
.99
Acsm5
KLA
ATP
ATP+KLA
NM_178758
acyl-CoA synthetase medium-chain family member 5 (Acsm5), mRNA [NM_178758]
KLA
.96
.98
1.04
1.00
1.04
1.05
1.01
ATP
1.01
1.00
1.01
1.02
.94
1.05
1.00
KLA/ATP
.97
1.05
1.04
1.01
1.07
1.00
.96
Acss1
KLA
ATP
ATP+KLA
NM_080575
acyl-CoA synthetase short-chain family member 1 (Acss1), nuclear gene encoding mitochondrial protein, mRNA [NM_080575]
KLA
.45
.41
.45
.62
.70
1.05
.43
ATP
.95
.89
1.35
.86
.81
.57
.55
KLA/ATP
.38
.37
.61
.51
1.13
1.17
.38
Acss2
KLA
ATP
ATP+KLA
AK003738
18-day embryo whole body cDNA, RIKEN full-length enriched library, clone:1110017C11 product:acetyl-Coenzyme A synthetase 1 (AMP forming), full insert sequence. [AK003738]
KLA
1.03
.94
1.02
.97
.93
1.01
1.16
ATP
1.05
.97
.98
1.03
.95
1.31
1.40
KLA/ATP
.88
1.02
1.01
.93
.93
1.02
1.12
Acss2
KLA
ATP
ATP+KLA
NM_019811
acyl-CoA synthetase short-chain family member 2 (Acss2), mRNA [NM_019811]
KLA
1.19
1.23
1.40
1.49
1.68
1.67
1.82
ATP
1.10
1.19
1.13
1.16
1.06
3.14
2.63
KLA/ATP
1.27
1.35
1.37
1.42
1.47
3.47
2.86
Acss3
KLA
ATP
ATP+KLA
NM_198636
acyl-CoA synthetase short-chain family member 3 (Acss3), mRNA [NM_198636]
KLA
.99
.98
.92
1.01
.99
1.03
.98
ATP
.98
1.06
1.01
.97
.98
1.04
1.00
KLA/ATP
.96
.97
1.05
1.01
.91
.98
1.04
Acy1
KLA
ATP
ATP+KLA
NM_025371
aminoacylase 1 (Acy1), mRNA [NM_025371]
KLA
1.09
1.23
1.15
1.16
1.14
1.11
.71
ATP
1.00
1.03
.98
1.13
1.30
1.30
1.13
KLA/ATP
1.22
1.18
.95
1.22
1.08
1.03
.71
Ada
KLA
ATP
ATP+KLA
NM_007398
adenosine deaminase (Ada), mRNA [NM_007398]
KLA
.92
.93
.83
.92
.71
.59
.70
ATP
.90
.91
1.24
1.79
1.48
.91
.43
KLA/ATP
.82
.96
1.18
1.41
1.49
.78
.32
Adc
KLA
ATP
ATP+KLA
NM_172875
arginine decarboxylase (Adc), mRNA [NM_172875]
KLA
.94
1.00
.90
.94
1.05
1.06
1.06
ATP
.95
.94
.88
.90
.88
.75
.95
KLA/ATP
.98
1.01
.86
.92
.90
.98
1.24
Adh1
KLA
ATP
ATP+KLA
AK082149
0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230014D21 product:unclassifiable, full insert sequence [AK082149]
KLA
.94
.96
.97
.95
1.01
.95
.96
ATP
.99
1.05
.93
.91
1.02
1.04
1.00
KLA/ATP
.87
.88
.94
.92
.86
1.04
.93
Adh1
KLA
ATP
ATP+KLA
NM_007409
alcohol dehydrogenase 1 (class I) (Adh1), mRNA [NM_007409]
KLA
1.02
.98
.96
1.04
1.01
1.04
1.08
ATP
.96
1.03
1.00
1.03
1.05
1.01
1.04
KLA/ATP
1.02
1.03
1.04
1.01
1.04
1.09
1.04
Adh4
KLA
ATP
ATP+KLA
NM_011996
alcohol dehydrogenase 4 (class II), pi polypeptide (Adh4), mRNA [NM_011996]
KLA
.95
.94
.93
1.07
1.04
.96
.99
ATP
.95
.95
.95
.99
1.02
.93
.97
KLA/ATP
1.03
1.02
.92
.97
1.02
1.01
.99
Adh5
KLA
ATP
ATP+KLA
NM_007410
alcohol dehydrogenase 5 (class III), chi polypeptide (Adh5), mRNA [NM_007410]
KLA
.93
.76
.71
.83
.61
.63
.76
ATP
1.02
.98
1.19
1.06
1.08
.85
.86
KLA/ATP
.77
.76
1.06
.86
.87
.84
.62
Adh7
KLA
ATP
ATP+KLA
NM_009626
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide (Adh7), mRNA [NM_009626]
KLA
1.07
1.01
1.02
.98
1.03
.99
1.01
ATP
1.03
1.09
1.02
1.08
1.03
1.09
1.01
KLA/ATP
1.10
1.03
1.06
1.02
1.05
1.06
1.13
Adi1
KLA
ATP
ATP+KLA
NM_134052
acireductone dioxygenase 1 (Adi1), mRNA [NM_134052]
KLA
.53
.57
.42
.51
.42
.47
.78
ATP
1.21
1.20
1.11
1.26
1.07
.72
1.07
KLA/ATP
.59
.52
.53
.58
.56
.71
.68
Adk
KLA
ATP
ATP+KLA
NM_134079
adenosine kinase (Adk), mRNA [NM_134079]
KLA
.96
.94
.92
.79
.64
.45
.97
ATP
1.06
1.01
1.34
1.13
1.15
.97
.51
KLA/ATP
.86
.94
1.22
.96
.85
.76
.32
Ado
KLA
ATP
ATP+KLA
NM_001005419
2-aminoethanethiol (cysteamine) dioxygenase (Ado), mRNA [NM_001005419]
KLA
.33
.27
.24
.26
.35
.55
.84
ATP
1.07
1.26
1.21
1.07
.80
.54
.95
KLA/ATP
.29
.30
.29
.31
.30
.27
.37
Adpgk
KLA
ATP
ATP+KLA
NM_028121
ADP-dependent glucokinase (Adpgk), mRNA [NM_028121]
KLA
.77
.82
.76
.66
.66
.64
1.08
ATP
1.09
1.15
1.11
1.14
.89
.61
.87
KLA/ATP
.90
.83
.71
.84
.56
.57
.47
Adsl
KLA
ATP
ATP+KLA
NM_009634
adenylosuccinate lyase (Adsl), mRNA [NM_009634]
KLA
.87
.93
.90
.97
.82
.64
1.06
ATP
1.08
1.12
1.06
1.04
.80
.60
.86
KLA/ATP
1.02
.95
1.00
.86
.66
.49
.49
Adss
KLA
ATP
ATP+KLA
NM_007422
adenylosuccinate synthetase, non muscle (Adss), mRNA [NM_007422]
KLA
1.21
1.15
.96
.70
.35
.24
.51
ATP
.93
1.08
.97
1.14
.93
.75
.47
KLA/ATP
1.24
1.19
.87
.99
.56
.40
.33
Adssl1
KLA
ATP
ATP+KLA
NM_007421
adenylosuccinate synthetase like 1 (Adssl1), mRNA [NM_007421]
KLA
.67
.67
.53
.51
.32
.17
.20
ATP
.87
.76
.96
.74
.73
.38
.60
KLA/ATP
.58
.59
.64
.48
.62
.49
.37
Afmid
KLA
ATP
ATP+KLA
NM_027827
arylformamidase (Afmid), mRNA [NM_027827]
KLA
.85
.95
.89
.82
1.00
1.22
1.18
ATP
1.06
1.11
1.05
1.16
1.11
.95
.69
KLA/ATP
.96
1.09
.95
1.06
1.00
.99
.91
Agk
KLA
ATP
ATP+KLA
NM_023538
acylglycerol kinase (Agk), mRNA [NM_023538]
KLA
1.16
1.30
1.23
1.15
.96
.85
.86
ATP
.97
.99
.99
1.04
.92
.88
.81
KLA/ATP
1.15
1.25
1.25
1.39
1.09
.93
.56
Agl
KLA
ATP
ATP+KLA
AK036225
16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630046L06 product:similar to GLYCOGEN DEBRANCHING ENZYME (GLYCOGEN DEBRANCHER) [INCLUDES: 4-ALPHA-GLUCANOTRANSFERASE (EC 2.4.1.25) (OLIGO-1,4-1,4-GLUCANTRANSFERAS
KLA
.94
.95
.94
.94
.97
.97
1.01
ATP
1.00
1.08
1.01
.86
1.03
1.02
1.01
KLA/ATP
1.05
1.02
.93
.85
.93
1.01
.94
Agl
KLA
ATP
ATP+KLA
NM_001081326
amylo-1,6-glucosidase, 4-alpha-glucanotransferase (Agl), mRNA [NM_001081326]
KLA
.58
.51
.44
.39
.43
.64
.92
ATP
.99
.98
1.01
.68
.90
1.23
.65
KLA/ATP
.51
.50
.45
.33
.54
.85
.49
Agmat
KLA
ATP
ATP+KLA
NM_001081408
agmatine ureohydrolase (agmatinase) (Agmat), mRNA [NM_001081408]
KLA
1.13
1.09
1.11
1.30
1.10
1.15
1.17
ATP
.85
.86
1.30
1.22
1.15
1.16
.95
KLA/ATP
.95
1.04
1.53
1.30
1.37
1.10
1.03
Agpat1
KLA
ATP
ATP+KLA
NM_018862
1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha) (Agpat1), mRNA [NM_018862]
KLA
1.24
1.27
1.16
1.37
1.37
1.51
1.65
ATP
.99
1.09
1.19
1.29
1.20
1.03
1.27
KLA/ATP
1.27
1.33
1.37
1.49
1.28
1.17
1.55
Agpat2
KLA
ATP
ATP+KLA
NM_026212
1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta) (Agpat2), mRNA [NM_026212]
KLA
.88
.86
1.05
1.00
1.28
1.13
1.05
ATP
1.06
1.15
.95
1.09
.97
1.22
1.04
KLA/ATP
.96
.94
.73
.87
.78
.97
.63
Agpat3
KLA
ATP
ATP+KLA
NM_053014
1-acylglycerol-3-phosphate O-acyltransferase 3 (Agpat3), mRNA [NM_053014]
KLA
1.13
1.10
1.05
1.19
1.28
1.33
1.53
ATP
.95
.95
.89
.84
.79
.82
1.41
KLA/ATP
.95
1.03
1.08
.94
.77
.75
1.42
Agpat4
KLA
ATP
ATP+KLA
NM_026644
1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta) (Agpat4), mRNA [NM_026644]
KLA
1.37
1.26
1.06
1.10
.98
1.29
1.77
ATP
1.05
.95
1.02
1.26
1.86
3.88
2.42
KLA/ATP
1.38
1.32
1.44
1.22
1.29
2.06
5.07
Agpat6
KLA
ATP
ATP+KLA
NM_018743
1-acylglycerol-3-phosphate O-acyltransferase 6 (lysophosphatidic acid acyltransferase, zeta) (Agpat6), mRNA [NM_018743]
KLA
1.14
1.08
1.21
1.15
1.17
1.25
1.50
ATP
1.05
1.02
.91
.91
1.11
1.42
1.26
KLA/ATP
1.16
1.17
.96
.87
1.00
1.40
1.35
Agpat9
KLA
ATP
ATP+KLA
NM_172715
1-acylglycerol-3-phosphate O-acyltransferase 9 (Agpat9), transcript variant 1, mRNA [NM_172715]
KLA
.69
.70
.67
.64
.61
.61
.79
ATP
.89
.77
.69
.57
2.26
2.30
1.90
KLA/ATP
.67
.66
.68
.56
1.39
1.82
1.98
Agps
KLA
ATP
ATP+KLA
NM_172666
alkylglycerone phosphate synthase (Agps), mRNA [NM_172666]
KLA
.97
1.04
1.08
.98
.98
1.11
1.31
ATP
1.03
1.09
1.21
1.08
.76
.98
1.18
KLA/ATP
1.02
1.09
1.05
.90
.71
.78
1.56
Agxt
KLA
ATP
ATP+KLA
NM_016702
alanine-glyoxylate aminotransferase (Agxt), mRNA [NM_016702]
KLA
1.01
.95
.96
1.05
1.01
.98
.94
ATP
.95
1.03
1.03
.99
.97
.96
1.05
KLA/ATP
.94
.99
1.01
1.01
.96
.92
.96
Agxt2
KLA
ATP
ATP+KLA
NM_001031851
alanine-glyoxylate aminotransferase 2 (Agxt2), nuclear gene encoding mitochondrial protein, mRNA [NM_001031851]
KLA
.98
.99
1.04
1.05
.93
1.01
1.05
ATP
1.02
1.03
1.03
1.06
1.01
.96
.97
KLA/ATP
1.05
.98
.99
1.04
.99
1.02
1.01
Ahcy
KLA
ATP
ATP+KLA
AK154302
NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630016H08 product:S-adenosylhomocysteine hydrolase, full insert sequence. [AK154302]
KLA
.95
1.05
1.04
1.01
.92
.72
.57
ATP
1.05
1.14
1.15
1.38
1.30
.94
.51
KLA/ATP
1.04
1.15
1.21
1.25
.99
.70
.31
Ahcy
KLA
ATP
ATP+KLA
L32836
(clone C7/B9) S-adenosyl homocysteine hydrolase (ahcy) mRNA, complete cds. [L32836]
KLA
1.04
1.01
1.02
1.06
.90
.78
.61
ATP
.97
1.01
1.21
1.44
1.23
.98
.52
KLA/ATP
.97
1.06
1.18
1.30
1.05
.79
.32
Ahcy
KLA
ATP
ATP+KLA
NM_016661
S-adenosylhomocysteine hydrolase (Ahcy), mRNA [NM_016661]
KLA
1.07
1.02
1.18
1.07
1.07
.92
.72
ATP
1.04
1.11
1.13
1.51
1.21
.90
.59
KLA/ATP
1.13
1.28
1.17
1.33
.96
.84
.51
Ahcyl1
KLA
ATP
ATP+KLA
NM_145542
S-adenosylhomocysteine hydrolase-like 1 (Ahcyl1), mRNA [NM_145542]
KLA
1.19
1.36
1.32
1.12
1.03
.94
1.15
ATP
1.02
1.08
.88
.99
.97
.84
1.43
KLA/ATP
1.32
1.28
.99
1.29
.99
1.13
1.89
Ahcyl2
KLA
ATP
ATP+KLA
AB041551
brain cDNA, clone MNCb-5555. [AB041551]
KLA
.99
1.03
.90
.81
.88
.81
.90
ATP
1.38
1.48
1.04
1.22
1.10
.81
.98
KLA/ATP
1.06
.86
.82
.86
1.00
1.02
1.03
Ahcyl2
KLA
ATP
ATP+KLA
NM_021414
S-adenosylhomocysteine hydrolase-like 2 (Ahcyl2), mRNA [NM_021414]
KLA
1.43
1.40
1.57
1.56
1.44
1.03
1.27
ATP
1.12
1.17
1.23
1.45
1.50
1.61
2.13
KLA/ATP
1.60
1.72
1.66
1.45
1.42
2.00
2.84
Ak1
KLA
ATP
ATP+KLA
NM_021515
adenylate kinase 1 (Ak1), mRNA [NM_021515]
KLA
.81
.81
.75
.72
.58
.46
.29
ATP
.96
1.11
1.07
1.35
1.10
.69
.68
KLA/ATP
.81
.89
.83
1.08
.89
.59
.46
Ak2
KLA
ATP
ATP+KLA
NM_016895
adenylate kinase 2 (Ak2), transcript variant 2, mRNA [NM_016895]
KLA
1.50
1.55
1.69
1.55
1.64
1.56
1.85
ATP
1.13
1.11
1.16
1.44
1.46
1.66
1.40
KLA/ATP
1.70
1.81
2.01
1.94
1.81
1.51
1.96
Ak3l1
KLA
ATP
ATP+KLA
NM_009647
adenylate kinase 3 alpha-like 1 (Ak3l1), nuclear gene encoding mitochondrial protein, mRNA [NM_009647]
KLA
2.47
2.87
2.76
2.37
2.11
1.57
2.16
ATP
.97
1.03
1.13
1.13
1.98
3.05
1.11
KLA/ATP
2.67
2.98
2.40
2.27
2.78
2.30
1.22
Ak5
KLA
ATP
ATP+KLA
NM_001081277
adenylate kinase 5 (Ak5), mRNA [NM_001081277]
KLA
1.03
1.01
.98
1.03
.99
1.05
.97
ATP
.97
1.01
1.03
.98
.99
.97
1.01
KLA/ATP
.97
.96
1.08
.99
.98
.95
1.01
Ak7
KLA
ATP
ATP+KLA
AK029555
adult male testis cDNA, RIKEN full-length enriched library, clone:4921526N12 product:hypothetical Adenylate kinase containing protein, full insert sequence [AK029555]
KLA
.97
.98
.99
1.03
.98
.98
1.04
ATP
1.04
.99
1.05
1.01
1.05
1.07
1.01
KLA/ATP
1.05
1.00
1.00
1.02
1.14
1.49
1.13
Akp3
KLA
ATP
ATP+KLA
NM_007432
alkaline phosphatase 3, intestine, not Mn requiring (Akp3), mRNA [NM_007432]
KLA
.99
1.04
1.02
1.06
1.02
1.04
1.09
ATP
1.04
1.03
1.06
1.05
.98
1.01
1.05
KLA/ATP
1.04
1.01
1.00
1.02
1.06
1.07
1.01
Akp5
KLA
ATP
ATP+KLA
NM_007433
alkaline phosphatase 5 (Akp5), mRNA [NM_007433]
KLA
.99
.97
.95
.95
.98
1.01
.96
ATP
1.01
.94
1.03
.96
.94
1.04
1.05
KLA/ATP
.92
.94
.97
.96
.94
.94
.90
Akr1a4
KLA
ATP
ATP+KLA
NM_021473
aldo-keto reductase family 1, member A4 (aldehyde reductase) (Akr1a4), mRNA [NM_021473]
KLA
.96
1.00
1.13
.96
1.13
1.16
1.43
ATP
1.06
1.07
.77
.94
.86
1.17
2.12
KLA/ATP
1.06
1.03
.65
.93
.85
1.38
2.61
Akr1b3
KLA
ATP
ATP+KLA
AK054167
2 days pregnant adult female oviduct cDNA, RIKEN full-length enriched library, clone:E230024H01 product:unclassifiable, full insert sequence [AK054167]
KLA
1.06
.92
.98
1.01
1.02
1.04
.96
ATP
1.08
1.02
.99
.97
1.09
1.02
.99
KLA/ATP
.99
1.01
.97
.99
1.02
.99
1.08
Akr1b3
KLA
ATP
ATP+KLA
NM_009658
aldo-keto reductase family 1, member B3 (aldose reductase) (Akr1b3), mRNA [NM_009658]
KLA
.97
.99
.96
.91
.92
.93
.77
ATP
1.08
1.13
1.09
1.15
1.00
1.03
1.18
KLA/ATP
1.06
.98
.95
1.15
.89
.88
.82
Akr1b7
KLA
ATP
ATP+KLA
NM_009731
aldo-keto reductase family 1, member B7 (Akr1b7), mRNA [NM_009731]
KLA
.92
.93
.93
.93
.97
.96
.84
ATP
.97
1.01
.93
.88
.85
.95
.88
KLA/ATP
.86
.92
.92
.82
.85
.94
1.02
Akr1b8
KLA
ATP
ATP+KLA
NM_008012
aldo-keto reductase family 1, member B8 (Akr1b8), mRNA [NM_008012]
KLA
.64
.56
.49
.46
.31
.25
.25
ATP
.95
.97
1.17
.90
.85
2.25
2.02
KLA/ATP
.55
.53
.63
.47
.50
1.00
2.18
Akr1d1
KLA
ATP
ATP+KLA
NM_145364
aldo-keto reductase family 1, member D1 (Akr1d1), mRNA [NM_145364]
KLA
1.00
1.04
1.01
1.02
.98
1.01
.97
ATP
1.01
.99
.99
1.04
1.01
.99
1.00
KLA/ATP
.98
1.03
.93
.96
.99
1.08
1.02
Alad
KLA
ATP
ATP+KLA
AK044938
9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130014K12 product:unclassifiable, full insert sequence [AK044938]
KLA
.98
.94
.97
.84
.90
.92
1.00
ATP
1.04
.93
.94
.91
.95
.93
.99
KLA/ATP
.95
.95
.98
.94
.97
.87
.96
Alad
KLA
ATP
ATP+KLA
NM_008525
aminolevulinate, delta-, dehydratase (Alad), mRNA [NM_008525]
KLA
.64
.69
.59
.51
.45
.49
.77
ATP
1.05
1.11
1.09
1.25
.89
.70
.94
KLA/ATP
.74
.66
.63
.72
.53
.48
.64
Alas1
KLA
ATP
ATP+KLA
NM_020559
aminolevulinic acid synthase 1 (Alas1), mRNA [NM_020559]
KLA
1.90
2.05
1.99
2.15
2.41
2.00
1.62
ATP
.96
1.03
.87
.98
2.70
9.15
6.49
KLA/ATP
1.88
2.04
1.63
1.99
3.06
7.03
8.41
Alas2
KLA
ATP
ATP+KLA
NM_009653
aminolevulinic acid synthase 2, erythroid (Alas2), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_009653]
KLA
.94
1.05
1.03
.98
.93
.99
1.00
ATP
1.00
1.03
1.02
1.05
.95
.96
1.04
KLA/ATP
1.07
1.08
1.03
.94
.97
.98
.98
Aldh18a1
KLA
ATP
ATP+KLA
NM_019698
aldehyde dehydrogenase 18 family, member A1 (Aldh18a1), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_019698]
KLA
.71
.71
.63
.58
.72
1.04
1.22
ATP
1.25
1.41
.88
1.39
1.25
.73
1.37
KLA/ATP
.86
.91
.43
.66
.47
.59
.59
Aldh1a1
KLA
ATP
ATP+KLA
NM_013467
aldehyde dehydrogenase family 1, subfamily A1 (Aldh1a1), mRNA [NM_013467]
KLA
1.06
.95
1.04
1.03
.98
1.08
1.07
ATP
.94
1.03
1.01
1.00
1.00
1.07
.99
KLA/ATP
1.03
.98
1.02
1.01
1.05
1.05
1.02
Aldh1a2
KLA
ATP
ATP+KLA
NM_009022
aldehyde dehydrogenase family 1, subfamily A2 (Aldh1a2), mRNA [NM_009022]
KLA
1.10
1.09
1.04
1.05
1.16
1.14
1.06
ATP
1.03
1.02
1.03
.99
1.04
1.07
1.02
KLA/ATP
1.04
1.10
1.02
1.15
1.33
1.26
1.01
Aldh1a3
KLA
ATP
ATP+KLA
AK086764
15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930050B08 product:aldehyde dehydrogenase family 1, subfamily A3, full insert sequence. [AK086764]
KLA
.97
1.05
1.05
1.01
1.00
.98
.97
ATP
1.00
1.03
.99
.92
1.01
1.09
1.02
KLA/ATP
1.01
.99
1.06
1.00
.97
.98
1.00
Aldh1a3
KLA
ATP
ATP+KLA
NM_053080
aldehyde dehydrogenase family 1, subfamily A3 (Aldh1a3), mRNA [NM_053080]
KLA
1.03
.96
1.03
1.03
.96
.98
1.01
ATP
.98
1.04
1.01
1.06
.98
1.01
1.08
KLA/ATP
1.02
1.00
1.02
.94
1.03
.99
.99
Aldh1a7
KLA
ATP
ATP+KLA
NM_011921
aldehyde dehydrogenase family 1, subfamily A7 (Aldh1a7), mRNA [NM_011921]
KLA
1.06
1.00
.97
1.04
1.05
1.03
.96
ATP
1.00
.94
1.04
1.06
1.01
1.00
1.05
KLA/ATP
1.06
.94
1.07
1.10
1.23
1.08
1.09
Aldh1b1
KLA
ATP
ATP+KLA
NM_028270
aldehyde dehydrogenase 1 family, member B1 (Aldh1b1), nuclear gene encoding mitochondrial protein, mRNA [NM_028270]
KLA
7.51
7.83
9.27
11.57
11.10
10.78
4.79
ATP
.93
.91
.90
.89
.73
2.27
2.30
KLA/ATP
6.45
7.40
9.33
9.54
8.82
12.15
10.67
Aldh2
KLA
ATP
ATP+KLA
AK163452
adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230105J09 product:aldehyde dehydrogenase 2, mitochondrial, full insert sequence [AK163452]
KLA
.62
.65
.59
.60
.63
.64
.49
ATP
1.01
.91
1.06
.93
1.18
.93
.41
KLA/ATP
.70
.68
.70
.84
1.16
.96
.45
Aldh2
KLA
ATP
ATP+KLA
NM_009656
aldehyde dehydrogenase 2, mitochondrial (Aldh2), nuclear gene encoding mitochondrial protein, mRNA [NM_009656]
KLA
.74
.81
.77
.65
.60
.53
.50
ATP
.98
1.10
.90
1.17
1.04
.82
.60
KLA/ATP
.84
.86
.77
.82
.72
.66
.51
Aldh3a1
KLA
ATP
ATP+KLA
NM_007436
aldehyde dehydrogenase family 3, subfamily A1 (Aldh3a1), transcript variant 1, mRNA [NM_007436]
KLA
.98
.98
1.03
1.01
1.03
1.04
.97
ATP
.98
1.01
1.06
.95
1.00
.96
1.02
KLA/ATP
1.07
1.08
.99
.98
1.03
.93
.98
Aldh3a2
KLA
ATP
ATP+KLA
NM_007437
aldehyde dehydrogenase family 3, subfamily A2 (Aldh3a2), mRNA [NM_007437]
KLA
.86
.83
.79
.79
.80
.97
1.00
ATP
.93
.98
.94
.89
.77
.87
1.02
KLA/ATP
.78
.81
.67
.72
.65
.81
.97
Aldh3b1
KLA
ATP
ATP+KLA
NM_026316
aldehyde dehydrogenase 3 family, member B1 (Aldh3b1), mRNA [NM_026316]
KLA
.82
.77
.69
.77
.72
.97
1.31
ATP
.88
.85
1.13
.89
.71
.56
1.25
KLA/ATP
.66
.72
.84
.66
.66
.52
1.17
Aldh3b2
KLA
ATP
ATP+KLA
XM_129134
gb|PREDICTED: Mus musculus aldehyde dehydrogenase 3 family, member B2 (Aldh3b2), mRNA [XM_129134]
KLA
.91
.93
.85
.88
1.01
.99
1.37
ATP
1.12
1.11
.99
1.19
.87
.61
1.31
KLA/ATP
.86
1.02
.90
1.01
.72
.54
1.21
Aldh4a1
KLA
ATP
ATP+KLA
NM_175438
aldehyde dehydrogenase 4 family, member A1 (Aldh4a1), nuclear gene encoding mitochondrial protein, mRNA [NM_175438]
KLA
.90
.85
.85
.82
.87
.94
.87
ATP
1.05
1.16
1.03
1.02
.81
.83
1.00
KLA/ATP
.92
.88
.84
.92
.82
.88
.91
Aldh5a1
KLA
ATP
ATP+KLA
AK051603
12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130059J11 product:succinate-semialdehyde dehydrogenase (EC 1.2.1.24) (fragment) homolog [Rattus norvegicus], full insert sequence. [AK051603]
KLA
1.04
.99
1.06
1.03
1.01
1.09
1.08
ATP
.94
.93
1.01
1.04
1.06
1.10
1.02
KLA/ATP
1.00
1.03
.83
1.02
1.06
1.03
1.04
Aldh5a1
KLA
ATP
ATP+KLA
NM_172532
aldhehyde dehydrogenase family 5, subfamily A1 (Aldh5a1), mRNA [NM_172532]
KLA
.99
.98
.84
.95
.81
.63
.52
ATP
.92
.83
1.21
1.06
.90
.70
.57
KLA/ATP
.92
.96
1.24
.95
.89
.62
.59
Aldh6a1
KLA
ATP
ATP+KLA
NM_134042
aldehyde dehydrogenase family 6, subfamily A1 (Aldh6a1), nuclear gene encoding mitochondrial protein, mRNA [NM_134042]
KLA
1.02
.97
.98
1.15
1.31
1.39
.67
ATP
.96
.92
1.21
.87
.64
.54
.55
KLA/ATP
.82
.97
1.04
.87
.80
.59
.36
Aldh7a1
KLA
ATP
ATP+KLA
NM_138600
aldehyde dehydrogenase family 7, member A1 (Aldh7a1), mRNA [NM_138600]
KLA
.98
1.03
1.08
1.12
1.08
.94
.99
ATP
1.01
1.03
1.00
1.03
.98
.82
.91
KLA/ATP
1.15
1.12
1.01
1.02
.90
.89
.83
Aldh9a1
KLA
ATP
ATP+KLA
NM_019993
aldehyde dehydrogenase 9, subfamily A1 (Aldh9a1), mRNA [NM_019993]
KLA
.64
.64
.67
.48
.42
.24
.33
ATP
1.07
1.02
.75
.94
.68
.46
.42
KLA/ATP
.72
.65
.43
.55
.37
.31
.24
Aldoa
KLA
ATP
ATP+KLA
NM_007438
aldolase 1, A isoform (Aldoa), mRNA [NM_007438]
KLA
.81
.83
.75
.81
.83
.80
1.22
ATP
.97
.93
.78
.78
1.01
1.14
1.35
KLA/ATP
.80
.86
.84
.70
.80
.81
1.12
Aldoart1
KLA
ATP
ATP+KLA
AK016845
adult male testis cDNA, RIKEN full-length enriched library, clone:4933417I20 product:ALDOLASE 1, A ISOFORM homolog [Mus musculus], full insert sequence [AK016845]
KLA
1.01
1.01
1.03
.98
.95
.96
1.03
ATP
1.00
1.01
.98
.90
.99
1.03
.91
KLA/ATP
.97
1.01
1.04
.99
1.07
1.00
.98
Aldob
KLA
ATP
ATP+KLA
NM_144903
aldolase 2, B isoform (Aldob), mRNA [NM_144903]
KLA
.99
1.01
1.02
1.02
1.02
1.03
1.04
ATP
1.02
1.02
1.00
1.05
1.02
1.02
1.01
KLA/ATP
1.01
1.04
1.00
1.03
1.03
1.02
.97
Aldoc
KLA
ATP
ATP+KLA
AK039267
adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330009L16 product:aldolase 3, C isoform, full insert sequence [AK039267]
KLA
.84
.77
.75
.78
.51
.34
.14
ATP
.86
.84
1.15
1.01
.85
.60
.33
KLA/ATP
.71
.78
.94
.76
.60
.34
.14
Aldoc
KLA
ATP
ATP+KLA
NM_009657
aldolase 3, C isoform (Aldoc), mRNA [NM_009657]
KLA
.88
.94
.93
.76
.72
.46
.16
ATP
1.02
1.17
1.00
1.29
1.00
.62
.76
KLA/ATP
.99
1.00
.82
1.04
.71
.46
.18
Alg1
KLA
ATP
ATP+KLA
NM_145362
asparagine-linked glycosylation 1 homolog (yeast, beta-1,4-mannosyltransferase) (Alg1), mRNA [NM_145362]
KLA
.79
.78
.77
.77
.77
1.01
1.26
ATP
.95
.98
1.09
1.04
.89
.57
1.18
KLA/ATP
.77
.83
.89
.78
.71
.62
.82
Alg11
KLA
ATP
ATP+KLA
BC061469
asparagine-linked glycosylation 11 homolog (yeast, alpha-1,2-mannosyltransferase), mRNA (cDNA clone MGC:67180 IMAGE:6821552), complete cds [BC061469]
KLA
1.14
1.03
1.11
1.24
1.36
1.33
1.92
ATP
1.13
1.01
.77
.62
.86
.98
1.04
KLA/ATP
1.32
1.05
.82
.69
.71
.81
.82
Alg11
KLA
ATP
ATP+KLA
NM_183142
asparagine-linked glycosylation 11 homolog (yeast, alpha-1,2-mannosyltransferase) (Alg11), mRNA [NM_183142]
KLA
1.30
1.30
1.18
1.35
1.28
1.33
1.56
ATP
.94
.97
.96
.84
.75
1.22
1.37
KLA/ATP
1.21
1.36
1.24
1.07
.87
.91
.96
Alg12
KLA
ATP
ATP+KLA
NM_145477
asparagine-linked glycosylation 12 homolog (yeast, alpha-1,6-mannosyltransferase) (Alg12), mRNA [NM_145477]
KLA
.90
.89
.96
1.01
1.25
1.45
1.51
ATP
.89
.79
.64
.58
.61
1.15
1.59
KLA/ATP
.89
.78
.67
.64
.72
.89
1.69
Alg13
KLA
ATP
ATP+KLA
NM_026247
asparagine-linked glycosylation 13 homolog (S. cerevisiae) (Alg13), mRNA [NM_026247]
KLA
1.17
1.10
1.22
1.18
1.05
1.11
1.12
ATP
1.07
1.02
1.39
1.23
1.09
1.06
.83
KLA/ATP
1.09
1.15
1.43
1.21
1.04
.97
1.00
Alg14
KLA
ATP
ATP+KLA
AK017354
6 days neonate head cDNA, RIKEN full-length enriched library, clone:5430428G01 product:weakly similar to probable glycosyl transferase [Schizosaccharomyces pombe], full insert sequence [AK017354]
KLA
.93
.96
.92
.92
.81
.88
.66
ATP
.93
.89
1.20
.94
.80
.58
.33
KLA/ATP
.91
.90
1.14
.93
.78
.54
.26
Alg14
KLA
ATP
ATP+KLA
NM_024178
asparagine-linked glycosylation 14 homolog (yeast) (Alg14), mRNA [NM_024178]
KLA
1.04
1.15
1.03
1.07
1.03
1.22
1.08
ATP
.93
1.06
1.19
1.21
1.01
.80
.63
KLA/ATP
1.05
1.16
1.24
1.37
1.15
1.09
.65
Alg2
KLA
ATP
ATP+KLA
NM_019998
asparagine-linked glycosylation 2 homolog (yeast, alpha-1,3-mannosyltransferase) (Alg2), mRNA [NM_019998]
KLA
.61
.55
.56
.45
.59
.67
1.43
ATP
1.31
1.64
1.04
1.28
.69
.37
1.64
KLA/ATP
.69
.82
.45
.66
.37
.37
.94
Alg3
KLA
ATP
ATP+KLA
NM_145939
asparagine-linked glycosylation 3 homolog (yeast, alpha-1,3-mannosyltransferase) (Alg3), mRNA [NM_145939]
KLA
1.20
1.27
1.20
1.19
1.20
1.21
1.40
ATP
1.05
1.11
1.02
1.35
1.17
1.01
1.20
KLA/ATP
1.36
1.34
1.13
1.51
1.20
1.17
1.02
Alg5
KLA
ATP
ATP+KLA
NM_025442
asparagine-linked glycosylation 5 homolog (yeast, dolichyl-phosphate beta-glucosyltransferase) (Alg5), mRNA [NM_025442]
KLA
.87
.92
.84
.82
.70
.73
.98
ATP
.95
.89
1.20
1.03
.87
.76
.96
KLA/ATP
.82
.89
1.12
.92
.77
.58
.61
Alg6
KLA
ATP
ATP+KLA
NM_001081264
asparagine-linked glycosylation 6 homolog (yeast, alpha-1,3,-glucosyltransferase) (Alg6), mRNA [NM_001081264]
KLA
.84
.83
.80
.69
.62
.58
.72
ATP
1.09
1.01
1.00
.90
.72
.46
.60
KLA/ATP
.83
.87
.77
.75
.60
.46
.44
Alg8
KLA
ATP
ATP+KLA
NM_199035
asparagine-linked glycosylation 8 homolog (yeast, alpha-1,3-glucosyltransferase) (Alg8), mRNA [NM_199035]
KLA
.94
.98
.94
.84
.84
.81
.96
ATP
1.02
1.15
.98
1.15
.90
.67
.66
KLA/ATP
.98
1.02
.86
1.01
.75
.64
.54
Alg9
KLA
ATP
ATP+KLA
AK021024
4 days neonate male adipose cDNA, RIKEN full-length enriched library, clone:B430313H07 product:unclassifiable, full insert sequence. [AK021024]
KLA
.98
.98
.96
1.01
1.00
.99
.97
ATP
.96
.93
.96
.98
.98
.98
1.03
KLA/ATP
.94
.91
1.02
1.04
1.00
1.01
1.01
Alg9
KLA
ATP
ATP+KLA
NM_133981
asparagine-linked glycosylation 9 homolog (yeast, alpha 1,2 mannosyltransferase) (Alg9), mRNA [NM_133981]
KLA
1.38
1.47
1.46
1.36
1.36
1.17
1.31
ATP
1.00
1.09
1.18
1.35
1.25
1.21
1.23
KLA/ATP
1.44
1.57
1.47
1.68
1.29
1.12
1.47
Allc
KLA
ATP
ATP+KLA
AF278712
allantoicase mRNA, complete cds [AF278712]
KLA
1.00
1.01
.95
1.01
1.10
1.05
1.01
ATP
1.00
1.05
1.05
1.04
1.04
1.10
.99
KLA/ATP
.99
.94
1.14
1.04
1.10
1.00
1.05
Alox12
KLA
ATP
ATP+KLA
NM_007440
arachidonate 12-lipoxygenase (Alox12), mRNA [NM_007440]
KLA
1.35
1.36
1.42
1.25
1.25
1.13
1.15
ATP
1.05
1.01
1.03
1.04
1.04
1.42
1.20
KLA/ATP
1.36
1.29
1.23
1.26
1.24
1.31
1.80
Alox12b
KLA
ATP
ATP+KLA
NM_009659
arachidonate 12-lipoxygenase, 12R type (Alox12b), mRNA [NM_009659]
KLA
1.09
1.09
1.18
1.15
1.14
1.28
1.26
ATP
.99
.92
1.09
1.07
1.03
1.10
1.29
KLA/ATP
1.16
1.20
1.27
1.30
1.21
1.19
1.30
Alox12e
KLA
ATP
ATP+KLA
NM_145684
arachidonate lipoxygenase, epidermal (Alox12e), mRNA [NM_145684]
KLA
.97
.99
1.05
.94
.99
1.01
.96
ATP
1.00
.97
1.01
.98
1.01
1.01
.94
KLA/ATP
.99
.92
.91
.98
.95
.95
.95
Alox15
KLA
ATP
ATP+KLA
NM_009660
arachidonate 15-lipoxygenase (Alox15), mRNA [NM_009660]
KLA
1.02
.93
.98
.96
.98
.95
.87
ATP
.92
.95
1.09
1.01
.98
1.00
.97
KLA/ATP
.97
.95
.98
.94
.98
.97
.92
Alox5
KLA
ATP
ATP+KLA
NM_009662
arachidonate 5-lipoxygenase (Alox5), mRNA [NM_009662]
KLA
.83
.87
.88
.87
.71
.58
.21
ATP
1.03
1.03
1.14
1.21
.93
.55
.41
KLA/ATP
.86
.85
.90
.97
.84
.61
.24
Alox8
KLA
ATP
ATP+KLA
NM_009661
arachidonate 8-lipoxygenase (Alox8), mRNA [NM_009661]
KLA
1.02
.99
1.01
1.00
.99
1.06
.95
ATP
1.04
.99
.86
.96
.92
1.02
.95
KLA/ATP
.98
.99
1.03
1.00
.98
.91
.90
Alpi
KLA
ATP
ATP+KLA
NM_001081082
alkaline phosphatase, intestinal (Alpi), mRNA [NM_001081082]
KLA
1.03
1.06
.97
.99
1.06
1.04
1.02
ATP
1.02
1.04
1.00
1.09
1.06
.96
1.01
KLA/ATP
.99
1.01
1.07
1.02
1.02
.93
.99
Alpl
KLA
ATP
ATP+KLA
NM_007431
alkaline phosphatase, liver/bone/kidney (Alpl), mRNA [NM_007431]
KLA
.98
.95
1.02
1.00
.97
.99
1.08
ATP
.99
1.06
.96
.99
.96
1.02
1.04
KLA/ATP
.96
1.05
1.02
.94
1.03
1.03
1.01
Amacr
KLA
ATP
ATP+KLA
NM_008537
alpha-methylacyl-CoA racemase (Amacr), mRNA [NM_008537]
KLA
.64
.63
.59
.57
.51
.48
.77
ATP
.99
.93
1.20
1.14
.69
.61
1.01
KLA/ATP
.62
.65
.73
.82
.67
.67
.51
Amd1
KLA
ATP
ATP+KLA
NM_009665
S-adenosylmethionine decarboxylase 1 (Amd1), mRNA [NM_009665]
KLA
.71
.69
.69
.65
.62
.90
1.66
ATP
1.13
1.16
.83
.88
.87
1.04
1.21
KLA/ATP
.80
.85
.61
.63
.63
.68
.77
Amd1
KLA
ATP
ATP+KLA
Z14986
gb|M.musculus mRNA encoding adenosylmethionine decarboxylase. [Z14986]
KLA
.55
.52
.41
.38
.38
.81
1.42
ATP
.87
.85
.86
.52
.84
1.43
1.06
KLA/ATP
.50
.46
.41
.33
.49
.60
.59
Amdhd1
KLA
ATP
ATP+KLA
XM_125854
gb|PREDICTED: Mus musculus amidohydrolase domain containing 1 (Amdhd1), mRNA [XM_125854]
KLA
1.09
.88
1.02
1.27
1.11
1.07
.97
ATP
.99
1.00
.98
.98
.94
.99
1.04
KLA/ATP
1.03
1.05
1.07
1.01
.98
.96
1.02
Ampd1
KLA
ATP
ATP+KLA
NM_001033303
adenosine monophosphate deaminase 1 (isoform M) (Ampd1), mRNA [NM_001033303]
KLA
1.16
1.10
1.14
1.19
1.09
1.15
1.15
ATP
.98
.96
1.45
4.08
3.21
2.03
1.20
KLA/ATP
1.21
1.17
1.71
3.85
3.43
2.96
1.55
Ampd2
KLA
ATP
ATP+KLA
NM_028779
adenosine monophosphate deaminase 2 (isoform L) (Ampd2), mRNA [NM_028779]
KLA
.81
.66
.53
.41
.43
.60
.87
ATP
.91
.83
.96
.74
.82
1.00
1.04
KLA/ATP
.72
.66
.66
.48
.67
.57
.48
Ampd3
KLA
ATP
ATP+KLA
NM_009667
AMP deaminase 3 (Ampd3), mRNA [NM_009667]
KLA
1.30
1.21
1.06
.72
.73
.81
1.16
ATP
1.07
1.16
1.00
1.22
2.65
2.99
1.80
KLA/ATP
1.38
1.30
.96
.91
.90
2.18
2.05
Amy1
KLA
ATP
ATP+KLA
NM_007446
amylase 1, salivary (Amy1), transcript variant 1, mRNA [NM_007446]
KLA
1.03
1.01
1.14
1.07
1.06
1.13
1.16
ATP
.99
.98
1.08
1.06
1.09
1.18
1.11
KLA/ATP
1.06
1.10
1.19
1.13
1.16
1.43
1.21
Anpep
KLA
ATP
ATP+KLA
NM_008486
alanyl (membrane) aminopeptidase (Anpep), mRNA [NM_008486]
KLA
.93
.81
.87
.91
1.05
1.06
.71
ATP
.99
.98
1.00
1.08
1.04
.93
1.45
KLA/ATP
.85
.89
.82
.97
.97
.93
.90
Aoc2
KLA
ATP
ATP+KLA
NM_178932
amine oxidase, copper containing 2 (retina-specific) (Aoc2), mRNA [NM_178932]
KLA
1.21
1.19
1.15
1.00
1.15
1.21
1.18
ATP
1.13
1.13
1.14
1.36
1.85
1.32
.76
KLA/ATP
1.27
1.34
1.12
1.32
1.67
1.37
1.05
Aoc3
KLA
ATP
ATP+KLA
NM_009675
amine oxidase, copper containing 3 (Aoc3), mRNA [NM_009675]
KLA
.95
1.06
1.00
1.05
1.00
1.02
1.01
ATP
1.01
.90
1.04
1.07
1.06
1.06
.97
KLA/ATP
1.06
.98
.92
1.10
1.11
1.09
1.01
Aox1
KLA
ATP
ATP+KLA
NM_009676
aldehyde oxidase 1 (Aox1), mRNA [NM_009676]
KLA
.87
.83
.82
.82
.71
.98
1.65
ATP
1.01
1.02
1.05
.84
.72
.86
.80
KLA/ATP
.82
.84
.90
.73
.72
.82
1.06
Aox3
KLA
ATP
ATP+KLA
NM_023617
aldehyde oxidase 3 (Aox3), mRNA [NM_023617]
KLA
.95
1.02
1.01
1.00
.99
1.01
1.04
ATP
1.04
1.03
1.01
.94
1.03
.92
.96
KLA/ATP
1.09
1.11
1.00
.97
.95
1.01
.94
Aox4
KLA
ATP
ATP+KLA
NM_023631
aldehyde oxidase 4 (Aox4), mRNA [NM_023631]
KLA
.95
.97
.98
1.00
.98
.91
1.06
ATP
.93
.99
.95
.99
.94
.95
1.00
KLA/ATP
1.05
1.00
.94
.98
.89
1.00
.93
Apip
KLA
ATP
ATP+KLA
NM_019735
APAF1 interacting protein (Apip), mRNA [NM_019735]
KLA
.99
.99
.87
.95
.83
.92
1.04
ATP
.86
.83
1.13
1.07
.91
.77
.91
KLA/ATP
.84
.92
1.17
1.00
1.02
.86
1.02
Aprt
KLA
ATP
ATP+KLA
M11310
gb|Mouse adenine phosphoribosyltransferase (APRT), complete cds [M11310]
KLA
.70
.70
.57
.69
.71
.78
1.14
ATP
.88
.63
.44
.81
.63
.73
1.24
KLA/ATP
.76
.59
.49
.67
.67
.68
.93
Aprt
KLA
ATP
ATP+KLA
NM_009698
adenine phosphoribosyl transferase (Aprt), mRNA [NM_009698]
KLA
.74
.70
.73
.69
.64
.65
1.02
ATP
1.17
1.10
.90
1.10
.98
.66
1.42
KLA/ATP
.84
.81
.70
.75
.73
.60
.95
Arg1
KLA
ATP
ATP+KLA
NM_007482
arginase 1, liver (Arg1), mRNA [NM_007482]
KLA
.98
1.01
.97
.97
1.12
1.83
1.27
ATP
.98
1.00
1.11
.94
.98
5.11
20.89
KLA/ATP
.92
1.03
1.02
1.02
.99
3.54
18.22
Arg2
KLA
ATP
ATP+KLA
NM_009705
arginase type II (Arg2), mRNA [NM_009705]
KLA
1.93
1.99
2.17
2.47
2.41
2.13
4.33
ATP
1.01
1.08
1.69
5.21
16.98
33.44
6.60
KLA/ATP
2.20
2.09
3.52
10.32
17.71
32.56
24.21
Arsb
KLA
ATP
ATP+KLA
AK083309
2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:C920003D12 product:arylsulfatase B structural, full insert sequence. [AK083309]
KLA
.99
.88
.99
.93
.92
.98
1.00
ATP
1.07
1.12
1.10
.95
1.01
.97
.90
KLA/ATP
.96
1.03
.95
.94
.94
.94
.99
Arsb
KLA
ATP
ATP+KLA
NM_009712
arylsulfatase B (Arsb), mRNA [NM_009712]
KLA
1.11
1.13
1.16
1.02
.93
.79
.60
ATP
1.04
1.21
1.12
1.46
1.00
.74
.56
KLA/ATP
1.20
1.32
1.05
1.33
.84
.72
.54
Asah1
KLA
ATP
ATP+KLA
NM_019734
N-acylsphingosine amidohydrolase 1 (Asah1), mRNA [NM_019734]
KLA
.80
.84
.84
.69
.72
.78
1.09
ATP
1.04
1.26
1.00
1.15
.82
.53
.72
KLA/ATP
.87
.89
.63
.82
.51
.47
.49
Asah2
KLA
ATP
ATP+KLA
NM_018830
N-acylsphingosine amidohydrolase 2 (Asah2), mRNA [NM_018830]
KLA
1.87
2.01
2.15
1.97
1.73
1.55
1.28
ATP
.94
.87
.90
.86
.68
.59
.69
KLA/ATP
1.87
1.92
1.74
1.48
1.02
.84
.87
Asah3
KLA
ATP
ATP+KLA
NM_175731
N-acylsphingosine amidohydrolase (alkaline ceramidase) 3 (Asah3), mRNA [NM_175731]
KLA
1.01
.98
.99
1.01
1.09
1.01
1.05
ATP
.97
1.02
1.00
1.01
1.01
1.07
1.08
KLA/ATP
.96
.97
1.05
1.04
1.05
1.01
1.07
Asah3l
KLA
ATP
ATP+KLA
AK046888
10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930001C21 product:hypothetical protein, full insert sequence. [AK046888]
KLA
1.18
1.09
1.15
1.30
1.15
1.19
1.02
ATP
1.05
1.06
1.33
1.50
1.65
1.53
.99
KLA/ATP
1.29
1.32
1.73
1.71
1.67
1.54
1.41
Asah3l
KLA
ATP
ATP+KLA
NM_139306
N-acylsphingosine amidohydrolase 3-like (Asah3l), mRNA [NM_139306]
KLA
1.16
1.09
1.05
.94
.82
.89
.89
ATP
1.10
.98
1.17
3.98
4.06
2.11
1.04
KLA/ATP
1.00
1.07
1.04
2.15
2.34
2.03
1.00
Asl
KLA
ATP
ATP+KLA
NM_133768
argininosuccinate lyase (Asl), mRNA [NM_133768]
KLA
.88
.92
.83
.75
.78
.83
1.05
ATP
1.00
1.09
.93
1.21
1.02
.85
1.41
KLA/ATP
.89
.96
.74
1.01
.81
.85
1.55
Asns
KLA
ATP
ATP+KLA
NM_012055
asparagine synthetase (Asns), mRNA [NM_012055]
KLA
.89
.91
.75
.69
.53
.85
2.04
ATP
.87
.80
1.06
.79
2.07
2.78
1.76
KLA/ATP
.85
.80
.84
.58
1.02
1.08
.97
Ass1
KLA
ATP
ATP+KLA
M31690
gb|Mouse argininosuccinate synthetase (Ass) mRNA, complete cds. [M31690]
KLA
4.67
5.37
6.47
6.68
8.75
9.43
8.52
ATP
1.17
1.32
1.27
1.78
2.00
6.66
7.95
KLA/ATP
5.78
6.01
5.41
6.67
6.73
8.48
13.11
Ass1
KLA
ATP
ATP+KLA
NM_007494
argininosuccinate synthetase 1 (Ass1), mRNA [NM_007494]
KLA
4.88
5.58
7.14
7.84
10.68
11.29
9.93
ATP
1.12
1.29
1.28
1.75
2.04
7.76
9.44
KLA/ATP
5.70
6.62
5.49
8.11
6.90
9.65
16.23
Atic
KLA
ATP
ATP+KLA
NM_026195
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (Atic), mRNA [NM_026195]
KLA
.86
.91
.91
.70
.63
.49
.77
ATP
1.16
1.33
1.00
1.41
.87
.41
.59
KLA/ATP
1.07
1.15
.70
1.01
.57
.31
.26
Atp5a1
KLA
ATP
ATP+KLA
NM_007505
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit, isoform 1 (Atp5a1), nuclear gene encoding mitochondrial protein, mRNA [NM_007505]
KLA
1.02
1.10
1.08
1.14
1.13
1.03
.85
ATP
1.07
1.00
.95
.88
.91
.80
.75
KLA/ATP
1.11
1.09
1.08
.98
.88
.83
.61
Atp5b
KLA
ATP
ATP+KLA
NM_016774
ATP synthase, H+ transporting mitochondrial F1 complex, beta subunit (Atp5b), nuclear gene encoding mitochondrial protein, mRNA [NM_016774]
KLA
1.11
1.13
1.13
1.09
1.15
1.07
1.24
ATP
1.02
1.09
.93
1.03
1.00
.97
1.00
KLA/ATP
1.11
1.19
.98
1.15
.89
1.01
1.03
Atp5c1
KLA
ATP
ATP+KLA
NM_020615
ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 (Atp5c1), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_020615]
KLA
.88
.85
.87
.98
.79
.90
.98
ATP
.92
.82
1.11
.82
.80
.68
.77
KLA/ATP
.79
.76
.96
.73
.83
.80
.68
Atp5d
KLA
ATP
ATP+KLA
NM_025313
ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit (Atp5d), nuclear gene encoding mitochondrial protein, mRNA [NM_025313]
KLA
.84
.97
.92
.82
.91
.85
1.08
ATP
1.07
1.23
.92
1.35
1.15
.96
.97
KLA/ATP
1.05
1.00
.71
1.22
.91
1.09
1.16
Atp5e
KLA
ATP
ATP+KLA
NM_025983
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit (Atp5e), nuclear gene encoding mitochondrial protein, mRNA [NM_025983]
KLA
.97
1.02
.91
.99
.90
.89
1.09
ATP
1.01
1.01
1.09
1.18
1.07
1.04
.87
KLA/ATP
.99
.97
1.05
1.13
1.13
.90
.87
Atp5f1
KLA
ATP
ATP+KLA
AK081249
adult male corpus striatum cDNA, RIKEN full-length enriched library, clone:C030026E11 product:ATP synthase, H+ transporting, mitochondrial F0 complex, subunit b, isoform 1, full insert sequence. [AK081249]
KLA
1.19
1.09
1.16
1.04
1.10
1.05
1.16
ATP
.89
1.05
1.03
.97
.94
.98
1.20
KLA/ATP
1.09
.99
1.09
1.11
.98
.99
1.09
Atp5f1
KLA
ATP
ATP+KLA
BC049640
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit b, isoform 1, mRNA (cDNA clone IMAGE:6590806), complete cds. [BC049640]
KLA
1.10
1.21
1.29
1.24
1.32
1.26
1.11
ATP
.99
1.05
1.11
1.16
1.11
.86
.84
KLA/ATP
1.11
1.21
1.32
1.30
1.30
1.06
.77
Atp5f1
KLA
ATP
ATP+KLA
NM_009725
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit b, isoform 1 (Atp5f1), nuclear gene encoding mitochondrial protein, mRNA [NM_009725]
KLA
1.05
1.15
1.15
1.21
1.22
1.27
1.11
ATP
1.04
1.02
.99
.95
.97
.83
.88
KLA/ATP
1.18
1.08
1.14
1.02
1.06
.98
.69
Atp5g1
KLA
ATP
ATP+KLA
NM_007506
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9), isoform 1 (Atp5g1), nuclear gene encoding mitochondrial protein, mRNA [NM_007506]
KLA
.87
.97
.86
.93
.86
.82
.88
ATP
1.02
.97
1.09
1.28
1.26
1.00
.82
KLA/ATP
.98
1.03
.99
1.16
1.15
1.02
.61
Atp5g2
KLA
ATP
ATP+KLA
NM_026468
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9), isoform 2 (Atp5g2), nuclear gene encoding mitochondrial protein, mRNA [NM_026468]
KLA
.86
.84
.84
.81
.78
.71
.70
ATP
1.05
1.08
1.06
1.30
1.15
.78
.62
KLA/ATP
.92
.92
.92
1.09
.95
.74
.52
Atp5g3
KLA
ATP
ATP+KLA
NM_175015
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9), isoform 3 (Atp5g3), nuclear gene encoding mitochondrial protein, mRNA [NM_175015]
KLA
1.29
1.12
1.05
1.36
1.13
1.16
.86
ATP
1.06
.96
1.44
.84
1.01
1.25
.81
KLA/ATP
.89
.93
1.74
.96
1.00
1.07
.71
Atp5h
KLA
ATP
ATP+KLA
NM_027862
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d (Atp5h), nuclear gene encoding mitochondrial protein, mRNA [NM_027862]
KLA
.86
.93
.85
.84
.84
.79
.84
ATP
1.01
1.04
.92
1.09
1.00
.89
.78
KLA/ATP
.94
.92
.83
1.03
.92
.86
.78
Atp5j
KLA
ATP
ATP+KLA
NM_016755
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F (Atp5j), nuclear gene encoding mitochondrial protein, mRNA [NM_016755]
KLA
.89
.90
.87
.96
.86
.90
.92
ATP
.94
.96
1.06
.94
.89
1.04
.85
KLA/ATP
.89
.88
1.04
.91
.94
.93
.87
Atp5j2
KLA
ATP
ATP+KLA
AK153846
2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:C920021K10 product:hypothetical protein, full insert sequence [AK153846]
KLA
.84
.87
.89
.90
1.00
.94
.99
ATP
.50
.39
.43
.61
.93
.87
.82
KLA/ATP
.64
.50
.54
.75
.88
.99
.97
Atp5j2
KLA
ATP
ATP+KLA
NM_020582
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit f, isoform 2 (Atp5j2), nuclear gene encoding mitochondrial protein, mRNA [NM_020582]
KLA
.91
.88
.87
.84
.81
.90
.91
ATP
.93
1.00
1.16
1.20
1.10
.96
.82
KLA/ATP
.86
.90
1.07
1.09
1.10
1.00
.86
Atp5k
KLA
ATP
ATP+KLA
NM_007507
ATP synthase, H+ transporting, mitochondrial F1F0 complex, subunit e (Atp5k), nuclear gene encoding mitochondrial protein, mRNA [NM_007507]
KLA
1.14
1.10
1.07
1.20
1.11
.80
.99
ATP
1.11
1.20
1.24
1.47
1.48
1.20
1.01
KLA/ATP
1.22
1.24
1.36
1.58
1.41
1.33
1.37
Atp5l
KLA
ATP
ATP+KLA
NM_013795
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit g (Atp5l), nuclear gene encoding mitochondrial protein, mRNA [NM_013795]
KLA
1.04
.97
1.03
.98
.92
.93
.90
ATP
1.16
1.09
1.26
1.28
1.23
1.06
.71
KLA/ATP
1.05
1.03
1.30
1.27
1.28
1.07
.82
Atp5o
KLA
ATP
ATP+KLA
NM_138597
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit (Atp5o), nuclear gene encoding mitochondrial protein, mRNA [NM_138597]
KLA
1.01
.99
1.01
1.15
1.17
1.28
1.19
ATP
1.06
1.05
1.12
1.08
1.08
.95
.93
KLA/ATP
1.10
.98
1.13
1.28
1.04
1.05
1.05
Atp6ap1
KLA
ATP
ATP+KLA
NM_018794
ATPase, H+ transporting, lysosomal accessory protein 1 (Atp6ap1), mRNA [NM_018794]
KLA
.73
.83
.89
.71
.74
.71
1.06
ATP
1.05
1.08
.94
1.12
.99
.79
1.07
KLA/ATP
.90
.81
.72
.84
.62
.64
.97
Atp6v0a1
KLA
ATP
ATP+KLA
AK045877
adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230316H04 product:unclassifiable, full insert sequence [AK045877]
KLA
.65
.64
.58
.48
.57
.46
.29
ATP
.64
.28
.48
.28
.45
.30
.91
KLA/ATP
.51
.26
.37
.31
.54
.45
.63
Atp6v0a1
KLA
ATP
ATP+KLA
NM_016920
ATPase, H+ transporting, lysosomal V0 subunit A1 (Atp6v0a1), mRNA [NM_016920]
KLA
.88
.91
.88
.80
.66
.52
.45
ATP
1.05
1.22
.91
1.05
.58
.40
1.46
KLA/ATP
.97
1.04
.80
.89
.55
.43
.75
Atp6v0a2
KLA
ATP
ATP+KLA
AK160318
16 days embryo lung cDNA, RIKEN full-length enriched library, clone:8430408C20 product:unclassifiable, full insert sequence [AK160318]
KLA
1.21
1.13
1.18
1.30
1.39
1.58
1.38
ATP
1.10
.94
.55
.35
.72
.96
.84
KLA/ATP
1.12
1.08
.82
.54
.81
1.05
.59
Atp6v0a2
KLA
ATP
ATP+KLA
BC112905
ATPase, H+ transporting, lysosomal V0 subunit A2, mRNA (cDNA clone MGC:118073 IMAGE:3670722), complete cds [BC112905]
KLA
1.65
1.66
1.74
2.07
1.97
2.78
2.71
ATP
.88
.61
.53
.30
.38
1.26
2.12
KLA/ATP
1.38
1.29
.91
.62
.59
1.36
2.13
Atp6v0a2
KLA
ATP
ATP+KLA
NM_011596
ATPase, H+ transporting, lysosomal V0 subunit A2 (Atp6v0a2), mRNA [NM_011596]
KLA
2.26
2.07
2.01
2.71
2.48
3.69
2.76
ATP
.79
.64
.62
.42
.62
2.31
3.11
KLA/ATP
1.69
1.57
1.47
.90
1.06
2.56
4.84
Atp6v0a4
KLA
ATP
ATP+KLA
NM_080467
ATPase, H+ transporting, lysosomal V0 subunit A4 (Atp6v0a4), mRNA [NM_080467]
KLA
1.01
1.00
.99
1.03
1.01
1.02
.98
ATP
1.02
1.05
.93
1.03
1.05
1.01
.97
KLA/ATP
1.02
.94
1.00
.99
1.00
1.01
1.03
Atp6v0b
KLA
ATP
ATP+KLA
NM_033617
ATPase, H+ transporting, lysosomal V0 subunit B (Atp6v0b), mRNA [NM_033617]
KLA
.91
1.00
1.07
.81
1.25
1.34
1.44
ATP
1.12
1.33
.80
1.41
1.47
1.67
1.77
KLA/ATP
1.20
1.16
.62
1.28
1.01
1.77
2.37
Atp6v0c
KLA
ATP
ATP+KLA
NM_009729
ATPase, H+ transporting, lysosomal V0 subunit C (Atp6v0c), mRNA [NM_009729]
KLA
.89
.98
1.05
.90
1.18
1.38
1.52
ATP
1.07
1.28
.93
1.66
1.48
1.35
2.35
KLA/ATP
1.10
1.12
.67
1.50
1.18
1.66
2.51
Atp6v0d1
KLA
ATP
ATP+KLA
NM_013477
ATPase, H+ transporting, lysosomal V0 subunit D1 (Atp6v0d1), mRNA [NM_013477]
KLA
.84
.85
.94
.79
1.10
1.24
1.27
ATP
1.18
1.48
.94
1.40
1.12
.75
1.85
KLA/ATP
1.05
1.06
.59
1.06
.83
.85
1.96
Atp6v0d2
KLA
ATP
ATP+KLA
NM_175406
ATPase, H+ transporting, lysosomal V0 subunit D2 (Atp6v0d2), mRNA [NM_175406]
KLA
.77
.72
.64
.54
.43
.27
.18
ATP
1.19
1.35
1.06
1.47
1.46
.79
.96
KLA/ATP
.78
.95
.63
1.12
1.21
1.01
.50
Atp6v0e
KLA
ATP
ATP+KLA
AK134836
adult male medulla oblongata cDNA, RIKEN full-length enriched library, clone:6330589P19 product:ATPase, H+ transporting, V0 subunit, full insert sequence. [AK134836]
KLA
1.09
1.06
1.02
1.42
1.32
1.14
.92
ATP
.93
1.18
1.02
1.34
1.72
1.34
1.44
KLA/ATP
.97
.89
.94
1.32
2.01
1.43
1.72
Atp6v0e
KLA
ATP
ATP+KLA
NM_025272
ATPase, H+ transporting, lysosomal V0 subunit E (Atp6v0e), mRNA [NM_025272]
KLA
1.00
.95
.87
.99
.98
1.20
1.26
ATP
.91
.98
1.11
1.17
1.29
1.54
1.59
KLA/ATP
.86
.94
1.07
1.05
1.29
1.57
1.83
Atp6v0e2
KLA
ATP
ATP+KLA
NM_133764
ATPase, H+ transporting, lysosomal V0 subunit E2 (Atp6v0e2), mRNA [NM_133764]
KLA
.98
.93
.90
.99
.88
.90
.92
ATP
1.08
1.02
1.03
1.07
.98
.88
.94
KLA/ATP
.98
.99
.97
1.00
.89
.90
.88
Atp6v1a
KLA
ATP
ATP+KLA
NM_007508
ATPase, H+ transporting, lysosomal V1 subunit A (Atp6v1a), mRNA [NM_007508]
KLA
.77
.77
.70
.59
.58
.61
.84
ATP
1.04
1.45
.99
1.82
1.34
1.00
1.21
KLA/ATP
.82
.97
.55
1.13
.73
.99
1.09
Atp6v1b1
KLA
ATP
ATP+KLA
NM_134157
ATPase, H+ transporting, lysosomal V1 subunit B1 (Atp6v1b1), mRNA [NM_134157]
KLA
1.00
1.03
1.11
.95
1.01
1.00
1.03
ATP
1.02
1.05
1.01
.97
1.02
.97
1.02
KLA/ATP
.98
.94
1.03
1.02
.99
1.00
.96
Atp6v1b2
KLA
ATP
ATP+KLA
NM_007509
ATPase, H+ transporting, lysosomal V1 subunit B2 (Atp6v1b2), mRNA [NM_007509]
KLA
.89
.98
1.11
1.07
1.24
1.13
1.12
ATP
1.05
1.11
1.02
1.09
1.03
.79
1.39
KLA/ATP
.97
1.05
.95
1.12
1.12
1.37
1.67
Atp6v1c1
KLA
ATP
ATP+KLA
NM_025494
ATPase, H+ transporting, lysosomal V1 subunit C1 (Atp6v1c1), mRNA [NM_025494]
KLA
.61
.62
.59
.51
.56
.71
.92
ATP
.98
.97
.93
1.07
1.42
1.00
1.28
KLA/ATP
.61
.57
.48
.57
1.04
1.18
1.18
Atp6v1c2
KLA
ATP
ATP+KLA
NM_133699
ATPase, H+ transporting, lysosomal V1 subunit C2 (Atp6v1c2), mRNA [NM_133699]
KLA
1.00
.93
.98
.97
1.04
.99
.97
ATP
1.07
.97
.99
.97
.97
1.04
1.06
KLA/ATP
1.01
1.03
1.00
1.03
1.00
.91
.97
Atp6v1d
KLA
ATP
ATP+KLA
NM_023721
ATPase, H+ transporting, lysosomal V1 subunit D (Atp6v1d), mRNA [NM_023721]
KLA
1.45
1.39
1.73
1.95
1.83
2.08
1.29
ATP
.91
.88
1.19
1.12
1.73
1.64
2.34
KLA/ATP
1.25
1.32
1.80
1.46
2.05
2.00
2.22
Atp6v1e1
KLA
ATP
ATP+KLA
NM_007510
VATPase, H+ transporting, lysosomal V1 subunit E1 (Atp6v1e1), mRNA [NM_007510]
KLA
1.48
1.55
1.79
1.73
1.79
1.59
1.37
ATP
.88
.73
.59
.73
1.30
1.59
1.40
KLA/ATP
1.50
1.43
1.24
1.30
1.57
1.69
1.76
Atp6v1e2
KLA
ATP
ATP+KLA
NM_029121
ATPase, H+ transporting, lysosomal V1 subunit E2 (Atp6v1e2), mRNA [NM_029121]
KLA
1.01
1.04
1.11
1.14
1.19
1.15
1.11
ATP
1.00
.97
1.11
1.06
1.07
1.02
1.08
KLA/ATP
1.03
1.10
1.19
1.10
1.13
1.06
1.09
Atp6v1f
KLA
ATP
ATP+KLA
NM_025381
ATPase, H+ transporting, lysosomal V1 subunit F (Atp6v1f), mRNA [NM_025381]
KLA
.92
.94
.93
.96
.96
1.02
1.05
ATP
.97
.96
1.07
1.18
1.31
1.16
1.11
KLA/ATP
.92
.96
1.06
1.12
1.28
1.24
1.14
Atp6v1g1
KLA
ATP
ATP+KLA
NM_024173
ATPase, H+ transporting, lysosomal V1 subunit G1 (Atp6v1g1), mRNA [NM_024173]
KLA
.97
.94
.87
.99
.98
1.01
.96
ATP
1.02
1.02
1.09
1.10
1.29
1.23
1.41
KLA/ATP
.83
.92
1.12
1.10
1.23
1.04
.97
Atp6v1g2
KLA
ATP
ATP+KLA
NM_023179
ATPase, H+ transporting, lysosomal V1 subunit G2 (Atp6v1g2), mRNA [NM_023179]
KLA
1.12
1.09
1.03
1.05
1.16
1.15
1.01
ATP
.96
1.01
.93
1.06
.85
.83
1.05
KLA/ATP
1.04
1.07
.99
1.07
.90
.82
.98
Atp6v1g3
KLA
ATP
ATP+KLA
NM_177397
ATPase, H+ transporting, lysosomal V1 subunit G3 (Atp6v1g3), mRNA [NM_177397]
KLA
1.05
1.03
1.00
.99
.97
1.02
1.00
ATP
1.04
1.07
1.02
.98
1.05
1.00
1.00
KLA/ATP
.99
.98
1.01
1.02
1.03
1.01
1.05
Atp6v1h
KLA
ATP
ATP+KLA
AK081492
16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130021C16 product:hypothetical V-ATPase subunit H containing protein, full insert sequence. [AK081492]
KLA
1.09
.98
.77
.93
1.08
1.00
1.10
ATP
1.16
1.43
2.03
3.91
3.02
1.23
1.46
KLA/ATP
1.02
.98
1.06
2.30
2.07
1.28
1.06
Atp6v1h
KLA
ATP
ATP+KLA
NM_133826
ATPase, H+ transporting, lysosomal V1 subunit H (Atp6v1h), mRNA [NM_133826]
KLA
1.13
1.15
1.12
1.05
1.05
.96
1.20
ATP
1.04
1.04
.86
1.06
2.07
2.38
1.90
KLA/ATP
1.14
1.17
.98
1.09
1.55
2.06
1.29
Auh
KLA
ATP
ATP+KLA
NM_016709
AU RNA binding protein/enoyl-coenzyme A hydratase (Auh), nuclear gene encoding mitochondrial protein, mRNA [NM_016709]
KLA
1.02
.97
1.20
1.24
1.26
1.18
.91
ATP
1.11
.97
1.26
1.31
1.10
.88
.62
KLA/ATP
1.06
1.11
1.48
1.24
1.57
1.08
.90
B3galnt1
KLA
ATP
ATP+KLA
NM_020026
UDP-GalNAc:betaGlcNAc beta 1,3-galactosaminyltransferase, polypeptide 1 (B3galnt1), mRNA [NM_020026]
KLA
.64
.60
.62
.55
.47
.61
.93
ATP
1.00
.94
1.10
.85
.52
.44
.68
KLA/ATP
.61
.62
.65
.53
.49
.49
.71
B3galt1
KLA
ATP
ATP+KLA
NM_020283
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 (B3galt1), mRNA [NM_020283]
KLA
1.02
1.01
.99
1.00
1.04
.97
1.04
ATP
.95
1.03
1.00
.98
.98
1.02
1.00
KLA/ATP
.95
.96
1.00
1.02
1.00
1.03
1.01
B3galt2
KLA
ATP
ATP+KLA
NM_020025
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 (B3galt2), mRNA [NM_020025]
KLA
1.03
1.03
1.00
1.02
1.01
1.02
1.06
ATP
1.06
1.04
.99
1.07
1.03
1.04
1.03
KLA/ATP
1.03
.99
1.07
1.04
1.00
1.11
1.03
B3galt4
KLA
ATP
ATP+KLA
NM_019420
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 (B3galt4), mRNA [NM_019420]
KLA
.77
.78
.99
1.07
1.51
1.56
1.56
ATP
1.08
1.12
.94
.81
.46
1.04
1.44
KLA/ATP
.90
.88
.74
.85
.64
.97
1.21
B3galt5
KLA
ATP
ATP+KLA
NM_033149
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 (B3galt5), transcript variant 1, mRNA [NM_033149]
KLA
.78
.84
.81
.88
.86
.90
.80
ATP
1.03
.88
1.08
.91
.87
.73
.83
KLA/ATP
.85
.80
.85
.85
.96
.89
.72
B3galt6
KLA
ATP
ATP+KLA
NM_080445
UDP-Gal:betaGal beta 1,3-galactosyltransferase, polypeptide 6 (B3galt6), mRNA [NM_080445]
KLA
.81
.80
.75
.72
.67
.82
1.26
ATP
.94
.95
1.24
1.05
.63
.73
1.11
KLA/ATP
.74
.76
.84
.75
.67
.61
.61
B3gat3
KLA
ATP
ATP+KLA
AK079723
0 day neonate thymus cDNA, RIKEN full-length enriched library, clone:A430034G17 product:beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I), full insert sequence [AK079723]
KLA
1.21
1.11
.94
.98
1.25
.98
.87
ATP
.73
.53
.44
.56
1.39
1.36
.92
KLA/ATP
.61
.59
.47
.75
1.73
1.08
.87
B3gat3
KLA
ATP
ATP+KLA
NM_024256
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) (B3gat3), mRNA [NM_024256]
KLA
.95
1.03
1.06
.98
1.29
1.33
1.26
ATP
1.10
1.20
.96
1.25
.99
.86
1.13
KLA/ATP
1.13
1.12
.89
1.19
.99
.98
1.40
B3gnt1
KLA
ATP
ATP+KLA
NM_175383
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 (B3gnt1), mRNA [NM_175383]
KLA
.65
.62
.59
.58
.52
.53
.68
ATP
.95
.97
1.14
1.07
.70
.60
1.38
KLA/ATP
.66
.65
.72
.63
.51
.56
.86
B3gnt2
KLA
ATP
ATP+KLA
NM_016888
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 (B3gnt2), mRNA [NM_016888]
KLA
6.47
6.07
7.88
5.30
4.92
2.72
2.46
ATP
1.22
1.39
1.13
1.57
3.07
2.25
2.06
KLA/ATP
7.06
7.52
5.27
7.28
4.11
2.44
1.98
B3gnt3
KLA
ATP
ATP+KLA
NM_028189
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 (B3gnt3), mRNA [NM_028189]
KLA
1.13
1.04
1.04
1.01
.99
.79
.72
ATP
1.09
1.20
1.06
1.35
.93
.72
1.38
KLA/ATP
1.17
1.16
1.11
1.28
.82
.78
1.13
B3gnt4
KLA
ATP
ATP+KLA
NM_198611
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4 (B3gnt4), mRNA [NM_198611]
KLA
1.17
1.22
1.16
1.14
1.07
1.04
.99
ATP
1.01
1.04
1.01
.98
.99
1.02
.92
KLA/ATP
1.14
1.20
1.15
1.10
1.12
1.08
1.15
B3gnt5
KLA
ATP
ATP+KLA
NM_054052
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 (B3gnt5), mRNA [NM_054052]
KLA
1.10
1.13
1.09
1.05
.95
.97
.94
ATP
1.04
1.03
1.08
1.20
1.53
1.55
1.34
KLA/ATP
1.08
1.17
1.07
1.08
1.18
1.58
2.54
B4galnt1
KLA
ATP
ATP+KLA
BC022180
beta-1,4-N-acetyl-galactosaminyl transferase 1, mRNA (cDNA clone IMAGE:4006866), complete cds. [BC022180]
KLA
.96
.90
.91
.98
.85
.63
.76
ATP
1.00
.91
1.19
1.19
1.01
.78
1.38
KLA/ATP
.95
.90
1.11
1.03
.90
.76
.90
B4galnt1
KLA
ATP
ATP+KLA
NM_008080
beta-1,4-N-acetyl-galactosaminyl transferase 1 (B4galnt1), mRNA [NM_008080]
KLA
.72
.81
.80
.67
.64
.51
.63
ATP
1.01
1.16
.85
1.04
.67
.50
.82
KLA/ATP
.87
.87
.52
.81
.49
.41
.57
B4galt1
KLA
ATP
ATP+KLA
NM_022305
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 (B4galt1), mRNA [NM_022305]
KLA
.58
.56
.55
.59
.75
1.18
1.17
ATP
1.10
1.15
1.07
1.14
1.05
.71
1.11
KLA/ATP
.60
.62
.62
.66
.74
.71
1.10
B4galt2
KLA
ATP
ATP+KLA
NM_017377
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 (B4galt2), mRNA [NM_017377]
KLA
1.02
.98
.98
1.02
1.04
1.04
1.00
ATP
.98
1.01
1.09
1.64
1.22
.96
.94
KLA/ATP
.98
1.03
1.04
1.25
1.10
1.00
1.01
B4galt3
KLA
ATP
ATP+KLA
BC021830
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 3, mRNA (cDNA clone IMAGE:3978260), **** WARNING: chimeric clone ****. [BC021830]
KLA
.94
.90
.98
1.03
.97
.92
1.01
ATP
.89
.82
.99
.87
.86
.91
.94
KLA/ATP
.94
.93
.95
.97
.91
.96
.97
B4galt3
KLA
ATP
ATP+KLA
NM_020579
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 3 (B4galt3), mRNA [NM_020579]
KLA
2.83
2.66
2.21
1.34
.99
1.02
1.09
ATP
1.08
1.11
.77
.64
1.24
1.15
1.12
KLA/ATP
3.28
2.99
2.00
1.55
2.04
2.13
1.47
B4galt4
KLA
ATP
ATP+KLA
NM_019804
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 4 (B4galt4), mRNA [NM_019804]
KLA
.88
.92
.89
.94
.68
.49
.40
ATP
.93
.93
1.09
.94
.56
.38
.47
KLA/ATP
.91
.86
.98
.94
.78
.45
.30
B4galt6
KLA
ATP
ATP+KLA
NM_019737
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6 (B4galt6), mRNA [NM_019737]
KLA
.46
.48
.57
.53
.90
.96
.81
ATP
1.09
1.13
.72
.53
.18
.22
.51
KLA/ATP
.56
.51
.26
.30
.15
.25
.60
B4galt7
KLA
ATP
ATP+KLA
NM_146045
xylosylprotein beta1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I) (B4galt7), mRNA [NM_146045]
KLA
.52
.55
.52
.57
.66
.82
1.05
ATP
1.00
1.02
.75
.66
.70
.83
1.48
KLA/ATP
.53
.54
.49
.46
.49
.71
1.05
BB135800
KLA
ATP
ATP+KLA
BB135800
gb|BB135800 RIKEN full-length enriched, adult male bone Mus musculus cDNA clone 9830130K22 3. [BB135800]
KLA
1.36
1.43
1.30
1.43
1.57
2.06
1.47
ATP
1.10
1.08
.99
1.05
1.12
1.64
1.99
KLA/ATP
1.45
1.58
1.65
1.46
1.76
2.32
6.28
Baat
KLA
ATP
ATP+KLA
NM_007519
bile acid-Coenzyme A: amino acid N-acyltransferase (Baat), mRNA [NM_007519]
KLA
.98
.99
1.01
.95
.97
.97
1.01
ATP
.97
.97
1.01
.99
1.12
1.01
1.00
KLA/ATP
1.02
1.04
1.00
1.05
1.10
.99
1.01
Bcat1
KLA
ATP
ATP+KLA
NM_001024468
branched chain aminotransferase 1, cytosolic (Bcat1), transcript variant 1, mRNA [NM_001024468]
KLA
1.04
1.03
.98
1.04
.99
1.02
1.03
ATP
1.00
1.01
1.02
1.01
1.12
1.25
1.09
KLA/ATP
.99
1.00
1.04
1.04
1.01
1.08
1.15
Bcat2
KLA
ATP
ATP+KLA
NM_009737
branched chain aminotransferase 2, mitochondrial (Bcat2), nuclear gene encoding mitochondrial protein, mRNA [NM_009737]
KLA
1.06
1.05
1.08
.97
1.08
.96
1.61
ATP
1.07
1.42
.96
1.55
.87
.66
.96
KLA/ATP
1.27
1.29
.84
1.36
.81
.76
.92
Bckdha
KLA
ATP
ATP+KLA
NM_007533
branched chain ketoacid dehydrogenase E1, alpha polypeptide (Bckdha), mRNA [NM_007533]
KLA
.81
.83
.84
.77
.72
.67
.73
ATP
1.14
1.20
1.15
1.50
1.10
.74
.69
KLA/ATP
.97
.94
.83
1.03
.86
.75
.71
Bckdhb
KLA
ATP
ATP+KLA
NM_199195
branched chain ketoacid dehydrogenase E1, beta polypeptide (Bckdhb), nuclear gene encoding mitochondrial protein, mRNA [NM_199195]
KLA
2.08
2.24
2.30
2.39
2.45
1.95
1.17
ATP
.95
1.02
1.24
1.37
.98
.41
.44
KLA/ATP
2.12
2.34
2.71
3.07
2.12
1.25
.54
Bcmo1
KLA
ATP
ATP+KLA
NM_021486
beta-carotene 15,15-monooxygenase (Bcmo1), mRNA [NM_021486]
KLA
1.05
.97
1.02
1.07
1.00
1.04
1.15
ATP
.96
.98
1.03
1.06
.98
1.05
1.02
KLA/ATP
1.01
1.03
1.08
1.09
1.03
1.09
1.03
Bdh1
KLA
ATP
ATP+KLA
NM_001122683
3-hydroxybutyrate dehydrogenase, type 1 (Bdh1), transcript variant 2, mRNA [NM_001122683]
KLA
.89
.82
.80
.87
.90
.92
1.01
ATP
.94
1.00
.89
.90
.82
.91
1.24
KLA/ATP
.84
.82
.88
.76
.90
.88
.91
Bdh1
KLA
ATP
ATP+KLA
NM_175177
3-hydroxybutyrate dehydrogenase, type 1 (Bdh1), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_175177]
KLA
.61
.62
.57
.76
.75
.63
.64
ATP
.95
.95
1.24
1.06
.81
1.28
1.87
KLA/ATP
.57
.65
.78
.64
.63
.81
.70
Bdh2
KLA
ATP
ATP+KLA
NM_027208
3-hydroxybutyrate dehydrogenase, type 2 (Bdh2), mRNA [NM_027208]
KLA
.85
.86
.78
.83
.75
.88
.83
ATP
.95
.96
1.24
1.15
1.27
1.15
.95
KLA/ATP
.82
.86
1.01
.97
1.04
1.05
1.09
Bhmt
KLA
ATP
ATP+KLA
NM_016668
betaine-homocysteine methyltransferase (Bhmt), mRNA [NM_016668]
KLA
1.02
1.04
1.02
.95
1.04
1.03
1.05
ATP
.98
.96
1.08
1.02
.98
1.02
1.08
KLA/ATP
.96
1.02
1.04
1.01
.98
.94
1.01
Bpgm
KLA
ATP
ATP+KLA
NM_007563
2,3-bisphosphoglycerate mutase (Bpgm), mRNA [NM_007563]
KLA
.78
.85
.78
.85
.98
1.02
1.07
ATP
.98
.81
.61
.49
.38
.73
1.33
KLA/ATP
.74
.74
.64
.57
.51
.73
.97
Bpnt1
KLA
ATP
ATP+KLA
NM_011794
bisphosphate 3-nucleotidase 1 (Bpnt1), mRNA [NM_011794]
KLA
1.14
1.15
1.07
1.09
.98
.90
1.07
ATP
.93
.96
1.17
1.28
1.02
1.02
1.16
KLA/ATP
1.06
1.15
1.27
1.28
1.01
.90
.85
Bst1
KLA
ATP
ATP+KLA
NM_009763
bone marrow stromal cell antigen 1 (Bst1), mRNA [NM_009763]
KLA
2.26
2.15
2.90
3.73
4.89
5.96
6.57
ATP
1.05
1.06
1.31
1.52
1.57
4.31
4.76
KLA/ATP
2.29
2.31
3.10
2.98
3.09
5.35
13.91
Btd
KLA
ATP
ATP+KLA
NM_025295
biotinidase (Btd), mRNA [NM_025295]
KLA
.89
.88
.87
.74
.90
1.07
1.06
ATP
.97
1.05
1.26
1.39
1.39
2.45
2.08
KLA/ATP
.86
.89
1.01
1.14
1.11
1.74
2.61
C1galt1
KLA
ATP
ATP+KLA
AK008884
adult male stomach cDNA, RIKEN full-length enriched library, clone:2210410E06 product:hypothetical protein, full insert sequence. [AK008884]
KLA
.54
.48
.42
.32
.28
.45
.72
ATP
1.17
1.18
1.11
.81
1.43
1.00
.59
KLA/ATP
.51
.48
.48
.44
.68
.64
.27
C1galt1
KLA
ATP
ATP+KLA
NM_052993
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 (C1galt1), mRNA [NM_052993]
KLA
.93
.90
.80
.78
.68
.99
1.98
ATP
1.02
1.14
1.15
1.19
1.43
2.25
2.52
KLA/ATP
.87
.85
.75
.89
.81
1.82
3.06
C1galt1c
1
KLA
ATP
ATP+KLA
AK161729
adult male thymus cDNA, RIKEN full-length enriched library, clone:5830428K17 product:hypothetical protein, full insert sequence. [AK161729]
KLA
.93
.94
.93
.99
.96
1.04
1.00
ATP
.99
.95
.97
.97
1.00
.95
.95
KLA/ATP
1.02
.97
.99
.87
.91
.92
.90
C1galt1c
1
KLA
ATP
ATP+KLA
NM_021550
C1GALT1-specific chaperone 1 (C1galt1c1), mRNA [NM_021550]
KLA
1.20
1.10
1.28
1.27
1.23
1.09
1.29
ATP
1.13
1.00
1.24
1.01
.86
1.05
1.48
KLA/ATP
1.17
1.25
1.55
1.15
1.24
1.14
1.63
Cad
KLA
ATP
ATP+KLA
NM_023525
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (Cad), mRNA [NM_023525]
KLA
.88
.82
.73
.65
.53
.46
.59
ATP
1.00
1.00
.94
.86
.74
.60
.67
KLA/ATP
.86
.81
.76
.65
.55
.46
.44
Cbr1
KLA
ATP
ATP+KLA
U31966
carbonyl reductase (Cbr1) mRNA, complete cds. [U31966]
KLA
.79
.82
.80
.76
.69
.91
.89
ATP
.95
.90
1.24
1.29
1.39
1.58
2.18
KLA/ATP
.82
.79
1.22
1.01
1.41
1.76
1.89
Cbr2
KLA
ATP
ATP+KLA
NM_007621
carbonyl reductase 2 (Cbr2), mRNA [NM_007621]
KLA
1.04
1.02
.94
1.08
1.10
1.15
.31
ATP
1.04
.97
1.18
1.27
1.37
1.11
.44
KLA/ATP
1.06
1.09
1.32
1.27
1.33
1.00
.41
Cbr3
KLA
ATP
ATP+KLA
NM_173047
carbonyl reductase 3 (Cbr3), mRNA [NM_173047]
KLA
.37
.38
.29
.33
.21
.23
.42
ATP
.97
.84
1.07
.78
1.72
6.22
1.28
KLA/ATP
.38
.35
.52
.33
1.22
2.51
1.25
Cbs
KLA
ATP
ATP+KLA
NM_144855
cystathionine beta-synthase (Cbs), transcript variant 1, mRNA [NM_144855]
KLA
.95
1.02
.94
.94
.99
.99
1.00
ATP
1.00
1.14
1.04
.85
.99
.94
.91
KLA/ATP
1.01
1.08
.97
1.02
.97
.88
.98
Ccbl1
KLA
ATP
ATP+KLA
NM_172404
cysteine conjugate-beta lyase 1 (Ccbl1), mRNA [NM_172404]
KLA
.68
.64
.61
.59
.58
.75
.89
ATP
1.02
.96
.89
.80
.63
.48
.97
KLA/ATP
.71
.68
.61
.64
.53
.50
.60
Ccbl2
KLA
ATP
ATP+KLA
NM_173763
cysteine conjugate-beta lyase 2 (Ccbl2), mRNA [NM_173763]
KLA
2.01
2.14
2.03
1.98
1.40
.85
.65
ATP
.96
.91
1.14
.95
.81
1.04
.68
KLA/ATP
2.05
2.10
2.27
1.79
1.55
1.00
.57
Cd38
KLA
ATP
ATP+KLA
NM_007646
CD38 antigen (Cd38), mRNA [NM_007646]
KLA
3.61
5.39
8.63
9.62
24.42
36.25
76.13
ATP
1.00
1.05
1.36
1.70
2.26
8.41
7.84
KLA/ATP
4.45
4.89
5.01
7.93
5.74
14.08
40.05
Cda
KLA
ATP
ATP+KLA
NM_028176
cytidine deaminase (Cda), mRNA [NM_028176]
KLA
.92
.97
.89
.86
.87
.85
.88
ATP
1.08
1.11
1.00
1.40
1.40
1.04
1.09
KLA/ATP
.98
.95
.90
.96
.88
.93
.97
Cdipt
KLA
ATP
ATP+KLA
NM_026638
CDP-diacylglycerol--inositol 3-phosphatidyltransferase (phosphatidylinositol synthase) (Cdipt), mRNA [NM_026638]
KLA
.75
.74
.71
.67
.79
.87
1.15
ATP
1.07
1.03
.76
.81
.75
.77
1.18
KLA/ATP
.82
.72
.51
.53
.51
.72
1.22
Cdo1
KLA
ATP
ATP+KLA
NM_033037
cysteine dioxygenase 1, cytosolic (Cdo1), mRNA [NM_033037]
KLA
1.28
1.33
1.27
1.30
1.24
1.26
1.10
ATP
1.09
1.13
1.79
7.13
7.75
3.67
1.26
KLA/ATP
1.31
1.37
1.77
5.21
6.82
4.19
1.94
Cds1
KLA
ATP
ATP+KLA
NM_173370
CDP-diacylglycerol synthase 1 (Cds1), mRNA [NM_173370]
KLA
2.81
2.96
3.63
3.43
3.28
1.96
.97
ATP
1.08
1.05
.86
.90
.78
.83
1.17
KLA/ATP
2.84
2.92
2.34
2.04
1.61
1.01
.98
Cds2
KLA
ATP
ATP+KLA
NM_138651
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2 (Cds2), mRNA [NM_138651]
KLA
1.05
1.06
1.06
1.17
1.32
1.73
2.21
ATP
.97
.93
.91
.77
.97
1.88
3.79
KLA/ATP
1.09
1.12
1.07
.94
1.16
1.49
4.77
Cel
KLA
ATP
ATP+KLA
NM_009885
carboxyl ester lipase (Cel), mRNA [NM_009885]
KLA
1.06
1.02
1.06
1.07
1.07
1.08
1.11
ATP
1.01
1.04
1.18
1.09
1.09
1.21
1.09
KLA/ATP
1.06
.97
1.24
1.16
1.19
1.21
1.10
Cept1
KLA
ATP
ATP+KLA
NM_133869
choline/ethanolaminephosphotransferase 1 (Cept1), mRNA [NM_133869]
KLA
3.40
3.07
3.72
5.13
5.83
5.57
2.91
ATP
1.09
1.05
1.09
.81
1.14
2.16
1.37
KLA/ATP
3.35
3.19
4.07
2.89
3.10
3.27
4.09
Ces3
KLA
ATP
ATP+KLA
NM_053200
carboxylesterase 3 (Ces3), mRNA [NM_053200]
KLA
1.04
.95
.92
1.03
1.00
1.02
.88
ATP
1.02
.98
1.01
.95
.99
1.01
.98
KLA/ATP
1.02
.93
1.03
.97
1.05
1.00
1.01
Chdh
KLA
ATP
ATP+KLA
AK052715
0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630034H06 product:CHOLINE DEHYDROGENASE (FRAGMENT) homolog [Homo sapiens], full insert sequence [AK052715]
KLA
1.05
1.02
1.04
1.10
1.06
1.17
.88
ATP
.96
1.01
.99
1.00
1.01
.98
.97
KLA/ATP
.99
1.01
1.00
1.04
.99
.99
1.06
Chdh
KLA
ATP
ATP+KLA
NM_175343
choline dehydrogenase (Chdh), mRNA [NM_175343]
KLA
.97
.99
1.07
1.01
.81
.98
1.15
ATP
.98
1.06
1.04
1.17
1.02
1.00
.99
KLA/ATP
1.06
1.01
1.01
.99
.98
.99
1.12
Chka
KLA
ATP
ATP+KLA
AK014174
13 days embryo head cDNA, RIKEN full-length enriched library, clone:3110043M12 product:choline kinase, full insert sequence. [AK014174]
KLA
.42
.41
.44
.58
.89
.72
.81
ATP
.83
.53
3.69
5.23
2.51
1.20
.99
KLA/ATP
.37
.40
3.80
4.15
2.66
1.08
1.73
Chka
KLA
ATP
ATP+KLA
NM_013490
choline kinase alpha (Chka), transcript variant 1, mRNA [NM_013490]
KLA
.62
.60
.67
.66
.85
.88
1.05
ATP
1.09
1.02
2.21
7.77
6.32
3.01
1.39
KLA/ATP
.67
.65
1.77
6.85
7.26
3.77
2.70
Chkb
KLA
ATP
ATP+KLA
NM_007692
choline kinase beta (Chkb), mRNA [NM_007692]
KLA
.71
.73
.70
.66
.86
.79
.78
ATP
.97
.86
.73
.87
1.36
1.43
.96
KLA/ATP
.68
.55
.52
.62
1.24
1.30
1.11
Chpf
KLA
ATP
ATP+KLA
NM_001001566
chondroitin polymerizing factor (Chpf), transcript variant 1, mRNA [NM_001001566]
KLA
1.22
1.19
1.09
1.18
1.71
2.50
3.34
ATP
1.06
1.08
1.08
.97
1.05
1.69
3.23
KLA/ATP
1.12
1.19
1.20
1.18
1.23
1.54
2.83
Chpt1
KLA
ATP
ATP+KLA
NM_144807
choline phosphotransferase 1 (Chpt1), mRNA [NM_144807]
KLA
1.16
1.18
1.24
1.15
1.16
1.10
1.23
ATP
1.01
1.05
1.16
1.09
.99
.97
.98
KLA/ATP
1.20
1.15
1.13
1.18
1.17
1.33
1.25
Chsy1
KLA
ATP
ATP+KLA
NM_001081163
carbohydrate (chondroitin) synthase 1 (Chsy1), mRNA [NM_001081163]
KLA
.48
.42
.32
.36
.30
.44
.73
ATP
.87
.88
1.09
.66
.54
1.20
.79
KLA/ATP
.39
.39
.50
.37
.48
.47
.36
Chsy3
KLA
ATP
ATP+KLA
AK043732
10 days neonate cortex cDNA, RIKEN full-length enriched library, clone:A830026G02 product:hypothetical protein, full insert sequence. [AK043732]
KLA
1.07
1.05
1.07
.97
1.00
1.04
.98
ATP
1.00
.92
.99
1.01
1.04
1.02
1.03
KLA/ATP
1.02
1.04
.95
.97
1.01
1.06
.98
Chsy3
KLA
ATP
ATP+KLA
NM_001081328
chondroitin sulfate synthase 3 (Chsy3), mRNA [NM_001081328]
KLA
1.11
1.07
1.03
1.01
1.01
.99
1.04
ATP
1.01
1.00
1.05
1.00
1.01
.98
1.02
KLA/ATP
1.10
1.07
.97
.98
.99
1.03
.99
Ckb
KLA
ATP
ATP+KLA
NM_021273
creatine kinase, brain (Ckb), mRNA [NM_021273]
KLA
.72
.75
.67
.61
.56
.45
.48
ATP
1.11
1.16
.92
1.17
1.13
.63
.75
KLA/ATP
.82
.83
.67
.68
.56
.46
.28
Ckm
KLA
ATP
ATP+KLA
NM_007710
creatine kinase, muscle (Ckm), mRNA [NM_007710]
KLA
.93
1.01
1.07
.99
.95
1.03
1.08
ATP
.94
1.00
1.04
1.05
.96
1.02
.99
KLA/ATP
.90
1.10
1.07
1.05
1.05
.99
.98
Ckmt1
KLA
ATP
ATP+KLA
NM_009897
creatine kinase, mitochondrial 1, ubiquitous (Ckmt1), nuclear gene encoding mitochondrial protein, mRNA [NM_009897]
KLA
1.05
.99
1.00
1.02
1.02
1.02
1.12
ATP
1.02
1.04
.99
.94
1.01
.95
1.10
KLA/ATP
.98
1.03
1.06
1.00
.99
1.06
1.19
Ckmt2
KLA
ATP
ATP+KLA
NM_198415
creatine kinase, mitochondrial 2 (Ckmt2), nuclear gene encoding mitochondrial protein, mRNA [NM_198415]
KLA
1.10
.99
1.01
1.02
1.07
1.06
1.02
ATP
.97
1.00
1.05
1.00
.96
1.03
1.02
KLA/ATP
1.02
.99
1.10
.96
.99
1.06
1.02
Cmas
KLA
ATP
ATP+KLA
NM_009908
cytidine monophospho-N-acetylneuraminic acid synthetase (Cmas), mRNA [NM_009908]
KLA
.47
.49
.45
.51
.54
.58
.90
ATP
1.08
1.07
.97
1.19
1.07
.58
.84
KLA/ATP
.53
.54
.48
.48
.46
.51
.61
Cmbl
KLA
ATP
ATP+KLA
NM_181588
carboxymethylenebutenolidase-like (Pseudomonas) (Cmbl), mRNA [NM_181588]
KLA
.63
.61
.59
.44
.28
.18
.16
ATP
.90
.88
1.29
1.08
.77
.19
.40
KLA/ATP
.57
.60
.76
.60
.50
.20
.17
Cmpk1
KLA
ATP
ATP+KLA
NM_025647
cytidine monophosphate (UMP-CMP) kinase 1 (Cmpk1), mRNA [NM_025647]
KLA
1.32
1.31
1.32
1.37
1.15
1.07
1.22
ATP
1.12
1.11
1.24
1.48
1.19
1.05
1.40
KLA/ATP
1.32
1.50
1.51
1.61
1.38
1.22
1.69
Cmpk2
KLA
ATP
ATP+KLA
NM_020557
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial (Cmpk2), nuclear gene encoding mitochondrial protein, mRNA [NM_020557]
KLA
45.62
35.73
40.02
38.05
26.87
32.74
16.83
ATP
1.12
1.13
1.07
1.09
1.70
19.99
11.48
KLA/ATP
40.89
44.06
53.14
44.67
39.01
36.20
40.60
Cndp1
KLA
ATP
ATP+KLA
NM_177450
carnosine dipeptidase 1 (metallopeptidase M20 family) (Cndp1), mRNA [NM_177450]
KLA
.98
1.00
1.00
1.00
.99
.93
1.04
ATP
1.02
.96
.98
.97
.97
.95
.96
KLA/ATP
1.04
1.04
.95
.94
.98
.96
.94
Cndp2
KLA
ATP
ATP+KLA
NM_023149
CNDP dipeptidase 2 (metallopeptidase M20 family) (Cndp2), mRNA [NM_023149]
KLA
.88
.96
1.08
.98
1.35
1.73
1.59
ATP
1.09
1.27
.77
1.02
1.04
1.30
1.67
KLA/ATP
1.17
1.04
.63
1.09
.95
1.78
2.70
Coasy
KLA
ATP
ATP+KLA
NM_027896
Coenzyme A synthase (Coasy), mRNA [NM_027896]
KLA
.50
.51
.45
.46
.58
.74
.99
ATP
.98
.99
.91
.94
.55
.52
1.08
KLA/ATP
.50
.48
.44
.45
.39
.39
.72
Comt
KLA
ATP
ATP+KLA
NM_007744
catechol-O-methyltransferase (Comt), transcript variant 2, mRNA [NM_007744]
KLA
.46
.45
.42
.38
.37
.38
.50
ATP
.91
.90
.89
.84
.73
.38
.72
KLA/ATP
.44
.44
.43
.37
.39
.31
.32
Coq2
KLA
ATP
ATP+KLA
NM_027978
coenzyme Q2 homolog, prenyltransferase (yeast) (Coq2), mRNA [NM_027978]
KLA
.94
.98
1.00
.84
.87
.84
.96
ATP
1.05
.97
1.18
.86
.67
.48
.60
KLA/ATP
.96
1.03
1.20
.81
.67
.58
.64
Coq3
KLA
ATP
ATP+KLA
NM_172687
coenzyme Q3 homolog, methyltransferase (yeast) (Coq3), mRNA [NM_172687]
KLA
.99
.93
.95
.84
.81
.85
1.04
ATP
1.02
1.06
.91
.90
.74
.77
.88
KLA/ATP
1.02
1.08
.83
.85
.73
.75
.87
Coq5
KLA
ATP
ATP+KLA
NM_026504
coenzyme Q5 homolog, methyltransferase (yeast) (Coq5), mRNA [NM_026504]
KLA
.94
.96
1.00
1.10
1.24
1.27
1.36
ATP
.94
.95
.91
.98
.75
.63
1.01
KLA/ATP
.93
.97
1.02
1.00
.87
.74
.90
Coq6
KLA
ATP
ATP+KLA
NM_172582
coenzyme Q6 homolog (yeast) (Coq6), mRNA [NM_172582]
KLA
1.02
1.14
1.11
1.07
.94
.78
1.01
ATP
1.06
1.14
.99
1.34
1.08
.63
.79
KLA/ATP
1.09
1.29
1.02
1.21
.93
.73
.76
Coq7
KLA
ATP
ATP+KLA
NM_009940
demethyl-Q 7 (Coq7), mRNA [NM_009940]
KLA
.99
1.01
.91
.99
.88
.91
1.25
ATP
.98
.95
1.19
1.19
1.06
.99
.87
KLA/ATP
.98
.99
1.24
1.14
1.08
.95
.71
Cox10
KLA
ATP
ATP+KLA
NM_178379
COX10 homolog, cytochrome c oxidase assembly protein, heme A: farnesyltransferase (yeast) (Cox10), nuclear gene encoding mitochondrial protein, mRNA [NM_178379]
KLA
1.17
1.20
1.24
1.24
1.14
1.13
1.35
ATP
1.16
1.18
.99
1.15
.83
.98
1.06
KLA/ATP
1.24
1.39
1.07
1.11
.85
.95
.91
Cox11
KLA
ATP
ATP+KLA
NM_199008
COX11 homolog, cytochrome c oxidase assembly protein (yeast) (Cox11), nuclear gene encoding mitochondrial protein, mRNA [NM_199008]
KLA
1.83
1.61
1.94
2.09
1.50
1.70
1.52
ATP
1.03
.81
.97
.50
1.06
1.67
1.34
KLA/ATP
1.64
1.57
2.06
1.10
1.38
2.09
2.00
Cox15
KLA
ATP
ATP+KLA
NM_144874
COX15 homolog, cytochrome c oxidase assembly protein (yeast) (Cox15), nuclear gene encoding mitochondrial protein, mRNA [NM_144874]
KLA
1.93
1.96
2.10
2.26
1.93
1.90
1.24
ATP
.98
.84
1.17
.86
.65
1.34
1.12
KLA/ATP
1.85
2.05
2.30
2.09
1.97
2.46
1.74
Cox17
KLA
ATP
ATP+KLA
BU555670
gb|AGENCOURT_10230668 NIH_MGC_143 Mus musculus cDNA clone IMAGE:6583112 5, mRNA sequence [BU555670]
KLA
1.13
.87
1.10
1.08
1.01
1.29
.91
ATP
1.04
1.13
1.24
1.15
1.22
1.79
1.07
KLA/ATP
1.19
1.12
1.39
1.48
1.39
2.27
1.69
Cox17
KLA
ATP
ATP+KLA
NM_001017429
cytochrome c oxidase, subunit XVII assembly protein homolog (yeast) (Cox17), mRNA [NM_001017429]
KLA
1.62
1.49
1.47
1.96
1.86
1.75
1.72
ATP
1.00
.96
1.10
1.07
1.36
1.54
1.37
KLA/ATP
1.61
1.70
2.34
1.84
2.25
2.44
2.17
Cox4i1
KLA
ATP
ATP+KLA
NM_009941
cytochrome c oxidase subunit IV isoform 1 (Cox4i1), mRNA [NM_009941]
KLA
.94
.92
.88
1.05
1.00
.86
.85
ATP
1.02
1.01
1.03
1.06
1.15
1.18
.91
KLA/ATP
1.05
1.01
1.12
1.05
.99
1.07
1.02
Cox4i2
KLA
ATP
ATP+KLA
NM_053091
cytochrome c oxidase subunit IV isoform 2 (Cox4i2), nuclear gene encoding mitochondrial protein, mRNA [NM_053091]
KLA
1.10
.97
1.01
1.05
1.10
1.15
1.47
ATP
.99
1.00
.98
.95
1.01
1.10
1.06
KLA/ATP
1.06
1.05
1.08
.94
1.03
1.01
1.20
Cox5a
KLA
ATP
ATP+KLA
NM_007747
cytochrome c oxidase, subunit Va (Cox5a), nuclear gene encoding mitochondrial protein, mRNA [NM_007747]
KLA
1.45
1.31
1.22
1.31
1.35
1.54
1.90
ATP
.98
.98
1.08
.97
1.06
1.24
1.11
KLA/ATP
1.11
1.27
1.38
1.29
1.36
1.54
1.48
Cox5b
KLA
ATP
ATP+KLA
NM_009942
cytochrome c oxidase, subunit Vb (Cox5b), mRNA [NM_009942]
KLA
1.02
.96
.93
.98
.98
1.10
1.09
ATP
.92
1.01
1.08
1.17
1.01
1.05
1.08
KLA/ATP
.94
1.03
1.08
1.23
1.18
1.30
1.19
Cox6a1
KLA
ATP
ATP+KLA
NM_007748
cytochrome c oxidase, subunit VI a, polypeptide 1 (Cox6a1), nuclear gene encoding mitochondrial protein, mRNA [NM_007748]
KLA
.93
.94
.90
.98
.95
1.01
1.03
ATP
.93
.91
1.03
.89
.86
.88
.82
KLA/ATP
.98
.83
1.08
1.06
.96
.81
.79
Cox6a2
KLA
ATP
ATP+KLA
NM_009943
cytochrome c oxidase, subunit VI a, polypeptide 2 (Cox6a2), nuclear gene encoding mitochondrial protein, mRNA [NM_009943]
KLA
1.12
1.15
1.13
1.37
2.13
3.23
3.70
ATP
1.02
.99
1.31
1.51
1.15
.69
1.13
KLA/ATP
1.01
1.21
1.40
1.46
1.17
1.00
1.89
Cox6b1
KLA
ATP
ATP+KLA
NM_025628
cytochrome c oxidase, subunit VIb polypeptide 1 (Cox6b1), mRNA [NM_025628]
KLA
1.28
1.19
1.23
1.20
1.23
1.33
1.13
ATP
.89
1.05
1.22
1.48
1.35
1.33
.93
KLA/ATP
1.28
1.39
1.48
1.91
1.50
1.65
1.25
Cox6b2
KLA
ATP
ATP+KLA
NM_183405
cytochrome c oxidase subunit VIb polypeptide 2 (Cox6b2), mRNA [NM_183405]
KLA
1.74
1.90
2.21
2.20
2.20
2.21
1.17
ATP
1.01
1.01
1.20
1.47
1.39
1.37
1.06
KLA/ATP
1.86
1.94
2.28
2.62
2.56
2.12
1.80
Cox6c
KLA
ATP
ATP+KLA
NM_053071
cytochrome c oxidase, subunit VIc (Cox6c), mRNA [NM_053071]
KLA
1.13
1.05
1.01
1.38
1.02
.85
.90
ATP
1.01
.89
1.23
1.09
1.26
1.24
.80
KLA/ATP
1.01
1.08
1.66
1.12
1.34
1.19
.89
Cox7b
KLA
ATP
ATP+KLA
NM_025379
cytochrome c oxidase subunit VIIb (Cox7b), nuclear gene encoding mitochondrial protein, mRNA [NM_025379]
KLA
1.00
.91
.98
.97
.97
.91
.92
ATP
1.06
1.12
1.35
1.42
1.21
1.06
.78
KLA/ATP
1.13
1.07
1.26
1.41
1.18
1.06
.91
Cox7b2
KLA
ATP
ATP+KLA
NM_030052
cytochrome c oxidase subunit VIIb2 (Cox7b2), mRNA [NM_030052]
KLA
1.03
1.07
.98
1.02
1.03
1.04
.95
ATP
.97
1.00
1.04
.97
1.04
.99
1.01
KLA/ATP
.95
.96
1.02
.97
1.06
1.05
.99
Cox7c
KLA
ATP
ATP+KLA
NM_007749
cytochrome c oxidase, subunit VIIc (Cox7c), nuclear gene encoding mitochondrial protein, mRNA [NM_007749]
KLA
1.38
1.24
1.08
1.42
1.21
1.05
1.06
ATP
1.03
1.05
1.34
1.43
1.33
1.13
.77
KLA/ATP
1.16
1.32
1.73
1.81
1.60
1.55
1.03
Cox8a
KLA
ATP
ATP+KLA
NM_007750
cytochrome c oxidase, subunit VIIIa (Cox8a), mRNA [NM_007750]
KLA
.91
.91
.96
1.02
1.01
.98
1.19
ATP
1.07
1.05
1.03
1.22
1.11
.97
.85
KLA/ATP
.98
1.02
1.10
1.14
1.21
.97
.90
Cox8b
KLA
ATP
ATP+KLA
NM_007751
cytochrome c oxidase, subunit VIIIb (Cox8b), nuclear gene encoding mitochondrial protein, mRNA [NM_007751]
KLA
.98
1.03
.99
.98
1.06
1.05
1.03
ATP
1.01
.99
.91
1.09
1.06
.98
.99
KLA/ATP
1.07
1.02
.86
1.03
1.06
1.04
1.00
Cox8c
KLA
ATP
ATP+KLA
NM_001039049
cytochrome c oxidase, subunit VIIIc (Cox8c), nuclear gene encoding mitochondrial protein, mRNA [NM_001039049]
KLA
.97
1.03
1.05
1.05
1.00
1.03
1.03
ATP
1.06
1.04
1.04
1.02
.95
1.06
1.01
KLA/ATP
1.04
1.01
1.01
1.03
1.00
1.16
.98
Cpox
KLA
ATP
ATP+KLA
NM_007757
coproporphyrinogen oxidase (Cpox), mRNA [NM_007757]
KLA
.92
.75
.68
.69
.53
.37
.61
ATP
1.07
1.05
.90
.59
.39
.65
.95
KLA/ATP
.68
.71
.78
.57
.35
.38
.40
Cps1
KLA
ATP
ATP+KLA
AK028683
10 days neonate skin cDNA, RIKEN full-length enriched library, clone:4732433M03 product:weakly similar to carbamoyl-phosphate synthase (glutamine-hydrolyzing) (EC 6.3.5.5) large chain [Schizosaccharomyces pombe], full insert sequence. [A
KLA
.99
1.01
1.08
1.02
1.01
.96
1.05
ATP
.96
1.00
.94
.97
.98
.98
1.05
KLA/ATP
.97
1.09
1.04
.99
1.05
1.03
.96
Cps1
KLA
ATP
ATP+KLA
AK028683
10 days neonate skin cDNA, RIKEN full-length enriched library, clone:4732433M03 product:weakly similar to carbamoyl-phosphate synthase (glutamine-hydrolyzing) (EC 6.3.5.5) large chain [Schizosaccharomyces pombe], full insert sequence. [AK
KLA
1.03
1.04
1.06
.96
1.08
1.08
1.03
ATP
.99
.98
1.09
1.07
.97
1.02
1.09
KLA/ATP
.98
1.00
.95
1.10
1.00
1.05
1.09
Crls1
KLA
ATP
ATP+KLA
AK078599
11 days embryo gonad cDNA, RIKEN full-length enriched library, clone:7030418E13 product:unclassifiable, full insert sequence [AK078599]
KLA
.82
.86
.79
.88
.81
.89
.89
ATP
.92
.91
1.00
.98
.87
.90
.68
KLA/ATP
.77
.84
.81
.83
.80
.84
.58
Crls1
KLA
ATP
ATP+KLA
NM_001024385
cardiolipin synthase 1 (Crls1), transcript variant 1, mRNA [NM_001024385]
KLA
.95
.98
.88
.88
.83
.67
1.02
ATP
1.13
1.14
.96
1.08
1.26
1.02
.86
KLA/ATP
.98
.98
.83
.81
.73
.74
.77
Cryl1
KLA
ATP
ATP+KLA
AK020717
adult male hypothalamus cDNA, RIKEN full-length enriched library, clone:A230106J09 product:crystallin, lamda 1, full insert sequence. [AK020717]
KLA
.45
.49
.55
.54
.60
.51
.76
ATP
.89
.88
.99
.73
.60
.51
.87
KLA/ATP
.45
.48
.62
.57
.61
.45
.72
Cryl1
KLA
ATP
ATP+KLA
NM_030004
crystallin, lambda 1 (Cryl1), mRNA [NM_030004]
KLA
.79
.72
.81
.65
.59
.40
.39
ATP
1.13
1.20
1.20
1.36
1.02
.41
.39
KLA/ATP
.88
.87
.87
.99
.73
.46
.24
Cs
KLA
ATP
ATP+KLA
NM_026444
citrate synthase (Cs), nuclear gene encoding mitochondrial protein, mRNA [NM_026444]
KLA
1.09
1.07
1.04
1.05
1.08
1.15
1.14
ATP
.91
.93
1.02
.90
.90
1.08
1.38
KLA/ATP
.99
1.04
1.09
.98
.98
.90
1.13
Csad
KLA
ATP
ATP+KLA
NM_144942
cysteine sulfinic acid decarboxylase (Csad), mRNA [NM_144942]
KLA
.93
.95
.94
.92
.97
.90
.78
ATP
.92
.80
.70
.68
.73
.64
.62
KLA/ATP
.87
.86
.82
.81
.97
.69
.57
Csgalnac
t1
KLA
ATP
ATP+KLA
NM_172753
chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Csgalnact1), mRNA [NM_172753]
KLA
1.01
.98
.84
.94
.95
.94
1.02
ATP
.97
1.00
.98
.93
.92
1.00
1.03
KLA/ATP
.99
.94
.94
.86
.94
.93
1.04
Csgalnac
t2
KLA
ATP
ATP+KLA
NM_030165
chondroitin sulfate N-acetylgalactosaminyltransferase 2 (Csgalnact2), mRNA [NM_030165]
KLA
.41
.41
.39
.42
.41
.65
.65
ATP
.94
.95
1.04
.77
1.00
1.01
.98
KLA/ATP
.35
.37
.38
.32
.70
1.01
.79
Csl
KLA
ATP
ATP+KLA
NM_027945
citrate synthase like (Csl), mRNA [NM_027945]
KLA
1.41
1.32
1.35
1.51
1.61
1.39
1.58
ATP
1.17
1.15
.98
1.23
1.18
1.33
2.00
KLA/ATP
1.32
1.53
1.45
1.59
1.13
1.14
1.77
Cth
KLA
ATP
ATP+KLA
NM_145953
cystathionase (cystathionine gamma-lyase) (Cth), mRNA [NM_145953]
KLA
1.95
1.88
2.04
1.99
1.70
1.19
1.05
ATP
1.05
1.03
1.17
1.26
1.76
2.05
1.00
KLA/ATP
1.79
2.03
2.06
1.83
1.66
1.53
.99
Ctps
KLA
ATP
ATP+KLA
NM_016748
cytidine 5-triphosphate synthase (Ctps), mRNA [NM_016748]
KLA
.47
.41
.26
.18
.14
.21
.37
ATP
.87
.80
1.08
.67
.73
.63
.33
KLA/ATP
.40
.39
.41
.28
.27
.38
.13
Ctps2
KLA
ATP
ATP+KLA
NM_018737
cytidine 5-triphosphate synthase 2 (Ctps2), mRNA [NM_018737]
KLA
.76
.77
.71
.73
.67
.75
1.09
ATP
.98
.93
.99
.86
.76
.64
.81
KLA/ATP
.77
.74
.71
.63
.62
.60
.86
Cyc1
KLA
ATP
ATP+KLA
NM_025567
cytochrome c-1 (Cyc1), mRNA [NM_025567]
KLA
1.02
1.01
1.02
.89
1.07
1.03
1.22
ATP
1.11
1.23
1.08
1.20
1.16
.87
1.09
KLA/ATP
1.15
1.07
.97
1.22
.91
.94
1.12
Cyp11a1
KLA
ATP
ATP+KLA
NM_019779
cytochrome P450, family 11, subfamily a, polypeptide 1 (Cyp11a1), nuclear gene encoding mitochondrial protein, mRNA [NM_019779]
KLA
1.03
1.00
.96
1.04
1.05
1.03
.97
ATP
1.00
.99
.99
1.02
1.04
1.00
.99
KLA/ATP
.99
1.03
1.05
.98
.95
.95
.96
Cyp11b2
KLA
ATP
ATP+KLA
NM_009991
cytochrome P450, family 11, subfamily b, polypeptide 2 (Cyp11b2), nuclear gene encoding mitochondrial protein, mRNA [NM_009991]
KLA
.93
1.00
1.03
1.05
1.04
1.09
1.03
ATP
1.01
1.00
1.02
1.11
.99
1.02
1.01
KLA/ATP
1.03
.98
.84
1.10
1.05
1.38
.98
Cyp17a1
KLA
ATP
ATP+KLA
NM_007809
cytochrome P450, family 17, subfamily a, polypeptide 1 (Cyp17a1), mRNA [NM_007809]
KLA
1.55
1.60
1.71
1.73
1.51
1.58
1.18
ATP
.94
1.01
1.27
1.44
1.39
1.36
1.11
KLA/ATP
1.48
1.79
1.95
2.05
1.92
1.75
1.56
Cyp19a1
KLA
ATP
ATP+KLA
NM_007810
cytochrome P450, family 19, subfamily a, polypeptide 1 (Cyp19a1), mRNA [NM_007810]
KLA
1.04
.97
1.05
1.03
.99
1.02
.98
ATP
1.00
1.02
1.00
.93
.97
.99
1.08
KLA/ATP
.99
.99
1.07
1.02
.98
.97
.98
Cyp1a1
KLA
ATP
ATP+KLA
NM_009992
cytochrome P450, family 1, subfamily a, polypeptide 1 (Cyp1a1), mRNA [NM_009992]
KLA
1.07
.99
1.02
1.01
1.00
1.00
1.11
ATP
.99
1.02
1.01
.95
.96
.94
1.09
KLA/ATP
1.01
1.03
.98
.96
.96
.95
1.51
Cyp1a2
KLA
ATP
ATP+KLA
NM_009993
cytochrome P450, family 1, subfamily a, polypeptide 2 (Cyp1a2), mRNA [NM_009993]
KLA
1.01
.99
.98
1.02
.97
.97
1.00
ATP
1.01
.98
1.03
1.01
1.04
1.02
1.04
KLA/ATP
.99
1.00
1.05
1.03
.98
.97
.99
Cyp21a1
KLA
ATP
ATP+KLA
NM_009995
cytochrome P450, family 21, subfamily a, polypeptide 1 (Cyp21a1), mRNA [NM_009995]
KLA
.96
1.04
.98
1.05
1.00
.98
1.03
ATP
1.02
.93
1.02
1.11
1.03
1.04
1.10
KLA/ATP
.91
1.00
1.02
1.01
1.04
.90
1.00
Cyp24a1
KLA
ATP
ATP+KLA
NM_009996
cytochrome P450, family 24, subfamily a, polypeptide 1 (Cyp24a1), nuclear gene encoding mitochondrial protein, mRNA [NM_009996]
KLA
.98
.91
1.01
1.00
1.01
1.01
1.02
ATP
.97
.93
1.01
1.01
1.01
.97
1.05
KLA/ATP
1.00
1.04
.98
.95
.97
1.03
.85
Cyp27a1
KLA
ATP
ATP+KLA
NM_024264
cytochrome P450, family 27, subfamily a, polypeptide 1 (Cyp27a1), nuclear gene encoding mitochondrial protein, mRNA [NM_024264]
KLA
1.03
.98
1.22
1.00
.87
.57
.40
ATP
1.07
1.06
.99
1.18
.71
.41
.38
KLA/ATP
1.02
1.10
1.24
1.03
.72
.50
.34
Cyp27b1
KLA
ATP
ATP+KLA
AB006034
mRNA for 25-hydroxyvitamin D3 1alpha-hydroxylase, partial cds. [AB006034]
KLA
1.04
.99
.98
.99
.97
.97
1.00
ATP
1.00
.99
.94
.99
1.05
.95
1.00
KLA/ATP
1.02
.97
.99
.99
.97
.92
1.00
Cyp27b1
KLA
ATP
ATP+KLA
NM_010009
cytochrome P450, family 27, subfamily b, polypeptide 1 (Cyp27b1), nuclear gene encoding mitochondrial protein, mRNA [NM_010009]
KLA
1.18
1.18
1.27
1.18
1.24
1.23
1.12
ATP
1.07
.95
1.21
1.13
1.17
1.17
1.03
KLA/ATP
1.13
1.10
1.36
1.27
1.34
1.13
1.06
Cyp2a12
KLA
ATP
ATP+KLA
NM_133657
cytochrome P450, family 2, subfamily a, polypeptide 12 (Cyp2a12), mRNA [NM_133657]
KLA
1.03
1.08
1.00
.98
1.00
1.03
1.03
ATP
1.01
.98
1.03
1.08
1.02
.99
1.01
KLA/ATP
.97
1.01
.97
1.06
1.03
1.03
.99
Cyp2a4
KLA
ATP
ATP+KLA
NM_009997
cytochrome P450, family 2, subfamily a, polypeptide 4 (Cyp2a4), mRNA [NM_009997]
KLA
1.02
.99
1.00
1.00
.98
1.04
1.01
ATP
1.01
1.00
1.01
1.03
.99
1.01
.99
KLA/ATP
1.03
1.03
1.01
1.04
.98
1.03
1.01
Cyp2a5
KLA
ATP
ATP+KLA
NM_007812
cytochrome P450, family 2, subfamily a, polypeptide 5 (Cyp2a5), mRNA [NM_007812]
KLA
1.04
.95
.95
1.02
1.01
.94
1.06
ATP
1.03
.95
1.05
1.08
.99
.97
1.03
KLA/ATP
1.01
1.06
.92
1.08
1.05
1.01
1.01
Cyp2b10
KLA
ATP
ATP+KLA
NM_009999
cytochrome P450, family 2, subfamily b, polypeptide 10 (Cyp2b10), transcript variant 2, mRNA [NM_009999]
KLA
.98
1.03
.97
1.02
1.02
.97
1.03
ATP
1.03
.99
1.02
1.02
.98
1.02
.99
KLA/ATP
1.04
1.00
1.02
.93
.97
.93
.91
Cyp2b13
KLA
ATP
ATP+KLA
NM_007813
cytochrome P450, family 2, subfamily b, polypeptide 13 (Cyp2b13), mRNA [NM_007813]
KLA
.99
1.02
1.00
1.06
1.05
1.03
.99
ATP
.96
.96
.96
.98
.99
.95
.98
KLA/ATP
1.00
1.03
1.04
1.02
1.01
1.06
.99
Cyp2b19
KLA
ATP
ATP+KLA
AK029227
0 day neonate head cDNA, RIKEN full-length enriched library, clone:4831430P04 product:cytochrome P450, 2b19, full insert sequence. [AK029227]
KLA
.96
.98
1.02
1.09
1.06
1.00
1.08
ATP
1.02
1.06
.91
1.05
1.00
.97
.95
KLA/ATP
.99
.93
.96
1.03
1.00
1.04
1.00
Cyp2b19
KLA
ATP
ATP+KLA
NM_007814
cytochrome P450, family 2, subfamily b, polypeptide 19 (Cyp2b19), mRNA [NM_007814]
KLA
1.14
1.20
1.18
1.17
1.17
1.21
1.14
ATP
.96
1.01
1.11
1.08
.99
1.08
1.10
KLA/ATP
1.09
1.05
1.17
1.16
1.16
1.10
1.07
Cyp2b23
KLA
ATP
ATP+KLA
NM_001081148
cytochrome P450, family 2, subfamily b, polypeptide 23 (Cyp2b23), mRNA [NM_001081148]
KLA
1.09
.96
1.01
.95
.97
1.01
.92
ATP
.97
1.00
.92
.92
.98
.97
.94
KLA/ATP
1.01
1.02
1.03
.94
.94
.93
.97
Cyp2b9
KLA
ATP
ATP+KLA
NM_010000
cytochrome P450, family 2, subfamily b, polypeptide 9 (Cyp2b9), mRNA [NM_010000]
KLA
.99
1.00
1.02
1.01
1.03
.98
1.03
ATP
1.01
.98
.97
.98
1.01
.96
.98
KLA/ATP
1.00
1.04
.94
1.04
1.02
1.03
.99
Cyp2c29
KLA
ATP
ATP+KLA
NM_007815
cytochrome P450, family 2, subfamily c, polypeptide 29 (Cyp2c29), mRNA [NM_007815]
KLA
1.01
.95
1.06
1.12
1.01
1.02
1.12
ATP
1.03
1.02
1.01
1.06
.98
.98
.96
KLA/ATP
1.09
1.14
1.02
.98
.99
.98
.98
Cyp2c37
KLA
ATP
ATP+KLA
NM_010001
cytochrome P450, family 2. subfamily c, polypeptide 37 (Cyp2c37), mRNA [NM_010001]
KLA
1.27
1.43
1.64
1.52
1.65
1.43
1.45
ATP
.99
.96
1.03
1.13
1.10
1.03
1.27
KLA/ATP
1.37
1.49
1.22
1.46
1.16
1.12
1.24
Cyp2c38
KLA
ATP
ATP+KLA
NM_010002
cytochrome P450, family 2, subfamily c, polypeptide 38 (Cyp2c38), mRNA [NM_010002]
KLA
1.01
1.06
.98
.96
1.07
.98
.97
ATP
1.01
1.09
1.04
.98
1.00
1.03
.98
KLA/ATP
1.03
.98
1.03
1.04
1.00
1.00
1.01
Cyp2c39
KLA
ATP
ATP+KLA
NM_010003
cytochrome P450, family 2, subfamily c, polypeptide 39 (Cyp2c39), mRNA [NM_010003]
KLA
1.04
1.01
.97
1.00
.99
1.01
.98
ATP
1.04
1.07
.95
1.00
.96
1.03
1.01
KLA/ATP
1.03
1.01
1.02
1.01
1.05
1.05
.99
Cyp2c40
KLA
ATP
ATP+KLA
NM_010004
cytochrome P450, family 2, subfamily c, polypeptide 40 (Cyp2c40), mRNA [NM_010004]
KLA
.96
1.06
1.05
1.03
.99
1.01
1.02
ATP
.96
1.01
1.02
.97
1.01
1.02
.99
KLA/ATP
1.06
1.03
1.04
.98
1.05
1.01
.97
Cyp2c44
KLA
ATP
ATP+KLA
NM_001001446
cytochrome P450, family 2, subfamily c, polypeptide 44 (Cyp2c44), mRNA [NM_001001446]
KLA
.98
1.04
.93
1.05
1.01
.93
.94
ATP
1.02
1.01
1.01
1.04
1.02
1.02
1.00
KLA/ATP
.93
.95
1.00
1.05
1.07
1.01
1.01
Cyp2c54
KLA
ATP
ATP+KLA
NM_206537
cytochrome P450, family 2, subfamily c, polypeptide 54 (Cyp2c54), mRNA [NM_206537]
KLA
.98
.99
1.04
.97
1.06
1.03
1.04
ATP
.99
.98
1.10
1.03
1.03
.98
1.03
KLA/ATP
1.02
1.04
.89
.98
.99
.93
.99
Cyp2c55
KLA
ATP
ATP+KLA
NM_028089
cytochrome P450, family 2, subfamily c, polypeptide 55 (Cyp2c55), mRNA [NM_028089]
KLA
.97
1.02
1.01
.99
.99
1.00
.94
ATP
1.04
.98
1.09
.97
1.05
.99
1.06
KLA/ATP
1.04
1.01
1.15
1.03
1.05
1.05
1.09
Cyp2c65
KLA
ATP
ATP+KLA
AK008688
adult male stomach cDNA, RIKEN full-length enriched library, clone:2210009K14 product:similar to CYTOCHROME P450 2C18 (EC 1.14.14.1) (CYPIIC18) (P450-6B [AK008688]
KLA
.95
.97
1.02
1.00
.97
1.10
1.04
ATP
.98
1.05
1.00
1.10
.98
.99
1.03
KLA/ATP
.96
.97
.99
1.01
1.03
1.04
1.03
Cyp2c66
KLA
ATP
ATP+KLA
NM_001011707
cytochrome P450, family 2, subfamily c, polypeptide 66 (Cyp2c66), mRNA [NM_001011707]
KLA
1.03
1.04
.99
1.00
1.06
1.11
1.01
ATP
.97
1.01
1.03
1.00
.98
1.03
1.04
KLA/ATP
1.08
.97
1.15
1.02
1.04
1.06
1.08
Cyp2c70
KLA
ATP
ATP+KLA
NM_145499
cytochrome P450, family 2, subfamily c, polypeptide 70 (Cyp2c70), mRNA [NM_145499]
KLA
1.05
.94
.95
.86
1.06
.96
.99
ATP
1.01
.98
.69
.69
.97
.87
1.09
KLA/ATP
1.00
.97
.74
.74
.81
.86
1.17
Cyp2e1
KLA
ATP
ATP+KLA
NM_021282
cytochrome P450, family 2, subfamily e, polypeptide 1 (Cyp2e1), mRNA [NM_021282]
KLA
.99
1.03
1.05
1.01
.99
1.06
1.00
ATP
.96
.93
.98
1.05
1.01
1.03
1.10
KLA/ATP
1.04
.99
1.02
1.00
1.05
1.04
.99
Cyp2j11
KLA
ATP
ATP+KLA
NM_001004141
cytochrome P450, family 2, subfamily j, polypeptide 11 (Cyp2j11), mRNA [NM_001004141]
KLA
.95
1.02
1.07
.95
.95
.92
.83
ATP
.95
1.02
1.05
.93
.92
.90
1.00
KLA/ATP
1.05
.96
1.00
.97
.90
.82
.86
Cyp2j13
KLA
ATP
ATP+KLA
NM_145548
cytochrome P450, family 2, subfamily j, polypeptide 13 (Cyp2j13), mRNA [NM_145548]
KLA
1.01
.99
.98
1.00
.98
.96
.92
ATP
.99
1.03
1.01
.98
.95
1.01
1.02
KLA/ATP
.96
1.03
1.02
1.03
.96
.95
.96
Cyp2j5
KLA
ATP
ATP+KLA
NM_010007
cytochrome P450, family 2, subfamily j, polypeptide 5 (Cyp2j5), mRNA [NM_010007]
KLA
1.00
.99
1.05
1.01
1.00
1.06
1.06
ATP
.99
1.00
1.03
1.09
1.00
1.03
1.01
KLA/ATP
1.03
.98
1.09
1.11
1.06
1.09
1.01
Cyp2j9
KLA
ATP
ATP+KLA
NM_028979
cytochrome P450, family 2, subfamily j, polypeptide 9 (Cyp2j9), mRNA [NM_028979]
KLA
.84
.88
.97
.91
.75
.66
.66
ATP
1.10
.98
.99
.92
.90
.73
.64
KLA/ATP
.88
.95
.93
.86
.80
.78
.59
Cyp2r1
KLA
ATP
ATP+KLA
NM_177382
cytochrome P450, family 2, subfamily r, polypeptide 1 (Cyp2r1), mRNA [NM_177382]
KLA
.98
1.09
1.11
1.07
1.12
1.16
1.47
ATP
1.05
1.11
1.12
1.00
.84
.69
1.11
KLA/ATP
1.05
1.01
1.17
.99
.85
.76
.79
Cyp2u1
KLA
ATP
ATP+KLA
AK142740
16 days neonate heart cDNA, RIKEN full-length enriched library, clone:D830039I11 product:cytochrome P450, family 2, subfamily u, polypeptide 1, full insert sequence [AK142740]
KLA
.85
.89
.83
.86
.76
.80
.94
ATP
.97
1.09
.99
.90
.84
.87
.96
KLA/ATP
.82
.88
.85
.80
.79
.81
.89
Cyp3a11
KLA
ATP
ATP+KLA
NM_007818
cytochrome P450, family 3, subfamily a, polypeptide 11 (Cyp3a11), mRNA [NM_007818]
KLA
.96
.94
1.06
1.04
.96
.94
.97
ATP
1.00
1.01
.94
.95
.94
.92
.98
KLA/ATP
.98
1.06
1.06
.98
.88
.93
.91
Cyp3a13
KLA
ATP
ATP+KLA
NM_007819
cytochrome P450, family 3, subfamily a, polypeptide 13 (Cyp3a13), mRNA [NM_007819]
KLA
.99
.98
.98
1.03
.97
1.01
1.07
ATP
1.00
1.01
1.01
1.04
1.01
.99
1.00
KLA/ATP
1.06
1.01
1.00
1.08
1.09
1.01
1.09
Cyp3a16
KLA
ATP
ATP+KLA
NM_007820
cytochrome P450, family 3, subfamily a, polypeptide 16 (Cyp3a16), mRNA [NM_007820]
KLA
.95
.99
.96
.96
1.00
1.03
.99
ATP
1.04
1.03
.98
.97
.98
1.03
1.01
KLA/ATP
.96
.91
.96
.97
1.03
1.00
1.04
Cyp3a25
KLA
ATP
ATP+KLA
NM_019792
cytochrome P450, family 3, subfamily a, polypeptide 25 (Cyp3a25), mRNA [NM_019792]
KLA
1.00
.96
1.01
1.04
.99
.99
1.01
ATP
1.01
1.02
.97
1.01
1.02
.93
.95
KLA/ATP
.97
1.09
1.04
1.01
.99
.97
.97
Cyp3a41a
KLA
ATP
ATP+KLA
NM_017396
cytochrome P450, family 3, subfamily a, polypeptide 41A (Cyp3a41a), mRNA [NM_017396]
KLA
1.02
.99
.98
.95
.93
.93
1.06
ATP
1.00
.96
1.02
.97
.97
.95
1.02
KLA/ATP
1.03
1.02
1.07
.97
.93
.97
.97
Cyp3a44
KLA
ATP
ATP+KLA
NM_177380
cytochrome P450, family 3, subfamily a, polypeptide 44 (Cyp3a44), mRNA [NM_177380]
KLA
1.05
1.03
1.05
1.02
1.08
1.00
1.03
ATP
.97
1.00
1.03
1.07
.99
.99
.99
KLA/ATP
1.04
.99
.99
1.06
1.04
1.06
1.00
Cyp4a10
KLA
ATP
ATP+KLA
NM_010011
cytochrome P450, family 4, subfamily a, polypeptide 10 (Cyp4a10), mRNA [NM_010011]
KLA
1.14
1.13
1.13
1.13
1.15
1.12
1.06
ATP
1.02
1.01
1.09
1.03
1.10
1.11
1.00
KLA/ATP
1.09
1.11
1.36
1.23
1.25
1.09
1.02
Cyp4a10
KLA
ATP
ATP+KLA
X71478
gb|M.musculus Cyp4a-10 mRNA. [X71478]
KLA
.94
.97
.93
1.01
1.01
1.09
1.26
ATP
.96
1.07
1.04
1.18
.88
.77
1.18
KLA/ATP
1.00
.99
.98
.98
.84
.80
1.24
Cyp4a12a
KLA
ATP
ATP+KLA
NM_177406
cytochrome P450, family 4, subfamily a, polypeptide 12a (Cyp4a12a), mRNA [NM_177406]
KLA
1.08
1.04
1.02
1.06
.98
1.05
1.05
ATP
.98
1.00
1.10
.99
.96
1.04
.98
KLA/ATP
1.07
1.05
1.11
.96
1.06
1.02
.97
Cyp4a12b
KLA
ATP
ATP+KLA
NM_172306
cytochrome P450, family 4, subfamily a, polypeptide 12B (Cyp4a12b), mRNA [NM_172306]
KLA
1.03
1.05
.95
.99
.94
1.02
1.12
ATP
.93
.99
.95
1.00
.93
.95
1.01
KLA/ATP
.98
1.01
1.09
1.00
.90
.91
.93
Cyp4a14
KLA
ATP
ATP+KLA
NM_007822
cytochrome P450, family 4, subfamily a, polypeptide 14 (Cyp4a14), mRNA [NM_007822]
KLA
.99
1.00
1.00
.97
.96
.97
1.01
ATP
.95
.95
.93
.90
.93
.99
1.03
KLA/ATP
.97
.99
1.04
.93
.95
.96
.97
Cyp4a29
KLA
ATP
ATP+KLA
NM_001100183
cytochrome P450, family 4, subfamily a, polypeptide 29 (Cyp4a29), mRNA [NM_001100183]
KLA
.94
.98
1.04
1.00
.98
1.06
1.03
ATP
1.01
1.02
1.03
1.02
1.01
1.02
.97
KLA/ATP
1.05
1.09
1.03
1.03
.97
1.02
.91
Cyp4a31
KLA
ATP
ATP+KLA
NM_201640
cytochrome P450, family 4, subfamily a, polypeptide 31 (Cyp4a31), mRNA [NM_201640]
KLA
1.14
.99
1.00
.98
1.06
1.03
.96
ATP
1.01
1.05
1.04
.91
.98
.99
.99
KLA/ATP
.99
1.03
1.04
.99
.95
.97
1.06
Cyp4f13
KLA
ATP
ATP+KLA
NM_130882
cytochrome P450, family 4, subfamily f, polypeptide 13 (Cyp4f13), mRNA [NM_130882]
KLA
.96
.94
1.02
.99
1.11
1.26
1.34
ATP
1.03
1.05
1.03
1.24
.88
.61
.88
KLA/ATP
1.05
1.02
1.01
1.13
.87
.75
1.20
Cyp4f14
KLA
ATP
ATP+KLA
NM_022434
cytochrome P450, family 4, subfamily f, polypeptide 14 (Cyp4f14), mRNA [NM_022434]
KLA
1.06
1.01
1.08
1.04
1.03
1.00
1.05
ATP
1.07
.94
.92
1.01
1.00
.97
1.06
KLA/ATP
1.04
.99
.82
.95
.93
1.05
1.11
Cyp4f15
KLA
ATP
ATP+KLA
NM_134127
cytochrome P450, family 4, subfamily f, polypeptide 15 (Cyp4f15), mRNA [NM_134127]
KLA
.98
.95
1.05
1.02
.98
.96
1.05
ATP
1.01
.98
1.09
1.03
1.03
1.02
1.08
KLA/ATP
1.02
.97
.98
.98
.99
1.01
1.02
Cyp4f16
KLA
ATP
ATP+KLA
NM_024442
cytochrome P450, family 4, subfamily f, polypeptide 16 (Cyp4f16), mRNA [NM_024442]
KLA
.87
.91
.89
.94
1.01
1.03
1.34
ATP
1.12
1.16
1.07
1.15
.88
.61
1.00
KLA/ATP
.95
1.05
.92
.98
.72
.68
1.02
Cyp4f18
KLA
ATP
ATP+KLA
NM_024444
cytochrome P450, family 4, subfamily f, polypeptide 18 (Cyp4f18), mRNA [NM_024444]
KLA
1.03
1.06
1.06
1.15
1.13
1.14
1.29
ATP
1.00
1.06
1.16
1.36
1.36
1.11
1.06
KLA/ATP
1.03
1.11
1.14
1.22
1.20
1.93
2.92
Cyp4f39
KLA
ATP
ATP+KLA
NM_177307
cytochrome P450, family 4, subfamily f, polypeptide 39 (Cyp4f39), mRNA [NM_177307]
KLA
.96
1.00
.97
1.06
1.03
1.09
1.07
ATP
.99
.95
.93
1.05
.81
.86
1.24
KLA/ATP
.97
.88
.84
.91
.89
.96
1.07
Cyp51
KLA
ATP
ATP+KLA
NM_020010
cytochrome P450, family 51 (Cyp51), mRNA [NM_020010]
KLA
1.05
1.08
1.11
.93
.82
.50
.52
ATP
1.01
1.07
1.27
1.22
.98
.75
1.09
KLA/ATP
1.06
1.10
1.09
1.03
.72
.44
.39
Cyp7a1
KLA
ATP
ATP+KLA
NM_007824
cytochrome P450, family 7, subfamily a, polypeptide 1 (Cyp7a1), mRNA [NM_007824]
KLA
1.03
.99
.97
1.00
.97
1.03
.99
ATP
.99
.99
1.02
1.04
.99
.99
1.03
KLA/ATP
1.03
1.00
.99
.99
.91
.97
.99
Cyp8b1
KLA
ATP
ATP+KLA
NM_010012
cytochrome P450, family 8, subfamily b, polypeptide 1 (Cyp8b1), mRNA [NM_010012]
KLA
.98
1.06
1.04
1.00
1.03
1.03
1.06
ATP
1.00
.99
1.02
1.04
1.06
1.01
1.09
KLA/ATP
1.08
.99
1.05
1.19
1.11
1.11
1.01
D5Wsu178
e
KLA
ATP
ATP+KLA
NM_027652
DNA segment, Chr 5, Wayne State University 178, expressed (D5Wsu178e), mRNA [NM_027652]
KLA
.78
.80
.72
.75
.69
.70
.96
ATP
1.03
1.09
1.13
1.04
1.22
1.10
.91
KLA/ATP
.78
.82
.72
.80
.96
.87
.73
Dak
KLA
ATP
ATP+KLA
NM_145496
dihydroxyacetone kinase 2 homolog (yeast) (Dak), mRNA [NM_145496]
KLA
1.00
1.03
1.04
.98
1.06
.90
.85
ATP
1.13
1.16
.89
1.01
.74
.67
.85
KLA/ATP
1.07
1.07
.90
.98
.66
.56
.81
Dao1
KLA
ATP
ATP+KLA
NM_010018
D-amino acid oxidase 1 (Dao1), mRNA [NM_010018]
KLA
1.00
.95
1.02
1.00
.97
1.03
.99
ATP
1.00
.93
.99
.92
1.02
.98
1.03
KLA/ATP
1.00
1.01
1.05
.99
1.03
1.00
1.08
Dbh
KLA
ATP
ATP+KLA
NM_138942
dopamine beta hydroxylase (Dbh), mRNA [NM_138942]
KLA
1.01
1.08
1.18
1.11
1.17
1.25
1.19
ATP
.95
1.03
1.04
1.10
1.11
1.06
1.06
KLA/ATP
1.12
1.04
1.05
1.17
1.16
1.11
1.11
Dbt
KLA
ATP
ATP+KLA
NM_010022
dihydrolipoamide branched chain transacylase E2 (Dbt), nuclear gene encoding mitochondrial protein, mRNA [NM_010022]
KLA
.98
1.06
1.02
1.14
1.31
1.11
1.09
ATP
1.04
.96
.97
1.07
.71
.84
1.09
KLA/ATP
.97
1.09
.96
.96
.79
.81
.68
Dck
KLA
ATP
ATP+KLA
NM_007832
deoxycytidine kinase (Dck), mRNA [NM_007832]
KLA
2.69
2.67
3.17
3.00
3.16
3.18
2.10
ATP
1.15
1.32
1.25
1.48
1.19
3.17
1.47
KLA/ATP
2.71
2.88
2.59
4.36
3.64
4.49
3.08
Dct
KLA
ATP
ATP+KLA
NM_010024
dopachrome tautomerase (Dct), mRNA [NM_010024]
KLA
1.01
.97
.97
1.01
1.00
.99
1.02
ATP
.97
1.00
1.00
1.00
.98
.98
1.01
KLA/ATP
.97
1.01
1.07
1.02
.97
.95
1.04
Dctd
KLA
ATP
ATP+KLA
NM_178788
dCMP deaminase (Dctd), mRNA [NM_178788]
KLA
.70
.66
.64
.65
.59
.62
.71
ATP
1.02
1.10
.86
.84
.63
.60
.62
KLA/ATP
.72
.68
.66
.62
.63
.59
.65
Dcxr
KLA
ATP
ATP+KLA
AK161732
adult male thymus cDNA, RIKEN full-length enriched library, clone:5830431D24 product:dicarbonyl L-xylulose reductase, full insert sequence [AK161732]
KLA
.98
.92
1.04
1.10
1.00
.86
.81
ATP
.94
.87
1.16
.99
.91
.72
.93
KLA/ATP
.92
.86
1.14
.92
.91
.73
.80
Dcxr
KLA
ATP
ATP+KLA
NM_026428
dicarbonyl L-xylulose reductase (Dcxr), mRNA [NM_026428]
KLA
1.10
1.11
1.23
1.31
1.68
1.35
.62
ATP
1.17
1.23
1.04
1.66
1.10
.59
.64
KLA/ATP
1.23
1.19
.99
1.74
1.06
.87
.82
Ddc
KLA
ATP
ATP+KLA
NM_016672
dopa decarboxylase (Ddc), mRNA [NM_016672]
KLA
1.27
1.28
1.34
1.33
1.34
1.21
1.05
ATP
1.02
.99
1.05
.98
1.02
1.02
1.14
KLA/ATP
1.24
1.22
1.28
1.25
1.12
1.20
1.35
Ddost
KLA
ATP
ATP+KLA
NM_007838
dolichyl-di-phosphooligosaccharide-protein glycotransferase (Ddost), mRNA [NM_007838]
KLA
.88
.99
1.00
.83
.86
.92
.96
ATP
1.11
1.34
1.05
1.20
.91
.83
.87
KLA/ATP
1.07
1.01
.77
1.11
.66
.79
.82
Degs1
KLA
ATP
ATP+KLA
NM_007853
degenerative spermatocyte homolog 1 (Drosophila) (Degs1), mRNA [NM_007853]
KLA
.83
.80
.78
.74
.58
.38
.67
ATP
1.14
1.08
1.10
1.18
1.53
1.19
.96
KLA/ATP
.88
.88
.82
.78
.76
.57
.52
Degs2
KLA
ATP
ATP+KLA
NM_027299
degenerative spermatocyte homolog 2 (Drosophila), lipid desaturase (Degs2), mRNA [NM_027299]
KLA
1.03
.99
.93
.99
1.05
1.03
.94
ATP
1.00
1.02
1.05
.97
1.06
.92
.99
KLA/ATP
1.04
1.06
1.00
.93
1.00
.94
.94
Dgat1
KLA
ATP
ATP+KLA
NM_010046
diacylglycerol O-acyltransferase 1 (Dgat1), mRNA [NM_010046]
KLA
1.05
1.03
1.09
.93
1.04
1.06
1.42
ATP
1.06
1.12
1.23
1.57
1.34
2.37
1.50
KLA/ATP
1.11
1.10
.97
1.24
1.10
2.12
2.03
Dgat2
KLA
ATP
ATP+KLA
NM_026384
diacylglycerol O-acyltransferase 2 (Dgat2), mRNA [NM_026384]
KLA
2.44
2.65
2.86
3.52
3.45
2.83
1.41
ATP
.97
.97
1.07
1.81
1.69
2.29
1.29
KLA/ATP
2.21
2.45
2.36
2.76
3.16
4.51
3.63
Dgka
KLA
ATP
ATP+KLA
NM_016811
diacylglycerol kinase, alpha (Dgka), mRNA [NM_016811]
KLA
3.34
3.15
3.23
3.20
2.95
1.29
.45
ATP
1.11
.97
1.01
.90
1.32
1.39
1.33
KLA/ATP
2.97
3.42
3.95
2.85
2.49
1.47
1.21
Dgkb
KLA
ATP
ATP+KLA
AK032509
adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430574F24 product:DIACYLGLYCEROL KINASE, BETA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK- BETA) (DAG KINASE BETA) (90 KDA DIACYLGLYCEROL KINASE) homolog [Rattus nor
KLA
.92
.92
.98
.93
1.01
1.06
1.00
ATP
1.03
1.05
.97
1.00
.95
1.03
.99
KLA/ATP
1.00
1.07
1.02
.97
1.00
.96
.97
Dgkb
KLA
ATP
ATP+KLA
AK083222
adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630029D13 product:DIACYLGLYCEROL KINASE, BETA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK- BETA) (DAG KINASE BETA) (90 KDA DIACYLGLYCEROL KINASE) homolog [Rattus norvegi
KLA
1.02
1.02
1.12
1.01
1.00
1.05
.99
ATP
.97
1.01
1.06
.95
1.07
1.03
1.03
KLA/ATP
.95
.99
1.05
1.02
1.04
.96
1.06
Dgkb
KLA
ATP
ATP+KLA
AK122355
mRNA for mKIAA0718 protein [AK122355]
KLA
1.03
.96
1.11
1.02
.95
.94
.97
ATP
1.00
.99
1.09
1.01
1.02
.96
.95
KLA/ATP
.97
1.00
1.05
1.03
.95
1.02
.95
Dgkb
KLA
ATP
ATP+KLA
NM_178681
diacylglycerol kinase, beta (Dgkb), mRNA [NM_178681]
KLA
1.05
1.08
1.03
1.04
.94
1.01
1.04
ATP
1.04
1.02
1.04
.95
1.01
1.03
1.05
KLA/ATP
1.09
.95
1.00
1.03
1.06
1.05
1.05
Dgkd
KLA
ATP
ATP+KLA
AK076439
0 day neonate head cDNA, RIKEN full-length enriched library, clone:4832425N18 product:DIACYLGLYCEROL KINASE, DELTA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK-DELTA) (DAG KINASE DELTA) (130 KDA DIACYLGLYCEROL KINASE) (FRAGMENT) homolog [Homo
KLA
.43
.42
.38
.38
.44
.36
.28
ATP
1.08
1.06
.96
1.28
1.01
.42
.25
KLA/ATP
.42
.41
.38
.39
.46
.40
.23
Dgkd
KLA
ATP
ATP+KLA
AK172901
mRNA for mKIAA0145 protein [AK172901]
KLA
.27
.25
.22
.22
.23
.23
.22
ATP
.87
.79
.81
.66
.58
.34
.31
KLA/ATP
.22
.22
.19
.15
.20
.22
.15
Dgke
KLA
ATP
ATP+KLA
NM_019505
diacylglycerol kinase, epsilon (Dgke), mRNA [NM_019505]
KLA
1.17
1.16
1.09
.92
.86
.99
1.25
ATP
1.02
1.01
.92
.79
.99
1.14
1.10
KLA/ATP
1.19
1.16
.98
.87
.97
1.05
.88
Dgkg
KLA
ATP
ATP+KLA
AK089261
NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630107L03 product:SIMILAR TO DIACYLGLYCEROL KINASE 3 (GAMMA) homolog [Mus musculus], full insert sequence. [AK089261]
KLA
.95
.91
.97
.98
.97
.93
.96
ATP
1.04
1.02
.96
.93
.98
.89
.88
KLA/ATP
1.02
.99
.92
.86
.95
.92
.90
Dgkg
KLA
ATP
ATP+KLA
NM_138650
diacylglycerol kinase, gamma (Dgkg), mRNA [NM_138650]
KLA
.65
.64
.62
.78
.86
.68
.53
ATP
.92
.99
1.04
.83
.67
.71
.55
KLA/ATP
.60
.66
.66
.65
.84
1.00
.59
Dgkh
KLA
ATP
ATP+KLA
AK031069
13 days embryo forelimb cDNA, RIKEN full-length enriched library, clone:5930402B05 product:DIACYLGLYCEROL KINASE, DELTA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK- DELTA) (DAG KINASE DELTA) (130 KDA DIACYLGLYCEROL KINASE) (DIACYLGLYCEROL KI
KLA
3.02
2.91
2.42
2.25
1.93
1.46
1.40
ATP
1.04
1.08
1.10
1.28
1.46
1.35
.98
KLA/ATP
3.66
4.04
3.53
1.88
1.69
1.34
1.47
Dgkh
KLA
ATP
ATP+KLA
NM_001081336
diacylglycerol kinase, eta (Dgkh), mRNA [NM_001081336]
KLA
6.71
7.34
7.44
7.69
6.90
4.13
3.15
ATP
.98
.96
1.02
1.20
2.01
3.95
2.09
KLA/ATP
6.79
7.17
6.53
7.03
4.73
5.21
5.62
Dgki
KLA
ATP
ATP+KLA
AK086550
15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930036J18 product:DIACYLGLYCEROL KINASE, IOTA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK- IOTA) (DAG KINASE IOTA) homolog [Homo sapiens], full insert sequence. [AK086550]
KLA
1.03
1.00
.96
1.07
1.00
1.08
.95
ATP
1.06
.99
1.02
.96
.98
1.02
1.03
KLA/ATP
.99
.99
.99
.97
.99
.92
.99
Dgki
KLA
ATP
ATP+KLA
NM_001081206
diacylglycerol kinase, iota (Dgki), mRNA [NM_001081206]
KLA
.99
.96
.89
.99
.92
.98
1.02
ATP
1.00
1.01
.95
1.00
.95
.90
1.02
KLA/ATP
.91
.86
1.02
.99
1.02
.90
.98
Dgkq
KLA
ATP
ATP+KLA
NM_199011
diacylglycerol kinase, theta (Dgkq), mRNA [NM_199011]
KLA
1.09
.95
1.05
.98
.93
.96
1.11
ATP
.99
.78
.66
.44
.99
1.04
1.23
KLA/ATP
.98
.73
.66
.47
.67
.89
1.15
Dgkz
KLA
ATP
ATP+KLA
NM_138306
diacylglycerol kinase zeta (Dgkz), mRNA [NM_138306]
KLA
.21
.22
.23
.29
.56
1.23
1.39
ATP
1.08
1.25
.90
1.22
.85
.57
1.44
KLA/ATP
.23
.22
.18
.31
.60
.80
1.45
Dguok
KLA
ATP
ATP+KLA
NM_013764
deoxyguanosine kinase (Dguok), nuclear gene encoding mitochondrial protein, mRNA [NM_013764]
KLA
.83
.71
.91
.93
1.12
1.27
.96
ATP
1.13
.93
1.13
1.04
.65
.51
.91
KLA/ATP
.81
.79
1.05
.80
.90
.68
.86
Dhcr24
KLA
ATP
ATP+KLA
NM_053272
24-dehydrocholesterol reductase (Dhcr24), mRNA [NM_053272]
KLA
.50
.50
.44
.42
.35
.28
.36
ATP
1.09
1.12
1.01
1.09
.72
.43
1.05
KLA/ATP
.51
.54
.46
.54
.33
.22
.18
Dhcr7
KLA
ATP
ATP+KLA
NM_007856
7-dehydrocholesterol reductase (Dhcr7), mRNA [NM_007856]
KLA
.58
.54
.52
.49
.39
.47
.71
ATP
1.01
1.09
1.17
1.19
.71
.39
.74
KLA/ATP
.58
.56
.58
.64
.47
.45
.32
Dhfr
KLA
ATP
ATP+KLA
L26316
dihydrofolate reductase (dhfr) mRNA, complete cds. [L26316]
KLA
.63
.69
.61
.62
.53
.57
.45
ATP
.93
.93
1.10
1.12
.84
.49
.39
KLA/ATP
.66
.59
.72
.74
.67
.65
.90
Dhfr
KLA
ATP
ATP+KLA
NM_010049
dihydrofolate reductase (Dhfr), mRNA [NM_010049]
KLA
.52
.51
.48
.47
.39
.49
.33
ATP
.90
.90
1.13
1.05
.76
.40
.28
KLA/ATP
.46
.48
.58
.59
.59
.57
.68
Dhodh
KLA
ATP
ATP+KLA
NM_020046
dihydroorotate dehydrogenase (Dhodh), nuclear gene encoding mitochondrial protein, mRNA [NM_020046]
KLA
.75
.68
.63
.77
.65
.59
.86
ATP
1.10
1.01
1.16
1.14
.95
.53
.71
KLA/ATP
.70
.74
.85
.83
.64
.54
.42
Dhrs3
KLA
ATP
ATP+KLA
NM_011303
dehydrogenase/reductase (SDR family) member 3 (Dhrs3), mRNA [NM_011303]
KLA
.40
.37
.41
.39
.50
.67
.72
ATP
1.15
1.16
.94
1.04
.84
.34
.92
KLA/ATP
.47
.44
.35
.40
.48
.49
.89
Dhrs4
KLA
ATP
ATP+KLA
NM_030686
dehydrogenase/reductase (SDR family) member 4 (Dhrs4), transcript variant 2, mRNA [NM_030686]
KLA
.94
1.05
1.17
.99
.96
.84
.74
ATP
1.03
1.09
1.11
1.45
1.11
.79
.88
KLA/ATP
1.10
1.17
1.19
1.38
1.09
.87
.69
Dhrs9
KLA
ATP
ATP+KLA
AK089247
NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630104J01 product:RETINOL DEHYDROGENASE HOMOLOG ISOFORM-2 homolog [Homo sapiens], full insert sequence [AK089247]
KLA
1.17
1.17
1.22
1.43
1.27
1.05
.64
ATP
1.09
1.08
1.50
1.44
1.47
1.25
2.42
KLA/ATP
1.06
1.17
1.87
1.67
1.52
1.25
1.91
Dhrs9
KLA
ATP
ATP+KLA
NM_175512
dehydrogenase/reductase (SDR family) member 9 (Dhrs9), mRNA [NM_175512]
KLA
1.04
1.13
1.20
1.23
1.16
1.05
1.00
ATP
1.04
1.21
1.12
1.45
1.05
1.06
2.49
KLA/ATP
1.13
1.25
1.10
1.35
.98
1.26
1.97
Dlat
KLA
ATP
ATP+KLA
NM_145614
dihydrolipoamide S-acetyltransferase (E2 component of pyruvate dehydrogenase complex) (Dlat), mRNA [NM_145614]
KLA
1.00
1.05
1.03
.95
.87
.83
1.15
ATP
.94
1.01
1.22
1.09
.80
.57
.91
KLA/ATP
.96
1.01
1.05
.98
.70
.48
.54
Dld
KLA
ATP
ATP+KLA
NM_007861
dihydrolipoamide dehydrogenase (Dld), mRNA [NM_007861]
KLA
1.60
1.66
1.84
1.66
1.47
1.16
1.17
ATP
1.05
1.08
1.21
1.06
1.15
1.24
.93
KLA/ATP
1.52
1.63
1.65
1.42
1.17
1.05
.79
Dld
KLA
ATP
ATP+KLA
U73445
dihydrolipoamide dehydrogenase (Dld) mRNA, complete cds. [U73445]
KLA
1.48
1.43
1.43
1.47
1.25
1.05
1.16
ATP
.94
.93
1.18
.86
1.02
1.46
.97
KLA/ATP
1.39
1.37
1.50
1.10
1.11
1.14
.85
Dlst
KLA
ATP
ATP+KLA
AK171100
NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630223O05 product:dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex), full insert sequence [AK171100]
KLA
.90
.87
.88
.83
1.10
.86
1.09
ATP
.97
.78
.47
.80
2.22
1.46
1.21
KLA/ATP
1.00
.91
.66
.76
1.24
1.06
1.04
Dlst
KLA
ATP
ATP+KLA
NM_030225
dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) (Dlst), mRNA [NM_030225]
KLA
1.15
1.22
1.20
1.11
1.02
.97
1.13
ATP
1.02
1.01
1.02
.95
1.01
1.36
1.19
KLA/ATP
1.23
1.29
1.23
1.19
.99
.98
.99
Dmgdh
KLA
ATP
ATP+KLA
NM_028772
dimethylglycine dehydrogenase precursor (Dmgdh), nuclear gene encoding mitochondrial protein, mRNA [NM_028772]
KLA
.97
1.02
.98
.99
1.02
.92
.99
ATP
1.04
.94
.91
1.03
1.04
.94
1.01
KLA/ATP
.95
.97
.99
.99
.98
1.06
1.02
Dnmt1
KLA
ATP
ATP+KLA
NM_010066
DNA methyltransferase (cytosine-5) 1 (Dnmt1), mRNA [NM_010066]
KLA
.32
.30
.28
.26
.32
.58
.51
ATP
.94
1.04
.99
.78
.75
.47
.68
KLA/ATP
.33
.31
.30
.30
.56
.66
.52
Dnmt3a
KLA
ATP
ATP+KLA
NM_007872
DNA methyltransferase 3A (Dnmt3a), transcript variant 1, mRNA [NM_007872]
KLA
.58
.57
.54
.54
.65
.85
.94
ATP
1.01
1.05
1.03
1.60
2.57
1.20
2.38
KLA/ATP
.59
.60
.65
1.00
2.83
2.61
2.34
Dnmt3a
KLA
ATP
ATP+KLA
NM_153743
DNA methyltransferase 3A (Dnmt3a), transcript variant 2, mRNA [NM_153743]
KLA
.46
.49
.44
.48
.60
.82
.90
ATP
.90
.86
.91
1.13
2.27
.71
2.86
KLA/ATP
.43
.49
.58
.72
2.57
1.56
2.61
Dnmt3b
KLA
ATP
ATP+KLA
NM_001003961
DNA methyltransferase 3B (Dnmt3b), transcript variant 1, mRNA [NM_001003961]
KLA
.74
.72
.79
.63
.66
.62
.62
ATP
1.02
.92
.95
.66
.63
.90
.74
KLA/ATP
.68
.74
.78
.61
.59
.69
.58
Dnmt3l
KLA
ATP
ATP+KLA
NM_019448
DNA (cytosine-5-)-methyltransferase 3-like (Dnmt3l), transcript variant 1, mRNA [NM_019448]
KLA
1.22
1.26
1.09
1.10
1.00
1.56
4.71
ATP
.97
1.05
1.19
1.16
1.91
11.10
2.62
KLA/ATP
1.30
1.33
1.44
1.18
1.29
5.28
5.91
Dolk
KLA
ATP
ATP+KLA
NM_177648
dolichol kinase (Dolk), mRNA [NM_177648]
KLA
.55
.54
.57
.56
.59
.71
.77
ATP
.91
.89
.74
.44
.28
.25
.78
KLA/ATP
.57
.53
.44
.34
.28
.20
.27
Dpagt1
KLA
ATP
ATP+KLA
NM_007875
dolichyl-phosphate (UDP-N-acetylglucosamine) acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase) (Dpagt1), mRNA [NM_007875]
KLA
.72
.75
.76
.66
.61
.52
.61
ATP
1.07
1.04
1.06
.99
.89
.67
.69
KLA/ATP
.81
.75
.80
.69
.58
.41
.35
Dpm1
KLA
ATP
ATP+KLA
NM_010072
dolichol-phosphate (beta-D) mannosyltransferase 1 (Dpm1), mRNA [NM_010072]
KLA
.89
.88
.83
.96
.90
.85
.84
ATP
.93
.86
1.07
.88
.80
.81
.86
KLA/ATP
.85
.79
.99
.84
.82
.76
.67
Dpm2
KLA
ATP
ATP+KLA
NM_010073
dolichol-phosphate (beta-D) mannosyltransferase 2 (Dpm2), mRNA [NM_010073]
KLA
.83
.89
.88
.88
1.15
1.34
1.44
ATP
.99
1.01
.87
.98
1.09
1.49
1.65
KLA/ATP
.90
.82
.73
.93
1.04
1.74
2.55
Dpm3
KLA
ATP
ATP+KLA
NM_026767
dolichyl-phosphate mannosyltransferase polypeptide 3 (Dpm3), mRNA [NM_026767]
KLA
1.10
1.06
.99
1.08
.96
1.08
.91
ATP
.93
.97
1.24
1.24
1.12
1.03
1.00
KLA/ATP
1.07
1.15
1.24
1.28
1.15
1.07
1.05
Dpyd
KLA
ATP
ATP+KLA
NM_170778
dihydropyrimidine dehydrogenase (Dpyd), mRNA [NM_170778]
KLA
.94
.95
1.00
.98
.99
.98
.97
ATP
1.04
.95
1.02
1.01
1.02
1.02
.98
KLA/ATP
1.03
.98
.98
1.02
1.02
1.05
.93
Dse
KLA
ATP
ATP+KLA
NM_172508
dermatan sulfate epimerase (Dse), mRNA [NM_172508]
KLA
4.51
4.22
4.21
3.25
2.18
1.50
1.26
ATP
1.04
1.26
1.07
1.08
.92
.85
.88
KLA/ATP
3.97
4.74
3.69
4.03
1.65
.68
.90
Dtymk
KLA
ATP
ATP+KLA
NM_001105667
deoxythymidylate kinase (Dtymk), transcript variant 1, mRNA [NM_001105667]
KLA
.62
.62
.59
.51
.46
.53
.50
ATP
1.02
.99
1.24
1.08
.67
.33
.36
KLA/ATP
.60
.58
.73
.64
.47
.31
.26
Dtymk
KLA
ATP
ATP+KLA
NM_023136
deoxythymidylate kinase (Dtymk), transcript variant 2, mRNA [NM_023136]
KLA
.69
.65
.55
.62
.39
.37
.38
ATP
.90
.88
1.44
1.32
.99
.48
.33
KLA/ATP
.57
.63
.88
.81
.67
.35
.14
Dut
KLA
ATP
ATP+KLA
NM_023595
deoxyuridine triphosphatase (Dut), nuclear gene encoding mitochondrial protein, mRNA [NM_023595]
KLA
.50
.47
.37
.34
.18
.14
.16
ATP
1.01
.97
1.27
1.27
.94
.23
.17
KLA/ATP
.47
.48
.62
.52
.41
.22
.12
Ears2
KLA
ATP
ATP+KLA
AK129469
mRNA for mKIAA1970 protein [AK129469]
KLA
.84
.88
.83
.81
.86
.92
.97
ATP
.98
.97
.85
.85
.90
.92
.86
KLA/ATP
.85
.84
.85
.97
.90
.95
.90
Ears2
KLA
ATP
ATP+KLA
NM_026140
glutamyl-tRNA synthetase 2 (mitochondrial)(putative) (Ears2), nuclear gene encoding mitochondrial protein, mRNA [NM_026140]
KLA
.75
.73
.71
.69
.75
.84
1.22
ATP
1.12
1.02
.87
.70
.41
.53
.83
KLA/ATP
.79
.84
.72
.56
.42
.38
.44
Ebp
KLA
ATP
ATP+KLA
NM_007898
phenylalkylamine Ca2+ antagonist (emopamil) binding protein (Ebp), mRNA [NM_007898]
KLA
.77
.75
.66
.77
.61
.71
.67
ATP
.83
.83
1.15
.99
.88
.83
.95
KLA/ATP
.67
.72
.95
.79
.86
.75
.74
Echs1
KLA
ATP
ATP+KLA
NM_053119
enoyl Coenzyme A hydratase, short chain, 1, mitochondrial (Echs1), nuclear gene encoding mitochondrial protein, mRNA [NM_053119]
KLA
.57
.55
.52
.54
.60
.82
.90
ATP
.99
.97
1.07
1.15
.77
.37
.81
KLA/ATP
.55
.56
.55
.66
.53
.39
.41
Ehhadh
KLA
ATP
ATP+KLA
NM_023737
enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase (Ehhadh), mRNA [NM_023737]
KLA
.74
.77
.80
.88
.71
.67
.74
ATP
1.02
1.06
1.04
.90
.70
.84
.83
KLA/ATP
.79
.81
.80
.65
.59
.79
.55
Eno1
KLA
ATP
ATP+KLA
NM_023119
enolase 1, alpha non-neuron (Eno1), mRNA [NM_023119]
KLA
.95
1.06
1.16
.78
1.04
.91
1.33
ATP
1.32
1.63
.81
1.78
1.08
1.07
1.65
KLA/ATP
1.50
1.43
.46
1.67
.61
1.02
1.97
Eno2
KLA
ATP
ATP+KLA
NM_013509
enolase 2, gamma neuronal (Eno2), mRNA [NM_013509]
KLA
.84
.85
.72
.81
1.23
1.24
2.08
ATP
1.07
1.13
1.14
3.24
4.11
1.61
2.43
KLA/ATP
.93
.89
.85
1.68
3.37
1.66
2.69
Eno3
KLA
ATP
ATP+KLA
NM_007933
enolase 3, beta muscle (Eno3), mRNA [NM_007933]
KLA
.85
.86
.88
.84
.67
.70
1.00
ATP
.92
.90
1.28
1.20
.96
.59
.68
KLA/ATP
.82
.90
1.10
.99
.94
.52
.51
Enpp1
KLA
ATP
ATP+KLA
ENSMUST00000105520
ens|Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (E- NPP 1) (Phosphodiesterase I/nucleotide pyrophosphatase 1) (Plasma-cell membrane glycoprotein PC-1) (Lymphocyte antigen 41) (Ly-41) [Includes: Alkaline phosphodiesterase I (EC 3.1.4.1
KLA
.71
.79
.64
.61
.55
.51
.32
ATP
.85
.97
.85
.72
.62
.45
.28
KLA/ATP
.72
.73
.61
.66
.60
.55
.27
Enpp1
KLA
ATP
ATP+KLA
NM_008813
ectonucleotide pyrophosphatase/phosphodiesterase 1 (Enpp1), mRNA [NM_008813]
KLA
.82
.83
.77
.83
.65
.64
.51
ATP
.89
.90
1.21
1.00
.98
.87
.64
KLA/ATP
.72
.76
.96
.87
1.00
.94
.51
Enpp3
KLA
ATP
ATP+KLA
BC005527
ectonucleotide pyrophosphatase [BC005527]
KLA
1.06
.99
.98
1.01
.97
.99
.96
ATP
.93
1.08
.99
1.05
.94
1.05
1.10
KLA/ATP
.95
.96
1.10
.99
.95
.94
1.03
Enpp3
KLA
ATP
ATP+KLA
BC006944
ectonucleotide pyrophosphatase/phosphodiesterase 3, mRNA (cDNA clone IMAGE:2655671), complete cds. [BC006944]
KLA
1.02
1.01
1.03
1.08
1.04
1.01
1.01
ATP
.97
1.01
.96
1.00
.98
1.07
.99
KLA/ATP
1.01
.99
1.07
1.02
.97
.98
.92
Enpp3
KLA
ATP
ATP+KLA
NM_134005
ectonucleotide pyrophosphatase/phosphodiesterase 3 (Enpp3), mRNA [NM_134005]
KLA
1.01
.95
.99
.98
1.05
1.04
.98
ATP
.98
.98
1.03
.98
.96
1.00
.98
KLA/ATP
.97
1.03
1.04
.93
1.02
.99
1.04
Enpp7
KLA
ATP
ATP+KLA
NM_001030291
ectonucleotide pyrophosphatase/phosphodiesterase 7 (Enpp7), mRNA [NM_001030291]
KLA
1.00
1.03
1.01
1.01
.95
1.07
1.05
ATP
1.01
1.01
.99
.99
1.04
.98
1.01
KLA/ATP
.96
.96
.95
.96
1.02
1.01
.99
Ephx2
KLA
ATP
ATP+KLA
NM_007940
epoxide hydrolase 2, cytoplasmic (Ephx2), mRNA [NM_007940]
KLA
1.03
.96
.96
1.03
1.02
1.03
.87
ATP
.97
.95
1.09
1.08
1.00
1.06
.96
KLA/ATP
.97
1.03
1.07
1.09
1.13
.98
1.00
Eprs
KLA
ATP
ATP+KLA
NM_029735
glutamyl-prolyl-tRNA synthetase (Eprs), mRNA [NM_029735]
KLA
.91
.97
.84
.80
.73
.74
1.32
ATP
.97
1.13
1.17
1.10
1.19
.83
1.03
KLA/ATP
.95
.98
.91
.76
.72
.61
.70
Es1
KLA
ATP
ATP+KLA
NM_007954
esterase 1 (Es1), mRNA [NM_007954]
KLA
1.02
1.01
.99
1.03
1.03
1.00
1.03
ATP
.98
1.03
1.05
1.00
.97
1.03
1.05
KLA/ATP
1.02
1.01
.99
1.03
1.00
1.01
.99
Es22
KLA
ATP
ATP+KLA
NM_133660
esterase 22 (Es22), mRNA [NM_133660]
KLA
1.14
1.11
1.11
1.11
1.03
1.00
1.00
ATP
1.01
.94
1.00
.95
1.01
.97
.96
KLA/ATP
1.05
1.13
1.08
1.01
1.00
1.00
1.02
Etnk1
KLA
ATP
ATP+KLA
XM_908334
gb|PREDICTED: Mus musculus ethanolamine kinase 1 (Etnk1), mRNA [XM_908334]
KLA
5.38
5.56
5.81
5.53
4.73
4.65
2.51
ATP
1.01
1.05
1.13
1.21
1.24
2.34
2.30
KLA/ATP
5.41
5.64
5.14
6.04
5.38
4.90
5.42
Etnk2
KLA
ATP
ATP+KLA
NM_175443
ethanolamine kinase 2 (Etnk2), mRNA [NM_175443]
KLA
3.96
3.87
3.49
2.74
1.76
1.22
1.04
ATP
1.03
1.09
1.14
1.15
1.11
1.20
1.10
KLA/ATP
3.78
3.98
3.07
2.56
1.95
1.49
1.15
Ext1
KLA
ATP
ATP+KLA
NM_010162
exostoses (multiple) 1 (Ext1), mRNA [NM_010162]
KLA
8.02
9.48
10.78
9.03
6.83
4.24
1.43
ATP
1.00
.94
.88
1.62
4.37
4.32
1.35
KLA/ATP
9.43
9.15
8.69
10.86
8.81
4.92
3.46
Ext2
KLA
ATP
ATP+KLA
NM_010163
exostoses (multiple) 2 (Ext2), mRNA [NM_010163]
KLA
.99
.95
.85
.85
.72
.67
.60
ATP
1.07
1.02
1.01
.90
.70
.49
.86
KLA/ATP
.99
.91
.88
.85
.58
.50
.64
Extl1
KLA
ATP
ATP+KLA
NM_019578
exostoses (multiple)-like 1 (Extl1), mRNA [NM_019578]
KLA
1.03
1.03
1.03
.99
1.03
.95
.97
ATP
1.03
1.09
1.03
.94
.99
.98
1.02
KLA/ATP
.99
1.01
1.01
1.07
.95
.92
.95
Extl2
KLA
ATP
ATP+KLA
NM_021388
exostoses (multiple)-like 2 (Extl2), mRNA [NM_021388]
KLA
1.36
1.48
1.15
1.02
.99
1.10
.79
ATP
1.09
1.00
.81
1.52
1.76
.97
1.13
KLA/ATP
1.63
1.39
1.03
1.04
.96
.73
.78
Extl3
KLA
ATP
ATP+KLA
NM_018788
exostoses (multiple)-like 3 (Extl3), mRNA [NM_018788]
KLA
.83
.84
.88
.82
.79
.91
1.10
ATP
.98
1.03
.90
.74
.63
.82
1.25
KLA/ATP
.87
.87
.81
.70
.67
.73
1.10
Fah
KLA
ATP
ATP+KLA
NM_010176
fumarylacetoacetate hydrolase (Fah), mRNA [NM_010176]
KLA
1.01
1.09
1.04
1.13
1.02
.76
.69
ATP
1.09
1.09
1.02
1.22
1.08
.90
.58
KLA/ATP
1.14
1.09
1.13
1.19
.97
.91
.65
Fahd1
KLA
ATP
ATP+KLA
NM_023480
fumarylacetoacetate hydrolase domain containing 1 (Fahd1), nuclear gene encoding mitochondrial protein, mRNA [NM_023480]
KLA
.36
.34
.34
.40
.42
.55
.63
ATP
.88
.86
.83
.71
.35
.42
.73
KLA/ATP
.34
.32
.39
.36
.37
.41
.52
Fasn
KLA
ATP
ATP+KLA
NM_007988
fatty acid synthase (Fasn), mRNA [NM_007988]
KLA
.51
.49
.46
.44
.41
.35
.41
ATP
.98
.93
.98
.96
.83
.67
.62
KLA/ATP
.52
.47
.48
.58
.51
.44
.25
Fbp1
KLA
ATP
ATP+KLA
NM_019395
fructose bisphosphatase 1 (Fbp1), mRNA [NM_019395]
KLA
.91
.95
1.03
1.01
1.00
1.02
.80
ATP
.96
.96
.99
.95
.86
.84
.64
KLA/ATP
.88
.96
.87
.92
.92
.84
.70
Fbp2
KLA
ATP
ATP+KLA
NM_007994
fructose bisphosphatase 2 (Fbp2), mRNA [NM_007994]
KLA
1.03
1.03
.95
1.02
1.02
1.03
1.06
ATP
1.03
1.03
1.05
1.01
.97
1.01
1.17
KLA/ATP
.96
.92
1.06
.85
1.07
.97
1.12
Fdft1
KLA
ATP
ATP+KLA
NM_010191
farnesyl diphosphate farnesyl transferase 1 (Fdft1), mRNA [NM_010191]
KLA
.96
.99
.98
.99
.88
.78
.77
ATP
1.00
1.01
1.08
1.10
.93
1.02
1.28
KLA/ATP
.98
.97
.98
1.04
.97
.87
.73
Fdps
KLA
ATP
ATP+KLA
AK077979
13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030492I17 product:farnesyl diphosphate synthetase, full insert sequence. [AK077979]
KLA
.76
.79
.79
.69
.65
.37
.49
ATP
.63
.70
.85
.30
.46
.89
.86
KLA/ATP
.54
.52
.63
.39
.42
.40
.31
Fdps
KLA
ATP
ATP+KLA
NM_134469
farnesyl diphosphate synthetase (Fdps), mRNA [NM_134469]
KLA
.87
.93
.89
.97
.76
.43
.48
ATP
1.12
1.10
1.05
1.23
1.05
.60
.88
KLA/ATP
.93
.99
1.00
1.02
.70
.45
.33
Fech
KLA
ATP
ATP+KLA
NM_007998
ferrochelatase (Fech), nuclear gene encoding mitochondrial protein, mRNA [NM_007998]
KLA
.93
.80
.68
.81
.65
.59
.57
ATP
.97
.91
1.31
.95
.74
.97
.77
KLA/ATP
.65
.77
.98
.70
.62
.64
.52
Fh1
KLA
ATP
ATP+KLA
NM_010209
fumarate hydratase 1 (Fh1), mRNA [NM_010209]
KLA
1.00
.88
.79
.83
.55
.36
.39
ATP
1.05
1.05
1.08
.98
.89
.49
.45
KLA/ATP
.91
.95
1.06
.92
.72
.41
.18
Flad1
KLA
ATP
ATP+KLA
NM_177041
RFad1, flavin adenine dinucleotide synthetase, homolog (yeast) (Flad1), mRNA [NM_177041]
KLA
.86
.91
.90
1.00
1.13
1.42
1.85
ATP
.94
.96
.95
.99
.68
1.02
2.24
KLA/ATP
.84
.82
.78
.87
.70
1.08
2.77
Fpgs
KLA
ATP
ATP+KLA
NM_010236
folylpolyglutamyl synthetase (Fpgs), nuclear gene encoding mitochondrial protein, mRNA [NM_010236]
KLA
.45
.40
.39
.37
.40
.40
.69
ATP
.98
.87
1.10
.89
.80
.93
.82
KLA/ATP
.46
.39
.44
.39
.59
.56
.43
Fpgt
KLA
ATP
ATP+KLA
AK030969
adult male thymus cDNA, RIKEN full-length enriched library, clone:5830472G17 product:unclassifiable, full insert sequence. [AK030969]
KLA
.98
1.01
1.03
1.02
.99
.99
1.07
ATP
1.04
.96
.98
.98
.99
1.02
.99
KLA/ATP
1.03
.94
.87
1.01
1.02
1.01
1.03
Fpgt
KLA
ATP
ATP+KLA
NM_029330
fucose-1-phosphate guanylyltransferase (Fpgt), mRNA [NM_029330]
KLA
1.06
1.10
1.12
1.10
1.13
1.14
1.23
ATP
.99
.98
.91
.84
1.02
1.31
1.51
KLA/ATP
1.05
1.02
.93
.87
.99
1.52
1.55
Ftcd
KLA
ATP
ATP+KLA
NM_080845
formiminotransferase cyclodeaminase (Ftcd), mRNA [NM_080845]
KLA
1.01
.93
.98
.93
.99
1.06
1.05
ATP
1.01
1.00
.96
.96
.95
.93
1.04
KLA/ATP
1.00
.99
.99
.97
.98
.92
.93
Fuk
KLA
ATP
ATP+KLA
NM_172283
fucokinase (Fuk), transcript variant 1, mRNA [NM_172283]
KLA
.74
.78
.76
.78
.75
.87
.85
ATP
.91
.92
1.22
.75
.54
1.26
1.16
KLA/ATP
.73
.74
.95
.64
.72
1.37
1.01
Fut1
KLA
ATP
ATP+KLA
NM_008051
fucosyltransferase 1 (Fut1), mRNA [NM_008051]
KLA
.94
1.00
.99
1.00
.97
.98
1.00
ATP
1.05
.97
1.00
.99
1.04
1.00
.98
KLA/ATP
1.01
1.02
.99
1.02
1.06
1.04
.99
Fut2
KLA
ATP
ATP+KLA
NM_018876
fucosyltransferase 2 (Fut2), mRNA [NM_018876]
KLA
.97
.97
1.01
1.02
.98
1.04
1.01
ATP
1.05
1.00
.97
.99
1.05
1.02
1.07
KLA/ATP
1.00
.99
1.03
1.00
1.03
.99
1.07
Fut4
KLA
ATP
ATP+KLA
NM_010242
fucosyltransferase 4 (Fut4), mRNA [NM_010242]
KLA
.90
.81
.83
.74
.60
.54
.76
ATP
1.13
.97
.68
.48
1.03
.99
.60
KLA/ATP
.89
.89
.65
.50
.67
.78
.43
Fut7
KLA
ATP
ATP+KLA
NM_013524
fucosyltransferase 7 (Fut7), mRNA [NM_013524]
KLA
.32
.32
.32
.49
.61
.56
.53
ATP
.95
.77
.83
.56
.29
.40
.60
KLA/ATP
.28
.28
.35
.29
.29
.26
.40
Fut8
KLA
ATP
ATP+KLA
NM_016893
fucosyltransferase 8 (Fut8), mRNA [NM_016893]
KLA
1.94
2.07
2.76
2.41
2.70
1.87
1.31
ATP
1.04
1.15
1.04
1.06
.69
.88
1.12
KLA/ATP
1.99
2.22
1.76
2.02
1.28
1.78
1.60
Fut9
KLA
ATP
ATP+KLA
NM_010243
fucosyltransferase 9 (Fut9), mRNA [NM_010243]
KLA
.99
.99
1.02
1.02
1.02
1.02
.98
ATP
.99
1.01
.99
.98
1.01
.99
1.04
KLA/ATP
1.00
.97
1.06
1.00
.96
1.01
.96
G6pc
KLA
ATP
ATP+KLA
NM_008061
glucose-6-phosphatase, catalytic (G6pc), mRNA [NM_008061]
KLA
.96
.94
1.04
1.07
1.09
1.06
1.02
ATP
.98
1.05
1.09
1.04
1.05
1.00
1.01
KLA/ATP
1.03
1.05
1.06
.96
1.02
1.00
.99
G6pc2
KLA
ATP
ATP+KLA
NM_021331
glucose-6-phosphatase, catalytic, 2 (G6pc2), mRNA [NM_021331]
KLA
.99
1.03
1.00
.98
.95
1.02
.98
ATP
.95
1.06
.97
1.08
1.16
1.26
1.04
KLA/ATP
.94
.99
1.05
6.99
3.55
1.48
1.11
G6pc3
KLA
ATP
ATP+KLA
NM_175935
glucose 6 phosphatase, catalytic, 3 (G6pc3), mRNA [NM_175935]
KLA
.88
.89
.89
.80
.75
.68
.88
ATP
.99
1.05
.95
1.14
.92
.64
.81
KLA/ATP
.92
.90
.79
.94
.70
.62
.58
G6pd2
KLA
ATP
ATP+KLA
NM_019468
glucose-6-phosphate dehydrogenase 2 (G6pd2), mRNA [NM_019468]
KLA
1.07
1.13
1.31
.96
1.22
1.19
1.70
ATP
1.23
1.51
.85
1.48
.93
.89
1.34
KLA/ATP
1.56
1.52
.71
1.40
.72
1.04
2.61
G6pdx
KLA
ATP
ATP+KLA
NM_008062
glucose-6-phosphate dehydrogenase X-linked (G6pdx), mRNA [NM_008062]
KLA
.77
.81
.85
.74
.84
.90
1.44
ATP
1.11
1.12
.85
.85
.76
.86
1.07
KLA/ATP
.96
.88
.63
.72
.58
.77
1.91
Gaa
KLA
ATP
ATP+KLA
NM_008064
glucosidase, alpha, acid (Gaa), mRNA [NM_008064]
KLA
.85
.84
.84
.78
.83
.87
1.18
ATP
.97
.96
.75
.78
.74
.72
1.01
KLA/ATP
.88
.91
.78
.78
.71
.71
.86
Gad1
KLA
ATP
ATP+KLA
AK054554
10 days neonate olfactory brain cDNA, RIKEN full-length enriched library, clone:E530004P22 product:glutamic acid decarboxylase 1, full insert sequence. [AK054554]
KLA
1.03
1.00
1.00
1.00
1.00
.98
1.10
ATP
1.03
.91
1.01
1.05
.99
.97
1.08
KLA/ATP
.97
.99
.99
1.10
1.02
1.09
.96
Gad1
KLA
ATP
ATP+KLA
NM_008077
glutamic acid decarboxylase 1 (Gad1), mRNA [NM_008077]
KLA
1.03
.99
1.00
1.01
1.01
.97
.99
ATP
1.02
1.02
1.01
.99
1.02
1.03
.98
KLA/ATP
.96
1.03
1.04
.99
.99
1.04
1.01
Gad2
KLA
ATP
ATP+KLA
NM_008078
glutamic acid decarboxylase 2 (Gad2), mRNA [NM_008078]
KLA
1.03
1.07
1.11
1.11
1.04
.99
1.07
ATP
.97
.99
1.02
1.02
1.01
.95
.97
KLA/ATP
1.05
1.08
1.04
1.01
1.00
1.06
1.00
Gal3st1
KLA
ATP
ATP+KLA
NM_016922
galactose-3-O-sulfotransferase 1 (Gal3st1), mRNA [NM_016922]
KLA
1.02
.94
.99
.97
.97
.95
.97
ATP
.97
1.03
.97
1.04
1.02
.98
.96
KLA/ATP
.95
1.00
.93
1.04
.96
1.01
.99
Galc
KLA
ATP
ATP+KLA
NM_008079
galactosylceramidase (Galc), mRNA [NM_008079]
KLA
.70
.68
.66
.54
.40
.42
.62
ATP
1.11
1.33
1.00
1.23
.90
.72
.61
KLA/ATP
.80
.80
.56
.71
.46
.53
.48
Gale
KLA
ATP
ATP+KLA
NM_178389
galactose-4-epimerase, UDP (Gale), mRNA [NM_178389]
KLA
.74
.68
.72
.72
.67
.68
.54
ATP
1.13
.96
1.10
.91
.82
1.20
1.42
KLA/ATP
.74
.69
.84
.71
.93
1.03
1.13
Galk1
KLA
ATP
ATP+KLA
NM_016905
galactokinase 1 (Galk1), mRNA [NM_016905]
KLA
.85
.85
.76
.72
.63
.46
.50
ATP
1.02
1.07
1.02
1.33
1.01
.53
.62
KLA/ATP
.90
.94
.87
1.00
.79
.50
.35
Galk2
KLA
ATP
ATP+KLA
NM_175154
galactokinase 2 (Galk2), mRNA [NM_175154]
KLA
.86
.78
.66
.78
.65
.65
.67
ATP
.96
.83
.79
.61
.54
.66
.95
KLA/ATP
.62
.68
.67
.50
.42
.70
.94
Galns
KLA
ATP
ATP+KLA
NM_016722
galactosamine (N-acetyl)-6-sulfate sulfatase (Galns), mRNA [NM_016722]
KLA
.99
1.00
1.06
1.00
1.07
1.14
1.41
ATP
1.18
1.19
.97
1.33
1.03
.80
1.15
KLA/ATP
1.11
1.12
.96
1.38
.85
.83
1.55
Galnt1
KLA
ATP
ATP+KLA
NM_013814
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 (Galnt1), mRNA [NM_013814]
KLA
.93
1.00
.93
.94
.87
.95
.98
ATP
1.13
1.22
1.08
1.18
.89
.59
.75
KLA/ATP
1.11
1.10
.91
1.11
.60
.53
.49
Galnt10
KLA
ATP
ATP+KLA
BC016585
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10, mRNA (cDNA clone MGC:27969 IMAGE:3595220), complete cds. [BC016585]
KLA
.83
.86
.89
.79
.73
.64
.74
ATP
1.11
.96
.89
1.06
.81
.71
1.01
KLA/ATP
.92
.94
.85
.86
.70
.67
.94
Galnt10
KLA
ATP
ATP+KLA
NM_134189
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (Galnt10), mRNA [NM_134189]
KLA
.74
.71
.67
.70
.55
.58
.62
ATP
.82
.75
1.10
.88
.68
.74
.94
KLA/ATP
.63
.69
.91
.72
.68
.64
.82
Galnt11
KLA
ATP
ATP+KLA
AK079811
0 day neonate thymus cDNA, RIKEN full-length enriched library, clone:A430075I06 product:unclassifiable, full insert sequence. [AK079811]
KLA
1.05
.98
.97
.97
.99
.96
1.01
ATP
.99
1.04
.96
.95
.95
.93
1.01
KLA/ATP
.98
1.04
1.04
.90
.93
1.01
1.01
Galnt11
KLA
ATP
ATP+KLA
NM_144908
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 (Galnt11), mRNA [NM_144908]
KLA
.57
.54
.46
.38
.41
.48
.71
ATP
.93
1.00
.94
.92
.58
.32
.55
KLA/ATP
.52
.57
.50
.47
.40
.33
.23
Galnt12
KLA
ATP
ATP+KLA
NM_172693
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12 (Galnt12), mRNA [NM_172693]
KLA
.40
.35
.35
.28
.18
.19
.29
ATP
1.16
1.05
1.10
.93
.58
.27
.37
KLA/ATP
.42
.38
.41
.26
.27
.18
.15
Galnt13
KLA
ATP
ATP+KLA
AK035964
16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630021K14 product:unclassifiable, full insert sequence [AK035964]
KLA
.99
1.03
1.05
.98
1.00
.99
.99
ATP
.99
1.02
.98
.98
.97
1.04
.98
KLA/ATP
.97
1.02
1.01
.94
1.01
.99
.95
Galnt13
KLA
ATP
ATP+KLA
NM_173030
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (Galnt13), mRNA [NM_173030]
KLA
1.01
1.03
1.04
1.06
1.02
1.02
.99
ATP
.98
.95
1.02
.98
1.03
.99
1.04
KLA/ATP
1.01
.97
1.00
1.09
1.02
1.00
1.03
Galnt14
KLA
ATP
ATP+KLA
AK002747
adult male kidney cDNA, RIKEN full-length enriched library, clone:0610033M06 product:RIKEN cDNA 0610033M06 gene, full insert sequence. [AK002747]
KLA
1.07
1.00
1.08
1.05
.96
1.02
.97
ATP
.96
1.05
1.04
1.00
1.04
.99
1.06
KLA/ATP
1.05
.97
1.00
.98
1.06
.99
1.02
Galnt14
KLA
ATP
ATP+KLA
NM_027864
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (Galnt14), mRNA [NM_027864]
KLA
1.05
1.07
1.08
1.06
1.03
1.06
1.08
ATP
1.06
1.04
1.05
1.00
1.00
.97
1.04
KLA/ATP
1.04
1.08
1.03
1.02
1.02
1.00
1.06
Galnt2
KLA
ATP
ATP+KLA
NM_139272
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (Galnt2), mRNA [NM_139272]
KLA
.75
.72
.72
.68
.70
.97
1.07
ATP
1.14
1.14
.98
1.07
.88
.76
1.42
KLA/ATP
.85
.80
.61
.70
.53
.78
1.52
Galnt3
KLA
ATP
ATP+KLA
AK087219
0 day neonate lung cDNA, RIKEN full-length enriched library, clone:E030036B02 product:UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3, full insert sequence. [AK087219]
KLA
1.04
1.00
.95
.98
.95
1.00
.98
ATP
1.02
1.01
1.02
.95
1.15
.96
.96
KLA/ATP
.96
.94
.92
.94
1.02
.96
.97
Galnt3
KLA
ATP
ATP+KLA
NM_015736
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (Galnt3), mRNA [NM_015736]
KLA
1.28
1.22
1.16
1.13
.85
.79
.57
ATP
.90
.93
1.04
.95
1.43
2.94
.63
KLA/ATP
1.12
1.21
1.17
1.08
1.08
1.17
.79
Galnt3
KLA
ATP
ATP+KLA
U70538
UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-T3 mRNA, complete cds. [U70538]
KLA
1.21
1.09
1.14
1.04
.82
.70
.57
ATP
.91
.91
1.08
.91
1.33
2.59
.52
KLA/ATP
1.03
1.11
1.11
.90
.89
1.08
.57
Galnt4
KLA
ATP
ATP+KLA
NM_015737
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4 (Galnt4), mRNA [NM_015737]
KLA
.79
.79
.66
.65
.52
.57
.71
ATP
.90
.78
.52
.44
.34
.70
.82
KLA/ATP
.74
.67
.50
.54
.41
.42
.47
Galnt6
KLA
ATP
ATP+KLA
NM_172451
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (Galnt6), mRNA [NM_172451]
KLA
.58
.53
.62
.59
.79
1.35
1.55
ATP
1.06
1.06
.76
1.03
2.22
2.64
3.21
KLA/ATP
.63
.59
.51
.55
1.24
2.04
2.79
Galnt7
KLA
ATP
ATP+KLA
NM_144731
UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 7 (Galnt7), mRNA [NM_144731]
KLA
1.89
2.01
1.94
1.67
1.45
.84
.63
ATP
1.03
1.12
1.07
1.12
.68
.44
.76
KLA/ATP
2.08
2.11
1.58
1.78
.87
.62
.53
Galntl1
KLA
ATP
ATP+KLA
NM_001081421
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 1 (Galntl1), mRNA [NM_001081421]
KLA
1.03
1.01
1.01
.96
.91
.99
.97
ATP
1.03
1.01
1.02
.95
.94
.92
.99
KLA/ATP
1.02
1.03
.97
.92
.97
.89
.96
Galntl2
KLA
ATP
ATP+KLA
AK019470
0 day neonate skin cDNA, RIKEN full-length enriched library, clone:4631401E18 product:similar to UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 7 [Homo sapiens], full insert sequence [AK019470]
KLA
.90
.94
.88
.98
.81
1.02
1.21
ATP
.99
.92
1.16
1.48
2.08
1.48
1.01
KLA/ATP
.98
.99
.93
1.14
2.12
1.85
1.11
Galntl4
KLA
ATP
ATP+KLA
AK084671
13 days embryo heart cDNA, RIKEN full-length enriched library, clone:D330027L06 product:hypothetical protein, full insert sequence. [AK084671]
KLA
.99
1.05
.99
1.02
.86
1.02
1.03
ATP
.98
.97
1.07
1.03
.95
.93
.98
KLA/ATP
1.05
.99
.95
.99
.99
.95
1.04
Galntl4
KLA
ATP
ATP+KLA
NM_173739
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 4 (Galntl4), mRNA [NM_173739]
KLA
1.07
1.00
1.04
.94
1.04
1.03
1.03
ATP
1.05
1.02
.99
1.00
.95
.99
.96
KLA/ATP
1.01
1.01
.98
.96
1.00
.98
1.00
Galntl5
KLA
ATP
ATP+KLA
NM_026449
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5 (Galntl5), mRNA [NM_026449]
KLA
.98
1.09
1.04
1.00
.97
.90
.96
ATP
1.06
1.03
1.01
1.00
1.11
.92
.99
KLA/ATP
1.08
.99
1.04
.93
.98
.97
.96
Galt
KLA
ATP
ATP+KLA
NM_016658
galactose-1-phosphate uridyl transferase (Galt), mRNA [NM_016658]
KLA
.63
.59
.54
.59
.57
.79
1.08
ATP
.88
.77
.92
.79
.74
.88
.95
KLA/ATP
.53
.53
.60
.49
.59
.80
1.10
Gamt
KLA
ATP
ATP+KLA
NM_010255
guanidinoacetate methyltransferase (Gamt), mRNA [NM_010255]
KLA
.83
.81
.79
.71
.64
.49
.39
ATP
1.01
1.05
1.07
1.29
1.03
.50
.40
KLA/ATP
.84
.88
.86
1.02
.84
.52
.21
Ganab
KLA
ATP
ATP+KLA
NM_008060
alpha glucosidase 2 alpha neutral subunit (Ganab), mRNA [NM_008060]
KLA
.91
.99
.97
.88
.86
.84
.88
ATP
1.01
1.20
.99
1.02
.77
.70
.76
KLA/ATP
1.02
1.10
.90
.85
.66
.66
.77
Ganc
KLA
ATP
ATP+KLA
NM_172672
glucosidase, alpha; neutral C (Ganc), mRNA [NM_172672]
KLA
1.02
.97
1.02
1.00
1.00
.98
.98
ATP
1.06
1.04
1.03
1.00
.71
.71
1.05
KLA/ATP
1.02
1.09
1.18
.97
.83
.79
1.07
Gapdh
KLA
ATP
ATP+KLA
NM_008084
glyceraldehyde-3-phosphate dehydrogenase (Gapdh), mRNA [NM_008084]
KLA
.83
.87
.98
.70
.98
.82
1.34
ATP
1.24
1.33
.70
1.26
.95
.96
1.64
KLA/ATP
1.08
1.18
.50
.98
.61
.79
1.40
Gapdhs
KLA
ATP
ATP+KLA
NM_008085
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic (Gapdhs), mRNA [NM_008085]
KLA
.99
.98
.97
.99
1.00
1.01
1.02
ATP
1.02
1.01
.98
1.05
.98
.97
1.02
KLA/ATP
1.00
1.02
.95
1.02
.95
.94
.94
Gart
KLA
ATP
ATP+KLA
AK168445
13 days embryo liver cDNA, RIKEN full-length enriched library, clone:I920021A03 product:phosphoribosylglycinamide formyltransferase, full insert sequence. [AK168445]
KLA
.88
.80
.73
.71
.52
.48
.75
ATP
1.03
.98
1.11
1.02
.61
.37
.52
KLA/ATP
.81
.86
.87
.75
.49
.30
.26
Gart
KLA
ATP
ATP+KLA
NM_010256
phosphoribosylglycinamide formyltransferase (Gart), mRNA [NM_010256]
KLA
.68
.73
.60
.50
.46
.57
.70
ATP
.97
1.03
.93
.91
.59
.39
.58
KLA/ATP
.69
.70
.58
.59
.39
.32
.33
Gatm
KLA
ATP
ATP+KLA
NM_025961
glycine amidinotransferase (L-arginine:glycine amidinotransferase) (Gatm), nuclear gene encoding mitochondrial protein, mRNA [NM_025961]
KLA
1.12
1.10
1.08
1.22
1.29
1.64
.65
ATP
1.02
1.14
1.14
1.48
.82
.21
.15
KLA/ATP
1.15
1.11
1.08
1.36
.67
.26
.17
Gba
KLA
ATP
ATP+KLA
NM_001077411
glucosidase, beta, acid (Gba), mRNA [NM_001077411]
KLA
.86
.89
.92
.84
.95
1.11
1.65
ATP
.97
.99
.60
.74
.63
.76
2.19
KLA/ATP
.95
.85
.52
.74
.50
.81
2.57
Gbe1
KLA
ATP
ATP+KLA
NM_028803
glucan (1,4-alpha-), branching enzyme 1 (Gbe1), mRNA [NM_028803]
KLA
1.04
1.04
.96
.99
.65
.63
.96
ATP
.90
.75
1.15
.71
.93
3.49
.88
KLA/ATP
.92
1.00
1.08
.79
.86
1.22
.74
Gbgt1
KLA
ATP
ATP+KLA
NM_139197
globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (Gbgt1), mRNA [NM_139197]
KLA
1.13
1.21
1.26
1.34
1.62
1.88
2.04
ATP
1.00
1.02
1.02
1.04
.93
.92
1.07
KLA/ATP
1.14
1.22
1.11
1.13
.98
1.08
1.62
Gcdh
KLA
ATP
ATP+KLA
U18992
glutaryl-CoA dehydrogenase mRNA, complete cds. [U18992]
KLA
.93
.79
.71
.83
.76
.74
.79
ATP
1.03
1.08
1.25
1.15
.86
.56
.75
KLA/ATP
.72
.82
1.12
.93
.68
.50
.48
Gch1
KLA
ATP
ATP+KLA
NM_008102
GTP cyclohydrolase 1 (Gch1), mRNA [NM_008102]
KLA
7.78
7.74
8.92
8.50
8.61
6.39
4.13
ATP
1.00
1.05
1.80
4.55
8.06
5.95
2.30
KLA/ATP
7.70
8.52
9.93
14.71
14.00
8.42
4.27
Gck
KLA
ATP
ATP+KLA
NM_010292
glucokinase (Gck), mRNA [NM_010292]
KLA
1.03
.99
1.04
1.02
.97
.98
1.00
ATP
1.01
.97
1.08
.99
1.06
.98
.96
KLA/ATP
1.06
1.01
.96
.98
.98
1.01
1.01
Gclc
KLA
ATP
ATP+KLA
NM_010295
glutamate-cysteine ligase, catalytic subunit (Gclc), mRNA [NM_010295]
KLA
.42
.38
.24
.19
.22
.26
.59
ATP
1.07
1.03
1.24
2.13
4.71
25.45
1.33
KLA/ATP
.35
.36
.44
1.21
2.16
4.41
1.54
Gclm
KLA
ATP
ATP+KLA
NM_008129
glutamate-cysteine ligase , modifier subunit (Gclm), mRNA [NM_008129]
KLA
.87
.91
.79
.58
.46
.46
1.30
ATP
1.26
1.41
.93
1.28
2.39
5.57
2.40
KLA/ATP
.98
1.10
.59
.93
.97
2.74
2.75
Gcnt1
KLA
ATP
ATP+KLA
NM_010265
glucosaminyl (N-acetyl) transferase 1, core 2 (Gcnt1), mRNA [NM_010265]
KLA
.33
.30
.26
.23
.20
.22
.28
ATP
1.02
.99
1.11
.96
1.12
.71
1.76
KLA/ATP
.31
.27
.29
.31
.34
.38
.42
Gcnt1
KLA
ATP
ATP+KLA
NM_173442
glucosaminyl (N-acetyl) transferase 1, core 2 (Gcnt1), mRNA [NM_173442]
KLA
.13
.10
.07
.06
.05
.08
.12
ATP
.91
.82
1.08
.69
1.32
.45
.88
KLA/ATP
.11
.10
.08
.06
.23
.25
.12
Gcnt2
KLA
ATP
ATP+KLA
NM_133219
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (Gcnt2), transcript variant 3, mRNA [NM_133219]
KLA
2.85
3.32
3.45
3.25
3.04
2.61
1.40
ATP
1.04
1.11
1.09
1.14
1.36
2.40
1.76
KLA/ATP
3.01
3.24
2.59
2.73
2.30
2.47
2.34
Gcnt3
KLA
ATP
ATP+KLA
NM_028087
glucosaminyl (N-acetyl) transferase 3, mucin type (Gcnt3), mRNA [NM_028087]
KLA
1.01
1.07
.98
.93
1.07
1.03
1.01
ATP
1.06
1.00
1.02
1.00
1.01
1.07
1.03
KLA/ATP
1.10
1.01
.95
.97
.97
1.04
.98
Gcs1
KLA
ATP
ATP+KLA
NM_020619
glucosidase 1 (Gcs1), mRNA [NM_020619]
KLA
.62
.60
.59
.54
.50
.56
.95
ATP
.95
.96
1.04
.81
.62
.68
1.23
KLA/ATP
.63
.61
.68
.53
.46
.42
.60
Gda
KLA
ATP
ATP+KLA
NM_010266
guanine deaminase (Gda), mRNA [NM_010266]
KLA
3.01
3.35
3.91
4.08
3.78
1.70
1.21
ATP
1.05
1.05
1.15
1.13
1.25
1.99
1.32
KLA/ATP
3.04
3.63
3.25
3.16
2.29
1.87
1.59
Gfpt1
KLA
ATP
ATP+KLA
NM_013528
glutamine fructose-6-phosphate transaminase 1 (Gfpt1), mRNA [NM_013528]
KLA
1.65
1.73
1.88
1.89
1.81
1.81
2.11
ATP
1.13
1.24
1.25
1.43
2.76
2.99
3.85
KLA/ATP
1.78
2.02
1.88
1.75
1.97
3.84
6.84
Gfpt2
KLA
ATP
ATP+KLA
NM_013529
glutamine fructose-6-phosphate transaminase 2 (Gfpt2), mRNA [NM_013529]
KLA
1.28
1.31
1.50
1.32
1.18
1.25
1.11
ATP
.98
1.00
1.05
1.72
2.72
2.21
1.07
KLA/ATP
1.34
1.42
1.38
2.19
2.19
1.93
1.54
Ggps1
KLA
ATP
ATP+KLA
AK138564
adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330064P13 product:geranylgeranyl diphosphate synthase 1, full insert sequence [AK138564]
KLA
1.17
1.19
1.22
1.09
1.12
1.25
1.22
ATP
1.02
1.06
.90
.91
1.06
1.11
.92
KLA/ATP
1.23
1.10
1.10
1.19
1.22
1.09
.89
Ggps1
KLA
ATP
ATP+KLA
NM_010282
geranylgeranyl diphosphate synthase 1 (Ggps1), mRNA [NM_010282]
KLA
1.17
1.17
1.29
1.28
1.22
1.57
1.73
ATP
.88
.84
.99
.85
.97
2.03
2.04
KLA/ATP
1.08
1.10
1.34
1.11
1.23
1.95
2.71
Ggt1
KLA
ATP
ATP+KLA
NM_008116
gamma-glutamyltransferase 1 (Ggt1), mRNA [NM_008116]
KLA
1.03
1.00
1.00
1.05
1.00
1.02
1.02
ATP
1.00
1.00
.96
1.00
1.03
1.02
.99
KLA/ATP
.98
.99
1.04
1.00
.99
.98
.98
Ggt5
KLA
ATP
ATP+KLA
NM_011820
gamma-glutamyltransferase 5 (Ggt5), mRNA [NM_011820]
KLA
.89
.91
.92
.89
.86
.79
.58
ATP
1.00
1.03
.93
.97
.84
.80
.59
KLA/ATP
1.00
.92
.93
.98
.83
.79
.68
Ggt6
KLA
ATP
ATP+KLA
NM_027819
gamma-glutamyltransferase 6 (Ggt6), mRNA [NM_027819]
KLA
1.03
.90
.98
1.07
1.00
1.02
.98
ATP
1.02
1.07
.90
1.02
1.03
1.03
.94
KLA/ATP
.99
1.04
.98
.97
1.02
1.01
.96
Ggt7
KLA
ATP
ATP+KLA
NM_144786
gamma-glutamyltransferase 7 (Ggt7), mRNA [NM_144786]
KLA
.96
1.03
.97
1.01
1.00
.98
.89
ATP
1.03
1.02
1.01
.92
.94
.97
1.00
KLA/ATP
.98
.95
1.05
.89
.92
.94
.94
Gk2
KLA
ATP
ATP+KLA
NM_010294
glycerol kinase 2 (Gk2), mRNA [NM_010294]
KLA
1.26
1.28
1.65
1.55
1.96
1.59
1.41
ATP
.99
1.02
1.00
1.17
1.20
1.63
1.06
KLA/ATP
1.39
1.49
1.34
1.36
1.21
1.45
1.30
Glb1
KLA
ATP
ATP+KLA
NM_009752
galactosidase, beta 1 (Glb1), mRNA [NM_009752]
KLA
.93
.96
1.02
.85
.86
.81
.80
ATP
1.03
1.10
1.01
1.13
.97
.82
.75
KLA/ATP
1.08
1.04
.86
1.06
.81
.81
.66
Glce
KLA
ATP
ATP+KLA
NM_033320
glucuronyl C5-epimerase (Glce), mRNA [NM_033320]
KLA
1.00
.97
.88
.78
.59
.68
1.00
ATP
1.10
1.02
1.03
.95
2.32
2.94
2.07
KLA/ATP
.95
.95
.94
.78
1.49
1.99
1.84
Gldc
KLA
ATP
ATP+KLA
NM_138595
glycine decarboxylase (Gldc), mRNA [NM_138595]
KLA
.77
.75
.63
.67
.70
.76
.89
ATP
.98
1.02
.97
1.03
1.33
2.46
2.61
KLA/ATP
.84
.69
.75
.73
.87
2.08
2.77
Gls2
KLA
ATP
ATP+KLA
NM_001033264
glutaminase 2 (liver, mitochondrial) (Gls2), nuclear gene encoding mitochondrial protein, mRNA [NM_001033264]
KLA
1.03
.98
1.02
.97
.98
.88
.80
ATP
.94
1.01
1.04
1.08
1.26
1.20
.87
KLA/ATP
.95
.98
1.15
1.02
1.29
.99
.87
Glt28d2
KLA
ATP
ATP+KLA
NM_177130
glycosyltransferase 28 domain containing 2 (Glt28d2), mRNA [NM_177130]
KLA
.98
1.02
1.04
.99
.93
.98
1.05
ATP
.98
1.01
1.04
1.07
.97
1.00
.94
KLA/ATP
1.01
1.05
.98
.99
.94
.99
1.02
Glud1
KLA
ATP
ATP+KLA
NM_008133
glutamate dehydrogenase 1 (Glud1), mRNA [NM_008133]
KLA
.70
.70
.63
.54
.52
.54
.59
ATP
.96
.91
1.01
1.05
.96
.66
.47
KLA/ATP
.67
.66
.61
.69
.70
.51
.27
Glul
KLA
ATP
ATP+KLA
NM_008131
glutamate-ammonia ligase (glutamine synthetase) (Glul), mRNA [NM_008131]
KLA
.58
.54
.47
.41
.30
.31
.40
ATP
.96
.99
1.46
2.55
2.16
2.88
1.34
KLA/ATP
.57
.56
.83
1.52
1.27
1.20
.97
Glul
KLA
ATP
ATP+KLA
X16314
gb|M.musculus mRNA for glutamine synthetase. [X16314]
KLA
.86
.95
.79
.87
.78
.99
.83
ATP
.95
1.03
1.09
1.27
1.14
1.37
1.00
KLA/ATP
.88
.97
.89
1.12
1.01
1.19
.91
Glyctk
KLA
ATP
ATP+KLA
NM_174846
glycerate kinase (Glyctk), transcript variant 1, mRNA [NM_174846]
KLA
.98
1.05
1.12
1.07
1.13
1.16
1.11
ATP
1.04
1.07
.93
.93
.72
.97
1.22
KLA/ATP
1.02
1.02
.94
.89
.82
1.00
1.26
Gmds
KLA
ATP
ATP+KLA
NM_146041
GDP-mannose 4, 6-dehydratase (Gmds), mRNA [NM_146041]
KLA
1.08
1.19
1.08
1.00
.87
.56
.41
ATP
.97
1.07
1.05
1.30
1.03
.55
.37
KLA/ATP
1.18
1.12
.98
1.11
.75
.53
.27
Gmppa
KLA
ATP
ATP+KLA
NM_133708
GDP-mannose pyrophosphorylase A (Gmppa), mRNA [NM_133708]
KLA
1.03
1.04
1.03
.92
1.02
1.04
1.35
ATP
1.05
1.17
.81
1.16
.73
.59
1.61
KLA/ATP
1.19
1.16
.74
1.16
.72
.72
1.46
Gmppb
KLA
ATP
ATP+KLA
NM_177910
GDP-mannose pyrophosphorylase B (Gmppb), mRNA [NM_177910]
KLA
2.41
2.66
2.76
3.33
3.47
3.38
1.74
ATP
.91
.92
.78
.74
.43
1.76
2.06
KLA/ATP
2.31
2.72
2.59
2.32
1.87
2.93
2.37
Gmps
KLA
ATP
ATP+KLA
NM_001033300
guanine monphosphate synthetase (Gmps), mRNA [NM_001033300]
KLA
1.04
1.13
1.05
.91
.79
.75
.96
ATP
1.12
1.17
1.01
1.24
.99
1.02
.82
KLA/ATP
1.18
1.08
.92
1.11
.86
.94
.62
Gne
KLA
ATP
ATP+KLA
AK033507
adult male colon cDNA, RIKEN full-length enriched library, clone:9030414E18 product:UDP-N-acetylglucosamine-2-epimerase [AK033507]
KLA
.70
.66
.67
.69
.61
.68
.75
ATP
.86
.72
.65
.66
.94
.74
.60
KLA/ATP
.66
.56
.66
.60
.67
.64
.51
Gne
KLA
ATP
ATP+KLA
NM_015828
glucosamine (Gne), mRNA [NM_015828]
KLA
.60
.61
.65
.67
.62
.56
.62
ATP
.92
.78
.51
.54
.98
.55
.73
KLA/ATP
.57
.47
.37
.36
.54
.39
.27
Gnpda1
KLA
ATP
ATP+KLA
NM_011937
glucosamine-6-phosphate deaminase 1 (Gnpda1), mRNA [NM_011937]
KLA
.33
.30
.29
.21
.22
.42
.62
ATP
.98
1.09
.86
.92
.71
.43
1.17
KLA/ATP
.36
.34
.29
.31
.35
.54
.75
Gnpda2
KLA
ATP
ATP+KLA
NM_001038015
glucosamine-6-phosphate deaminase 2 (Gnpda2), mRNA [NM_001038015]
KLA
.86
.82
.76
.87
.74
.89
1.14
ATP
.92
.83
1.04
.83
.77
.88
.72
KLA/ATP
.75
.81
.97
.79
.85
1.04
.88
Gns
KLA
ATP
ATP+KLA
AK040524
0 day neonate thymus cDNA, RIKEN full-length enriched library, clone:A430105C13 product:glucosamine (N-acetyl)-6-sulfatase, full insert sequence. [AK040524]
KLA
2.06
2.05
1.93
2.03
2.37
1.56
1.22
ATP
1.18
1.15
.98
2.24
1.28
1.03
1.52
KLA/ATP
2.15
2.20
1.53
2.63
1.61
1.42
1.54
Gns
KLA
ATP
ATP+KLA
NM_029364
glucosamine (N-acetyl)-6-sulfatase (Gns), mRNA [NM_029364]
KLA
1.48
1.47
1.80
1.48
1.81
2.03
1.87
ATP
1.09
1.27
.92
1.16
.95
.85
1.54
KLA/ATP
1.57
1.62
1.22
1.69
.98
1.34
1.93
Got1
KLA
ATP
ATP+KLA
NM_010324
glutamate oxaloacetate transaminase 1, soluble (Got1), mRNA [NM_010324]
KLA
.68
.70
.66
.56
.50
.57
.99
ATP
1.01
1.24
1.55
1.59
1.47
1.03
1.68
KLA/ATP
.68
.71
.66
.77
1.13
2.33
1.89
Got2
KLA
ATP
ATP+KLA
NM_010325
glutamate oxaloacetate transaminase 2, mitochondrial (Got2), nuclear gene encoding mitochondrial protein, mRNA [NM_010325]
KLA
.84
.86
.88
.75
.75
.63
.61
ATP
1.02
1.12
.98
1.15
.98
.67
.86
KLA/ATP
.92
.89
.75
.89
.68
.70
.77
Gpaa1
KLA
ATP
ATP+KLA
NM_010331
GPI anchor attachment protein 1 (Gpaa1), mRNA [NM_010331]
KLA
.93
.99
.97
.99
.87
.85
.87
ATP
1.05
1.16
1.03
1.14
1.03
.85
.79
KLA/ATP
1.05
1.08
.96
1.01
.81
.89
.81
Gpam
KLA
ATP
ATP+KLA
NM_008149
glycerol-3-phosphate acyltransferase, mitochondrial (Gpam), nuclear gene encoding mitochondrial protein, mRNA [NM_008149]
KLA
1.04
.97
1.00
1.04
.90
.96
1.00
ATP
.98
1.18
1.10
.95
.70
.98
1.37
KLA/ATP
1.03
1.06
1.05
1.01
.79
.89
1.00
Gpi1
KLA
ATP
ATP+KLA
L09104
glucose phosphate isomerase mRNA, 3 end. [L09104]
KLA
.92
1.02
.99
1.01
.92
1.04
1.07
ATP
1.05
1.06
1.11
1.14
1.01
1.00
1.04
KLA/ATP
1.06
1.09
1.01
.96
.93
.93
1.04
Gpi1
KLA
ATP
ATP+KLA
NM_008155
glucose phosphate isomerase 1 (Gpi1), mRNA [NM_008155]
KLA
.77
.76
.69
.66
.61
.59
.85
ATP
.96
.97
.97
.93
.90
.73
.77
KLA/ATP
.75
.76
.73
.69
.66
.54
.59
Gpt
KLA
ATP
ATP+KLA
NM_182805
glutamic pyruvic transaminase, soluble (Gpt), mRNA [NM_182805]
KLA
.82
.81
.80
.82
.78
.83
1.05
ATP
1.01
1.00
1.07
1.23
1.20
.77
1.01
KLA/ATP
.85
.86
.93
1.01
1.32
.83
.97
Gpt2
KLA
ATP
ATP+KLA
NM_173866
glutamic pyruvate transaminase (alanine aminotransferase) 2 (Gpt2), mRNA [NM_173866]
KLA
.82
.87
.84
.69
.64
.80
.91
ATP
.97
1.08
1.06
.95
1.33
2.66
1.89
KLA/ATP
.81
.83
.67
.70
1.07
2.66
1.63
Grhpr
KLA
ATP
ATP+KLA
NM_080289
glyoxylate reductase/hydroxypyruvate reductase (Grhpr), mRNA [NM_080289]
KLA
.82
.79
.68
.60
.42
.28
.56
ATP
.93
.99
1.24
1.33
.91
.54
.71
KLA/ATP
.74
.78
.84
.86
.61
.31
.39
Gss
KLA
ATP
ATP+KLA
NM_008180
glutathione synthetase (Gss), mRNA [NM_008180]
KLA
1.21
1.26
1.25
1.17
1.00
.75
1.11
ATP
1.06
1.12
1.04
1.21
3.15
7.87
2.60
KLA/ATP
1.24
1.35
1.22
1.38
2.28
4.32
2.63
Gstz1
KLA
ATP
ATP+KLA
NM_010363
glutathione transferase zeta 1 (maleylacetoacetate isomerase) (Gstz1), mRNA [NM_010363]
KLA
.94
.85
.93
.85
.83
.71
.87
ATP
1.12
1.08
1.17
1.16
.78
.44
.71
KLA/ATP
.96
.98
.97
1.03
.74
.47
.56
Guk1
KLA
ATP
ATP+KLA
NM_008193
guanylate kinase 1 (Guk1), mRNA [NM_008193]
KLA
1.32
1.31
1.23
1.15
1.08
.77
.77
ATP
1.09
1.09
1.12
1.12
.96
.68
1.24
KLA/ATP
1.22
1.31
1.39
1.38
1.05
.85
.87
Gulo
KLA
ATP
ATP+KLA
NM_178747
gulonolactone (L-) oxidase (Gulo), mRNA [NM_178747]
KLA
1.01
.97
1.03
1.04
1.01
.98
.99
ATP
1.00
.99
.99
.98
1.04
1.02
.98
KLA/ATP
.97
.98
1.03
1.00
.98
.94
.97
Gusb
KLA
ATP
ATP+KLA
NM_010368
glucuronidase, beta (Gusb), mRNA [NM_010368]
KLA
.65
.67
.62
.52
.52
.47
.52
ATP
1.07
1.11
.95
1.00
.80
.57
.58
KLA/ATP
.72
.71
.56
.62
.52
.48
.38
Gyk
KLA
ATP
ATP+KLA
AK037633
16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130030N17 product:unclassifiable, full insert sequence [AK037633]
KLA
5.44
4.98
5.36
4.61
4.88
2.89
1.97
ATP
1.17
1.65
4.22
2.33
6.88
2.27
1.07
KLA/ATP
5.99
9.29
15.97
4.69
3.09
3.74
2.06
Gyk
KLA
ATP
ATP+KLA
AK086200
15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930012N15 product:glycerol kinase, full insert sequence. [AK086200]
KLA
1.16
1.08
1.12
1.03
1.02
1.07
.98
ATP
.93
1.01
1.12
.95
1.14
.96
.98
KLA/ATP
1.23
1.24
1.22
.95
1.10
.96
1.06
Gyk
KLA
ATP
ATP+KLA
NM_008194
glycerol kinase (Gyk), transcript variant 1, mRNA [NM_008194]
KLA
2.56
2.95
3.62
4.16
5.93
5.02
2.77
ATP
1.04
1.19
1.02
1.51
2.16
4.68
1.09
KLA/ATP
2.65
2.96
2.71
4.15
2.62
4.18
3.09
Gyk
KLA
ATP
ATP+KLA
NM_212444
glycerol kinase (Gyk), transcript variant 2, mRNA [NM_212444]
KLA
3.95
4.35
5.39
5.59
8.90
6.88
3.32
ATP
1.12
1.38
1.20
1.70
2.32
4.01
.95
KLA/ATP
3.99
4.03
4.00
5.56
2.86
3.73
3.14
H2-Ke6
KLA
ATP
ATP+KLA
NM_013543
H2-K region expressed gene 6 (H2-Ke6), mRNA [NM_013543]
KLA
1.00
1.03
.95
.96
.88
.79
.63
ATP
.96
1.01
.98
1.44
1.13
.66
.59
KLA/ATP
.99
1.08
1.19
1.48
1.19
.73
.49
H6pd
KLA
ATP
ATP+KLA
NM_173371
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) (H6pd), mRNA [NM_173371]
KLA
.89
.91
.89
.78
.64
.85
1.14
ATP
.98
1.06
.86
.67
.38
.49
1.45
KLA/ATP
.96
.96
.81
.70
.44
.43
1.19
Hadh
KLA
ATP
ATP+KLA
NM_008212
hydroxyacyl-Coenzyme A dehydrogenase (Hadh), nuclear gene encoding mitochondrial protein, mRNA [NM_008212]
KLA
.75
.75
.72
.64
.54
.37
.49
ATP
1.12
1.19
1.08
1.28
.96
.43
.41
KLA/ATP
.76
.81
.68
.85
.56
.42
.21
Hadha
KLA
ATP
ATP+KLA
AK050856
9 days embryo whole body cDNA, RIKEN full-length enriched library, clone:D030026J11 product:hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit, full insert
KLA
.96
.92
.91
.80
.97
.92
.90
ATP
.72
.64
.63
.71
.91
.93
.93
KLA/ATP
.79
.72
.68
.73
.87
.90
.88
Hadha
KLA
ATP
ATP+KLA
NM_178878
hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit (Hadha), nuclear gene encoding mitochondrial protein, mRNA [NM_178878]
KLA
1.10
1.17
1.36
1.16
1.23
1.10
1.00
ATP
1.16
1.22
1.03
1.40
1.09
.79
1.11
KLA/ATP
1.33
1.35
1.16
1.41
1.00
.92
1.31
Hadhb
KLA
ATP
ATP+KLA
NM_145558
hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit (Hadhb), nuclear gene encoding mitochondrial protein, mRNA [NM_145558]
KLA
.85
.88
.76
.77
.70
.54
.58
ATP
1.08
1.13
1.05
1.01
.84
.53
.58
KLA/ATP
.79
.91
.83
.80
.61
.46
.44
Hal
KLA
ATP
ATP+KLA
NM_010401
histidine ammonia lyase (Hal), mRNA [NM_010401]
KLA
.97
1.01
1.01
.99
.83
.90
.97
ATP
1.03
1.12
1.05
1.07
1.20
1.74
1.70
KLA/ATP
.96
1.00
.97
.99
1.07
1.72
1.29
Hao1
KLA
ATP
ATP+KLA
AF104312
glycolate oxidase mRNA, complete cds. [AF104312]
KLA
.85
.89
.77
.82
.79
.79
1.13
ATP
.88
.99
.95
1.90
1.11
.82
1.22
KLA/ATP
.86
.81
.72
1.28
1.14
.91
1.07
Hao3
KLA
ATP
ATP+KLA
NM_019545
hydroxyacid oxidase (glycolate oxidase) 3 (Hao3), mRNA [NM_019545]
KLA
1.03
1.03
1.00
1.08
.97
.99
.94
ATP
1.04
1.01
1.03
.97
1.07
1.01
1.01
KLA/ATP
1.00
.97
1.03
.98
1.01
1.02
1.04
Hdc
KLA
ATP
ATP+KLA
NM_008230
histidine decarboxylase (Hdc), mRNA [NM_008230]
KLA
27.59
25.41
24.74
28.27
21.96
24.39
9.08
ATP
1.04
1.03
1.59
2.85
3.81
12.00
3.74
KLA/ATP
25.83
28.35
36.64
27.70
32.70
29.32
26.26
Hexa
KLA
ATP
ATP+KLA
NM_010421
hexosaminidase A (Hexa), mRNA [NM_010421]
KLA
.74
.76
.70
.63
.57
.52
.51
ATP
.98
1.04
.82
.81
.68
.52
.64
KLA/ATP
.76
.78
.63
.60
.48
.37
.31
Hexb
KLA
ATP
ATP+KLA
NM_010422
hexosaminidase B (Hexb), mRNA [NM_010422]
KLA
.82
.90
.81
.70
.64
.64
.71
ATP
.95
1.03
1.11
.83
.72
.58
.63
KLA/ATP
.80
.83
.77
.68
.53
.45
.50
Hgd
KLA
ATP
ATP+KLA
NM_013547
homogentisate 1, 2-dioxygenase (Hgd), mRNA [NM_013547]
KLA
.97
1.03
.95
1.05
1.02
1.00
.99
ATP
1.02
1.00
.99
.99
.97
.96
1.06
KLA/ATP
1.00
.96
1.00
.97
1.08
1.12
1.08
Hgsnat
KLA
ATP
ATP+KLA
NM_029884
heparan-alpha-glucosaminide N-acetyltransferase (Hgsnat), mRNA [NM_029884]
KLA
.73
.74
.73
.76
.70
1.27
1.85
ATP
.91
.98
1.13
1.21
1.13
1.59
2.63
KLA/ATP
.69
.68
.78
.98
1.06
2.45
4.56
Hibadh
KLA
ATP
ATP+KLA
NM_145567
3-hydroxyisobutyrate dehydrogenase (Hibadh), mRNA [NM_145567]
KLA
1.18
1.20
1.52
1.58
1.53
1.48
.93
ATP
1.13
1.04
1.21
1.15
1.07
.87
.79
KLA/ATP
1.27
1.34
1.79
1.40
1.49
1.17
.93
Hibch
KLA
ATP
ATP+KLA
NM_146108
3-hydroxyisobutyryl-Coenzyme A hydrolase (Hibch), mRNA [NM_146108]
KLA
.47
.44
.40
.33
.30
.39
.82
ATP
.92
.92
1.45
1.12
.69
.61
.91
KLA/ATP
.42
.41
.56
.40
.34
.45
.55
Hk1
KLA
ATP
ATP+KLA
J05277
gb|Mouse hexokinase mRNA, complete cds [J05277]
KLA
1.49
1.45
1.66
1.78
1.51
1.29
.99
ATP
1.11
1.05
1.15
1.20
2.31
2.17
1.09
KLA/ATP
1.63
1.51
1.70
1.47
1.94
1.92
1.40
Hk1
KLA
ATP
ATP+KLA
NM_010438
hexokinase 1 (Hk1), nuclear gene encoding mitochondrial protein, mRNA [NM_010438]
KLA
1.58
1.75
2.05
1.84
1.96
1.67
1.31
ATP
1.06
1.25
1.01
1.49
2.23
1.79
1.20
KLA/ATP
1.87
1.96
1.51
1.93
1.71
1.94
1.72
Hk2
KLA
ATP
ATP+KLA
NM_013820
hexokinase 2 (Hk2), mRNA [NM_013820]
KLA
4.09
4.09
3.17
2.37
1.53
1.62
2.02
ATP
.98
.92
1.08
2.24
3.82
3.86
.97
KLA/ATP
4.07
3.94
4.17
3.53
5.42
4.65
1.54
Hk3
KLA
ATP
ATP+KLA
NM_001033245
hexokinase 3 (Hk3), nuclear gene encoding mitochondrial protein, mRNA [NM_001033245]
KLA
1.52
1.68
1.94
1.85
2.21
2.89
1.98
ATP
1.01
1.07
.87
.99
1.01
1.26
2.62
KLA/ATP
1.63
1.74
1.67
1.69
1.44
2.01
3.53
Hkdc1
KLA
ATP
ATP+KLA
NM_145419
hexokinase domain containing 1 (Hkdc1), mRNA [NM_145419]
KLA
1.10
1.08
1.12
1.12
1.02
1.07
1.04
ATP
.96
1.04
1.06
4.28
10.50
3.91
1.34
KLA/ATP
.98
1.04
1.14
5.33
12.44
8.68
1.77
Hlcs
KLA
ATP
ATP+KLA
NM_139145
holocarboxylase synthetase (biotin- [propriony-Coenzyme A-carboxylase (ATP-hydrolysing)] ligase) (Hlcs), mRNA [NM_139145]
KLA
.60
.62
.54
.59
.71
1.01
1.28
ATP
1.07
1.06
.91
.85
.54
.41
.51
KLA/ATP
.65
.64
.48
.58
.48
.56
.86
Hmbs
KLA
ATP
ATP+KLA
AK158160
adult inner ear cDNA, RIKEN full-length enriched library, clone:F930036J03 product:unclassifiable, full insert sequence. [AK158160]
KLA
.95
1.03
.98
.98
.94
1.01
1.06
ATP
.98
1.02
1.04
.98
.87
.97
.95
KLA/ATP
.99
.98
.97
.97
.94
.98
1.02
Hmbs
KLA
ATP
ATP+KLA
NM_013551
hydroxymethylbilane synthase (Hmbs), transcript variant 1, mRNA [NM_013551]
KLA
.51
.49
.44
.43
.43
.57
.76
ATP
.94
.95
.98
.88
.61
.35
.72
KLA/ATP
.50
.46
.41
.37
.32
.31
.37
Hmgcl
KLA
ATP
ATP+KLA
NM_008254
3-hydroxy-3-methylglutaryl-Coenzyme A lyase (Hmgcl), mRNA [NM_008254]
KLA
.37
.34
.39
.48
.63
.86
.71
ATP
.87
.84
.93
.82
.69
.91
1.21
KLA/ATP
.32
.33
.38
.38
.71
1.31
1.25
Hmgcr
KLA
ATP
ATP+KLA
NM_008255
3-hydroxy-3-methylglutaryl-Coenzyme A reductase (Hmgcr), mRNA [NM_008255]
KLA
2.15
2.09
2.02
1.44
1.13
.88
1.02
ATP
1.05
1.16
1.43
1.53
1.83
2.60
1.87
KLA/ATP
2.16
2.23
1.99
1.81
1.34
1.81
1.79
Hmgcs1
KLA
ATP
ATP+KLA
AK078743
15 days embryo male testis cDNA, RIKEN full-length enriched library, clone:8030402P03 product:similar to hydroxymethylglutaryl-CoA synthase (EC 4.1.3.5) (fragment) [Gallus gallus], full insert sequence. [AK078743]
KLA
1.06
1.08
.98
.81
.88
.71
.86
ATP
1.39
1.87
10.43
2.82
1.19
1.14
1.09
KLA/ATP
1.36
1.59
5.22
1.83
1.21
.75
.66
Hmgcs1
KLA
ATP
ATP+KLA
NM_145942
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (Hmgcs1), mRNA [NM_145942]
KLA
1.16
1.10
1.26
1.16
.88
.63
.69
ATP
1.01
1.10
1.87
2.36
1.98
.89
.97
KLA/ATP
1.12
1.20
1.33
1.69
1.39
.67
.51
Hmgcs2
KLA
ATP
ATP+KLA
NM_008256
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (Hmgcs2), nuclear gene encoding mitochondrial protein, mRNA [NM_008256]
KLA
.92
1.10
1.00
.99
1.08
1.06
1.14
ATP
.99
1.02
1.00
1.00
.98
1.08
.92
KLA/ATP
.99
1.00
1.00
1.03
1.28
1.06
1.00
Hpd
KLA
ATP
ATP+KLA
NM_008277
4-hydroxyphenylpyruvic acid dioxygenase (Hpd), mRNA [NM_008277]
KLA
.94
1.10
1.04
1.02
.97
.97
1.06
ATP
1.05
1.07
.96
1.01
1.09
.97
1.01
KLA/ATP
1.02
1.03
1.12
1.00
.98
1.06
1.02
Hprt1
KLA
ATP
ATP+KLA
NM_013556
hypoxanthine guanine phosphoribosyl transferase 1 (Hprt1), mRNA [NM_013556]
KLA
.82
.77
.81
.79
.53
.43
.39
ATP
.97
.89
1.40
.89
.82
.68
.25
KLA/ATP
.73
.69
1.09
.68
.66
.42
.13
Hpse
KLA
ATP
ATP+KLA
NM_152803
heparanase (Hpse), mRNA [NM_152803]
KLA
1.99
1.93
2.60
2.97
2.72
1.99
1.34
ATP
1.17
1.20
1.06
1.43
1.25
.98
1.30
KLA/ATP
2.23
2.49
2.45
2.70
1.84
2.05
2.71
Hrasls3
KLA
ATP
ATP+KLA
AK052657
0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630015C01 product:H-REV 107 PROTEIN homolog [Rattus norvegicus], full insert sequence. [AK052657]
KLA
4.07
4.01
2.57
2.26
1.94
1.66
1.10
ATP
.93
.92
1.00
.96
.95
.99
1.08
KLA/ATP
3.36
2.63
1.76
1.26
1.41
1.22
1.27
Hrasls3
KLA
ATP
ATP+KLA
NM_139269
HRAS like suppressor 3 (Hrasls3), mRNA [NM_139269]
KLA
11.37
10.85
12.50
16.13
13.98
17.12
6.64
ATP
.86
.78
.96
.89
.84
.99
1.03
KLA/ATP
8.90
10.50
15.81
13.10
11.95
11.16
10.19
Hsd11b1
KLA
ATP
ATP+KLA
NM_008288
hydroxysteroid 11-beta dehydrogenase 1 (Hsd11b1), transcript variant 1, mRNA [NM_008288]
KLA
1.02
1.05
1.08
1.06
1.17
1.25
2.06
ATP
1.06
1.08
1.05
1.15
1.10
1.21
1.70
KLA/ATP
1.09
1.13
1.12
1.11
1.15
1.21
1.71
Hsd17b1
KLA
ATP
ATP+KLA
NM_010475
hydroxysteroid (17-beta) dehydrogenase 1 (Hsd17b1), mRNA [NM_010475]
KLA
.85
.93
.83
.86
.82
.84
.92
ATP
1.11
1.11
1.02
1.96
1.92
1.07
.99
KLA/ATP
.88
.92
.89
1.56
2.01
1.13
1.34
Hsd17b10
KLA
ATP
ATP+KLA
NM_016763
hydroxysteroid (17-beta) dehydrogenase 10 (Hsd17b10), nuclear gene encoding mitochondrial protein, mRNA [NM_016763]
KLA
.90
.86
.78
.80
.83
.71
1.06
ATP
1.11
1.05
1.19
1.30
1.25
.80
.80
KLA/ATP
.83
.95
1.30
1.16
1.00
.86
.88
Hsd17b12
KLA
ATP
ATP+KLA
AK076088
10, 11 days embryo whole body cDNA, RIKEN full-length enriched library, clone:2810004A21 product:hydroxysteroid (17-beta) dehydrogenase 12, full insert sequence. [AK076088]
KLA
1.03
.87
.97
1.11
1.17
1.00
1.15
ATP
1.03
1.11
1.81
1.27
1.57
1.18
1.14
KLA/ATP
1.00
.90
1.26
.97
1.03
.97
.98
Hsd17b12
KLA
ATP
ATP+KLA
NM_019657
hydroxysteroid (17-beta) dehydrogenase 12 (Hsd17b12), mRNA [NM_019657]
KLA
1.12
1.30
1.47
1.16
1.07
1.34
1.20
ATP
1.01
1.28
1.28
1.14
1.06
1.05
.93
KLA/ATP
1.21
1.44
1.63
1.51
.91
.81
.87
Hsd17b2
KLA
ATP
ATP+KLA
NM_008290
hydroxysteroid (17-beta) dehydrogenase 2 (Hsd17b2), mRNA [NM_008290]
KLA
.99
1.05
.95
1.05
1.04
1.04
.97
ATP
1.03
.98
.98
1.03
.97
.99
1.06
KLA/ATP
1.10
1.01
1.01
1.03
1.02
.97
1.03
Hsd17b3
KLA
ATP
ATP+KLA
NM_008291
hydroxysteroid (17-beta) dehydrogenase 3 (Hsd17b3), mRNA [NM_008291]
KLA
.99
.93
.99
1.04
.96
1.00
.96
ATP
1.01
.98
.98
.95
.98
1.01
.98
KLA/ATP
.96
1.07
.99
.96
.91
.95
.94
Hsd17b4
KLA
ATP
ATP+KLA
NM_008292
hydroxysteroid (17-beta) dehydrogenase 4 (Hsd17b4), mRNA [NM_008292]
KLA
.86
.77
.82
.76
.61
.63
.59
ATP
.98
.98
1.31
1.09
1.02
.80
.64
KLA/ATP
.80
.86
1.04
.87
.85
.68
.54
Hsd17b6
KLA
ATP
ATP+KLA
NM_013786
hydroxysteroid (17-beta) dehydrogenase 6 (Hsd17b6), mRNA [NM_013786]
KLA
.97
1.03
.99
1.00
1.02
.96
1.02
ATP
.96
1.04
.94
.97
.97
1.04
1.01
KLA/ATP
.89
.99
1.03
.94
.98
.98
.95
Hsd17b7
KLA
ATP
ATP+KLA
NM_010476
hydroxysteroid (17-beta) dehydrogenase 7 (Hsd17b7), mRNA [NM_010476]
KLA
.87
.86
.78
.85
.86
.76
.77
ATP
1.05
.94
1.22
.87
.69
.67
1.48
KLA/ATP
.88
.76
.91
.70
.53
.34
.36
Hsd3b1
KLA
ATP
ATP+KLA
NM_008293
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 (Hsd3b1), mRNA [NM_008293]
KLA
.98
.97
.93
.92
1.00
.98
.95
ATP
.93
1.01
1.00
1.04
.94
1.01
.88
KLA/ATP
1.01
.92
1.06
.98
1.03
.95
.97
Hsd3b2
KLA
ATP
ATP+KLA
ENSMUST00000107022
ens|3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 (3- beta-HSD II) [Includes: 3-beta-hydroxy-Delta(5)-steroid dehydrogenase (EC 1.1.1.145) (3-beta-hydroxy-5-ene steroid dehydrogenase) (Progesterone reductase); Steroid Delta-isomerase (E
KLA
1.06
.89
.93
.99
1.00
1.03
.96
ATP
.94
1.03
.96
.91
.94
1.01
.93
KLA/ATP
.93
1.01
.99
1.02
1.00
1.05
1.01
Hsd3b2
KLA
ATP
ATP+KLA
NM_153193
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 (Hsd3b2), mRNA [NM_153193]
KLA
1.00
.99
1.00
1.05
.97
1.00
1.07
ATP
.99
.99
.97
1.07
1.02
.99
1.01
KLA/ATP
1.02
1.07
.96
.98
1.02
1.08
.98
Hsd3b4
KLA
ATP
ATP+KLA
NM_001111336
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 4 (Hsd3b4), transcript variant 1, mRNA [NM_001111336]
KLA
1.01
1.03
.98
1.02
1.03
1.00
.92
ATP
1.06
1.06
1.03
.94
1.06
.96
.97
KLA/ATP
1.04
1.04
1.10
.94
.94
.98
.97
Hsd3b4
KLA
ATP
ATP+KLA
NM_008294
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 4 (Hsd3b4), transcript variant 2, mRNA [NM_008294]
KLA
1.06
1.09
1.11
1.13
1.04
1.13
1.12
ATP
1.00
.96
1.24
1.06
1.11
1.04
1.12
KLA/ATP
1.06
1.05
1.15
1.15
1.16
1.14
1.12
Hsd3b5
KLA
ATP
ATP+KLA
NM_008295
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 5 (Hsd3b5), mRNA [NM_008295]
KLA
1.00
.97
1.10
.92
.98
1.05
1.09
ATP
1.02
.95
.99
.95
.97
.93
.99
KLA/ATP
.96
1.06
1.01
1.03
1.02
1.00
1.00
Hsd3b6
KLA
ATP
ATP+KLA
NM_013821
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 6 (Hsd3b6), mRNA [NM_013821]
KLA
1.06
1.09
1.05
1.02
.98
1.09
1.04
ATP
1.03
.96
1.05
1.01
1.02
1.00
1.04
KLA/ATP
1.02
1.02
1.06
1.03
1.04
1.14
1.06
Hsd3b7
KLA
ATP
ATP+KLA
NM_133943
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 (Hsd3b7), transcript variant 1, mRNA [NM_133943]
KLA
.44
.39
.41
.32
.35
.47
.79
ATP
1.17
1.01
.82
.89
1.02
.96
1.61
KLA/ATP
.47
.42
.35
.34
.49
.56
.89
Hyal1
KLA
ATP
ATP+KLA
NM_008317
hyaluronoglucosaminidase 1 (Hyal1), mRNA [NM_008317]
KLA
.31
.28
.26
.26
.29
.53
.76
ATP
1.03
1.03
.71
1.21
1.31
.46
3.39
KLA/ATP
.31
.32
.33
.53
.84
.58
2.71
Hyal2
KLA
ATP
ATP+KLA
NM_010489
hyaluronoglucosaminidase 2 (Hyal2), mRNA [NM_010489]
KLA
.34
.25
.21
.25
.32
.56
.91
ATP
1.07
.83
.83
.66
1.51
1.39
2.21
KLA/ATP
.31
.25
.23
.20
.94
1.21
2.14
Hyal3
KLA
ATP
ATP+KLA
NM_178020
hyaluronoglucosaminidase 3 (Hyal3), mRNA [NM_178020]
KLA
1.07
1.00
.94
1.01
.99
1.03
1.03
ATP
1.03
1.06
2.20
4.46
3.50
1.36
1.02
KLA/ATP
.98
.97
1.03
1.73
2.32
1.45
1.09
Hyal4
KLA
ATP
ATP+KLA
AK014599
0 day neonate skin cDNA, RIKEN full-length enriched library, clone:4632428M18 product:similar to HYALURONIDASE 4 [Homo sapiens], full insert sequence [AK014599]
KLA
.95
.97
.88
.89
.91
.93
.90
ATP
.96
.97
.97
.97
.91
1.02
.91
KLA/ATP
.89
.88
.93
.93
.95
.97
.89
Hyal5
KLA
ATP
ATP+KLA
NM_028957
hyaluronoglucosaminidase 5 (Hyal5), mRNA [NM_028957]
KLA
1.02
1.02
1.01
.94
.96
1.06
1.05
ATP
1.01
1.00
.98
1.06
1.03
1.00
1.08
KLA/ATP
1.04
.97
1.00
1.01
1.11
1.02
1.05
Hyal6
KLA
ATP
ATP+KLA
NM_028920
hyaluronoglucosaminidase 6 (Hyal6), mRNA [NM_028920]
KLA
.92
.96
.90
1.00
.99
.98
1.01
ATP
1.02
1.01
1.06
.98
1.07
.99
1.02
KLA/ATP
.96
1.02
.97
1.01
1.03
1.06
.95
Hyi
KLA
ATP
ATP+KLA
NM_026601
hydroxypyruvate isomerase homolog (E. coli) (Hyi), mRNA [NM_026601]
KLA
.37
.43
.38
.50
.53
.54
.87
ATP
.92
.68
.59
.59
.52
.42
.44
KLA/ATP
.41
.36
.42
.33
.36
.32
.34
Idh1
KLA
ATP
ATP+KLA
NM_010497
isocitrate dehydrogenase 1 (NADP+), soluble (Idh1), transcript variant 2, mRNA [NM_010497]
KLA
.71
.74
.69
.70
.54
.45
.63
ATP
1.22
1.28
1.00
1.28
1.06
.62
.81
KLA/ATP
.76
.81
.68
.88
.55
.47
.40
Idh2
KLA
ATP
ATP+KLA
NM_173011
isocitrate dehydrogenase 2 (NADP+), mitochondrial (Idh2), nuclear gene encoding mitochondrial protein, mRNA [NM_173011]
KLA
.83
.83
.88
.94
.66
.31
.38
ATP
1.04
1.09
1.14
1.48
1.26
.39
.49
KLA/ATP
.90
.92
1.04
1.10
.82
.41
.20
Idh3a
KLA
ATP
ATP+KLA
NM_029573
isocitrate dehydrogenase 3 (NAD+) alpha (Idh3a), nuclear gene encoding mitochondrial protein, mRNA [NM_029573]
KLA
.99
1.06
.85
.83
.67
.51
.73
ATP
.95
1.07
1.12
1.22
.93
.46
.52
KLA/ATP
.92
1.00
.91
1.12
.75
.42
.21
Idh3b
KLA
ATP
ATP+KLA
NM_130884
isocitrate dehydrogenase 3 (NAD+) beta (Idh3b), nuclear gene encoding mitochondrial protein, mRNA [NM_130884]
KLA
.89
.94
.94
.89
.97
1.00
1.12
ATP
1.01
1.07
.94
1.16
.94
.52
.68
KLA/ATP
.92
.94
.78
1.05
.78
.73
.58
Idh3g
KLA
ATP
ATP+KLA
NM_008323
isocitrate dehydrogenase 3 (NAD+), gamma (Idh3g), nuclear gene encoding mitochondrial protein, mRNA [NM_008323]
KLA
.74
.69
.66
.68
.61
.55
.63
ATP
.94
.91
1.06
1.09
.93
.66
.62
KLA/ATP
.72
.74
.80
.80
.73
.56
.48
Idi1
KLA
ATP
ATP+KLA
NM_177960
isopentenyl-diphosphate delta isomerase (Idi1), transcript variant 2, mRNA [NM_177960]
KLA
1.43
1.49
1.51
1.22
.89
.45
.52
ATP
1.02
1.06
1.43
1.32
.86
.62
1.15
KLA/ATP
1.37
1.36
1.52
1.45
.84
.35
.32
Idi2
KLA
ATP
ATP+KLA
AK029364
0 day neonate head cDNA, RIKEN full-length enriched library, clone:4833405L16 product:weakly similar to ISOPENTENYL PYROPHOSPHATE ISOMERASE TYPE 2 (CDNA FLJ32388 FIS, CLONE SKMUS1000129, MODERATELY SIMILAR TO ISOPENTENYL-DIPHOSPHATE DELTA
KLA
1.08
1.09
1.06
1.07
1.08
1.05
1.05
ATP
1.02
1.05
1.01
1.04
1.00
1.13
1.07
KLA/ATP
1.09
1.01
1.00
1.07
1.07
1.04
1.06
Ids
KLA
ATP
ATP+KLA
NM_010498
iduronate 2-sulfatase (Ids), transcript variant 1, mRNA [NM_010498]
KLA
1.25
1.29
1.33
1.30
1.22
1.23
1.13
ATP
1.02
1.11
1.09
1.09
.81
.64
.83
KLA/ATP
1.24
1.22
1.13
1.13
.78
.77
.86
Idua
KLA
ATP
ATP+KLA
NM_008325
iduronidase, alpha-L- (Idua), mRNA [NM_008325]
KLA
.88
.91
1.00
.87
.91
1.00
1.22
ATP
.97
1.03
.99
1.04
.89
.64
.85
KLA/ATP
.93
.97
1.01
.97
.72
.63
.86
Il4i1
KLA
ATP
ATP+KLA
NM_010215
interleukin 4 induced 1 (Il4i1), mRNA [NM_010215]
KLA
13.98
13.74
14.90
14.92
13.89
12.12
3.25
ATP
1.02
.98
1.14
1.59
4.45
6.63
2.41
KLA/ATP
16.09
15.56
19.65
19.66
18.47
14.84
12.99
Impa1
KLA
ATP
ATP+KLA
NM_018864
inositol (myo)-1(or 4)-monophosphatase 1 (Impa1), mRNA [NM_018864]
KLA
.96
.92
.90
.96
.97
1.04
1.10
ATP
1.13
1.12
1.17
1.23
1.80
1.87
1.41
KLA/ATP
.92
.99
1.01
1.06
1.50
1.62
1.29
Impa2
KLA
ATP
ATP+KLA
NM_053261
inositol (myo)-1(or 4)-monophosphatase 2 (Impa2), mRNA [NM_053261]
KLA
.74
.70
.67
.66
.47
.34
.21
ATP
.95
.84
1.13
1.12
.78
.26
.24
KLA/ATP
.64
.65
.85
.82
.67
.31
.17
Impad1
KLA
ATP
ATP+KLA
AK147096
17 days embryo kidney cDNA, RIKEN full-length enriched library, clone:I920165A15 product:hypothetical protein, full insert sequence [AK147096]
KLA
1.24
1.16
1.08
.87
.84
.79
.67
ATP
1.01
.98
.87
.50
1.58
1.49
.50
KLA/ATP
1.17
1.08
.95
.59
1.31
.99
.41
Impad1
KLA
ATP
ATP+KLA
NM_177730
inositol monophosphatase domain containing 1 (Impad1), mRNA [NM_177730]
KLA
1.83
1.73
1.69
1.97
1.48
1.27
1.26
ATP
1.04
.91
.89
.57
1.14
3.17
2.06
KLA/ATP
1.67
1.65
1.64
.98
1.14
2.21
3.24
Impdh1
KLA
ATP
ATP+KLA
NM_011829
inosine 5-phosphate dehydrogenase 1 (Impdh1), mRNA [NM_011829]
KLA
1.03
.99
.86
.89
.71
.52
.55
ATP
.89
.81
.82
.81
.90
1.01
.85
KLA/ATP
.91
.79
.76
.83
.90
.99
.64
Impdh2
KLA
ATP
ATP+KLA
NM_011830
inosine 5-phosphate dehydrogenase 2 (Impdh2), mRNA [NM_011830]
KLA
.88
.92
.76
.67
.48
.46
.62
ATP
1.07
1.12
.90
1.26
1.15
.82
.48
KLA/ATP
.97
.98
.81
.98
.79
.61
.33
Indo
KLA
ATP
ATP+KLA
NM_008324
indoleamine-pyrrole 2,3 dioxygenase (Indo), mRNA [NM_008324]
KLA
1.56
1.62
1.87
1.73
1.52
1.38
1.28
ATP
1.09
1.01
1.08
1.02
1.00
1.06
1.07
KLA/ATP
1.53
1.60
1.78
1.50
1.49
1.40
3.38
Indol1
KLA
ATP
ATP+KLA
NM_145949
indoleamine-pyrrole 2,3 dioxygenase-like 1 (Indol1), mRNA [NM_145949]
KLA
2.01
2.13
2.31
2.13
2.14
2.14
2.52
ATP
.96
.98
1.06
1.12
.99
1.18
1.25
KLA/ATP
2.03
2.15
1.83
1.54
1.38
1.32
2.07
Inpp1
KLA
ATP
ATP+KLA
AK009002
adult male tongue cDNA, RIKEN full-length enriched library, clone:2300002C06 product:unclassifiable, full insert sequence. [AK009002]
KLA
1.33
1.23
1.55
1.72
1.37
1.24
.76
ATP
.95
.81
1.03
.79
.56
.87
.70
KLA/ATP
1.08
1.04
1.17
1.04
.89
.95
.92
Inpp1
KLA
ATP
ATP+KLA
NM_008384
inositol polyphosphate-1-phosphatase (Inpp1), mRNA [NM_008384]
KLA
1.43
1.67
2.01
2.24
1.74
1.68
1.01
ATP
1.10
1.00
.97
1.01
.73
1.01
.95
KLA/ATP
1.52
1.63
1.66
1.42
1.07
1.57
1.55
Inpp4a
KLA
ATP
ATP+KLA
NM_030266
inositol polyphosphate-4-phosphatase, type I (Inpp4a), transcript variant 1, mRNA [NM_030266]
KLA
1.25
1.48
1.49
1.81
2.10
1.96
1.57
ATP
.91
.89
.94
1.01
1.15
1.91
2.75
KLA/ATP
1.31
1.15
1.12
1.22
1.36
2.03
4.30
Inpp4a
KLA
ATP
ATP+KLA
NM_172971
inositol polyphosphate-4-phosphatase, type I (Inpp4a), transcript variant 2, mRNA [NM_172971]
KLA
1.05
1.09
1.20
1.18
1.27
1.06
1.05
ATP
1.07
1.00
.98
.98
1.06
1.00
1.34
KLA/ATP
1.12
1.10
.97
1.08
1.16
.96
1.00
Inpp4b
KLA
ATP
ATP+KLA
AK053554
0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130107I17 product:INOSITOL POLYPHOSPHATE 4-PHOSPHATASE TYPE II-ALPHA homolog [Rattus norvegicus], full insert sequence [AK053554]
KLA
.64
.55
.53
.51
.41
.54
.72
ATP
.99
.98
1.17
.82
.65
.47
.50
KLA/ATP
.57
.58
.71
.49
.52
.40
.26
Inpp4b
KLA
ATP
ATP+KLA
NM_001024617
inositol polyphosphate-4-phosphatase, type II (Inpp4b), mRNA [NM_001024617]
KLA
.72
.73
.54
.69
.58
.65
.90
ATP
1.10
1.11
.99
.95
.76
.52
.65
KLA/ATP
.72
.65
.70
.76
.65
.60
.41
Inpp5a
KLA
ATP
ATP+KLA
NM_183144
inositol polyphosphate-5-phosphatase A (Inpp5a), mRNA [NM_183144]
KLA
.69
.67
.56
.50
.52
.83
1.14
ATP
.97
1.04
.97
1.34
1.22
2.44
1.59
KLA/ATP
.66
.65
.53
.58
.76
2.72
1.65
Inpp5b
KLA
ATP
ATP+KLA
AF040095
inositol polyphosphate 5-phosphatase II splice variant (INPP5P) mRNA, partial cds. [AF040095]
KLA
.99
.98
1.05
1.03
1.06
1.15
1.09
ATP
1.05
1.00
.97
1.10
1.04
.99
1.00
KLA/ATP
1.03
.98
2.59
.99
1.05
1.05
1.20
Inpp5b
KLA
ATP
ATP+KLA
NM_008385
inositol polyphosphate-5-phosphatase B (Inpp5b), nuclear gene encoding mitochondrial protein, mRNA [NM_008385]
KLA
3.86
4.11
5.04
4.87
5.30
4.56
2.35
ATP
.95
.97
.87
.85
1.15
1.62
1.53
KLA/ATP
4.32
4.36
4.10
4.65
3.31
3.30
2.63
Inpp5e
KLA
ATP
ATP+KLA
NM_033134
inositol polyphosphate-5-phosphatase E (Inpp5e), mRNA [NM_033134]
KLA
.78
.76
.84
.81
.91
.96
1.16
ATP
1.17
1.19
.92
.82
.64
.87
1.30
KLA/ATP
.88
.85
.74
.69
.60
.78
1.26
Ippk
KLA
ATP
ATP+KLA
NM_199056
inositol 1,3,4,5,6-pentakisphosphate 2-kinase (Ippk), mRNA [NM_199056]
KLA
.92
.89
.86
.89
.91
.98
1.06
ATP
1.02
1.05
.88
.73
1.71
1.23
1.10
KLA/ATP
.88
.85
.83
.71
.77
1.07
.84
Isyna1
KLA
ATP
ATP+KLA
NM_023627
myo-inositol 1-phosphate synthase A1 (Isyna1), mRNA [NM_023627]
KLA
.81
.77
.83
.75
.74
.61
.82
ATP
1.21
1.16
1.10
1.74
1.62
1.17
.87
KLA/ATP
.97
.93
.80
1.24
1.27
.88
.52
Itpa
KLA
ATP
ATP+KLA
NM_025922
inosine triphosphatase (nucleoside triphosphate pyrophosphatase) (Itpa), mRNA [NM_025922]
KLA
1.02
.96
1.01
1.18
1.37
1.83
1.44
ATP
.96
.93
1.08
.95
.92
1.66
1.38
KLA/ATP
.86
.94
1.20
1.08
1.28
2.15
2.45
Itpk1
KLA
ATP
ATP+KLA
NM_172584
inositol 1,3,4-triphosphate 5/6 kinase (Itpk1), mRNA [NM_172584]
KLA
1.80
1.90
1.99
2.00
1.71
1.70
1.57
ATP
1.02
1.04
.98
1.13
1.20
1.21
.99
KLA/ATP
2.15
1.89
1.63
1.91
1.33
1.69
1.53
Itpka
KLA
ATP
ATP+KLA
NM_146125
inositol 1,4,5-trisphosphate 3-kinase A (Itpka), mRNA [NM_146125]
KLA
6.50
5.98
5.46
4.17
2.98
2.72
1.97
ATP
1.13
.98
1.19
1.19
2.36
2.47
1.17
KLA/ATP
7.72
7.92
10.01
7.02
8.80
6.84
1.93
Itpkc
KLA
ATP
ATP+KLA
AK051297
12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130031K05 product:weakly similar to INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE C [Homo sapiens], full insert sequence. [AK051297]
KLA
1.15
1.02
1.00
1.09
1.07
1.03
1.00
ATP
.91
1.03
1.02
.99
.98
1.03
1.02
KLA/ATP
.94
.95
1.06
.99
.95
.98
1.02
Itpkc
KLA
ATP
ATP+KLA
NM_181593
inositol 1,4,5-trisphosphate 3-kinase C (Itpkc), mRNA [NM_181593]
KLA
.76
.68
.76
1.00
1.61
1.01
1.14
ATP
1.18
1.09
1.14
4.49
3.58
1.64
1.04
KLA/ATP
.85
.78
1.05
2.67
3.12
1.34
1.41
Ivd
KLA
ATP
ATP+KLA
NM_019826
isovaleryl coenzyme A dehydrogenase (Ivd), nuclear gene encoding mitochondrial protein, mRNA [NM_019826]
KLA
.93
.88
.91
.89
.82
.81
.61
ATP
1.02
1.01
1.17
1.19
.90
1.34
1.05
KLA/ATP
.92
.96
1.01
.98
.79
.91
1.24
Kdsr
KLA
ATP
ATP+KLA
NM_027534
3-ketodihydrosphingosine reductase (Kdsr), mRNA [NM_027534]
KLA
.54
.46
.41
.39
.38
.40
.46
ATP
.98
.97
1.23
1.13
1.01
.68
.52
KLA/ATP
.48
.49
.59
.69
.92
.55
.31
Khk
KLA
ATP
ATP+KLA
NM_008439
ketohexokinase (Khk), mRNA [NM_008439]
KLA
.83
.86
.78
.75
.63
.49
.44
ATP
.95
.97
1.06
1.25
1.05
.65
.50
KLA/ATP
.84
.89
.92
1.03
.85
.57
.40
Kl
KLA
ATP
ATP+KLA
AB010088
mRNA for secreted isoform of Klotho protein, complete cds [AB010088]
KLA
1.02
1.00
1.01
.97
1.02
1.04
1.01
ATP
1.03
1.03
.99
1.00
.99
.97
1.01
KLA/ATP
1.03
.93
.98
.87
.96
.92
.93
Kl
KLA
ATP
ATP+KLA
NM_013823
klotho (Kl), mRNA [NM_013823]
KLA
.97
.96
1.08
.95
1.01
.95
1.05
ATP
.96
1.07
1.02
1.06
1.05
1.00
1.02
KLA/ATP
.95
1.02
1.04
1.04
1.11
1.01
.96
Kmo
KLA
ATP
ATP+KLA
NM_133809
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) (Kmo), mRNA [NM_133809]
KLA
2.27
2.39
2.79
2.51
2.33
1.55
.70
ATP
.95
1.15
1.11
1.08
.94
.98
.63
KLA/ATP
2.15
2.35
2.11
1.65
1.33
1.30
.72
Kynu
KLA
ATP
ATP+KLA
BC026950
kynureninase (L-kynurenine hydrolase), mRNA (cDNA clone MGC:30315 IMAGE:5136970), complete cds. [BC026950]
KLA
.99
1.04
1.04
1.02
1.11
1.05
.98
ATP
1.06
1.00
1.01
1.04
1.08
.99
.97
KLA/ATP
1.08
1.07
.95
.99
1.06
1.11
1.02
Kynu
KLA
ATP
ATP+KLA
NM_027552
kynureninase (L-kynurenine hydrolase) (Kynu), mRNA [NM_027552]
KLA
1.86
1.93
2.04
1.85
1.45
1.18
1.10
ATP
.99
1.01
1.05
1.12
1.00
1.03
1.09
KLA/ATP
1.84
1.75
2.04
1.63
1.46
1.26
1.27
LOC10003
9707
KLA
ATP
ATP+KLA
XM_001473273
gb|PREDICTED: Mus musculus similar to 5, 10-methenyltetrahydrofolate synthetase (LOC100039707), mRNA [XM_001473273]
KLA
1.15
1.22
1.34
1.10
1.24
.99
.95
ATP
1.05
1.05
1.00
1.00
.97
.91
.81
KLA/ATP
1.23
1.38
1.14
1.17
.91
.93
.86
LOC10004
4148
KLA
ATP
ATP+KLA
XM_001471861
ref|PREDICTED: Mus musculus hypothetical protein LOC100044148 (LOC100044148), mRNA [XM_001471861]
KLA
1.51
1.56
1.48
1.55
1.62
1.57
1.54
ATP
1.06
.97
1.08
.99
.93
1.35
1.36
KLA/ATP
1.54
1.49
1.70
1.46
1.47
1.47
1.60
Lalba
KLA
ATP
ATP+KLA
NM_010679
lactalbumin, alpha (Lalba), mRNA [NM_010679]
KLA
1.22
1.08
1.11
1.30
1.21
1.45
1.04
ATP
.90
.93
1.44
1.16
1.30
1.43
1.24
KLA/ATP
1.10
1.20
1.71
1.50
1.52
1.69
1.47
Lao1
KLA
ATP
ATP+KLA
NM_133892
L-amino acid oxidase 1 (Lao1), mRNA [NM_133892]
KLA
1.03
1.03
1.04
1.00
.98
1.01
.98
ATP
1.01
1.03
1.02
.92
1.05
.98
.99
KLA/ATP
1.02
.96
1.04
.94
.96
.97
.97
Lap3
KLA
ATP
ATP+KLA
NM_024434
leucine aminopeptidase 3 (Lap3), mRNA [NM_024434]
KLA
2.95
3.13
3.13
3.67
3.18
2.01
1.07
ATP
1.02
1.02
1.23
1.18
1.30
1.63
.91
KLA/ATP
2.72
3.04
4.11
3.89
3.99
3.42
.86
Lass2
KLA
ATP
ATP+KLA
NM_029789
LAG1 homolog, ceramide synthase 2 (Lass2), mRNA [NM_029789]
KLA
.79
.81
.81
.68
.72
.72
1.08
ATP
1.02
1.11
.95
1.07
.94
.70
1.25
KLA/ATP
.86
.86
.62
.78
.64
.63
.97
Lass4
KLA
ATP
ATP+KLA
AK036108
16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630036I10 product:longevity assurance homolog 4 (S. cerevisiae), full insert sequence. [AK036108]
KLA
.86
.82
.81
.76
.78
.71
.76
ATP
1.05
.97
.93
.71
.86
.79
.75
KLA/ATP
.90
.81
.80
.72
.80
.74
.72
Lass4
KLA
ATP
ATP+KLA
NM_026058
LAG1 homolog, ceramide synthase 4 (Lass4), mRNA [NM_026058]
KLA
.64
.61
.59
.67
.59
.56
.55
ATP
.91
.92
1.09
.90
.62
.55
.61
KLA/ATP
.63
.65
.73
.66
.60
.55
.55
Lass5
KLA
ATP
ATP+KLA
NM_028015
LAG1 homolog, ceramide synthase 5 (Lass5), mRNA [NM_028015]
KLA
.62
.60
.53
.42
.37
.34
.66
ATP
1.05
1.15
1.02
1.21
.85
.53
.90
KLA/ATP
.68
.64
.53
.54
.39
.37
.42
Lass6
KLA
ATP
ATP+KLA
AK136463
adult male colon cDNA, RIKEN full-length enriched library, clone:9030601N10 product:unclassifiable, full insert sequence [AK136463]
KLA
6.80
6.12
6.10
6.59
4.37
2.19
3.16
ATP
1.11
1.03
1.26
1.13
2.24
2.53
.84
KLA/ATP
6.23
6.58
7.50
5.95
5.29
2.64
1.33
Lass6
KLA
ATP
ATP+KLA
NM_172856
LAG1 homolog, ceramide synthase 6 (Lass6), mRNA [NM_172856]
KLA
8.82
11.21
11.49
12.30
10.83
7.97
7.15
ATP
1.11
1.13
1.22
1.58
2.13
4.41
4.45
KLA/ATP
10.82
12.09
9.72
11.37
7.17
5.10
9.51
Lct
KLA
ATP
ATP+KLA
NM_001081078
lactase (Lct), mRNA [NM_001081078]
KLA
.93
.83
.71
.83
.89
.99
.84
ATP
1.03
.98
.86
.92
.82
.85
.85
KLA/ATP
.80
.88
.75
.78
.89
.87
.86
Ldha
KLA
ATP
ATP+KLA
NM_010699
lactate dehydrogenase A (Ldha), mRNA [NM_010699]
KLA
.89
.80
.84
.93
.96
1.04
1.23
ATP
1.05
1.04
.96
.87
1.21
1.43
1.11
KLA/ATP
.93
.87
.87
.93
1.24
1.53
.96
Ldhal6b
KLA
ATP
ATP+KLA
NM_175349
lactate dehydrogenase A-like 6B (Ldhal6b), mRNA [NM_175349]
KLA
.89
.90
.94
.92
1.04
1.11
1.20
ATP
.99
.91
.90
.88
.90
.88
1.17
KLA/ATP
.93
.97
.87
.89
.91
1.00
1.20
Ldhb
KLA
ATP
ATP+KLA
NM_008492
lactate dehydrogenase B (Ldhb), mRNA [NM_008492]
KLA
1.00
.97
.96
1.00
.78
.63
.39
ATP
.84
.89
1.11
1.24
1.01
.67
.47
KLA/ATP
.94
1.03
1.35
1.92
1.40
.85
.47
Ldhc
KLA
ATP
ATP+KLA
NM_013580
lactate dehydrogenase C (Ldhc), mRNA [NM_013580]
KLA
.98
1.02
1.04
1.02
.97
.95
.99
ATP
1.02
1.00
.97
.96
1.00
1.00
.95
KLA/ATP
.96
1.10
1.07
.95
1.03
1.06
1.03
Lias
KLA
ATP
ATP+KLA
NM_024471
lipoic acid synthetase (Lias), nuclear gene encoding mitochondrial protein, mRNA [NM_024471]
KLA
1.05
1.12
1.11
1.12
1.22
1.24
1.31
ATP
.93
.95
.98
1.00
.81
.95
1.24
KLA/ATP
1.05
1.07
1.01
1.03
.90
1.18
1.14
Lipc
KLA
ATP
ATP+KLA
NM_008280
lipase, hepatic (Lipc), mRNA [NM_008280]
KLA
1.00
1.01
.96
.99
1.01
1.06
1.05
ATP
1.02
1.03
1.15
.98
.93
1.03
.89
KLA/ATP
1.04
.92
1.07
.98
.99
.93
1.00
Lipf
KLA
ATP
ATP+KLA
NM_026334
lipase, gastric (Lipf), mRNA [NM_026334]
KLA
.98
1.00
1.09
1.07
1.04
1.12
1.11
ATP
.96
.98
1.02
1.03
1.00
.99
1.05
KLA/ATP
1.03
1.05
.99
1.03
1.04
1.08
1.05
Lipg
KLA
ATP
ATP+KLA
NM_010720
lipase, endothelial (Lipg), mRNA [NM_010720]
KLA
10.93
11.98
13.48
13.21
13.64
13.36
3.84
ATP
1.02
.97
1.44
1.72
1.38
1.91
1.52
KLA/ATP
11.30
13.74
13.52
14.68
10.21
9.64
10.43
Lipt1
KLA
ATP
ATP+KLA
AK048005
16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130029F12 product:similar to LIPOYLTRANSFERASE [Homo sapiens], full insert sequence [AK048005]
KLA
1.00
1.02
1.00
.99
1.07
.93
.98
ATP
1.01
1.08
1.07
.94
.99
.98
.97
KLA/ATP
.92
1.03
1.01
.96
.93
.92
.91
Lipt1
KLA
ATP
ATP+KLA
NM_001037918
lipoyltransferase 1 (Lipt1), nuclear gene encoding mitochondrial protein, mRNA [NM_001037918]
KLA
.65
.69
.66
.67
.66
.69
1.01
ATP
.99
.92
.79
.67
.58
.81
.81
KLA/ATP
.74
.70
.66
.61
.57
.67
.72
Lpcat1
KLA
ATP
ATP+KLA
AK155286
NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630214O14 product:Hypothetical phospholipid and glycerol acyltransferase, full insert sequence [AK155286]
KLA
.94
.83
1.02
.83
1.42
.92
.90
ATP
1.33
1.28
1.03
.82
1.24
.58
.81
KLA/ATP
1.16
1.13
.83
.60
.71
.53
.50
Lpcat2
KLA
ATP
ATP+KLA
NM_173014
lysophosphatidylcholine acyltransferase 2 (Lpcat2), mRNA [NM_173014]
KLA
1.61
1.75
1.91
2.26
3.20
3.80
3.31
ATP
1.06
1.08
1.21
1.23
1.11
1.94
1.31
KLA/ATP
1.61
1.55
1.72
1.65
1.14
1.27
2.62
Lpin1
KLA
ATP
ATP+KLA
AF180471
Lpin1 (Kiaa0188) mRNA, complete cds [AF180471]
KLA
.26
.24
.29
.31
.26
.25
.24
ATP
1.23
.96
1.11
.97
.82
.43
.62
KLA/ATP
.27
.25
.42
.37
.49
.34
.22
Lpin1
KLA
ATP
ATP+KLA
NM_015763
lipin 1 (Lpin1), transcript variant 2, mRNA [NM_015763]
KLA
.19
.19
.18
.20
.18
.16
.19
ATP
1.02
.99
1.06
.93
.70
.35
.70
KLA/ATP
.18
.17
.27
.25
.30
.25
.16
Lpin3
KLA
ATP
ATP+KLA
NM_022883
lipin 3 (Lpin3), mRNA [NM_022883]
KLA
.99
.98
1.06
1.04
1.01
.99
.99
ATP
1.03
1.01
1.02
.92
1.00
1.03
.91
KLA/ATP
1.03
.97
.99
.99
.92
.91
1.02
Lss
KLA
ATP
ATP+KLA
AK147680
adult male brain UNDEFINED_CELL_LINE cDNA, RIKEN full-length enriched library, clone:M5C1106O04 product:lanosterol synthase, full insert sequence [AK147680]
KLA
.52
.46
.46
.47
.49
.43
.44
ATP
.93
.92
1.44
.97
.55
.39
.46
KLA/ATP
.46
.45
.56
.47
.44
.32
.15
Lss
KLA
ATP
ATP+KLA
NM_146006
lanosterol synthase (Lss), mRNA [NM_146006]
KLA
.77
.80
.87
.80
.90
.70
.80
ATP
1.04
1.09
1.03
1.18
.73
.67
1.63
KLA/ATP
.79
.89
.87
.88
.57
.46
.43
Lta4h
KLA
ATP
ATP+KLA
NM_008517
leukotriene A4 hydrolase (Lta4h), mRNA [NM_008517]
KLA
.84
.85
.77
.59
.48
.46
.63
ATP
.99
1.20
1.11
1.29
1.02
.98
.83
KLA/ATP
.86
.85
.72
.95
.72
.92
.59
Ltc4s
KLA
ATP
ATP+KLA
NM_008521
leukotriene C4 synthase (Ltc4s), mRNA [NM_008521]
KLA
.96
.97
.92
.83
.62
.43
.13
ATP
.94
.98
.97
1.09
.77
.51
.27
KLA/ATP
.92
.89
.88
.81
.68
.49
.26
Lycat
KLA
ATP
ATP+KLA
NM_001081071
lysocardiolipin acyltransferase (Lycat), mRNA [NM_001081071]
KLA
1.03
.96
1.02
.97
1.02
.94
.99
ATP
1.09
1.08
.99
.94
.75
.90
1.06
KLA/ATP
1.02
1.10
.98
.91
.73
.97
1.03
Man1a
KLA
ATP
ATP+KLA
NM_008548
mannosidase 1, alpha (Man1a), mRNA [NM_008548]
KLA
1.15
1.18
1.19
.93
.66
.37
.35
ATP
1.09
1.21
1.08
1.89
1.20
1.15
.63
KLA/ATP
1.15
1.25
1.02
1.36
.83
.61
.35
Man1a2
KLA
ATP
ATP+KLA
AK078291
adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430575L20 product:unclassifiable, full insert sequence [AK078291]
KLA
1.27
1.23
1.12
.98
.77
.89
.85
ATP
.97
1.03
1.00
.87
.74
1.09
1.05
KLA/ATP
1.19
1.20
1.11
1.02
.89
.94
.93
Man1a2
KLA
ATP
ATP+KLA
NM_010763
mannosidase, alpha, class 1A, member 2 (Man1a2), mRNA [NM_010763]
KLA
1.36
1.42
1.22
1.13
.86
1.12
1.12
ATP
.93
.98
.95
.76
.75
1.51
1.47
KLA/ATP
1.34
1.39
1.25
1.15
1.09
1.21
1.55
Man1b1
KLA
ATP
ATP+KLA
NM_001029983
mannosidase, alpha, class 1B, member 1 (Man1b1), mRNA [NM_001029983]
KLA
.72
.76
.73
.68
.84
.77
.93
ATP
.99
.79
.31
.46
.75
.75
1.03
KLA/ATP
.81
.58
.25
.36
.57
.55
.92
Man1c1
KLA
ATP
ATP+KLA
NM_207237
mannosidase, alpha, class 1C, member 1 (Man1c1), mRNA [NM_207237]
KLA
.46
.43
.41
.30
.26
.43
.44
ATP
1.03
1.12
.85
.98
.61
.35
.76
KLA/ATP
.48
.44
.32
.34
.33
.43
.34
Man2a1
KLA
ATP
ATP+KLA
NM_008549
mannosidase 2, alpha 1 (Man2a1), mRNA [NM_008549]
KLA
1.59
1.57
1.60
1.75
1.24
1.22
.67
ATP
.99
.83
.66
.40
.52
1.00
.61
KLA/ATP
1.42
1.35
1.26
.78
1.32
1.61
.88
Man2a2
KLA
ATP
ATP+KLA
AK029913
adult male testis cDNA, RIKEN full-length enriched library, clone:4931438M07 product:mannosidase 2, alpha 2, full insert sequence [AK029913]
KLA
.72
.64
.62
.65
.47
.34
.30
ATP
.93
.86
1.08
.96
.71
.60
.39
KLA/ATP
.63
.67
.76
.69
.74
.56
.31
Man2a2
KLA
ATP
ATP+KLA
BC055006
mannosidase 2, alpha 2, mRNA (cDNA clone MGC:57099 IMAGE:6491507), complete cds. [BC055006]
KLA
.57
.53
.48
.54
.43
.27
.31
ATP
1.17
.95
.96
.91
.80
.49
.27
KLA/ATP
.62
.61
.68
.59
.64
.46
.28
Man2a2
KLA
ATP
ATP+KLA
NM_172903
mannosidase 2, alpha 2 (Man2a2), mRNA [NM_172903]
KLA
.78
.79
.86
.87
.85
.83
.81
ATP
1.07
1.20
1.17
1.02
.92
.77
.72
KLA/ATP
.81
.79
.98
1.33
1.01
.84
.72
Maoa
KLA
ATP
ATP+KLA
NM_173740
monoamine oxidase A (Maoa), nuclear gene encoding mitochondrial protein, mRNA [NM_173740]
KLA
1.14
1.11
1.06
1.07
.84
.55
.53
ATP
1.10
1.07
1.33
1.20
1.44
2.37
1.38
KLA/ATP
.97
1.11
1.75
1.33
1.27
1.21
1.09
Maob
KLA
ATP
ATP+KLA
NM_172778
monoamine oxidase B (Maob), nuclear gene encoding mitochondrial protein, mRNA [NM_172778]
KLA
1.01
.97
1.01
1.05
1.01
.95
1.01
ATP
1.09
.98
.99
.97
1.03
1.03
.94
KLA/ATP
1.02
1.05
.99
1.02
1.00
.98
.98
Mat1a
KLA
ATP
ATP+KLA
NM_133653
methionine adenosyltransferase I, alpha (Mat1a), mRNA [NM_133653]
KLA
1.08
.94
1.05
.99
.99
1.08
1.05
ATP
1.00
1.02
1.03
1.03
1.00
1.06
1.03
KLA/ATP
1.04
1.03
1.00
1.04
.98
.96
.97
Mat2a
KLA
ATP
ATP+KLA
NM_145569
methionine adenosyltransferase II, alpha (Mat2a), mRNA [NM_145569]
KLA
.44
.42
.37
.38
.48
.65
.85
ATP
.82
.64
.76
.45
.32
.71
.87
KLA/ATP
.40
.38
.41
.33
.29
.53
.33
Mat2b
KLA
ATP
ATP+KLA
AK038303
16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130094D24 product:similar to 5 of METHIONINE ADENOSYLTRANSFERASE REGULATORY BETA SUBUNIT (HYPOTHETICAL 37.6 KDA PROTEIN) [Homo sapiens], full insert sequence [AK0383
KLA
.97
1.01
1.66
1.00
.96
1.05
1.11
ATP
.97
1.01
.93
.95
1.03
1.01
.93
KLA/ATP
.96
.90
.91
.97
1.04
.95
.91
Mat2b
KLA
ATP
ATP+KLA
NM_134017
methionine adenosyltransferase II, beta (Mat2b), mRNA [NM_134017]
KLA
.81
.85
.89
1.03
1.00
1.02
1.02
ATP
.99
1.03
1.00
.99
.77
.96
.84
KLA/ATP
.77
.88
.88
.92
1.06
1.26
.98
Mboat1
KLA
ATP
ATP+KLA
NM_153546
membrane bound O-acyltransferase domain containing 1 (Mboat1), mRNA [NM_153546]
KLA
.55
.57
.44
.39
.23
.14
.12
ATP
.86
.94
1.05
1.04
.90
.52
.14
KLA/ATP
.53
.53
.55
.53
.46
.35
.12
Mboat2
KLA
ATP
ATP+KLA
AK031682
13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030487B18 product:unclassifiable, full insert sequence [AK031682]
KLA
.94
.98
.99
.97
.92
1.08
1.08
ATP
1.00
.99
1.05
1.01
1.03
1.01
1.07
KLA/ATP
1.02
1.06
.99
1.06
1.08
1.14
.96
Mboat2
KLA
ATP
ATP+KLA
NM_026037
membrane bound O-acyltransferase domain containing 2 (Mboat2), transcript variant 1, mRNA [NM_026037]
KLA
.84
.87
.81
.81
.81
.83
.95
ATP
1.03
1.01
1.04
1.01
1.10
1.02
.88
KLA/ATP
.89
.88
.98
.91
.89
1.01
1.11
Mcat
KLA
ATP
ATP+KLA
NM_001030014
malonyl CoA:ACP acyltransferase (mitochondrial) (Mcat), nuclear gene encoding mitochondrial protein, mRNA [NM_001030014]
KLA
1.51
1.53
1.49
1.38
1.39
1.52
1.29
ATP
.97
.98
.85
.78
.40
.85
1.23
KLA/ATP
1.51
1.55
1.30
1.39
1.04
1.18
1.84
Mccc1
KLA
ATP
ATP+KLA
NM_023644
methylcrotonoyl-Coenzyme A carboxylase 1 (alpha) (Mccc1), mRNA [NM_023644]
KLA
.89
.88
.81
.85
.73
.82
1.18
ATP
.93
.88
1.22
1.07
.88
.65
1.26
KLA/ATP
.83
.88
1.12
.86
.77
.56
.79
Mccc2
KLA
ATP
ATP+KLA
NM_030026
methylcrotonoyl-Coenzyme A carboxylase 2 (beta) (Mccc2), nuclear gene encoding mitochondrial protein, mRNA [NM_030026]
KLA
.99
1.00
1.03
.76
.65
.55
.61
ATP
1.04
1.11
.80
.97
.53
.37
.51
KLA/ATP
.96
1.03
.63
.76
.49
.39
.35
Mcee
KLA
ATP
ATP+KLA
NM_028626
methylmalonyl CoA epimerase (Mcee), mRNA [NM_028626]
KLA
.94
.93
.88
.92
.77
.71
.87
ATP
.93
.97
1.28
1.51
1.31
.87
.80
KLA/ATP
.88
.96
1.18
1.37
1.28
.95
.83
Mdh1
KLA
ATP
ATP+KLA
AK077724
8 days embryo whole body cDNA, RIKEN full-length enriched library, clone:5730556L21 product:unclassifiable, full insert sequence [AK077724]
KLA
.85
.75
.69
.67
.72
.81
.82
ATP
.93
.83
.61
.59
.72
.72
.88
KLA/ATP
.79
.76
.67
.58
.74
.74
.80
Mdh1
KLA
ATP
ATP+KLA
NM_008618
malate dehydrogenase 1, NAD (soluble) (Mdh1), mRNA [NM_008618]
KLA
.79
.72
.66
.66
.52
.49
.57
ATP
.98
1.00
1.17
1.09
.96
.70
.66
KLA/ATP
.70
.73
.92
.78
.76
.65
.52
Mdh2
KLA
ATP
ATP+KLA
NM_008617
malate dehydrogenase 2, NAD (mitochondrial) (Mdh2), nuclear gene encoding mitochondrial protein, mRNA [NM_008617]
KLA
.90
.91
.81
.86
.81
.91
1.26
ATP
.96
.86
1.04
.80
1.01
1.36
1.33
KLA/ATP
.87
.79
1.04
.71
.95
1.04
.95
Me1
KLA
ATP
ATP+KLA
NM_008615
malic enzyme 1, NADP(+)-dependent, cytosolic (Me1), mRNA [NM_008615]
KLA
.95
1.01
1.01
.81
.71
.71
1.97
ATP
.94
1.03
1.19
1.09
.93
1.48
.67
KLA/ATP
.98
.96
1.04
.89
.65
.87
1.05
Me3
KLA
ATP
ATP+KLA
AK036221
16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630046K15 product:unclassifiable, full insert sequence. [AK036221]
KLA
1.04
.98
.99
1.02
1.01
.99
.96
ATP
1.02
1.02
1.01
.98
1.00
.95
1.04
KLA/ATP
.98
.99
1.00
1.01
.99
.99
1.00
Me3
KLA
ATP
ATP+KLA
NM_181407
malic enzyme 3, NADP(+)-dependent, mitochondrial (Me3), nuclear gene encoding mitochondrial protein, mRNA [NM_181407]
KLA
.97
1.00
.99
.96
.94
.99
.99
ATP
1.01
1.03
.98
.98
.96
.95
1.03
KLA/ATP
.98
1.01
.98
.96
1.00
.98
.97
Mecr
KLA
ATP
ATP+KLA
NM_025297
mitochondrial trans-2-enoyl-CoA reductase (Mecr), nuclear gene encoding mitochondrial protein, mRNA [NM_025297]
KLA
1.48
1.62
1.63
1.35
1.44
1.23
1.16
ATP
1.00
1.28
.97
1.45
1.09
.62
.55
KLA/ATP
1.77
1.77
1.16
2.13
1.26
1.00
.49
Mgam
KLA
ATP
ATP+KLA
AK033548
adult male colon cDNA, RIKEN full-length enriched library, clone:9030616M21 product:hypothetical protein, full insert sequence. [AK033548]
KLA
1.16
1.20
1.22
1.21
1.01
1.02
1.07
ATP
1.01
1.01
1.11
2.86
5.71
5.58
1.53
KLA/ATP
1.24
1.24
1.29
1.64
3.84
3.69
1.98
Mgam
KLA
ATP
ATP+KLA
XM_001481277
gb|PREDICTED: Mus musculus maltase-glucoamylase (Mgam), mRNA [XM_001481277]
KLA
1.03
1.04
1.03
1.04
.95
.98
1.06
ATP
1.06
.94
1.05
1.42
2.38
2.12
1.16
KLA/ATP
1.10
1.06
1.06
1.15
1.52
1.64
1.20
Mgat1
KLA
ATP
ATP+KLA
NM_010794
mannoside acetylglucosaminyltransferase 1 (Mgat1), transcript variant 2, mRNA [NM_010794]
KLA
2.09
2.17
2.90
2.22
1.90
1.60
1.14
ATP
1.10
1.31
1.13
1.24
1.25
1.42
1.23
KLA/ATP
2.52
2.52
2.20
2.41
1.84
1.68
1.22
Mgat2
KLA
ATP
ATP+KLA
NM_146035
mannoside acetylglucosaminyltransferase 2 (Mgat2), mRNA [NM_146035]
KLA
.64
.68
.66
.62
.78
.74
1.01
ATP
1.07
1.17
.62
.64
.51
.63
1.02
KLA/ATP
.65
.74
.40
.43
.38
.55
.60
Mgat3
KLA
ATP
ATP+KLA
NM_010795
mannoside acetylglucosaminyltransferase 3 (Mgat3), mRNA [NM_010795]
KLA
1.02
.98
1.16
.99
.99
1.03
1.08
ATP
1.02
1.03
.95
1.07
1.03
1.03
1.02
KLA/ATP
1.01
.95
1.02
1.03
1.04
1.03
1.07
Mgat4a
KLA
ATP
ATP+KLA
NM_173870
mannoside acetylglucosaminyltransferase 4, isoenzyme A (Mgat4a), mRNA [NM_173870]
KLA
4.19
4.15
4.78
4.90
3.82
4.33
2.57
ATP
.99
1.03
1.34
1.31
1.09
2.84
5.50
KLA/ATP
4.42
4.69
5.16
4.33
2.92
4.12
13.74
Mgat4b
KLA
ATP
ATP+KLA
BC026638
mannoside acetylglucosaminyltransferase 4, isoenzyme B, mRNA (cDNA clone MGC:37502 IMAGE:4984907), complete cds. [BC026638]
KLA
.85
.71
.64
.53
.43
.55
.75
ATP
1.01
.86
.70
.56
1.01
.92
.77
KLA/ATP
.87
.72
.63
.46
.71
.64
.86
Mgat4b
KLA
ATP
ATP+KLA
NM_145926
mannoside acetylglucosaminyltransferase 4, isoenzyme B (Mgat4b), mRNA [NM_145926]
KLA
1.02
.90
.94
.67
.59
.69
.88
ATP
1.11
.96
.66
.74
1.13
1.03
.86
KLA/ATP
1.14
1.02
.79
.65
.90
.84
1.02
Mgat4c
KLA
ATP
ATP+KLA
AK032009
adult male medulla oblongata cDNA, RIKEN full-length enriched library, clone:6330543K19 product:weakly similar to N-ACETYLGLUCOSAMINYLTRANSFERASE VI [Gallus gallus], full insert sequence [AK032009]
KLA
1.01
.95
.97
1.03
.96
1.02
1.02
ATP
.99
.95
.96
1.07
1.03
.93
.94
KLA/ATP
.97
.98
1.10
1.09
.92
.98
1.04
Mgat4c
KLA
ATP
ATP+KLA
NM_026243
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) (Mgat4c), mRNA [NM_026243]
KLA
1.04
.96
.99
1.03
1.00
.97
.97
ATP
.99
1.07
1.06
1.00
1.00
1.07
1.08
KLA/ATP
.97
1.08
1.06
1.06
.97
.96
1.09
Mgat5
KLA
ATP
ATP+KLA
AK015544
adult male testis cDNA, RIKEN full-length enriched library, clone:4930471A21 product:unclassifiable, full insert sequence [AK015544]
KLA
.40
.36
.29
.25
.39
.72
.74
ATP
1.06
.87
.62
.76
.67
.68
.73
KLA/ATP
.42
.31
.25
.30
.58
.78
.52
Mgat5
KLA
ATP
ATP+KLA
AK036567
adult male bone cDNA, RIKEN full-length enriched library, clone:9830134K01 product:ALPHA-1,3(6)-MANNOSYLGLYCOPROTEIN BETA-1,6-N-ACETYL- GLUCOSAMINYLTRANSFERASE V (EC 2.4.1.155) (ALPHA-MANNOSIDE BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE) (N
KLA
.34
.32
.36
.70
1.01
1.04
.77
ATP
1.30
.90
1.34
.66
1.41
1.08
1.35
KLA/ATP
.37
.30
.67
.49
1.55
.98
1.44
Mgat5
KLA
ATP
ATP+KLA
NM_145128
mannoside acetylglucosaminyltransferase 5 (Mgat5), mRNA [NM_145128]
KLA
.84
.85
.81
.86
.77
.98
.90
ATP
.97
.87
.82
.87
.78
.89
1.21
KLA/ATP
.89
.81
.77
.82
.79
.91
.96
Mgat5b
KLA
ATP
ATP+KLA
NM_172948
mannoside acetylglucosaminyltransferase 5, isoenzyme B (Mgat5b), mRNA [NM_172948]
KLA
.95
1.02
.99
1.03
1.05
.99
1.05
ATP
1.02
.96
1.00
1.03
1.02
1.01
1.04
KLA/ATP
1.00
1.05
1.02
1.03
1.01
1.02
1.05
Mgll
KLA
ATP
ATP+KLA
NM_011844
monoglyceride lipase (Mgll), mRNA [NM_011844]
KLA
.86
.83
.81
.85
.67
.57
.46
ATP
1.02
1.00
1.15
1.16
1.26
1.27
.74
KLA/ATP
.90
.85
1.01
1.05
1.26
1.20
.71
Mlycd
KLA
ATP
ATP+KLA
NM_019966
malonyl-CoA decarboxylase (Mlycd), nuclear gene encoding mitochondrial protein, mRNA [NM_019966]
KLA
.77
.70
.74
.89
.75
.81
.66
ATP
1.01
.91
1.04
.78
.38
.62
.81
KLA/ATP
.66
.66
.80
.56
.44
.57
.74
Mm.1070
KLA
ATP
ATP+KLA
158508616
Unknown
KLA
.89
.89
.78
.84
.68
.70
.71
ATP
.97
.94
1.17
1.00
.76
.86
.78
KLA/ATP
.86
.84
.86
.80
.67
.68
.60
Mm.10984
KLA
ATP
ATP+KLA
6678010
Unknown
KLA
.98
1.03
.96
1.03
.98
.98
.98
ATP
.96
.96
1.01
1.06
.93
.93
.93
KLA/ATP
.96
.93
.84
.93
1.08
1.19
1.04
Mm.1103
KLA
ATP
ATP+KLA
142363208
Unknown
KLA
.97
.98
.93
.96
.92
.94
1.02
ATP
.99
.99
1.20
1.21
1.11
1.01
.84
KLA/ATP
.99
1.07
1.17
1.26
1.19
1.09
.72
Mm.12773
1
KLA
ATP
ATP+KLA
142352287
Unknown
KLA
.97
.93
.99
.98
1.00
1.04
1.07
ATP
.98
1.05
1.00
.89
.96
.99
1.13
KLA/ATP
1.00
1.02
1.06
.96
1.00
.91
1.22
Mm.13558
1
KLA
ATP
ATP+KLA
34328145
Unknown
KLA
.73
.64
.50
.54
.38
.49
1.02
ATP
.88
.84
1.16
.94
.66
.72
.68
KLA/ATP
.56
.62
.71
.49
.40
.30
.42
Mm.13732
7
KLA
ATP
ATP+KLA
116686108
Unknown
KLA
.93
.84
.81
.69
.58
.47
.53
ATP
.94
.87
.87
.75
.38
.23
.41
KLA/ATP
.82
.80
.63
.63
.39
.27
.18
Mm.15164
0
KLA
ATP
ATP+KLA
23943833
Unknown
KLA
.99
1.01
1.02
.89
.85
.86
.83
ATP
1.05
1.26
.92
1.38
1.01
.90
1.15
KLA/ATP
1.08
1.15
.90
1.23
.78
.92
1.20
Mm.15303
0
KLA
ATP
ATP+KLA
124301197
Unknown
KLA
1.07
1.01
1.05
1.02
.67
.60
.91
ATP
.89
.85
1.38
1.28
1.54
1.92
.73
KLA/ATP
.90
1.00
1.20
1.05
.93
.58
.57
Mm.15744
2
KLA
ATP
ATP+KLA
41152515
Unknown
KLA
1.09
1.07
.96
1.02
1.04
1.00
1.07
ATP
1.04
.96
.98
1.04
1.04
1.13
1.11
KLA/ATP
1.02
.97
1.03
1.04
1.15
1.23
1.25
Mm.16006
7
KLA
ATP
ATP+KLA
124487226
Unknown
KLA
.90
.88
.87
.85
.80
.85
.64
ATP
.95
.95
1.00
.94
1.00
.91
.67
KLA/ATP
.89
.86
.93
.82
.85
.84
.63
Mm.17905
KLA
ATP
ATP+KLA
94536843
Unknown
KLA
1.05
1.02
1.06
1.01
.76
.88
.91
ATP
.91
.83
1.42
.91
.93
1.14
1.10
KLA/ATP
1.01
1.05
1.76
1.10
1.06
.89
.88
Mm.17932
KLA
ATP
ATP+KLA
142368657
Unknown
KLA
1.96
2.16
2.26
2.04
1.94
2.22
1.33
ATP
1.19
1.29
2.96
4.36
1.42
1.27
1.16
KLA/ATP
4.95
7.89
18.00
12.21
3.38
1.85
1.27
Mm.17942
1
KLA
ATP
ATP+KLA
84993735
Unknown
KLA
.93
1.00
1.05
1.00
.99
1.01
1.01
ATP
1.02
1.03
1.03
1.05
1.08
.98
1.01
KLA/ATP
1.05
.97
1.04
.99
1.09
1.10
1.00
Mm.1845
KLA
ATP
ATP+KLA
142351600
Unknown
KLA
.93
.92
.89
.81
.76
.84
.65
ATP
1.01
.94
1.08
1.00
.77
1.95
1.13
KLA/ATP
.91
.84
.85
.81
.59
.66
.77
Mm.18707
9
KLA
ATP
ATP+KLA
149268188
Unknown
KLA
4.07
3.11
3.86
4.46
3.31
3.46
1.63
ATP
1.17
.95
1.34
.60
1.22
1.61
1.03
KLA/ATP
3.87
3.25
5.63
2.01
3.05
3.28
2.19
Mm.18854
4
KLA
ATP
ATP+KLA
141802696
Unknown
KLA
.76
.82
.79
.80
.80
.91
.98
ATP
.92
.91
1.08
.88
.83
.86
.80
KLA/ATP
.73
.82
.86
.84
.85
.83
.66
Mm.18893
9
KLA
ATP
ATP+KLA
6754247
Unknown
KLA
.71
.85
.76
.78
.76
.81
.90
ATP
1.13
1.21
1.21
2.93
3.64
1.24
.96
KLA/ATP
.77
.82
.96
2.56
4.66
1.65
1.50
Mm.19666
8
KLA
ATP
ATP+KLA
118131189
Unknown
KLA
1.18
1.14
1.10
1.18
1.17
1.29
1.16
ATP
1.01
.95
1.10
1.17
1.10
1.04
1.08
KLA/ATP
1.19
1.15
1.34
1.29
1.33
1.17
1.24
Mm.1978
KLA
ATP
ATP+KLA
118129966
Unknown
KLA
.41
.34
.33
.29
.20
.17
.15
ATP
1.01
.98
1.28
1.12
.67
.28
.49
KLA/ATP
.35
.38
.45
.37
.33
.22
.20
Mm.21162
KLA
ATP
ATP+KLA
55742659
Unknown
KLA
.68
.65
.64
.66
.63
.80
.92
ATP
.97
.86
.68
.63
.51
.64
.75
KLA/ATP
.64
.64
.66
.57
.61
.62
.62
Mm.21511
5
KLA
ATP
ATP+KLA
146149315
Unknown
KLA
.94
.93
.96
.95
.89
.95
1.08
ATP
1.02
.93
1.00
.83
.78
.92
1.58
KLA/ATP
.90
.96
.93
.85
.77
.83
.83
Mm.21700
4
KLA
ATP
ATP+KLA
142350613
Unknown
KLA
1.16
1.21
1.14
1.10
1.08
1.08
1.03
ATP
1.02
1.12
1.05
.94
.90
1.04
.89
KLA/ATP
1.19
1.11
1.09
1.02
.98
.94
.95
Mm.22792
4
KLA
ATP
ATP+KLA
142373198
Unknown
KLA
1.61
1.61
1.22
1.43
1.87
1.90
1.75
ATP
1.08
1.06
1.09
2.61
2.93
1.89
2.18
KLA/ATP
1.40
1.68
1.35
1.68
1.51
1.39
2.31
Mm.23812
7
KLA
ATP
ATP+KLA
168823498
Unknown
KLA
1.07
.97
1.04
1.05
1.02
.98
1.02
ATP
.95
1.00
.98
1.01
.95
.93
.92
KLA/ATP
.93
.98
.98
1.04
1.01
1.02
.98
Mm.23951
KLA
ATP
ATP+KLA
145864487
Unknown
KLA
.97
1.03
1.12
.96
1.08
.98
1.33
ATP
1.11
1.26
.84
1.26
.75
.60
1.62
KLA/ATP
1.27
1.25
.70
1.19
.72
.64
1.43
Mm.24244
KLA
ATP
ATP+KLA
23956161
Unknown
KLA
1.04
1.00
.96
1.04
1.53
1.13
1.09
ATP
1.17
1.30
.97
1.10
1.09
1.26
1.10
KLA/ATP
.92
1.07
.82
.97
.80
.96
.74
Mm.24411
4
KLA
ATP
ATP+KLA
71892413
Unknown
KLA
.97
1.00
1.06
.95
.98
1.03
.99
ATP
1.01
1.04
1.01
.97
.98
1.00
1.05
KLA/ATP
1.05
1.00
.97
1.04
.97
1.04
.99
Mm.24987
3
KLA
ATP
ATP+KLA
161621251
Unknown
KLA
1.11
1.02
1.08
1.36
1.47
1.64
3.59
ATP
1.05
1.00
1.00
.96
1.04
1.20
1.13
KLA/ATP
1.08
1.12
1.23
1.06
1.09
1.31
1.81
Mm.25153
7
KLA
ATP
ATP+KLA
42475986
Unknown
KLA
1.18
1.02
1.08
1.18
1.25
1.39
1.49
ATP
1.09
1.02
1.28
1.04
.62
1.02
1.32
KLA/ATP
1.09
1.15
1.30
1.07
.86
1.04
1.42
Mm.25203
4
KLA
ATP
ATP+KLA
116268114
Unknown
KLA
1.22
1.14
1.15
1.25
1.52
1.40
.89
ATP
1.08
1.16
1.22
1.27
1.07
.83
.62
KLA/ATP
1.02
1.21
1.56
1.55
1.39
.93
.84
Mm.26057
7
KLA
ATP
ATP+KLA
48525358
Unknown
KLA
1.29
1.49
1.41
1.57
2.51
5.49
8.27
ATP
.97
.93
1.09
1.12
1.36
2.94
7.70
KLA/ATP
1.32
1.32
1.61
1.48
1.89
2.90
8.20
Mm.26105
4
KLA
ATP
ATP+KLA
124487274
Unknown
KLA
.95
1.04
.97
.98
1.01
.94
1.10
ATP
1.00
1.06
.94
1.07
1.01
1.00
.98
KLA/ATP
1.04
.99
.93
1.01
1.11
1.07
1.04
Mm.26684
3
KLA
ATP
ATP+KLA
94405693
Unknown
KLA
1.12
.99
.99
1.00
.97
.98
.96
ATP
1.02
1.08
1.01
.90
1.02
.97
.91
KLA/ATP
1.03
.96
.98
.91
1.05
.90
.97
Mm.26719
KLA
ATP
ATP+KLA
23680951
Unknown
KLA
.97
.96
.93
1.05
.94
1.09
.99
ATP
.96
1.00
1.02
1.02
1.01
1.04
.94
KLA/ATP
1.13
1.02
.97
1.00
1.09
1.05
1.08
Mm.26915
KLA
ATP
ATP+KLA
51921286
Unknown
KLA
1.02
1.03
.96
1.11
1.05
.96
.96
ATP
1.02
1.00
.98
1.06
1.04
.99
1.08
KLA/ATP
.96
.94
1.06
1.00
1.02
1.00
1.03
Mm.26930
KLA
ATP
ATP+KLA
124487296
Unknown
KLA
1.16
1.07
1.03
1.13
1.13
1.32
1.25
ATP
.99
1.00
1.05
1.24
1.38
1.37
1.06
KLA/ATP
1.03
1.16
1.14
1.22
1.32
1.29
1.32
Mm.26940
KLA
ATP
ATP+KLA
113680351
Unknown
KLA
.71
.71
.72
.65
.63
.83
.93
ATP
.94
.87
1.23
1.30
1.21
1.41
1.76
KLA/ATP
.70
.69
.89
.88
1.21
1.51
1.45
Mm.27292
7
KLA
ATP
ATP+KLA
141801850
Unknown
KLA
.91
.85
.82
.87
.74
.77
.76
ATP
.92
.96
1.13
1.28
1.01
.93
.94
KLA/ATP
.82
.88
1.06
1.11
.98
.92
.95
Mm.27395
8
KLA
ATP
ATP+KLA
31560783
Unknown
KLA
.84
.82
.82
.88
1.05
1.14
1.07
ATP
1.36
1.47
1.11
1.14
1.07
.85
.81
KLA/ATP
.97
.93
.90
1.13
1.05
.99
1.01
Mm.28058
KLA
ATP
ATP+KLA
27754143
Unknown
KLA
1.12
1.15
1.01
.86
.91
.85
.73
ATP
.96
.95
1.32
1.19
1.11
.67
.59
KLA/ATP
1.01
1.15
1.39
1.20
1.24
.68
.30
Mm.28349
KLA
ATP
ATP+KLA
140969945
Unknown
KLA
.72
.74
.71
.78
.71
.72
.71
ATP
.92
.89
1.15
1.10
.94
.84
.68
KLA/ATP
.70
.70
.91
.86
.88
.80
.51
Mm.28873
KLA
ATP
ATP+KLA
110431340
Unknown
KLA
.79
.72
.69
.71
.44
.32
.37
ATP
.89
.88
1.17
.98
1.11
.98
.73
KLA/ATP
.67
.72
.87
.74
.75
.53
.30
Mm.28924
4
KLA
ATP
ATP+KLA
118403321
Unknown
KLA
.84
.83
.89
.94
.83
.96
.76
ATP
.79
.69
.94
.64
.55
.66
.71
KLA/ATP
.66
.68
.83
.63
.66
.78
.65
Mm.28967
2
KLA
ATP
ATP+KLA
133893229
Unknown
KLA
1.01
1.03
1.00
.97
.97
1.02
1.02
ATP
.97
.98
.92
1.05
.98
.99
1.07
KLA/ATP
.93
1.03
.95
.99
1.02
1.04
1.05
Mm.29073
1
KLA
ATP
ATP+KLA
125347157
Unknown
KLA
.98
.99
1.12
1.02
1.04
1.04
1.05
ATP
1.02
1.06
.97
1.05
.99
1.07
1.02
KLA/ATP
.96
.96
.99
1.10
1.07
1.03
1.01
Mm.29128
6
KLA
ATP
ATP+KLA
89179305
Unknown
KLA
1.03
.97
1.00
1.05
1.09
.97
.92
ATP
1.07
1.00
1.01
.96
.93
.98
.93
KLA/ATP
1.06
1.05
1.05
1.04
1.03
.96
1.04
Mm.29150
3
KLA
ATP
ATP+KLA
34328333
Unknown
KLA
.61
.60
.60
.53
.51
.56
.69
ATP
1.05
.96
.93
.75
.81
.44
.78
KLA/ATP
.66
.58
.67
.52
.58
.47
.55
Mm.29323
3
KLA
ATP
ATP+KLA
118130035
Unknown
KLA
.98
1.04
.98
1.05
1.07
.97
.95
ATP
1.02
1.04
1.01
1.02
1.00
1.00
1.00
KLA/ATP
1.03
1.00
.98
.96
1.10
1.03
.98
Mm.29357
KLA
ATP
ATP+KLA
12963756
Unknown
KLA
.88
.79
.81
.76
.76
.65
.79
ATP
1.11
1.01
1.16
1.59
1.54
1.33
.84
KLA/ATP
.93
.86
.97
1.13
1.39
1.02
.60
Mm.29415
KLA
ATP
ATP+KLA
146141166
Unknown
KLA
1.13
1.04
.97
1.11
.87
.82
.87
ATP
.91
.84
1.37
1.34
1.20
1.10
.71
KLA/ATP
.97
1.02
1.48
1.40
1.30
1.12
.67
Mm.29467
8
KLA
ATP
ATP+KLA
124487254
Unknown
KLA
1.01
1.07
1.03
.98
1.02
1.09
1.02
ATP
1.02
1.00
1.02
1.08
.96
1.04
.97
KLA/ATP
1.01
1.00
1.05
1.05
1.01
1.06
1.01
Mm.29584
KLA
ATP
ATP+KLA
20270274
Unknown
KLA
.71
.64
.54
.49
.33
.33
.49
ATP
.84
.85
1.28
1.02
.82
.39
.47
KLA/ATP
.57
.64
.77
.60
.52
.30
.19
Mm.29625
KLA
ATP
ATP+KLA
34536833
Unknown
KLA
1.02
.99
1.07
.90
1.01
1.14
1.01
ATP
1.07
1.16
1.05
1.04
.93
.98
1.06
KLA/ATP
.98
1.04
1.04
1.06
.93
.96
1.04
Mm.29897
KLA
ATP
ATP+KLA
56711243
Unknown
KLA
.98
.97
.95
.97
.94
.93
1.23
ATP
.99
1.07
1.10
1.45
1.14
.94
.98
KLA/ATP
.97
1.05
1.02
1.31
1.07
1.03
.92
Mm.30009
5
KLA
ATP
ATP+KLA
145699117
Unknown
KLA
.70
.74
.85
.84
.90
.85
.90
ATP
.83
.77
.93
.98
1.05
1.04
.86
KLA/ATP
.72
.70
.86
.97
1.13
.80
.83
Mm.30084
KLA
ATP
ATP+KLA
158631245
Unknown
KLA
.80
.75
.72
.79
.65
.70
.67
ATP
.89
.81
1.13
.98
.90
.93
.83
KLA/ATP
.70
.71
.91
.75
.82
.76
.75
Mm.30102
KLA
ATP
ATP+KLA
142348692
Unknown
KLA
1.04
1.04
.97
1.07
1.02
.93
.90
ATP
1.06
.98
1.13
1.06
1.30
1.19
.78
KLA/ATP
.94
1.05
1.13
1.05
1.24
1.12
.84
Mm.30384
7
KLA
ATP
ATP+KLA
73661177
Unknown
KLA
.94
1.00
1.07
1.05
.96
1.04
1.08
ATP
1.06
1.01
.98
1.02
.98
.99
1.01
KLA/ATP
1.03
.94
1.13
1.06
1.03
1.03
.99
Mm.30978
KLA
ATP
ATP+KLA
172072649
Unknown
KLA
.94
.97
.98
1.02
.98
.97
.96
ATP
1.07
.96
1.09
.95
.99
.92
.96
KLA/ATP
.99
1.04
1.03
.98
1.03
1.00
.89
Mm.31830
2
KLA
ATP
ATP+KLA
124487482
Unknown
KLA
1.02
1.02
1.02
1.06
1.03
.98
1.05
ATP
1.00
.99
1.04
1.17
1.04
.98
.96
KLA/ATP
1.04
1.02
1.22
1.05
.99
.99
.99
Mm.31903
8
KLA
ATP
ATP+KLA
164518941
Unknown
KLA
.91
.84
.91
.94
.91
.78
.81
ATP
1.19
1.28
1.04
1.53
1.42
1.10
1.11
KLA/ATP
1.08
1.05
1.00
1.43
1.04
.92
.81
Mm.32260
6
KLA
ATP
ATP+KLA
141803200
Unknown
KLA
.95
.95
.98
1.03
.96
.93
1.00
ATP
1.02
1.05
.97
.99
1.02
.98
.99
KLA/ATP
.96
1.16
1.01
.88
1.02
1.05
1.00
Mm.32260
6
KLA
ATP
ATP+KLA
94411982
Unknown
KLA
1.00
1.02
1.09
1.05
1.08
1.11
1.07
ATP
1.01
.95
1.05
1.08
.97
.94
1.06
KLA/ATP
.96
.98
1.10
1.08
.99
1.00
1.04
Mm.32380
5
KLA
ATP
ATP+KLA
195546943
Unknown
KLA
1.01
.94
1.03
1.09
1.03
1.06
.97
ATP
.98
.98
1.06
.98
1.00
.95
1.17
KLA/ATP
1.05
1.06
1.05
1.08
1.05
1.09
1.21
Mm.32408
KLA
ATP
ATP+KLA
124486912
Unknown
KLA
.80
.80
.70
.70
.54
.49
.63
ATP
.90
.85
.99
.86
.71
.39
.56
KLA/ATP
.71
.75
.74
.67
.53
.35
.39
Mm.32919
4
KLA
ATP
ATP+KLA
124486721
Unknown
KLA
1.02
.91
.92
.99
.85
.96
.84
ATP
.97
.92
1.29
.82
.56
1.00
.95
KLA/ATP
.90
.98
1.13
.79
.71
1.06
.84
Mm.32981
0
KLA
ATP
ATP+KLA
55741832
Unknown
KLA
1.02
.84
.68
.95
1.70
.68
.70
ATP
1.13
1.06
1.48
1.46
1.40
1.58
.58
KLA/ATP
.82
.80
.95
.85
.60
.70
.50
Mm.33050
7
KLA
ATP
ATP+KLA
67906182
Unknown
KLA
.94
.98
.99
1.03
1.05
1.07
.98
ATP
.95
1.02
.97
.98
.99
1.05
1.02
KLA/ATP
1.02
1.05
1.01
1.03
.99
.98
.97
Mm.33127
2
KLA
ATP
ATP+KLA
114431239
Unknown
KLA
1.20
1.18
1.18
1.16
1.18
1.25
1.20
ATP
1.02
1.00
2.55
17.57
7.98
3.58
1.31
KLA/ATP
1.29
1.24
3.14
14.38
12.37
7.20
2.04
Mm.33401
KLA
ATP
ATP+KLA
149255058
Unknown
KLA
1.03
1.07
1.00
1.03
1.01
1.03
1.06
ATP
1.12
.98
1.12
1.36
2.32
2.03
1.10
KLA/ATP
1.03
1.00
.99
1.21
1.39
1.58
1.20
Mm.33438
KLA
ATP
ATP+KLA
46402174
Unknown
KLA
1.14
1.18
1.15
.97
.93
.89
.84
ATP
1.02
1.20
2.15
1.34
.98
.89
.86
KLA/ATP
1.23
1.19
.91
1.16
.78
.90
.86
Mm.34137
KLA
ATP
ATP+KLA
94405716
Unknown
KLA
1.11
1.12
1.10
1.07
1.08
1.13
1.36
ATP
1.09
1.14
1.01
1.25
.95
.79
1.23
KLA/ATP
1.01
1.24
.95
1.14
.83
.78
1.30
Mm.3458
KLA
ATP
ATP+KLA
119226250
Unknown
KLA
.85
.78
.75
.84
.74
.81
.79
ATP
.97
.83
1.09
.93
2.03
1.96
.89
KLA/ATP
.81
.72
.89
.63
1.72
1.77
.79
Mm.35517
4
KLA
ATP
ATP+KLA
142352582
Unknown
KLA
1.05
.97
.95
1.03
1.05
.98
.97
ATP
.98
1.02
1.00
1.03
.97
1.05
1.01
KLA/ATP
.98
.97
1.03
.97
1.00
1.02
.99
Mm.36205
4
KLA
ATP
ATP+KLA
118130030
Unknown
KLA
.79
.80
.81
.73
.86
.82
.88
ATP
1.00
1.12
.89
.98
.70
.55
1.34
KLA/ATP
.82
.85
.58
.75
.50
.63
.97
Mm.37812
8
KLA
ATP
ATP+KLA
162139826
Unknown
KLA
.94
.92
.89
.82
.67
.71
1.85
ATP
.88
.91
1.28
.99
.92
1.81
.61
KLA/ATP
.85
.89
1.10
.81
.72
.96
1.14
Mm.37889
8
KLA
ATP
ATP+KLA
93102385
Unknown
KLA
1.07
.94
.91
1.12
1.00
1.03
.96
ATP
1.08
1.00
1.10
.94
1.00
1.02
.67
KLA/ATP
.96
.94
1.29
1.07
1.14
1.08
.72
Mm.38329
7
KLA
ATP
ATP+KLA
124487166
Unknown
KLA
2.05
2.34
2.70
2.62
3.57
3.14
2.09
ATP
1.14
1.43
1.16
2.23
1.65
1.29
1.61
KLA/ATP
2.51
2.51
1.90
3.84
2.23
2.63
3.57
Mm.38984
8
KLA
ATP
ATP+KLA
116268117
Unknown
KLA
.98
1.02
1.01
1.05
.97
.97
.96
ATP
.95
1.01
1.04
1.14
.99
.91
1.01
KLA/ATP
1.08
.92
1.02
1.00
.97
.97
.99
Mm.39052
9
KLA
ATP
ATP+KLA
133892597
Unknown
KLA
.97
1.02
.97
.88
.79
.79
.92
ATP
.93
1.10
1.07
1.22
.76
.47
.72
KLA/ATP
.95
.99
.86
1.08
.67
.55
.67
Mm.39818
1
KLA
ATP
ATP+KLA
9790036
Unknown
KLA
.48
.51
.55
.56
.86
1.00
.82
ATP
.99
1.00
.70
.48
.19
.24
.54
KLA/ATP
.57
.48
.28
.29
.18
.29
.63
Mm.40681
KLA
ATP
ATP+KLA
153792802
Unknown
KLA
.96
1.01
1.08
.98
1.07
1.15
1.09
ATP
1.04
1.02
1.03
1.13
1.11
1.13
1.16
KLA/ATP
1.06
1.07
.57
1.13
1.25
1.20
1.10
Mm.41173
7
KLA
ATP
ATP+KLA
124486740
Unknown
KLA
6.95
6.26
6.49
5.66
6.34
2.93
3.01
ATP
1.18
1.40
1.03
1.27
1.96
1.87
1.53
KLA/ATP
6.62
7.00
6.07
6.81
2.75
2.22
2.84
Mm.42040
KLA
ATP
ATP+KLA
146149300
Unknown
KLA
7.51
8.44
6.42
6.50
4.95
2.64
3.74
ATP
.91
.86
1.41
1.06
5.00
13.26
.50
KLA/ATP
7.10
8.32
10.08
6.10
13.81
8.56
1.67
Mm.42309
9
KLA
ATP
ATP+KLA
74325340
Unknown
KLA
.96
1.03
1.01
.90
1.05
1.02
1.05
ATP
.97
.94
1.02
1.02
.93
1.05
.99
KLA/ATP
.95
.97
.94
1.00
1.05
1.02
.98
Mm.42607
7
KLA
ATP
ATP+KLA
58743309
Unknown
KLA
.98
.93
1.04
1.03
.97
.98
1.16
ATP
1.02
.95
1.02
1.06
.96
.95
1.04
KLA/ATP
.98
.97
.98
1.01
.99
1.11
.91
Mm.42677
1
KLA
ATP
ATP+KLA
149234310
Unknown
KLA
.98
.96
.91
1.07
1.00
.99
.98
ATP
.96
1.00
.97
.94
1.03
.95
1.01
KLA/ATP
1.01
.92
.96
.96
1.02
.99
1.00
Mm.42805
KLA
ATP
ATP+KLA
72004261
Unknown
KLA
.97
.94
.88
.98
.87
.98
1.02
ATP
.88
.91
1.10
1.09
.95
.81
.92
KLA/ATP
.85
.94
1.11
1.07
1.08
.98
.81
Mm.43970
2
KLA
ATP
ATP+KLA
38327645
Unknown
KLA
.89
.90
.82
.83
.70
.65
.67
ATP
1.00
.95
1.37
1.24
1.13
.76
.97
KLA/ATP
.87
.88
1.23
.98
1.02
.64
.36
Mm.43972
3
KLA
ATP
ATP+KLA
153792336
Unknown
KLA
.39
.33
.34
.30
.39
.58
.97
ATP
1.12
1.02
1.23
1.06
1.41
1.10
1.25
KLA/ATP
.42
.35
.50
.59
1.68
1.10
1.36
Mm.44046
5
KLA
ATP
ATP+KLA
164607131
Unknown
KLA
.65
.56
.59
.51
.33
.20
.24
ATP
1.07
.90
1.30
2.88
3.61
4.46
1.07
KLA/ATP
.60
.59
.95
2.38
2.99
2.31
.37
Mm.44250
5
KLA
ATP
ATP+KLA
124487070
Unknown
KLA
.93
.96
1.03
1.01
.97
.93
1.17
ATP
1.04
.91
.96
.96
.99
.89
.96
KLA/ATP
.95
.89
.70
1.01
.95
1.00
.96
Mm.44390
8
KLA
ATP
ATP+KLA
71043952
Unknown
KLA
.99
1.00
1.01
1.04
1.01
.98
1.06
ATP
1.03
.97
1.00
.94
.95
.98
.95
KLA/ATP
.98
.98
.89
1.04
.94
.99
1.00
Mm.44463
KLA
ATP
ATP+KLA
118129851
Unknown
KLA
1.01
.98
.97
1.02
.93
1.06
1.05
ATP
.97
1.01
1.04
1.06
1.02
1.08
.97
KLA/ATP
1.02
1.06
.95
1.04
1.09
1.14
1.03
Mm.44829
2
KLA
ATP
ATP+KLA
86198313
Unknown
KLA
1.12
1.03
1.02
1.14
1.04
1.07
1.02
ATP
.95
.98
1.18
1.06
1.12
1.07
1.04
KLA/ATP
1.04
1.15
1.29
1.11
1.16
1.21
1.14
Mm.45742
4
KLA
ATP
ATP+KLA
85838507
Unknown
KLA
.42
.38
.47
.72
1.01
1.27
.84
ATP
1.10
1.14
1.55
1.12
.55
.71
.55
KLA/ATP
.50
.42
.72
.55
1.18
.69
.68
Mm.45856
3
KLA
ATP
ATP+KLA
142351405
Unknown
KLA
.93
.96
.85
.74
.64
.68
.87
ATP
1.03
1.07
1.02
1.04
.94
1.01
1.14
KLA/ATP
.98
.98
.75
.87
.68
1.02
1.15
Mm.4610
KLA
ATP
ATP+KLA
142375308
Unknown
KLA
18.33
19.27
25.23
27.01
26.13
21.96
6.28
ATP
.93
.96
1.25
1.62
4.21
13.24
6.23
KLA/ATP
18.14
20.17
25.25
25.64
23.63
21.18
26.75
Mm.46142
7
KLA
ATP
ATP+KLA
120407063
Unknown
KLA
.93
.93
.95
.88
.83
.83
.97
ATP
1.03
1.01
1.04
1.24
1.43
1.21
1.82
KLA/ATP
.97
1.00
.91
.90
1.02
1.10
1.57
Mm.46661
0
KLA
ATP
ATP+KLA
82894546
Unknown
KLA
.86
.90
.99
.94
1.02
.83
.91
ATP
1.10
1.04
1.04
1.15
1.03
.93
.84
KLA/ATP
.86
.85
1.00
1.10
.94
.85
.90
Mm.46685
9
KLA
ATP
ATP+KLA
145699102
Unknown
KLA
.65
.64
.75
.87
.83
.79
.82
ATP
.80
.77
.97
.86
1.13
1.05
.85
KLA/ATP
.64
.65
.85
.86
1.16
.69
.72
Mm.46777
KLA
ATP
ATP+KLA
13385513
Unknown
KLA
.59
.57
.58
.68
.61
.73
1.13
ATP
.96
.91
.76
.66
.60
.70
.97
KLA/ATP
.56
.58
.64
.66
.66
.75
.75
Mm.47209
5
KLA
ATP
ATP+KLA
85861217
Unknown
KLA
.81
.77
.71
.75
.70
.72
.87
ATP
1.08
1.12
.79
.80
.68
.62
.59
KLA/ATP
.86
.83
.56
.66
.56
.63
.57
Mm.47565
8
KLA
ATP
ATP+KLA
145966880
Unknown
KLA
.20
.19
.15
.15
.17
.47
.71
ATP
.85
.82
.70
1.24
1.23
.39
3.48
KLA/ATP
.18
.20
.18
.38
.85
.56
2.73
Mm.5662
KLA
ATP
ATP+KLA
27369991
Unknown
KLA
1.04
1.09
.90
.88
.75
.70
1.19
ATP
1.09
1.21
.84
.88
.57
.63
.90
KLA/ATP
1.08
1.06
.73
.89
.61
.60
.72
Mm.58068
KLA
ATP
ATP+KLA
124487322
Unknown
KLA
1.01
.98
1.02
.99
1.04
1.10
1.07
ATP
1.05
1.00
1.07
1.00
1.01
1.02
1.08
KLA/ATP
.97
.94
.95
.94
.99
1.08
1.01
Mm.71913
KLA
ATP
ATP+KLA
118130231
Unknown
KLA
.93
1.00
1.06
.97
.95
.98
1.04
ATP
1.00
.98
1.08
1.02
.92
.90
.99
KLA/ATP
.99
1.01
1.00
.99
.99
.99
1.01
Mm.7329
KLA
ATP
ATP+KLA
158508431
Unknown
KLA
1.07
1.00
.89
.83
.87
.58
.44
ATP
1.19
1.31
1.06
1.47
1.11
.56
.46
KLA/ATP
.94
1.10
1.03
1.33
.87
.55
.27
Mm.76062
KLA
ATP
ATP+KLA
57527869
Unknown
KLA
1.29
1.49
1.51
1.51
1.60
1.61
1.64
ATP
.94
.88
.90
.96
.83
1.19
1.76
KLA/ATP
1.33
1.31
1.18
1.27
1.06
1.30
1.71
Mm.79179
KLA
ATP
ATP+KLA
141803280
Unknown
KLA
.95
1.09
1.04
1.13
1.00
1.10
.98
ATP
1.02
1.17
1.04
1.18
1.06
1.02
1.01
KLA/ATP
.98
1.00
1.02
1.01
.98
.93
.99
Mmab
KLA
ATP
ATP+KLA
NM_029956
methylmalonic aciduria (cobalamin deficiency) type B homolog (human) (Mmab), nuclear gene encoding mitochondrial protein, mRNA [NM_029956]
KLA
.85
.89
.82
.94
1.03
1.15
1.23
ATP
1.02
1.05
.91
.89
.60
.64
1.73
KLA/ATP
.82
.87
1.15
.83
.70
.66
1.02
Mocs1
KLA
ATP
ATP+KLA
NM_020042
molybdenum cofactor synthesis 1 (Mocs1), transcript variant 1, mRNA [NM_020042]
KLA
1.79
1.98
2.19
2.29
2.97
3.11
2.73
ATP
1.04
1.10
1.15
1.46
1.30
1.68
1.29
KLA/ATP
1.97
2.20
2.03
2.45
1.60
1.88
2.90
Mocs2
KLA
ATP
ATP+KLA
AF091872
molybdopterin-synthase small and large subunit (Mocs2) bicistronic mRNA, complete cds. [AF091872]
KLA
1.48
1.65
2.02
2.31
2.45
2.95
1.68
ATP
.94
.80
.87
.66
.81
1.86
2.21
KLA/ATP
1.47
1.31
1.62
1.29
1.85
2.40
3.27
Mocs2
KLA
ATP
ATP+KLA
NM_013826
molybdenum cofactor synthesis 2 (Mocs2), transcript variant 1, mRNA [NM_013826]
KLA
1.45
1.49
1.75
2.08
2.20
2.83
1.69
ATP
.83
.74
.80
.65
.77
1.68
2.23
KLA/ATP
1.32
1.23
1.38
1.18
1.67
2.36
2.99
Mpi
KLA
ATP
ATP+KLA
NM_025837
mannose phosphate isomerase (Mpi), mRNA [NM_025837]
KLA
1.54
1.45
1.45
1.54
1.57
1.73
1.47
ATP
1.14
1.14
1.15
1.20
1.21
1.34
1.76
KLA/ATP
1.60
1.57
1.94
1.67
1.51
1.73
2.21
Mpst
KLA
ATP
ATP+KLA
NM_138670
mercaptopyruvate sulfurtransferase (Mpst), nuclear gene encoding mitochondrial protein, mRNA [NM_138670]
KLA
.87
1.03
.83
.86
.79
1.21
1.35
ATP
.99
1.43
1.12
1.05
1.00
.91
1.24
KLA/ATP
.91
1.21
1.03
1.10
.87
.73
1.52
Mtap
KLA
ATP
ATP+KLA
NM_024433
methylthioadenosine phosphorylase (Mtap), mRNA [NM_024433]
KLA
.83
.89
.73
.73
.55
.39
.64
ATP
1.15
1.28
1.09
1.23
.72
.32
.38
KLA/ATP
.98
.95
.79
.89
.52
.29
.20
Mthfd1
KLA
ATP
ATP+KLA
NM_138745
methylenetetrahydrofolate dehydrogenase (NADP+ dependent), methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthase (Mthfd1), mRNA [NM_138745]
KLA
.69
.68
.59
.46
.33
.31
.53
ATP
.94
1.07
1.11
1.21
.84
.34
.48
KLA/ATP
.68
.71
.64
.66
.44
.25
.17
Mthfd1l
KLA
ATP
ATP+KLA
NM_172308
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like (Mthfd1l), mRNA [NM_172308]
KLA
.86
.88
.73
.64
.50
.40
.50
ATP
.97
.99
1.19
1.03
.96
.86
.32
KLA/ATP
.88
.86
.84
.74
.78
.65
.20
Mthfd2
KLA
ATP
ATP+KLA
NM_008638
methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase (Mthfd2), nuclear gene encoding mitochondrial protein, mRNA [NM_008638]
KLA
1.72
1.73
1.41
1.61
2.15
3.05
3.45
ATP
1.13
1.16
.97
1.23
2.55
2.27
2.28
KLA/ATP
1.42
1.75
1.68
1.84
2.13
2.41
2.12
Mthfr
KLA
ATP
ATP+KLA
AF404274
methylenetetrahydrofolate reductase short isoform (Mthfr) mRNA, partial cds; alternatively spliced. [AF404274]
KLA
1.05
.94
.98
.99
.96
1.03
1.08
ATP
.94
1.00
.96
1.01
.96
.84
1.11
KLA/ATP
.93
.99
.95
1.05
1.01
.99
1.08
Mthfr
KLA
ATP
ATP+KLA
NM_010840
5,10-methylenetetrahydrofolate reductase (Mthfr), mRNA [NM_010840]
KLA
5.09
5.09
6.32
5.94
6.76
6.97
3.52
ATP
.98
.92
.91
.80
1.52
3.30
4.30
KLA/ATP
5.03
4.79
4.71
3.89
5.46
7.22
9.94
Mthfs
KLA
ATP
ATP+KLA
NM_026829
5, 10-methenyltetrahydrofolate synthetase (Mthfs), mRNA [NM_026829]
KLA
1.92
1.98
2.10
1.90
1.83
1.41
1.00
ATP
.96
.96
1.23
1.33
1.21
.86
1.66
KLA/ATP
2.00
2.22
2.99
2.93
2.57
1.51
1.32
Mtm1
KLA
ATP
ATP+KLA
BC066847
cDNA clone IMAGE:30056108, containing frame-shift errors [BC066847]
KLA
1.95
1.54
1.59
1.45
1.67
1.72
1.56
ATP
1.13
.99
1.79
.67
1.45
1.50
1.16
KLA/ATP
1.94
1.67
2.49
.85
1.57
1.41
1.69
Mtm1
KLA
ATP
ATP+KLA
NM_019926
X-linked myotubular myopathy gene 1 (Mtm1), mRNA [NM_019926]
KLA
1.83
1.97
2.17
2.00
2.01
1.87
2.29
ATP
1.10
1.30
1.18
1.32
.93
1.12
1.07
KLA/ATP
2.00
2.06
1.71
2.12
1.12
1.14
1.76
Mtr
KLA
ATP
ATP+KLA
AK037599
16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130029B16 product:5-methyltetrahydrofolate-homocysteine methyltransferase, full insert sequence. [AK037599]
KLA
.89
.92
.81
.83
.73
.76
.98
ATP
.98
1.11
.85
.93
.68
.72
1.12
KLA/ATP
.92
.93
.71
.85
.66
.68
.77
Mtr
KLA
ATP
ATP+KLA
NM_001081128
5-methyltetrahydrofolate-homocysteine methyltransferase (Mtr), mRNA [NM_001081128]
KLA
.93
.91
.89
.77
.64
.58
.99
ATP
1.12
1.11
1.05
.87
.71
.69
1.59
KLA/ATP
1.02
.95
.96
.78
.54
.55
.92
Mut
KLA
ATP
ATP+KLA
X51941
gb|Mouse mRNA for methylmalonyl CoA mutase (EC 5.4.99.2) [X51941]
KLA
.57
.56
.51
.56
.55
.63
.69
ATP
.89
.83
1.05
.71
.41
.29
.88
KLA/ATP
.52
.51
.62
.40
.29
.23
.38
Mvd
KLA
ATP
ATP+KLA
NM_138656
mevalonate (diphospho) decarboxylase (Mvd), mRNA [NM_138656]
KLA
.53
.53
.53
.53
.54
.48
.81
ATP
.95
.97
1.05
1.29
1.06
.87
1.80
KLA/ATP
.54
.57
.60
.73
.77
.56
.47
Mvk
KLA
ATP
ATP+KLA
NM_023556
mevalonate kinase (Mvk), mRNA [NM_023556]
KLA
.87
.90
.89
.91
.90
.94
.99
ATP
.91
.79
.56
.59
.35
.47
1.40
KLA/ATP
.89
.74
.56
.61
.43
.43
.65
Nadk
KLA
ATP
ATP+KLA
NM_138671
NAD kinase (Nadk), mRNA [NM_138671]
KLA
1.14
1.21
1.18
1.21
1.38
1.48
2.34
ATP
.92
.84
.67
.56
.61
.69
.91
KLA/ATP
1.07
.97
.76
.64
.56
.54
1.71
Nadsyn1
KLA
ATP
ATP+KLA
NM_030221
NAD synthetase 1 (Nadsyn1), mRNA [NM_030221]
KLA
.94
.85
.89
.99
.96
1.02
.97
ATP
.98
.95
1.19
.81
.73
.70
1.01
KLA/ATP
.76
.87
1.17
.90
.82
.78
1.05
Naglu
KLA
ATP
ATP+KLA
AK158045
adult inner ear cDNA, RIKEN full-length enriched library, clone:F930021C23 product:alpha-N-acetylglucosaminidase (Sanfilippo disease IIIB), full insert sequence [AK158045]
KLA
1.06
1.01
1.05
.98
1.02
1.04
1.01
ATP
.99
1.05
.96
1.00
1.05
.93
1.03
KLA/ATP
1.03
.99
1.04
1.03
.96
.98
.91
Naglu
KLA
ATP
ATP+KLA
NM_013792
alpha-N-acetylglucosaminidase (Sanfilippo disease IIIB) (Naglu), mRNA [NM_013792]
KLA
.67
.71
.71
.63
.59
.60
.87
ATP
1.02
1.07
1.00
1.14
.84
.57
.95
KLA/ATP
.72
.72
.71
.84
.58
.54
.72
Nags
KLA
ATP
ATP+KLA
NM_145829
N-acetylglutamate synthase (Nags), transcript variant 1, mRNA [NM_145829]
KLA
.99
.97
1.02
1.06
1.03
1.03
1.08
ATP
.95
.98
1.07
1.12
1.17
1.38
1.26
KLA/ATP
.97
1.05
1.10
1.42
1.31
1.52
1.27
Nags
KLA
ATP
ATP+KLA
NM_178053
N-acetylglutamate synthase (Nags), transcript variant 2, mRNA [NM_178053]
KLA
1.01
.98
1.07
1.10
1.02
1.02
1.06
ATP
1.07
1.06
1.12
1.00
1.56
2.35
1.57
KLA/ATP
.98
1.02
1.09
.94
1.32
1.66
1.29
Nanp
KLA
ATP
ATP+KLA
NM_026086
N-acetylneuraminic acid phosphatase (Nanp), mRNA [NM_026086]
KLA
.56
.58
.56
.59
.66
.93
.79
ATP
.92
.82
.70
.42
.61
.53
.68
KLA/ATP
.52
.49
.52
.44
.64
.66
.47
Nans
KLA
ATP
ATP+KLA
NM_053179
N-acetylneuraminic acid synthase (sialic acid synthase) (Nans), mRNA [NM_053179]
KLA
.67
.67
.63
.55
.48
.54
.67
ATP
.95
.97
1.05
1.12
.95
.70
.77
KLA/ATP
.67
.67
.69
.70
.77
.59
.46
Naprt1
KLA
ATP
ATP+KLA
NM_172607
nicotinate phosphoribosyltransferase domain containing 1 (Naprt1), mRNA [NM_172607]
KLA
.70
.62
.67
.62
.50
.46
.56
ATP
1.01
.90
1.12
.94
.58
.39
.76
KLA/ATP
.69
.68
.82
.71
.60
.34
.42
Nat1
KLA
ATP
ATP+KLA
NM_008673
N-acetyltransferase 1 (arylamine N-acetyltransferase) (Nat1), mRNA [NM_008673]
KLA
.97
.98
1.00
.94
1.01
.95
1.02
ATP
1.03
.96
1.01
1.04
1.03
.99
1.01
KLA/ATP
1.03
.98
.94
1.00
.99
1.05
.86
Nat2
KLA
ATP
ATP+KLA
NM_010874
N-acetyltransferase 2 (arylamine N-acetyltransferase) (Nat2), mRNA [NM_010874]
KLA
3.59
3.77
3.60
2.69
2.11
2.24
1.44
ATP
.96
.91
.74
.42
.39
1.32
1.45
KLA/ATP
3.43
3.33
2.84
1.60
.89
2.12
2.09
Nat3
KLA
ATP
ATP+KLA
NM_008674
N-acetyltransferase 3 (Nat3), mRNA [NM_008674]
KLA
1.00
1.06
1.05
1.02
1.07
1.05
1.11
ATP
.98
.99
1.05
1.05
1.04
1.02
1.11
KLA/ATP
1.03
.95
.96
1.03
.96
1.04
.99
Ndst1
KLA
ATP
ATP+KLA
AK004787
adult male lung cDNA, RIKEN full-length enriched library, clone:1200015G06 product:unclassifiable, full insert sequence. [AK004787]
KLA
.57
.59
.51
.41
.33
.35
.46
ATP
.93
.82
1.09
.86
1.18
1.46
2.12
KLA/ATP
.54
.58
.64
.58
1.19
1.35
1.57
Ndst1
KLA
ATP
ATP+KLA
NM_008306
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 (Ndst1), mRNA [NM_008306]
KLA
1.04
1.05
1.03
1.00
1.04
.97
.96
ATP
1.07
1.09
.92
.97
.97
1.07
2.76
KLA/ATP
1.07
1.10
.85
.87
1.02
1.17
2.12
Ndst2
KLA
ATP
ATP+KLA
NM_010811
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2 (Ndst2), mRNA [NM_010811]
KLA
1.59
1.63
1.85
1.98
2.19
1.85
1.33
ATP
1.17
1.08
.72
.63
.85
1.06
1.80
KLA/ATP
1.78
1.61
1.03
1.13
1.68
1.70
1.96
Ndst3
KLA
ATP
ATP+KLA
NM_031186
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3 (Ndst3), mRNA [NM_031186]
KLA
1.02
.98
1.02
.98
.96
.97
1.01
ATP
.98
1.02
1.04
1.10
1.02
1.03
.89
KLA/ATP
1.09
1.11
.96
1.05
1.06
1.00
.91
Ndst4
KLA
ATP
ATP+KLA
NM_022565
N-deacetylase/N-sulfotransferase (heparin glucosaminyl) 4 (Ndst4), mRNA [NM_022565]
KLA
.98
.95
.97
1.06
.98
.98
1.02
ATP
1.01
.97
1.02
.97
1.01
1.03
1.01
KLA/ATP
.98
1.08
1.02
1.02
1.00
1.01
.95
Ndufa1
KLA
ATP
ATP+KLA
NM_019443
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1 (Ndufa1), nuclear gene encoding mitochondrial protein, mRNA [NM_019443]
KLA
1.12
.99
.94
1.16
.97
.95
.86
ATP
.95
.93
1.18
1.10
1.13
1.25
1.12
KLA/ATP
.93
1.02
1.37
1.17
1.18
1.13
1.07
Ndufa10
KLA
ATP
ATP+KLA
NM_024197
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 10 (Ndufa10), nuclear gene encoding mitochondrial protein, mRNA [NM_024197]
KLA
1.13
1.13
1.00
.96
1.07
.97
1.14
ATP
1.08
1.11
1.00
1.13
.94
.67
.83
KLA/ATP
1.05
1.21
1.03
1.19
.86
.86
.74
Ndufa11
KLA
ATP
ATP+KLA
BC053075
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 11, mRNA (cDNA clone IMAGE:5694421) [BC053075]
KLA
1.24
1.07
1.15
1.23
1.27
1.25
1.24
ATP
1.16
1.19
1.30
1.46
1.49
1.47
1.11
KLA/ATP
1.17
1.31
1.46
1.67
1.47
1.54
1.46
Ndufa12
KLA
ATP
ATP+KLA
NM_025551
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12 (Ndufa12), mRNA [NM_025551]
KLA
1.02
.99
.98
1.06
.92
.80
.82
ATP
1.06
1.08
1.43
1.49
1.33
1.01
.84
KLA/ATP
1.03
1.15
1.68
1.51
1.25
1.06
.67
Ndufa13
KLA
ATP
ATP+KLA
NM_023312
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 (Ndufa13), mRNA [NM_023312]
KLA
.90
.84
.76
.86
.85
.78
.97
ATP
1.05
.99
1.09
.97
.94
.87
.76
KLA/ATP
.82
.87
1.06
.95
.92
.81
.88
Ndufa2
KLA
ATP
ATP+KLA
NM_010885
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2 (Ndufa2), mRNA [NM_010885]
KLA
.85
.93
.79
.83
.79
.81
1.00
ATP
.99
1.05
1.12
1.31
1.25
1.09
.93
KLA/ATP
.91
.92
.98
1.22
1.15
1.06
1.05
Ndufa3
KLA
ATP
ATP+KLA
NM_025348
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3 (Ndufa3), mRNA [NM_025348]
KLA
.96
1.02
.98
.97
1.03
1.09
1.07
ATP
.95
1.08
1.03
1.38
1.17
.98
1.20
KLA/ATP
1.08
1.08
.97
1.42
1.13
1.17
1.48
Ndufa4
KLA
ATP
ATP+KLA
NM_010886
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4 (Ndufa4), nuclear gene encoding mitochondrial protein, mRNA [NM_010886]
KLA
1.01
1.00
.91
.96
.82
.78
.80
ATP
.98
.99
1.11
1.17
1.02
1.04
.75
KLA/ATP
1.00
1.08
1.01
1.17
.95
.92
.58
Ndufa5
KLA
ATP
ATP+KLA
NM_026614
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5 (Ndufa5), nuclear gene encoding mitochondrial protein, mRNA [NM_026614]
KLA
.92
.85
.78
.88
.74
.77
.74
ATP
.89
.89
1.16
1.14
.96
.86
.67
KLA/ATP
.80
.88
1.16
1.04
1.03
.93
.54
Ndufa6
KLA
ATP
ATP+KLA
NM_025987
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6 (B14) (Ndufa6), nuclear gene encoding mitochondrial protein, mRNA [NM_025987]
KLA
.81
.86
.79
.86
.81
.87
1.11
ATP
.98
.98
1.06
1.22
1.16
.73
.78
KLA/ATP
.87
.88
.97
1.09
.99
.83
.78
Ndufa7
KLA
ATP
ATP+KLA
NM_023202
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7 (B14.5a) (Ndufa7), mRNA [NM_023202]
KLA
.95
.97
.89
.95
.89
.89
1.01
ATP
.98
1.02
1.17
1.34
1.08
.98
.76
KLA/ATP
.91
.95
1.06
1.23
1.11
1.03
.98
Ndufa8
KLA
ATP
ATP+KLA
NM_026703
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8 (Ndufa8), nuclear gene encoding mitochondrial protein, mRNA [NM_026703]
KLA
.93
.87
.78
.98
.76
.89
.91
ATP
.94
.89
1.22
1.01
.95
.78
.96
KLA/ATP
.81
.81
1.11
.92
.92
.78
.73
Ndufa9
KLA
ATP
ATP+KLA
NM_025358
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9 (Ndufa9), mRNA [NM_025358]
KLA
.91
.80
.82
1.12
.89
.89
1.01
ATP
1.03
.99
1.12
1.08
1.11
.79
.86
KLA/ATP
.93
.91
1.43
1.08
1.05
.81
.85
Ndufab1
KLA
ATP
ATP+KLA
NM_028177
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1 (Ndufab1), mRNA [NM_028177]
KLA
1.14
1.08
1.12
1.16
1.05
1.07
1.14
ATP
.99
1.02
1.20
1.30
1.17
1.08
1.40
KLA/ATP
1.04
1.13
1.27
1.26
1.23
1.10
1.12
Ndufb10
KLA
ATP
ATP+KLA
NM_026684
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10 (Ndufb10), mRNA [NM_026684]
KLA
.74
.78
.73
.55
.68
.71
.70
ATP
.93
.86
1.09
.97
.93
.77
.84
KLA/ATP
.74
.76
.83
.77
.85
.75
.58
Ndufb11
KLA
ATP
ATP+KLA
NM_019435
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11 (Ndufb11), mRNA [NM_019435]
KLA
.75
.75
.69
.84
.72
.79
.61
ATP
1.00
.93
1.15
.96
1.03
.98
.83
KLA/ATP
.81
.68
1.03
.80
.81
.71
.77
Ndufb2
KLA
ATP
ATP+KLA
NM_026612
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2 (Ndufb2), nuclear gene encoding mitochondrial protein, mRNA [NM_026612]
KLA
.95
.94
.86
.92
.79
.75
.84
ATP
.95
.91
1.21
1.25
1.06
.95
.67
KLA/ATP
.89
.88
1.16
1.17
1.11
.89
.59
Ndufb3
KLA
ATP
ATP+KLA
NM_025597
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 3 (Ndufb3), mRNA [NM_025597]
KLA
.87
.87
.85
.93
.84
.94
.89
ATP
.92
.81
1.28
1.15
1.04
.77
.88
KLA/ATP
.86
.96
1.28
1.11
1.19
.89
.90
Ndufb4
KLA
ATP
ATP+KLA
NM_026610
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 4 (Ndufb4), nuclear gene encoding mitochondrial protein, mRNA [NM_026610]
KLA
.89
.87
.76
.84
.73
.77
.83
ATP
1.00
.99
1.13
1.03
.98
.77
.77
KLA/ATP
.93
.85
1.04
.99
.88
.78
.63
Ndufb5
KLA
ATP
ATP+KLA
NM_025316
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5 (Ndufb5), nuclear gene encoding mitochondrial protein, mRNA [NM_025316]
KLA
.99
1.09
1.14
.85
.95
.83
.70
ATP
1.01
1.01
1.32
1.15
1.01
.65
.63
KLA/ATP
1.09
1.02
1.36
1.14
1.07
.58
.30
Ndufb6
KLA
ATP
ATP+KLA
NM_001033305
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6 (Ndufb6), nuclear gene encoding mitochondrial protein, mRNA [NM_001033305]
KLA
1.08
1.08
.96
1.04
.94
.98
1.04
ATP
.93
.99
1.25
1.30
1.20
1.05
.83
KLA/ATP
1.01
1.10
1.30
1.44
1.33
1.14
.81
Ndufb7
KLA
ATP
ATP+KLA
NM_025843
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7 (Ndufb7), nuclear gene encoding mitochondrial protein, mRNA [NM_025843]
KLA
.87
.83
.85
.86
.81
.87
.88
ATP
.94
.93
1.08
1.08
.85
.72
.95
KLA/ATP
.83
.85
1.00
.96
.92
.83
.83
Ndufb8
KLA
ATP
ATP+KLA
AK028070
adult female placenta cDNA, RIKEN full-length enriched library, clone:1620401I19 product:similar to NADH-UBIQUINONE OXIDOREDUCTASE ASHI SUBUNIT, MITOCHONDRIAL PRECURSOR (EC 1.6.5.3) (EC 1.6.99.3) (COMPLEX I-ASHI) (CI-ASHI) [Bos taurus],
KLA
.68
.68
.68
.83
.90
1.08
1.20
ATP
.87
.84
.96
.85
.98
1.58
1.39
KLA/ATP
.64
.64
.67
.71
.93
1.43
1.53
Ndufb8
KLA
ATP
ATP+KLA
NM_026061
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 8 (Ndufb8), mRNA [NM_026061]
KLA
.79
.80
.70
.75
.68
.72
.90
ATP
.92
.94
.97
.95
.80
.65
.79
KLA/ATP
.74
.76
.78
.74
.70
.63
.68
Ndufb9
KLA
ATP
ATP+KLA
NM_023172
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9 (Ndufb9), mRNA [NM_023172]
KLA
.86
.82
.78
1.03
.93
1.07
1.31
ATP
.98
.95
1.05
.84
.78
.82
1.12
KLA/ATP
.85
.84
1.01
.80
.76
.99
1.31
Ndufc1
KLA
ATP
ATP+KLA
NM_025523
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1 (Ndufc1), mRNA [NM_025523]
KLA
1.00
.96
.87
.96
.85
.90
1.00
ATP
.91
.94
1.17
1.18
1.04
1.05
.87
KLA/ATP
.93
.96
1.14
1.16
1.08
1.06
.83
Ndufc2
KLA
ATP
ATP+KLA
NM_024220
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2 (Ndufc2), mRNA [NM_024220]
KLA
.93
.90
.83
.94
.86
.99
1.29
ATP
.92
.95
1.04
1.05
.91
.67
.83
KLA/ATP
.84
.88
.92
.91
.87
.78
.73
Ndufs1
KLA
ATP
ATP+KLA
AK017924
adult male thymus cDNA, RIKEN full-length enriched library, clone:5830412M15 product:unclassifiable, full insert sequence [AK017924]
KLA
1.07
1.00
.94
1.01
1.07
1.00
.96
ATP
1.00
1.00
1.04
.96
1.08
1.03
1.03
KLA/ATP
1.00
1.04
.93
1.00
1.02
1.01
1.04
Ndufs1
KLA
ATP
ATP+KLA
NM_145518
NADH dehydrogenase (ubiquinone) Fe-S protein 1 (Ndufs1), nuclear gene encoding mitochondrial protein, mRNA [NM_145518]
KLA
.84
.88
.82
.77
.68
.65
.69
ATP
1.04
1.00
.91
.73
.71
.61
.76
KLA/ATP
.92
.82
.76
.60
.54
.57
.56
Ndufs2
KLA
ATP
ATP+KLA
NM_153064
NADH dehydrogenase (ubiquinone) Fe-S protein 2 (Ndufs2), mRNA [NM_153064]
KLA
1.23
1.32
1.28
1.21
1.26
1.03
.94
ATP
1.23
1.26
.82
1.09
.81
.64
.94
KLA/ATP
1.32
1.42
1.17
1.45
.88
.75
.83
Ndufs3
KLA
ATP
ATP+KLA
NM_026688
NADH dehydrogenase (ubiquinone) Fe-S protein 3 (Ndufs3), mRNA [NM_026688]
KLA
1.10
1.03
1.16
1.15
1.08
1.15
1.13
ATP
1.10
1.05
1.21
1.31
1.11
.64
.97
KLA/ATP
1.13
1.10
1.23
1.35
1.20
1.12
1.09
Ndufs4
KLA
ATP
ATP+KLA
AK035175
12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430096G04 product:NADH dehydrogenase (ubiquinone) Fe-S protein 4, full insert sequence [AK035175]
KLA
.99
.98
.92
.96
.98
1.00
.97
ATP
1.01
1.03
.99
1.01
1.01
1.01
.98
KLA/ATP
.96
.98
1.00
1.00
1.01
1.03
.93
Ndufs4
KLA
ATP
ATP+KLA
NM_010887
NADH dehydrogenase (ubiquinone) Fe-S protein 4 (Ndufs4), nuclear gene encoding mitochondrial protein, mRNA [NM_010887]
KLA
1.41
1.47
1.53
1.80
1.68
1.89
1.38
ATP
.91
.92
1.27
1.19
.93
.79
1.01
KLA/ATP
1.33
1.45
2.08
1.91
1.90
1.39
1.11
Ndufs5
KLA
ATP
ATP+KLA
AK037635
16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130032A08 product:unclassifiable, full insert sequence [AK037635]
KLA
.92
.97
.91
.93
.94
.92
.92
ATP
.84
.78
.77
.75
.92
.98
.92
KLA/ATP
.83
.78
.84
.74
1.13
.96
.90
Ndufs5
KLA
ATP
ATP+KLA
NM_001030274
NADH dehydrogenase (ubiquinone) Fe-S protein 5 (Ndufs5), mRNA [NM_001030274]
KLA
.99
.92
.89
1.03
.91
.96
1.03
ATP
1.00
.96
1.11
1.03
.93
.80
.90
KLA/ATP
.89
.96
1.12
1.00
1.04
.91
.72
Ndufs6
KLA
ATP
ATP+KLA
NM_010888
NADH dehydrogenase (ubiquinone) Fe-S protein 6 (Ndufs6), mRNA [NM_010888]
KLA
.99
1.00
1.05
1.03
.98
.94
1.18
ATP
1.09
1.15
1.15
1.48
1.33
.91
1.00
KLA/ATP
1.07
1.12
1.10
1.36
1.21
1.05
.94
Ndufs7
KLA
ATP
ATP+KLA
NM_029272
NADH dehydrogenase (ubiquinone) Fe-S protein 7 (Ndufs7), nuclear gene encoding mitochondrial protein, mRNA [NM_029272]
KLA
.78
.75
.70
.70
.72
.73
.97
ATP
.97
1.02
.99
1.16
.86
.56
.87
KLA/ATP
.77
.76
.73
.86
.72
.64
.72
Ndufs8
KLA
ATP
ATP+KLA
NM_144870
NADH dehydrogenase (ubiquinone) Fe-S protein 8 (Ndufs8), mRNA [NM_144870]
KLA
.98
1.02
.88
.82
.77
.74
.83
ATP
1.00
1.13
1.00
1.42
1.13
.88
.81
KLA/ATP
.95
1.00
.76
1.21
.86
1.06
.91
Ndufv1
KLA
ATP
ATP+KLA
NM_133666
NADH dehydrogenase (ubiquinone) flavoprotein 1 (Ndufv1), nuclear gene encoding mitochondrial protein, mRNA [NM_133666]
KLA
.92
.88
.99
.91
.88
.87
.92
ATP
1.15
1.07
1.07
1.12
.92
.67
.83
KLA/ATP
.99
.97
.99
1.00
.84
.71
.71
Nme1
KLA
ATP
ATP+KLA
NM_008704
non-metastatic cells 1, protein (NM23A) expressed in (Nme1), mRNA [NM_008704]
KLA
.82
.85
.74
.76
.64
.62
.69
ATP
.92
.94
1.26
1.20
1.08
.69
1.01
KLA/ATP
.78
.84
1.03
.91
.92
.60
.31
Nme2
KLA
ATP
ATP+KLA
NM_001077529
non-metastatic cells 2, protein (NM23B) expressed in (Nme2), transcript variant 2, mRNA [NM_001077529]
KLA
.96
.98
.93
.97
.84
.87
.80
ATP
.97
.89
1.13
1.04
1.05
1.08
.56
KLA/ATP
.95
.95
1.07
1.10
1.06
1.02
.53
Nme3
KLA
ATP
ATP+KLA
NM_019730
non-metastatic cells 3, protein expressed in (Nme3), mRNA [NM_019730]
KLA
.74
.77
.74
.64
.53
.37
.29
ATP
1.03
1.05
1.14
1.30
1.07
.75
.75
KLA/ATP
.79
.82
.84
1.01
.84
.64
.44
Nme4
KLA
ATP
ATP+KLA
NM_019731
non-metastatic cells 4, protein expressed in (Nme4), mRNA [NM_019731]
KLA
.85
.85
.78
.75
.68
.56
.61
ATP
.98
1.09
1.08
1.37
.89
.43
.43
KLA/ATP
.89
.84
.76
1.08
.70
.48
.26
Nme5
KLA
ATP
ATP+KLA
NM_080637
non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase) (Nme5), mRNA [NM_080637]
KLA
.96
1.00
.99
1.00
1.03
1.02
1.02
ATP
1.01
1.05
1.04
1.03
1.00
1.00
1.05
KLA/ATP
1.06
.98
1.00
.95
1.03
.98
1.05
Nme6
KLA
ATP
ATP+KLA
NM_018757
non-metastatic cells 6, protein expressed in (nucleoside-diphosphate kinase) (Nme6), mRNA [NM_018757]
KLA
.72
.79
.85
.86
.96
1.12
1.75
ATP
.94
.95
1.01
.97
.65
.71
.95
KLA/ATP
.77
.77
.73
.77
.63
.63
.95
Nme7
KLA
ATP
ATP+KLA
NM_138314
non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase) (Nme7), transcript variant 1, mRNA [NM_138314]
KLA
.78
.77
.80
.93
1.07
1.28
.98
ATP
.95
.89
1.00
.88
.63
1.11
1.22
KLA/ATP
.73
.77
.81
.72
.77
1.83
1.30
Nmnat1
KLA
ATP
ATP+KLA
AK152407
bone marrow macrophage cDNA, RIKEN full-length enriched library, clone:I830068L10 product:NMN adenylyltransferase; nicotinamide mononucleotide adenylyl transferase, full insert sequence [AK152407]
KLA
1.59
1.41
1.71
1.75
1.77
1.74
1.49
ATP
.96
.88
1.13
1.05
.87
1.49
2.19
KLA/ATP
1.41
1.50
1.78
1.54
1.31
1.73
2.33
Nmnat2
KLA
ATP
ATP+KLA
NM_175460
nicotinamide nucleotide adenylyltransferase 2 (Nmnat2), mRNA [NM_175460]
KLA
.98
.98
1.02
.98
.95
1.00
1.04
ATP
1.04
1.05
1.04
1.00
.94
.96
1.03
KLA/ATP
1.02
1.04
.99
1.00
1.00
1.03
1.02
Nmnat3
KLA
ATP
ATP+KLA
NM_144533
nicotinamide nucleotide adenylyltransferase 3 (Nmnat3), mRNA [NM_144533]
KLA
.49
.44
.41
.40
.34
.52
.80
ATP
.94
.82
1.02
.64
.63
.50
.72
KLA/ATP
.42
.42
.41
.30
.56
.62
.42
Nnmt
KLA
ATP
ATP+KLA
NM_010924
nicotinamide N-methyltransferase (Nnmt), mRNA [NM_010924]
KLA
.98
.99
1.03
.98
.98
1.01
1.00
ATP
.92
1.03
1.04
1.02
1.04
5.10
5.18
KLA/ATP
.96
1.03
1.04
1.03
.99
2.30
4.68
Nnt
KLA
ATP
ATP+KLA
NM_008710
nicotinamide nucleotide transhydrogenase (Nnt), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_008710]
KLA
.90
.88
.87
.79
.72
.58
.50
ATP
1.10
1.11
1.11
.99
.76
.52
.41
KLA/ATP
.94
.95
.85
.79
.59
.48
.30
Nnt
KLA
ATP
ATP+KLA
Z49204
gb|M.musculus mRNA for NADP transhydrogenase. [Z49204]
KLA
.94
.91
1.05
.93
.79
.64
.54
ATP
1.15
1.17
1.23
1.09
.85
.47
.40
KLA/ATP
1.12
1.02
.91
.86
.62
.49
.30
Nos1
KLA
ATP
ATP+KLA
NM_008712
nitric oxide synthase 1, neuronal (Nos1), mRNA [NM_008712]
KLA
1.01
1.01
1.02
.99
1.02
1.02
1.01
ATP
1.01
1.03
1.02
1.04
1.03
1.01
1.00
KLA/ATP
1.05
1.02
1.02
1.00
1.02
1.03
1.03
Nos2
KLA
ATP
ATP+KLA
NM_010927
nitric oxide synthase 2, inducible, macrophage (Nos2), mRNA [NM_010927]
KLA
13.50
16.36
25.65
23.25
24.78
15.99
6.48
ATP
1.03
1.03
1.48
1.66
1.65
5.55
1.70
KLA/ATP
16.01
17.41
19.06
25.50
20.84
29.92
29.80
Nos3
KLA
ATP
ATP+KLA
NM_008713
nitric oxide synthase 3, endothelial cell (Nos3), mRNA [NM_008713]
KLA
.83
.79
.76
.78
.77
.85
.96
ATP
1.03
1.09
1.03
1.02
.85
.96
1.84
KLA/ATP
.80
.78
.79
.80
.79
.78
.91
Nsdhl
KLA
ATP
ATP+KLA
AK156993
activated spleen cDNA, RIKEN full-length enriched library, clone:F830111P16 product:unclassifiable, full insert sequence [AK156993]
KLA
1.06
.94
.95
.88
1.09
.86
.76
ATP
1.14
1.03
1.03
.75
.75
.92
1.02
KLA/ATP
1.05
.98
.92
.70
.84
.71
.76
Nsdhl
KLA
ATP
ATP+KLA
NM_010941
NAD(P) dependent steroid dehydrogenase-like (Nsdhl), mRNA [NM_010941]
KLA
.98
1.05
1.03
.95
.97
.87
.89
ATP
1.02
1.16
1.11
1.33
.91
.57
1.05
KLA/ATP
1.08
1.02
.86
1.20
.77
.58
.47
Nt5c
KLA
ATP
ATP+KLA
NM_015807
5,3-nucleotidase, cytosolic (Nt5c), mRNA [NM_015807]
KLA
.81
.85
.74
.73
.75
.83
1.14
ATP
.94
.90
.95
.96
.58
.52
1.07
KLA/ATP
.78
.79
.82
.88
.65
.43
.68
Nt5c1b
KLA
ATP
ATP+KLA
NM_027588
5-nucleotidase, cytosolic IB (Nt5c1b), mRNA [NM_027588]
KLA
1.00
.98
.99
.99
1.00
1.02
1.00
ATP
.98
1.02
1.01
.99
1.02
1.00
.94
KLA/ATP
1.01
1.02
.90
1.00
1.09
1.02
1.05
Nt5c2
KLA
ATP
ATP+KLA
NM_029810
5-nucleotidase, cytosolic II (Nt5c2), mRNA [NM_029810]
KLA
.68
.66
.66
.62
.73
1.00
.79
ATP
.98
1.02
1.06
.95
.65
.73
1.16
KLA/ATP
.66
.68
.67
.61
.57
.80
1.07
Nt5c3
KLA
ATP
ATP+KLA
NM_026004
5-nucleotidase, cytosolic III (Nt5c3), mRNA [NM_026004]
KLA
19.31
19.80
19.18
17.01
11.84
11.21
4.96
ATP
.98
.97
1.14
1.55
2.72
4.79
2.27
KLA/ATP
18.71
19.81
24.58
21.68
18.82
17.51
13.49
Nt5c3l
KLA
ATP
ATP+KLA
NM_026561
5-nucleotidase, cytosolic III-like (Nt5c3l), transcript variant 2, mRNA [NM_026561]
KLA
.94
.91
.95
.90
.80
.79
.91
ATP
.94
1.07
1.12
1.08
.86
.71
.87
KLA/ATP
.97
.97
.88
.97
.83
.77
.67
Nt5e
KLA
ATP
ATP+KLA
NM_011851
5 nucleotidase, ecto (Nt5e), mRNA [NM_011851]
KLA
.96
1.02
1.00
.95
1.00
.99
.99
ATP
.98
.99
1.05
1.02
1.04
1.03
1.11
KLA/ATP
.97
.99
.96
.95
.96
.99
1.04
Nt5m
KLA
ATP
ATP+KLA
NM_134029
5,3-nucleotidase, mitochondrial (Nt5m), nuclear gene encoding mitochondrial protein, mRNA [NM_134029]
KLA
.73
.78
.92
1.14
1.54
2.01
1.80
ATP
1.02
1.06
.94
1.05
.73
.63
1.43
KLA/ATP
.73
.76
.74
.85
.77
.87
1.50
Oat
KLA
ATP
ATP+KLA
NM_016978
ornithine aminotransferase (Oat), nuclear gene encoding mitochondrial protein, mRNA [NM_016978]
KLA
.79
.83
.76
.68
.61
.53
.63
ATP
.97
1.07
1.07
1.30
1.14
.98
.67
KLA/ATP
.78
.85
.82
.97
.92
.82
.38
Ocrl
KLA
ATP
ATP+KLA
NM_177215
oculocerebrorenal syndrome of Lowe (Ocrl), mRNA [NM_177215]
KLA
.99
.89
.92
.90
.90
1.11
1.10
ATP
1.02
1.03
1.17
.91
.65
.58
1.04
KLA/ATP
.93
.90
.90
.75
.58
.54
.81
Odc1
KLA
ATP
ATP+KLA
NM_013614
ornithine decarboxylase, structural 1 (Odc1), mRNA [NM_013614]
KLA
2.10
1.85
1.51
1.36
1.07
.99
.71
ATP
1.15
1.53
4.90
11.04
12.87
14.66
2.00
KLA/ATP
2.01
1.77
3.11
5.19
5.52
7.17
4.50
Ogdh
KLA
ATP
ATP+KLA
NM_010956
oxoglutarate dehydrogenase (lipoamide) (Ogdh), nuclear gene encoding mitochondrial protein, mRNA [NM_010956]
KLA
1.00
1.05
1.10
.95
1.06
1.08
1.30
ATP
1.10
1.28
.95
1.23
.93
1.15
1.82
KLA/ATP
1.27
1.11
.81
1.21
.76
1.13
1.83
Ogdhl
KLA
ATP
ATP+KLA
NM_001081130
oxoglutarate dehydrogenase-like (Ogdhl), mRNA [NM_001081130]
KLA
1.03
1.07
1.03
1.02
1.00
.97
.91
ATP
.94
.99
.98
.99
.93
.99
1.01
KLA/ATP
.97
1.02
1.03
.93
.95
.90
1.04
Olah
KLA
ATP
ATP+KLA
NM_145921
oleoyl-ACP hydrolase (Olah), mRNA [NM_145921]
KLA
1.09
1.08
.99
1.00
.96
1.07
1.10
ATP
.93
1.00
1.07
1.07
1.00
1.02
1.01
KLA/ATP
1.03
1.03
1.01
.97
.99
1.02
.94
Otc
KLA
ATP
ATP+KLA
BC024893
ornithine transcarbamylase, mRNA (cDNA clone MGC:28946 IMAGE:4196455), complete cds [BC024893]
KLA
1.00
1.00
.92
1.03
.95
.98
1.00
ATP
1.05
.95
1.03
1.01
.96
1.05
.99
KLA/ATP
.97
.99
.95
1.05
.92
1.00
1.01
Otc
KLA
ATP
ATP+KLA
NM_008769
ornithine transcarbamylase (Otc), mRNA [NM_008769]
KLA
1.01
.98
.99
1.00
.99
.96
1.02
ATP
1.04
1.01
1.02
1.01
1.00
.94
.94
KLA/ATP
.96
1.07
1.01
1.00
.95
1.00
.97
Oxsm
KLA
ATP
ATP+KLA
NM_027695
3-oxoacyl-ACP synthase, mitochondrial (Oxsm), nuclear gene encoding mitochondrial protein, mRNA [NM_027695]
KLA
1.05
1.03
1.11
1.27
1.24
1.26
1.18
ATP
.94
.81
.79
.56
.47
1.05
1.43
KLA/ATP
.99
.98
.95
.76
.59
.84
1.27
P4ha1
KLA
ATP
ATP+KLA
NM_011030
procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha 1 polypeptide (P4ha1), mRNA [NM_011030]
KLA
2.27
2.54
2.62
2.46
2.70
2.58
2.03
ATP
1.02
1.17
1.08
1.56
1.19
1.14
1.50
KLA/ATP
2.57
2.65
2.34
3.34
2.23
2.21
2.25
P4ha2
KLA
ATP
ATP+KLA
AK053504
0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130103J11 product:procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha II polypeptide, full insert sequence. [AK053504]
KLA
.98
.99
.96
1.00
1.00
.96
.99
ATP
1.03
1.03
1.00
1.00
1.12
1.01
.99
KLA/ATP
.97
1.00
.93
.96
1.01
.94
.97
P4ha2
KLA
ATP
ATP+KLA
NM_011031
procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha II polypeptide (P4ha2), mRNA [NM_011031]
KLA
.79
.75
.66
.63
.42
.33
.31
ATP
.88
.90
1.30
1.08
1.25
1.92
.52
KLA/ATP
.67
.77
.97
.79
.99
1.07
.55
P4ha3
KLA
ATP
ATP+KLA
NM_177161
procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha polypeptide III (P4ha3), mRNA [NM_177161]
KLA
1.12
1.03
.98
.97
1.00
.99
1.01
ATP
1.03
1.00
1.08
1.00
1.02
.95
1.05
KLA/ATP
.94
.95
1.06
.99
.94
.98
1.06
Pafah1b1
KLA
ATP
ATP+KLA
AK147229
cDNA, RIKEN full-length enriched library, clone:M421028C14 product:platelet-activating factor acetylhydrolase, isoform 1b, beta1 subunit, full insert sequence [AK147229]
KLA
.96
.98
.98
1.06
1.15
1.11
1.14
ATP
1.37
1.70
1.99
1.78
1.62
1.20
1.11
KLA/ATP
1.44
1.62
1.71
1.45
1.48
1.12
1.21
Pafah1b1
KLA
ATP
ATP+KLA
NM_013625
platelet-activating factor acetylhydrolase, isoform 1b, beta1 subunit (Pafah1b1), mRNA [NM_013625]
KLA
.91
.87
.93
.99
1.14
1.21
1.00
ATP
1.00
1.18
1.06
.73
.96
.65
.40
KLA/ATP
.82
.80
.87
.71
1.10
.90
.41
Pafah1b2
KLA
ATP
ATP+KLA
NM_008775
platelet-activating factor acetylhydrolase, isoform 1b, alpha2 subunit (Pafah1b2), mRNA [NM_008775]
KLA
1.71
1.86
1.93
1.95
2.18
1.98
1.74
ATP
1.10
1.18
1.04
1.04
1.16
1.73
1.68
KLA/ATP
1.82
1.83
1.66
1.81
1.60
1.70
1.90
Pafah1b3
KLA
ATP
ATP+KLA
NM_008776
platelet-activating factor acetylhydrolase, isoform 1b, alpha1 subunit (Pafah1b3), mRNA [NM_008776]
KLA
.87
.90
.84
.76
.75
.62
.71
ATP
1.05
1.14
1.00
1.24
.98
.69
1.00
KLA/ATP
.91
.91
.80
1.02
.83
.64
.83
Pafah2
KLA
ATP
ATP+KLA
NM_133880
platelet-activating factor acetylhydrolase 2 (Pafah2), mRNA [NM_133880]
KLA
.66
.65
.67
.62
.59
.62
.81
ATP
1.07
.90
.68
.48
.56
.91
.78
KLA/ATP
.75
.59
.52
.39
.44
.46
.50
Pah
KLA
ATP
ATP+KLA
NM_008777
phenylalanine hydroxylase (Pah), mRNA [NM_008777]
KLA
.99
.93
1.06
.99
1.01
.99
.98
ATP
1.09
1.02
.99
.95
.97
.98
.99
KLA/ATP
.97
.93
.97
.95
.95
1.00
.87
Paics
KLA
ATP
ATP+KLA
NM_025939
phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoribosylaminoimidazole, succinocarboxamide synthetase (Paics), mRNA [NM_025939]
KLA
.75
.84
.85
.62
.60
.40
.50
ATP
1.09
1.19
1.06
1.27
.94
.40
.38
KLA/ATP
.87
.90
.69
.95
.57
.34
.22
Pank1
KLA
ATP
ATP+KLA
AK019493
0 day neonate skin cDNA, RIKEN full-length enriched library, clone:4632412I06 product:hypothetical protein, full insert sequence. [AK019493]
KLA
.98
.91
.95
.97
.98
.95
.91
ATP
.96
1.04
1.05
.96
1.01
1.01
1.04
KLA/ATP
.95
1.05
.96
.97
.96
.96
.96
Pank1
KLA
ATP
ATP+KLA
NM_023792
pantothenate kinase 1 (Pank1), transcript variant 2, mRNA [NM_023792]
KLA
.47
.50
.46
.55
.39
.35
.42
ATP
1.02
1.06
1.11
1.02
.57
.50
.58
KLA/ATP
.48
.44
.56
.59
.48
.38
.34
Pank2
KLA
ATP
ATP+KLA
NM_153501
pantothenate kinase 2 (Hallervorden-Spatz syndrome) (Pank2), nuclear gene encoding mitochondrial protein, mRNA [NM_153501]
KLA
1.16
1.22
1.28
1.19
1.14
1.16
1.25
ATP
.97
1.03
1.01
1.01
.73
1.08
1.92
KLA/ATP
1.14
1.16
1.14
1.36
1.03
1.19
2.04
Pank3
KLA
ATP
ATP+KLA
NM_145962
pantothenate kinase 3 (Pank3), mRNA [NM_145962]
KLA
1.08
1.11
.96
.82
.72
.58
.67
ATP
1.10
1.15
1.34
1.53
1.31
.98
.94
KLA/ATP
1.13
1.23
1.10
1.19
1.11
.73
.60
Pank4
KLA
ATP
ATP+KLA
NM_172990
pantothenate kinase 4 (Pank4), mRNA [NM_172990]
KLA
.86
.90
.86
.79
.95
.87
1.14
ATP
1.01
1.02
1.07
1.06
1.17
.94
.86
KLA/ATP
.83
.85
.99
.92
1.15
.90
.75
Papss1
KLA
ATP
ATP+KLA
NM_011863
3-phosphoadenosine 5-phosphosulfate synthase 1 (Papss1), mRNA [NM_011863]
KLA
.86
.95
.84
.89
.77
.70
.81
ATP
.99
1.02
1.06
1.10
.74
.64
.75
KLA/ATP
.93
.89
.86
.93
.68
.56
.69
Papss2
KLA
ATP
ATP+KLA
AK029185
0 day neonate head cDNA, RIKEN full-length enriched library, clone:4831410G12 product:3-phosphoadenosine 5-phosphosulfate synthase 2, full insert sequence. [AK029185]
KLA
1.04
1.07
.97
.95
1.08
1.07
.94
ATP
.96
1.01
1.00
1.02
.96
1.01
.97
KLA/ATP
.99
1.01
1.02
1.11
1.01
.98
1.02
Papss2
KLA
ATP
ATP+KLA
NM_011864
3-phosphoadenosine 5-phosphosulfate synthase 2 (Papss2), mRNA [NM_011864]
KLA
1.72
1.84
1.85
1.50
1.56
1.01
1.14
ATP
1.07
1.14
1.07
1.00
1.19
1.75
1.07
KLA/ATP
1.64
1.73
1.57
1.58
1.46
1.54
1.10
Pcca
KLA
ATP
ATP+KLA
NM_144844
propionyl-Coenzyme A carboxylase, alpha polypeptide (Pcca), mRNA [NM_144844]
KLA
1.00
1.07
1.11
1.16
1.07
1.01
.68
ATP
.90
.97
1.10
1.14
.93
.53
.60
KLA/ATP
.99
1.12
1.16
1.19
.84
.59
.56
Pccb
KLA
ATP
ATP+KLA
NM_025835
propionyl Coenzyme A carboxylase, beta polypeptide (Pccb), mRNA [NM_025835]
KLA
.76
.77
.67
.65
.45
.41
.42
ATP
.97
1.12
.94
1.15
.90
.51
.37
KLA/ATP
.83
.82
.80
.88
.65
.46
.28
Pck2
KLA
ATP
ATP+KLA
NM_028994
phosphoenolpyruvate carboxykinase 2 (mitochondrial) (Pck2), nuclear gene encoding mitochondrial protein, mRNA [NM_028994]
KLA
.40
.37
.32
.28
.37
.56
.55
ATP
.99
.96
.86
.94
1.02
.57
.77
KLA/ATP
.40
.37
.31
.35
.42
.35
.46
Pcx
KLA
ATP
ATP+KLA
NM_008797
pyruvate carboxylase (Pcx), nuclear gene encoding mitochondrial protein, mRNA [NM_008797]
KLA
1.28
1.34
1.44
1.30
1.34
1.23
.91
ATP
1.11
1.09
1.19
1.29
1.19
1.49
1.16
KLA/ATP
1.34
1.41
1.63
1.53
1.39
1.05
1.15
Pcyt1a
KLA
ATP
ATP+KLA
AK163685
10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930020C23 product:phosphate cytidylyltransferase 1, choline, alpha isoform, full insert sequence [AK163685]
KLA
.63
.65
.76
.82
.87
1.04
.67
ATP
1.00
1.10
.81
1.07
2.85
1.72
1.60
KLA/ATP
.64
.63
.48
.97
2.62
2.63
1.66
Pcyt1a
KLA
ATP
ATP+KLA
NM_009981
phosphate cytidylyltransferase 1, choline, alpha isoform (Pcyt1a), mRNA [NM_009981]
KLA
.67
.77
.90
.96
.99
1.16
.81
ATP
.93
1.04
.85
1.22
2.93
1.57
1.91
KLA/ATP
.72
.73
.82
1.17
2.79
2.47
1.62
Pcyt1b
KLA
ATP
ATP+KLA
NM_211138
phosphate cytidylyltransferase 1, choline, beta isoform (Pcyt1b), transcript variant 1, mRNA [NM_211138]
KLA
.91
.84
.85
.88
.85
.79
.65
ATP
1.04
1.05
.96
.91
.82
.81
.68
KLA/ATP
.86
.84
.87
.87
.82
.78
.59
Pcyt2
KLA
ATP
ATP+KLA
NM_024229
phosphate cytidylyltransferase 2, ethanolamine (Pcyt2), mRNA [NM_024229]
KLA
.58
.57
.56
.46
.50
.42
.54
ATP
.98
.94
1.04
.99
.71
.66
1.11
KLA/ATP
.59
.59
.60
.54
.43
.35
.45
Pdha1
KLA
ATP
ATP+KLA
NM_008810
pyruvate dehydrogenase E1 alpha 1 (Pdha1), nuclear gene encoding mitochondrial protein, mRNA [NM_008810]
KLA
.92
.96
.94
.92
.94
1.04
1.18
ATP
.98
1.03
1.14
1.10
1.02
1.05
.91
KLA/ATP
.93
.93
.97
.94
.81
.82
.69
Pdha2
KLA
ATP
ATP+KLA
NM_008811
pyruvate dehydrogenase E1 alpha 2 (Pdha2), mRNA [NM_008811]
KLA
1.04
.95
.98
.99
1.00
1.04
.98
ATP
1.00
.97
.95
1.00
1.01
.99
1.01
KLA/ATP
1.05
1.07
.91
1.02
.98
1.00
1.05
Pdhb
KLA
ATP
ATP+KLA
NM_024221
pyruvate dehydrogenase (lipoamide) beta (Pdhb), mRNA [NM_024221]
KLA
1.14
1.05
1.00
.97
1.03
.90
.88
ATP
1.08
1.10
1.12
1.23
1.24
1.24
1.21
KLA/ATP
1.01
1.16
1.13
1.21
1.23
1.44
1.26
Pdhx
KLA
ATP
ATP+KLA
NM_175094
pyruvate dehydrogenase complex, component X (Pdhx), nuclear gene encoding mitochondrial protein, mRNA [NM_175094]
KLA
1.15
1.12
1.12
1.12
1.07
1.14
1.12
ATP
1.04
1.02
1.14
.94
1.03
1.30
.98
KLA/ATP
1.25
1.20
1.26
1.05
1.08
1.38
.89
Pdxk
KLA
ATP
ATP+KLA
NM_172134
pyridoxal (pyridoxine, vitamin B6) kinase (Pdxk), mRNA [NM_172134]
KLA
.40
.38
.31
.27
.21
.31
.50
ATP
1.01
.97
.93
1.01
1.12
.64
2.00
KLA/ATP
.41
.38
.32
.38
.74
.80
.80
Pdxp
KLA
ATP
ATP+KLA
NM_020271
pyridoxal (pyridoxine, vitamin B6) phosphatase (Pdxp), mRNA [NM_020271]
KLA
.59
.51
.55
.70
1.07
.99
.86
ATP
1.07
1.21
1.26
1.10
.57
.70
.58
KLA/ATP
.58
.56
.69
.61
.89
.62
.66
Pemt
KLA
ATP
ATP+KLA
NM_008819
phosphatidylethanolamine N-methyltransferase (Pemt), nuclear gene encoding mitochondrial protein, mRNA [NM_008819]
KLA
1.00
1.08
1.08
.99
.92
.83
.93
ATP
1.08
1.16
1.04
1.22
1.02
.89
.84
KLA/ATP
1.14
1.10
.92
1.05
.83
.76
.71
Pfkl
KLA
ATP
ATP+KLA
NM_008826
phosphofructokinase, liver, B-type (Pfkl), mRNA [NM_008826]
KLA
1.19
1.33
1.34
1.23
1.57
1.49
2.02
ATP
1.17
1.34
1.04
1.45
.92
1.53
.97
KLA/ATP
1.54
1.64
1.36
1.91
1.17
.89
1.61
Pfkm
KLA
ATP
ATP+KLA
NM_021514
phosphofructokinase, muscle (Pfkm), mRNA [NM_021514]
KLA
.73
.74
.70
.88
.80
.61
.55
ATP
1.09
1.05
1.01
1.06
.80
.50
.52
KLA/ATP
.76
.83
.86
.75
.57
.57
.46
Pfkp
KLA
ATP
ATP+KLA
BC050264
gb|Mus musculus, clone IMAGE:4503748, mRNA [BC050264]
KLA
4.07
3.58
3.25
2.41
1.31
.76
.81
ATP
1.26
1.26
2.77
2.20
4.63
2.57
4.92
KLA/ATP
4.81
4.66
8.95
3.50
3.96
1.60
.91
Pfkp
KLA
ATP
ATP+KLA
NM_019703
phosphofructokinase, platelet (Pfkp), mRNA [NM_019703]
KLA
1.94
1.99
2.15
2.05
1.90
1.20
.85
ATP
1.08
1.05
1.18
1.20
1.40
1.38
.93
KLA/ATP
1.94
2.12
2.35
2.26
1.91
1.36
.88
Pgam1
KLA
ATP
ATP+KLA
NM_023418
phosphoglycerate mutase 1 (Pgam1), mRNA [NM_023418]
KLA
.71
.69
.75
.85
.89
.84
1.30
ATP
1.02
1.10
1.00
.99
1.47
2.02
1.36
KLA/ATP
.83
.83
.74
.76
1.24
1.73
1.11
Pgam2
KLA
ATP
ATP+KLA
NM_018870
phosphoglycerate mutase 2 (Pgam2), mRNA [NM_018870]
KLA
.99
1.05
1.11
1.10
1.10
1.14
1.30
ATP
1.09
1.08
1.17
1.17
1.31
1.63
1.18
KLA/ATP
1.07
1.08
1.06
1.09
1.27
1.42
1.13
Pgap1
KLA
ATP
ATP+KLA
AK033485
adult male colon cDNA, RIKEN full-length enriched library, clone:9030223K07 product:unclassifiable, full insert sequence. [AK033485]
KLA
.77
.76
.70
.72
.59
.60
1.13
ATP
.92
1.04
1.03
.84
1.04
.78
.42
KLA/ATP
.68
.76
.86
.69
1.00
.78
.84
Pgap1
KLA
ATP
ATP+KLA
AK051360
12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130039I04 product:hypothetical protein, full insert sequence [AK051360]
KLA
1.03
1.03
1.03
1.08
1.02
1.03
1.13
ATP
1.06
1.09
.88
.90
1.02
.99
.99
KLA/ATP
1.00
.99
.91
.93
.99
.97
1.13
Pgd
KLA
ATP
ATP+KLA
NM_001081274
phosphogluconate dehydrogenase (Pgd), mRNA [NM_001081274]
KLA
.91
.94
.94
.76
.80
.67
.93
ATP
1.11
1.22
.84
.96
1.20
1.82
1.59
KLA/ATP
1.01
1.10
.79
.90
.83
1.30
1.75
Pgk1
KLA
ATP
ATP+KLA
NM_008828
phosphoglycerate kinase 1 (Pgk1), mRNA [NM_008828]
KLA
.98
1.04
1.04
.99
1.01
1.03
1.16
ATP
1.00
.94
.70
.64
.79
1.34
1.54
KLA/ATP
1.02
.96
.80
.72
.70
.90
1.24
Pgk2
KLA
ATP
ATP+KLA
NM_031190
phosphoglycerate kinase 2 (Pgk2), mRNA [NM_031190]
KLA
.96
.97
.96
1.08
.96
1.01
.98
ATP
.98
.98
1.07
1.03
1.03
1.00
1.00
KLA/ATP
1.01
1.04
1.02
.95
1.05
.98
1.04
Pgls
KLA
ATP
ATP+KLA
NM_025396
6-phosphogluconolactonase (Pgls), mRNA [NM_025396]
KLA
.82
.84
.72
.74
.68
.58
.74
ATP
1.08
1.13
.94
1.33
1.06
.66
.59
KLA/ATP
.94
.94
.81
.97
.72
.54
.46
Pgm1
KLA
ATP
ATP+KLA
NM_025700
phosphoglucomutase 1 (Pgm1), mRNA [NM_025700]
KLA
1.08
1.03
.95
.75
.59
.55
.73
ATP
1.02
1.23
1.22
1.42
1.07
.75
1.01
KLA/ATP
1.01
1.10
.84
1.12
.69
.61
.51
Pgm2
KLA
ATP
ATP+KLA
NM_028132
phosphoglucomutase 2 (Pgm2), mRNA [NM_028132]
KLA
1.13
1.21
1.26
1.48
1.52
1.81
1.81
ATP
.90
.92
1.07
.99
.80
1.60
1.17
KLA/ATP
1.01
1.16
1.40
1.25
1.48
1.99
1.94
Pgs1
KLA
ATP
ATP+KLA
NM_133757
phosphatidylglycerophosphate synthase 1 (Pgs1), mRNA [NM_133757]
KLA
2.65
2.70
2.52
2.72
2.54
2.28
1.89
ATP
.97
.98
1.06
1.17
1.57
2.20
1.91
KLA/ATP
2.60
2.62
2.92
2.95
2.95
2.64
2.37
Phgdh
KLA
ATP
ATP+KLA
NM_016966
3-phosphoglycerate dehydrogenase (Phgdh), mRNA [NM_016966]
KLA
1.06
1.11
.97
.89
.82
.80
.91
ATP
1.02
1.03
1.17
1.33
3.31
3.86
.74
KLA/ATP
1.07
1.06
1.15
1.38
1.78
1.84
.40
Phospho1
KLA
ATP
ATP+KLA
NM_153104
phosphatase, orphan 1 (Phospho1), mRNA [NM_153104]
KLA
.99
1.04
1.04
1.14
1.01
1.15
1.21
ATP
.95
1.01
.99
1.05
1.11
1.22
1.42
KLA/ATP
1.04
1.02
1.05
1.11
1.01
1.45
1.40
Phospho2
KLA
ATP
ATP+KLA
AK010147
adult male tongue cDNA, RIKEN full-length enriched library, clone:2310074E15 product:unclassifiable, full insert sequence. [AK010147]
KLA
1.03
1.02
1.06
.98
.98
1.00
1.04
ATP
1.08
.99
.96
1.05
1.02
1.03
1.03
KLA/ATP
1.01
.97
.97
.97
1.04
1.02
.93
Phospho2
KLA
ATP
ATP+KLA
NM_028521
phosphatase, orphan 2 (Phospho2), mRNA [NM_028521]
KLA
1.87
2.00
2.27
1.79
1.77
1.97
1.43
ATP
1.03
1.03
1.11
.97
1.82
2.55
1.88
KLA/ATP
1.95
2.13
1.70
1.94
2.10
3.72
2.83
Pi4k2a
KLA
ATP
ATP+KLA
NM_145501
phosphatidylinositol 4-kinase type 2 alpha (Pi4k2a), mRNA [NM_145501]
KLA
1.89
1.83
2.04
2.30
2.46
2.05
1.32
ATP
.95
.93
.93
.89
1.73
1.92
1.92
KLA/ATP
1.74
1.80
1.76
1.87
2.87
3.06
2.17
Pi4k2b
KLA
ATP
ATP+KLA
NM_025951
phosphatidylinositol 4-kinase type 2 beta (Pi4k2b), transcript variant 1, mRNA [NM_025951]
KLA
2.43
2.74
2.72
2.24
1.73
1.50
1.40
ATP
1.05
1.21
1.09
1.18
2.83
2.89
1.13
KLA/ATP
2.57
2.54
2.01
2.52
3.67
3.33
1.88
Pi4k2b
KLA
ATP
ATP+KLA
NM_028744
phosphatidylinositol 4-kinase type 2 beta (Pi4k2b), transcript variant 2, mRNA [NM_028744]
KLA
1.95
2.36
2.66
2.48
2.11
1.86
1.76
ATP
1.03
1.13
1.13
1.26
2.32
3.45
1.82
KLA/ATP
2.20
2.30
1.94
2.27
2.45
3.17
3.44
Pi4ka
KLA
ATP
ATP+KLA
NM_001001983
phosphatidylinositol 4-kinase, catalytic, alpha polypeptide (Pi4ka), mRNA [NM_001001983]
KLA
1.06
1.04
1.08
1.09
1.10
.94
.79
ATP
1.02
.99
1.06
.85
1.13
.82
.96
KLA/ATP
1.06
1.02
1.20
.90
1.27
.93
.56
Pi4kb
KLA
ATP
ATP+KLA
NM_175356
phosphatidylinositol 4-kinase, catalytic, beta polypeptide (Pi4kb), mRNA [NM_175356]
KLA
.96
.93
.97
1.08
1.24
1.40
1.15
ATP
1.22
1.22
1.14
1.46
1.44
1.15
1.67
KLA/ATP
1.18
1.13
.93
1.19
1.22
1.46
1.18
Pib5pa
KLA
ATP
ATP+KLA
NM_172439
phosphatidylinositol (4,5) bisphosphate 5-phosphatase, A (Pib5pa), mRNA [NM_172439]
KLA
1.02
.98
.92
1.00
.93
.94
1.06
ATP
1.02
1.13
.96
1.00
.95
.89
1.21
KLA/ATP
.95
1.00
.90
.91
.88
.93
1.85
Piga
KLA
ATP
ATP+KLA
NM_011081
phosphatidylinositol glycan anchor biosynthesis, class A (Piga), mRNA [NM_011081]
KLA
.93
.84
.81
.79
.69
.72
.89
ATP
.95
.86
1.11
.77
.86
1.94
1.15
KLA/ATP
.87
.77
.98
.63
.81
1.70
1.20
Pigb
KLA
ATP
ATP+KLA
NM_018889
phosphatidylinositol glycan anchor biosynthesis, class B (Pigb), mRNA [NM_018889]
KLA
.89
.93
.93
.89
.99
.93
1.23
ATP
1.00
1.04
1.01
1.04
.82
.77
1.16
KLA/ATP
.98
1.00
.85
.91
.81
.81
1.02
Pigc
KLA
ATP
ATP+KLA
NM_026078
phosphatidylinositol glycan anchor biosynthesis, class C (Pigc), transcript variant 1, mRNA [NM_026078]
KLA
.80
.76
.78
.91
.94
1.11
1.05
ATP
1.04
.86
1.04
.77
.61
1.12
1.21
KLA/ATP
.77
.72
.88
.58
.61
.72
1.16
Pigf
KLA
ATP
ATP+KLA
NM_008838
phosphatidylinositol glycan anchor biosynthesis, class F (Pigf), mRNA [NM_008838]
KLA
1.12
1.19
1.19
1.29
1.01
.87
.97
ATP
.94
.96
1.47
1.40
1.17
1.12
.93
KLA/ATP
1.02
1.14
1.63
1.40
1.37
1.24
.75
Pigh
KLA
ATP
ATP+KLA
NM_029988
phosphatidylinositol glycan anchor biosynthesis, class H (Pigh), mRNA [NM_029988]
KLA
.77
.84
.83
.83
.88
1.09
1.34
ATP
.92
.93
.91
.90
.59
.61
1.20
KLA/ATP
.71
.73
.70
.68
.60
.67
1.09
Pigk
KLA
ATP
ATP+KLA
NM_178016
phosphatidylinositol glycan anchor biosynthesis, class K (Pigk), transcript variant 2, mRNA [NM_178016]
KLA
1.23
1.40
1.38
1.35
1.21
1.09
1.30
ATP
1.02
1.03
1.15
1.32
1.11
.87
1.12
KLA/ATP
1.33
1.45
1.50
1.59
1.20
.88
.80
Pigl
KLA
ATP
ATP+KLA
NM_001039536
phosphatidylinositol glycan anchor biosynthesis, class L (Pigl), mRNA [NM_001039536]
KLA
1.15
1.24
1.19
1.07
1.29
1.27
1.91
ATP
1.05
1.24
1.09
1.17
.86
.88
1.83
KLA/ATP
1.21
1.18
.93
1.17
.87
.98
1.64
Pigm
KLA
ATP
ATP+KLA
NM_026234
phosphatidylinositol glycan anchor biosynthesis, class M (Pigm), mRNA [NM_026234]
KLA
1.13
1.22
1.28
1.15
1.20
1.10
1.16
ATP
.99
1.04
.99
.98
.79
1.01
1.15
KLA/ATP
1.22
1.19
1.07
1.03
.80
.98
1.13
Pign
KLA
ATP
ATP+KLA
AK082387
0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230045A22 product:phosphatidylinositol glycan, class N, full insert sequence. [AK082387]
KLA
1.05
.98
.94
1.00
.96
1.00
1.00
ATP
.98
1.02
1.03
1.07
.95
.95
.93
KLA/ATP
1.06
1.01
1.01
1.02
.94
.97
1.03
Pign
KLA
ATP
ATP+KLA
NM_013784
phosphatidylinositol glycan anchor biosynthesis, class N (Pign), mRNA [NM_013784]
KLA
1.59
1.62
1.78
1.81
2.02
2.07
2.03
ATP
1.00
1.01
1.16
1.07
.95
1.29
1.37
KLA/ATP
1.58
1.75
1.75
1.40
1.16
1.29
1.65
Pigo
KLA
ATP
ATP+KLA
NM_020035
phosphatidylinositol glycan anchor biosynthesis, class O (Pigo), mRNA [NM_020035]
KLA
.86
.89
.91
.80
.98
.90
1.17
ATP
1.07
1.10
.93
.95
.78
.90
1.61
KLA/ATP
.94
.89
.77
.75
.66
1.00
1.65
Pigp
KLA
ATP
ATP+KLA
NM_019543
phosphatidylinositol glycan anchor biosynthesis, class P (Pigp), mRNA [NM_019543]
KLA
.89
.83
.83
.84
.69
.64
.82
ATP
.89
.84
1.33
1.23
.96
.60
.82
KLA/ATP
.80
.83
1.01
1.02
.89
.61
.55
Pigq
KLA
ATP
ATP+KLA
NM_011822
phosphatidylinositol glycan anchor biosynthesis, class Q (Pigq), mRNA [NM_011822]
KLA
.76
.86
.83
.76
.89
.88
.89
ATP
1.10
1.14
.89
.98
.72
.55
1.34
KLA/ATP
.92
.83
.59
.78
.54
.61
1.01
Pigs
KLA
ATP
ATP+KLA
NM_201406
phosphatidylinositol glycan anchor biosynthesis, class S (Pigs), mRNA [NM_201406]
KLA
.85
.81
.80
.82
.77
.73
.88
ATP
1.02
1.11
1.06
1.11
.88
.70
.94
KLA/ATP
.89
.92
.82
.81
.56
.62
.93
Pigt
KLA
ATP
ATP+KLA
NM_133779
phosphatidylinositol glycan anchor biosynthesis, class T (Pigt), mRNA [NM_133779]
KLA
1.04
1.13
1.03
1.02
1.03
1.14
1.19
ATP
1.02
1.22
.89
1.09
.90
.82
.93
KLA/ATP
1.14
1.30
.86
1.06
.78
.87
.90
Pigu
KLA
ATP
ATP+KLA
NM_001004721
phosphatidylinositol glycan anchor biosynthesis, class U (Pigu), mRNA [NM_001004721]
KLA
1.05
1.10
1.07
.96
1.06
1.02
1.23
ATP
1.09
1.26
1.21
1.42
.99
.87
1.05
KLA/ATP
1.15
1.18
.98
1.28
.90
.83
1.05
Pigv
KLA
ATP
ATP+KLA
NM_178698
phosphatidylinositol glycan anchor biosynthesis, class V (Pigv), mRNA [NM_178698]
KLA
1.14
1.18
1.11
1.20
1.20
1.07
1.04
ATP
1.04
1.11
.98
.96
.91
1.06
.99
KLA/ATP
1.25
1.20
1.09
.98
1.00
.93
1.02
Pigw
KLA
ATP
ATP+KLA
NM_027388
phosphatidylinositol glycan anchor biosynthesis, class W (Pigw), transcript variant 1, mRNA [NM_027388]
KLA
.87
.90
.79
.81
.80
.89
1.13
ATP
.97
.97
.99
.84
.74
.87
1.12
KLA/ATP
.78
.85
.87
.85
.81
.74
.88
Pigx
KLA
ATP
ATP+KLA
NM_024464
phosphatidylinositol glycan anchor biosynthesis, class X (Pigx), transcript variant 1, mRNA [NM_024464]
KLA
1.02
1.04
.99
.96
.94
.98
1.06
ATP
.99
1.02
1.16
1.20
1.26
1.15
1.19
KLA/ATP
.96
1.08
1.04
1.16
1.06
1.04
1.45
Pik3c2a
KLA
ATP
ATP+KLA
AK013614
adult male hippocampus cDNA, RIKEN full-length enriched library, clone:2900035A08 product:phosphatidylinositol 3-kinase, C2 domain containing, alpha polypeptide, full insert sequence. [AK013614]
KLA
.74
.78
.79
.84
.92
.94
1.06
ATP
1.06
.97
1.01
.84
.84
1.01
1.21
KLA/ATP
.75
.70
.74
.76
.80
.88
1.15
Pik3c2a
KLA
ATP
ATP+KLA
NM_011083
phosphatidylinositol 3-kinase, C2 domain containing, alpha polypeptide (Pik3c2a), mRNA [NM_011083]
KLA
.77
.75
.74
.86
.90
.93
1.10
ATP
1.20
1.37
1.39
1.09
1.24
1.48
1.18
KLA/ATP
.82
.77
.84
1.03
.95
1.28
1.34
Pik3c2g
KLA
ATP
ATP+KLA
NM_207683
phosphatidylinositol 3-kinase, C2 domain containing, gamma polypeptide (Pik3c2g), transcript variant 1, mRNA [NM_207683]
KLA
1.06
1.04
1.07
1.03
1.00
1.06
1.07
ATP
1.04
1.02
1.06
1.00
.98
.98
.97
KLA/ATP
1.06
1.02
1.01
1.03
1.02
1.04
1.07
Pik3c3
KLA
ATP
ATP+KLA
NM_181414
phosphoinositide-3-kinase, class 3 (Pik3c3), mRNA [NM_181414]
KLA
.85
.82
.90
.91
.99
1.01
.87
ATP
.92
1.02
.97
1.08
.60
.82
.87
KLA/ATP
.80
.86
.79
.90
.66
.94
.92
Pip5k1a
KLA
ATP
ATP+KLA
NM_008847
phosphatidylinositol-4-phosphate 5-kinase, type 1 alpha (Pip5k1a), mRNA [NM_008847]
KLA
1.99
1.84
1.66
1.49
1.49
1.37
1.57
ATP
1.05
1.06
.89
1.54
4.20
2.72
1.58
KLA/ATP
1.95
1.90
1.55
1.60
3.26
2.64
2.25
Pip5k1b
KLA
ATP
ATP+KLA
NM_008846
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta (Pip5k1b), mRNA [NM_008846]
KLA
1.24
1.35
1.11
.92
.57
.72
.86
ATP
.86
1.00
.96
1.15
.85
.74
.89
KLA/ATP
1.20
1.22
.97
1.00
.78
.76
1.06
Pip5k1c
KLA
ATP
ATP+KLA
BC094665
phosphatidylinositol-4-phosphate 5-kinase, type 1 gamma, mRNA (cDNA clone MGC:102155 IMAGE:30356181), complete cds [BC094665]
KLA
.82
.90
.90
.70
.96
.86
1.21
ATP
1.19
1.45
.92
1.64
1.17
.83
1.33
KLA/ATP
.97
1.21
.66
1.20
.91
.92
1.69
Pip5k1c
KLA
ATP
ATP+KLA
NM_008844
phosphatidylinositol-4-phosphate 5-kinase, type 1 gamma (Pip5k1c), mRNA [NM_008844]
KLA
1.40
1.36
1.38
1.39
1.30
1.30
1.27
ATP
1.01
1.16
1.12
1.46
1.38
1.35
1.21
KLA/ATP
1.39
1.44
1.44
1.64
1.41
1.45
1.53
Pip5kl1
KLA
ATP
ATP+KLA
NM_198191
phosphatidylinositol-4-phosphate 5-kinase-like 1 (Pip5kl1), mRNA [NM_198191]
KLA
.99
.97
.96
1.03
1.01
1.04
1.02
ATP
.98
.92
.97
1.63
2.17
1.17
.99
KLA/ATP
1.05
1.00
1.10
1.19
1.24
1.27
1.06
Pipox
KLA
ATP
ATP+KLA
NM_008952
pipecolic acid oxidase (Pipox), mRNA [NM_008952]
KLA
.97
.94
1.00
1.00
.98
1.06
1.01
ATP
1.04
1.01
1.03
1.03
1.06
.93
1.01
KLA/ATP
1.03
1.12
1.07
1.06
.98
1.07
.97
Pisd
KLA
ATP
ATP+KLA
NM_177298
phosphatidylserine decarboxylase (Pisd), mRNA [NM_177298]
KLA
.71
.66
.72
.80
.95
.98
1.03
ATP
1.00
.89
.79
.67
.96
1.16
.99
KLA/ATP
.69
.65
.58
.58
.90
1.12
.99
Pklr
KLA
ATP
ATP+KLA
NM_013631
pyruvate kinase liver and red blood cell (Pklr), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_013631]
KLA
1.06
1.01
1.12
1.00
.98
1.01
1.07
ATP
.98
.94
1.05
1.06
1.01
1.06
1.10
KLA/ATP
.97
1.00
1.04
.95
.89
1.05
.97
Pkm2
KLA
ATP
ATP+KLA
D38379
mRNA for pyruvate kinase M, complete cds. [D38379]
KLA
.80
.83
.94
.67
.95
.95
1.42
ATP
1.22
1.30
.83
1.14
.99
1.23
2.53
KLA/ATP
.99
1.03
.61
.83
.70
1.16
2.54
Pkm2
KLA
ATP
ATP+KLA
NM_011099
pyruvate kinase, muscle (Pkm2), mRNA [NM_011099]
KLA
.84
.89
.95
.72
.92
1.03
1.34
ATP
1.05
1.23
.83
1.13
.96
1.20
2.14
KLA/ATP
.98
.97
.64
.89
.73
1.20
2.32
Pla2g10
KLA
ATP
ATP+KLA
NM_011987
phospholipase A2, group X (Pla2g10), mRNA [NM_011987]
KLA
.99
1.11
1.02
.99
1.00
1.01
1.02
ATP
1.02
.97
1.01
1.03
1.00
1.02
1.04
KLA/ATP
1.04
.96
.95
1.04
1.06
1.05
1.01
Pla2g12a
KLA
ATP
ATP+KLA
NM_023196
phospholipase A2, group XIIA (Pla2g12a), transcript variant 1, mRNA [NM_023196]
KLA
1.03
1.06
.97
1.00
.78
.75
.92
ATP
.91
.99
1.29
1.30
1.20
1.48
1.71
KLA/ATP
.92
.99
1.19
1.16
1.06
1.12
1.36
Pla2g12a
KLA
ATP
ATP+KLA
NM_183423
phospholipase A2, group XIIA (Pla2g12a), transcript variant 2, mRNA [NM_183423]
KLA
.90
1.00
.87
.95
.76
.68
.88
ATP
.96
.94
1.26
1.24
1.19
1.47
1.88
KLA/ATP
.89
.90
1.08
1.07
1.06
1.02
1.59
Pla2g12b
KLA
ATP
ATP+KLA
NM_023530
phospholipase A2, group XIIB (Pla2g12b), mRNA [NM_023530]
KLA
.98
.95
1.05
.99
1.03
.99
.94
ATP
1.02
1.04
1.07
1.05
.92
1.04
1.00
KLA/ATP
.98
.92
1.10
1.11
1.09
1.03
1.04
Pla2g1b
KLA
ATP
ATP+KLA
NM_011107
phospholipase A2, group IB, pancreas (Pla2g1b), mRNA [NM_011107]
KLA
1.00
1.01
1.01
1.11
1.00
1.28
1.00
ATP
.98
1.03
1.09
1.03
1.01
1.02
1.04
KLA/ATP
.93
.94
1.01
1.00
.94
1.09
1.07
Pla2g2a
KLA
ATP
ATP+KLA
NM_001082531
phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), mRNA [NM_001082531]
KLA
1.08
.99
1.00
1.06
.98
1.01
.94
ATP
1.07
.98
1.04
1.06
.90
.98
.98
KLA/ATP
.98
1.03
1.00
1.04
.94
.97
.96
Pla2g2c
KLA
ATP
ATP+KLA
NM_008868
phospholipase A2, group IIC (Pla2g2c), mRNA [NM_008868]
KLA
.98
.99
1.05
.98
1.01
1.00
1.04
ATP
1.08
1.06
1.09
.93
.92
.92
1.00
KLA/ATP
1.03
1.04
1.02
1.04
.98
1.01
1.02
Pla2g2d
KLA
ATP
ATP+KLA
NM_011109
phospholipase A2, group IID (Pla2g2d), mRNA [NM_011109]
KLA
1.02
1.02
.99
.99
1.00
1.01
1.00
ATP
.95
1.11
1.10
1.11
.98
.99
1.12
KLA/ATP
1.02
1.00
1.19
1.11
1.00
.96
1.01
Pla2g2e
KLA
ATP
ATP+KLA
NM_012044
phospholipase A2, group IIE (Pla2g2e), mRNA [NM_012044]
KLA
.78
.75
.74
.72
.62
.69
1.40
ATP
1.06
1.00
.92
1.04
.83
.76
3.74
KLA/ATP
.78
.80
.69
.74
.70
.74
2.24
Pla2g2f
KLA
ATP
ATP+KLA
NM_012045
phospholipase A2, group IIF (Pla2g2f), mRNA [NM_012045]
KLA
1.02
.99
1.03
1.01
1.00
.95
.99
ATP
1.01
1.06
1.11
.97
1.09
1.11
.99
KLA/ATP
1.10
1.05
1.04
.95
1.04
1.01
.96
Pla2g3
KLA
ATP
ATP+KLA
NM_172791
phospholipase A2, group III (Pla2g3), mRNA [NM_172791]
KLA
1.04
1.05
1.02
1.01
1.04
1.11
1.00
ATP
.96
.97
1.10
.91
.99
.97
1.08
KLA/ATP
1.03
1.11
1.10
.98
.95
.98
1.07
Pla2g4a
KLA
ATP
ATP+KLA
NM_008869
phospholipase A2, group IVA (cytosolic, calcium-dependent) (Pla2g4a), mRNA [NM_008869]
KLA
3.93
4.49
4.86
6.40
6.44
3.10
1.68
ATP
1.13
1.36
1.27
1.30
1.02
5.37
1.47
KLA/ATP
3.64
4.45
4.76
7.11
2.96
4.08
2.60
Pla2g4b
KLA
ATP
ATP+KLA
NM_145378
phospholipase A2, group IVB (cytosolic) (Pla2g4b), mRNA [NM_145378]
KLA
1.09
1.18
.95
1.01
.97
.97
.77
ATP
1.05
1.14
1.28
.94
.88
1.18
.70
KLA/ATP
1.23
1.43
1.21
1.02
1.15
1.16
.78
Pla2g4c
KLA
ATP
ATP+KLA
AK145339
1 cell embryo 1 cell cDNA, RIKEN full-length enriched library, clone:I0C0013F18 product:weakly similar to Cytosolic phospholipase A2 gamma [Homo sapiens], full insert sequence [AK145339]
KLA
1.09
1.21
1.33
1.17
1.26
1.30
1.05
ATP
.97
1.06
1.00
.98
.98
.98
1.05
KLA/ATP
1.19
1.16
1.18
1.13
1.04
1.02
1.06
Pla2g4c
KLA
ATP
ATP+KLA
NM_001004762
phospholipase A2, group IVC (cytosolic, calcium-independent) (Pla2g4c), mRNA [NM_001004762]
KLA
.93
1.00
.94
.93
.94
.94
.96
ATP
.98
.96
1.13
.97
.99
.89
.96
KLA/ATP
1.01
1.01
1.07
1.01
.94
1.01
.92
Pla2g4e
KLA
ATP
ATP+KLA
AK049063
0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230096D22 product:hypothetical Lysophospholipase catalytic domain containing protein, full insert sequence. [AK049063]
KLA
1.03
1.09
1.01
1.01
1.06
.94
1.05
ATP
1.03
1.00
1.06
1.01
.96
1.05
1.05
KLA/ATP
.98
1.00
1.01
.98
1.03
.95
1.01
Pla2g4e
KLA
ATP
ATP+KLA
NM_177845
phospholipase A2, group IVE (Pla2g4e), mRNA [NM_177845]
KLA
.97
.95
1.01
.97
1.02
1.03
1.05
ATP
.98
.99
1.00
1.10
.98
1.00
1.02
KLA/ATP
1.05
.93
.96
1.03
1.08
1.05
.99
Pla2g4f
KLA
ATP
ATP+KLA
NM_001024145
phospholipase A2, group IVF (Pla2g4f), mRNA [NM_001024145]
KLA
1.08
.99
1.04
1.02
1.04
.98
1.01
ATP
.99
1.04
.99
1.03
1.12
1.01
1.25
KLA/ATP
.97
1.04
1.10
1.06
1.04
1.03
1.03
Pla2g5
KLA
ATP
ATP+KLA
NM_011110
phospholipase A2, group V (Pla2g5), transcript variant 2, mRNA [NM_011110]
KLA
.65
.62
.56
.53
.62
1.60
3.01
ATP
.90
.82
.88
1.69
1.82
1.26
6.32
KLA/ATP
.63
.59
.65
.63
.91
1.56
5.59
Pla2g6
KLA
ATP
ATP+KLA
NM_016915
phospholipase A2, group VI (Pla2g6), mRNA [NM_016915]
KLA
.60
.59
.56
.60
.94
1.31
1.59
ATP
1.10
1.14
.95
1.05
1.06
1.13
1.14
KLA/ATP
.63
.56
.54
.56
.71
.97
1.55
Pla2g7
KLA
ATP
ATP+KLA
NM_013737
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) (Pla2g7), mRNA [NM_013737]
KLA
1.26
1.32
1.43
1.47
1.87
2.52
4.77
ATP
1.07
1.11
.94
1.24
1.14
3.60
7.17
KLA/ATP
1.38
1.44
1.13
1.63
1.40
4.09
10.65
Plb1
KLA
ATP
ATP+KLA
AK015993
adult male testis cDNA, RIKEN full-length enriched library, clone:4930539A06 product:weakly similar to PHOSPHOLIPASE B [Rattus norvegicus], full insert sequence. [AK015993]
KLA
.99
.99
1.05
1.02
1.03
1.07
1.02
ATP
1.04
1.03
1.07
1.06
1.09
1.01
1.02
KLA/ATP
1.07
1.00
.96
1.09
1.05
1.08
1.01
Plb1
KLA
ATP
ATP+KLA
AK087596
2 days pregnant adult female oviduct cDNA, RIKEN full-length enriched library, clone:E230021C09 product:hypothetical protein, full insert sequence. [AK087596]
KLA
.93
.99
.99
1.07
.98
1.00
.98
ATP
1.08
1.00
.97
1.07
1.04
1.09
.96
KLA/ATP
1.06
.96
1.00
.98
1.04
1.06
.98
Plb1
KLA
ATP
ATP+KLA
NM_001081407
phospholipase B1 (Plb1), mRNA [NM_001081407]
KLA
1.05
1.09
1.05
1.04
1.05
1.03
.85
ATP
.96
1.03
1.02
.95
1.06
1.01
.92
KLA/ATP
1.00
1.00
1.09
1.00
.97
.99
.86
Plcb1
KLA
ATP
ATP+KLA
AK129166
mRNA for mKIAA0581 protein [AK129166]
KLA
1.02
.98
.91
.91
.92
.95
.89
ATP
1.03
1.02
1.02
1.01
.90
1.02
1.04
KLA/ATP
.98
.97
.91
.93
.92
1.01
1.16
Plcb1
KLA
ATP
ATP+KLA
NM_019677
phospholipase C, beta 1 (Plcb1), mRNA [NM_019677]
KLA
.99
.94
.95
.97
.93
.92
.91
ATP
1.00
.96
.99
.95
.99
1.03
.98
KLA/ATP
.93
.96
.94
.93
.87
1.00
1.06
Plcb2
KLA
ATP
ATP+KLA
NM_177568
phospholipase C, beta 2 (Plcb2), mRNA [NM_177568]
KLA
.70
.68
.64
.67
.65
.76
.88
ATP
.95
.94
1.04
.94
.72
.57
1.19
KLA/ATP
.69
.68
.72
.63
.65
.55
.70
Plcb3
KLA
ATP
ATP+KLA
NM_008874
phospholipase C, beta 3 (Plcb3), mRNA [NM_008874]
KLA
1.72
1.78
1.82
1.65
1.67
1.44
1.21
ATP
.97
1.04
.81
.87
.78
.88
.94
KLA/ATP
1.69
1.89
1.44
1.66
1.12
.73
.93
Plcb4
KLA
ATP
ATP+KLA
AK082509
0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230058B11 product:unclassifiable, full insert sequence. [AK082509]
KLA
1.06
1.03
.97
.98
1.02
1.01
.99
ATP
.99
1.07
1.09
.95
.97
.97
1.02
KLA/ATP
.98
1.00
1.03
.96
1.02
.91
.98
Plcb4
KLA
ATP
ATP+KLA
NM_013829
phospholipase C, beta 4 (Plcb4), mRNA [NM_013829]
KLA
.88
.94
.81
.82
.81
.86
1.01
ATP
1.00
1.01
.92
.93
.88
.85
.89
KLA/ATP
.97
.94
.78
.80
.78
.86
.97
Plcd1
KLA
ATP
ATP+KLA
NM_019676
phospholipase C, delta 1 (Plcd1), mRNA [NM_019676]
KLA
2.80
2.76
2.50
2.05
1.09
.66
1.49
ATP
.93
.94
1.22
1.10
.99
1.35
.50
KLA/ATP
2.55
2.84
3.38
2.74
1.98
1.32
.80
Plcd3
KLA
ATP
ATP+KLA
NM_152813
phospholipase C, delta 3 (Plcd3), mRNA [NM_152813]
KLA
.58
.56
.49
.61
.70
.74
.87
ATP
.98
1.07
.91
.92
.80
.96
1.23
KLA/ATP
.58
.55
.59
.61
.75
1.03
1.68
Plcd4
KLA
ATP
ATP+KLA
NM_148937
phospholipase C, delta 4 (Plcd4), transcript variant 2, mRNA [NM_148937]
KLA
1.04
.99
1.00
.99
.95
1.02
1.06
ATP
.99
.98
.99
1.13
1.00
1.02
1.04
KLA/ATP
1.04
1.01
1.00
.97
1.10
.99
1.02
Plce1
KLA
ATP
ATP+KLA
AK035546
adult male urinary bladder cDNA, RIKEN full-length enriched library, clone:9530064F18 product:PANCREAS-ENRICHED PHOSPHOLIPASE C homolog [Homo sapiens], full insert sequence. [AK035546]
KLA
.99
1.08
1.03
1.00
1.06
1.04
.97
ATP
1.04
1.01
1.02
1.01
.96
1.01
1.06
KLA/ATP
.98
.98
.93
1.02
.95
.93
.97
Plce1
KLA
ATP
ATP+KLA
BC025027
phospholipase C, epsilon 1, mRNA (cDNA clone IMAGE:4948638), with apparent retained intron. [BC025027]
KLA
1.07
1.12
1.04
1.10
1.07
1.04
1.04
ATP
1.00
.96
1.06
.99
.98
.96
1.01
KLA/ATP
1.21
1.06
1.13
1.09
1.00
1.08
1.14
Plce1
KLA
ATP
ATP+KLA
NM_019588
phospholipase C, epsilon 1 (Plce1), mRNA [NM_019588]
KLA
.98
1.03
.99
.96
1.01
1.04
.96
ATP
.98
.99
1.02
1.13
.99
1.01
1.00
KLA/ATP
.97
1.11
1.00
1.07
.93
1.06
.99
Plcg2
KLA
ATP
ATP+KLA
NM_172285
phospholipase C, gamma 2 (Plcg2), mRNA [NM_172285]
KLA
.76
.74
.68
.66
.71
.92
.95
ATP
.96
.90
.95
.87
.81
.79
.91
KLA/ATP
.76
.71
.69
.62
.72
.78
.68
Plcz1
KLA
ATP
ATP+KLA
NM_054066
phospholipase C, zeta 1 (Plcz1), mRNA [NM_054066]
KLA
1.02
.99
.97
1.04
.98
.95
.98
ATP
1.01
1.03
1.03
.98
.97
1.00
1.04
KLA/ATP
1.02
1.04
1.03
.99
1.01
1.00
1.01
Pld1
KLA
ATP
ATP+KLA
NM_008875
phospholipase D1 (Pld1), mRNA [NM_008875]
KLA
.71
.73
.67
.73
.88
.96
1.25
ATP
.99
.88
.73
.68
.45
1.23
1.12
KLA/ATP
.70
.67
.58
.59
.48
.91
1.48
Pld2
KLA
ATP
ATP+KLA
NM_008876
phospholipase D2 (Pld2), mRNA [NM_008876]
KLA
.51
.54
.48
.51
.73
.79
1.02
ATP
1.06
1.10
.88
1.03
1.04
1.29
1.00
KLA/ATP
.63
.52
.40
.57
.65
1.03
1.35
Pld3
KLA
ATP
ATP+KLA
NM_011116
phospholipase D family, member 3 (Pld3), mRNA [NM_011116]
KLA
.81
.84
.90
.75
.75
.70
.82
ATP
1.06
1.14
.81
1.15
1.12
.97
1.32
KLA/ATP
.94
.92
.73
1.01
.94
1.05
1.20
Pld4
KLA
ATP
ATP+KLA
NM_178911
phospholipase D family, member 4 (Pld4), mRNA [NM_178911]
KLA
.66
.73
.82
.67
.90
1.14
1.94
ATP
1.08
1.24
.87
1.26
.86
.50
.75
KLA/ATP
.84
.83
.51
.83
.56
.61
1.00
Pmm1
KLA
ATP
ATP+KLA
NM_013872
phosphomannomutase 1 (Pmm1), mRNA [NM_013872]
KLA
.55
.55
.47
.42
.36
.34
.70
ATP
1.03
1.07
1.03
1.09
.86
.49
.80
KLA/ATP
.57
.56
.55
.54
.46
.36
.44
Pmm2
KLA
ATP
ATP+KLA
NM_016881
phosphomannomutase 2 (Pmm2), mRNA [NM_016881]
KLA
1.22
1.31
1.38
1.28
1.64
1.62
1.69
ATP
1.11
1.26
.84
1.15
.84
1.12
1.63
KLA/ATP
1.39
1.48
.86
1.51
.92
1.24
2.24
Pmvk
KLA
ATP
ATP+KLA
NM_026784
phosphomevalonate kinase (Pmvk), mRNA [NM_026784]
KLA
.89
.91
.96
.99
.92
.78
.88
ATP
1.13
.98
1.07
1.10
.70
.51
1.19
KLA/ATP
.94
.95
1.06
.91
.80
.44
.53
Pnlip
KLA
ATP
ATP+KLA
AK007357
10 day old male pancreas cDNA, RIKEN full-length enriched library, clone:1810007A24 product:PANCREATIC TRIGLYCERIDE LIPASE (FRAGMENT) homolog [Rattus norvegicus], full insert sequence. [AK007357]
KLA
.95
1.03
1.02
1.02
1.04
1.06
1.10
ATP
1.05
1.00
.95
1.10
1.00
1.03
1.02
KLA/ATP
1.02
1.00
.89
1.09
1.09
1.06
1.06
Pnlip
KLA
ATP
ATP+KLA
NM_026925
pancreatic lipase (Pnlip), mRNA [NM_026925]
KLA
1.04
.97
1.04
1.00
1.02
.99
.97
ATP
1.04
1.04
1.04
.96
.95
1.02
.97
KLA/ATP
.99
.95
.97
.99
.96
.93
1.00
Pnliprp1
KLA
ATP
ATP+KLA
NM_018874
pancreatic lipase related protein 1 (Pnliprp1), mRNA [NM_018874]
KLA
.99
.95
.96
.99
.94
.96
1.01
ATP
1.00
1.00
.98
.96
.99
.87
1.09
KLA/ATP
1.01
1.06
1.01
1.02
1.03
.96
.92
Pnliprp2
KLA
ATP
ATP+KLA
NM_011128
pancreatic lipase-related protein 2 (Pnliprp2), mRNA [NM_011128]
KLA
1.01
.97
1.02
1.07
1.08
.98
1.00
ATP
1.05
1.08
.98
1.02
1.00
1.00
1.02
KLA/ATP
1.05
1.04
.96
.99
1.01
1.03
1.05
Pnmt
KLA
ATP
ATP+KLA
NM_008890
phenylethanolamine-N-methyltransferase (Pnmt), mRNA [NM_008890]
KLA
.97
.99
.99
.91
1.02
.97
1.02
ATP
1.02
1.03
.92
1.09
1.05
1.09
.96
KLA/ATP
1.00
1.02
1.02
.96
.96
.93
.95
Pnp1
KLA
ATP
ATP+KLA
NM_013632
purine-nucleoside phosphorylase 1 (Pnp1), mRNA [NM_013632]
KLA
5.68
5.47
6.37
7.13
8.25
8.23
3.96
ATP
1.15
1.04
1.14
1.52
1.68
3.22
3.33
KLA/ATP
5.61
5.86
7.11
8.09
8.18
8.72
9.32
Pnpla2
KLA
ATP
ATP+KLA
NM_025802
patatin-like phospholipase domain containing 2 (Pnpla2), mRNA [NM_025802]
KLA
1.18
1.27
1.25
1.09
1.15
1.14
1.19
ATP
1.05
1.17
1.05
1.82
1.47
1.41
1.10
KLA/ATP
1.34
1.41
1.13
1.96
1.63
1.83
1.72
Pnpla3
KLA
ATP
ATP+KLA
NM_054088
patatin-like phospholipase domain containing 3 (Pnpla3), mRNA [NM_054088]
KLA
.88
.99
1.04
.97
1.00
.91
1.03
ATP
.95
1.03
1.05
1.03
1.01
.93
.99
KLA/ATP
1.02
1.05
1.00
.94
.95
.98
.95
Pnpo
KLA
ATP
ATP+KLA
NM_134021
pyridoxine 5-phosphate oxidase (Pnpo), mRNA [NM_134021]
KLA
.64
.66
.64
.60
.58
.62
.81
ATP
1.07
1.06
1.02
1.08
.78
.55
1.18
KLA/ATP
.73
.76
.60
.78
.54
.65
.78
Pola1
KLA
ATP
ATP+KLA
NM_008892
polymerase (DNA directed), alpha 1 (Pola1), mRNA [NM_008892]
KLA
.72
.68
.59
.56
.27
.19
.21
ATP
.81
.97
1.41
1.22
.71
.29
.16
KLA/ATP
.58
.70
.81
.56
.39
.27
.12
Pola2
KLA
ATP
ATP+KLA
BC006945
polymerase (DNA directed), alpha 2, mRNA (cDNA clone MGC:11533 IMAGE:3602559), complete cds [BC006945]
KLA
.74
.76
.70
.74
.88
.91
.98
ATP
.99
1.03
.83
.78
.96
.76
.92
KLA/ATP
.67
.69
.65
.77
.88
.83
1.02
Pola2
KLA
ATP
ATP+KLA
NM_008893
polymerase (DNA directed), alpha 2 (Pola2), mRNA [NM_008893]
KLA
.82
.76
.91
.72
.73
.74
.85
ATP
1.12
1.12
.88
1.20
.86
.82
.64
KLA/ATP
.89
.84
.75
.84
.78
.91
1.16
Pold1
KLA
ATP
ATP+KLA
NM_011131
polymerase (DNA directed), delta 1, catalytic subunit (Pold1), mRNA [NM_011131]
KLA
.24
.21
.20
.18
.18
.29
.36
ATP
1.05
1.05
.96
.99
.52
.26
.32
KLA/ATP
.26
.22
.21
.22
.16
.17
.18
Pold2
KLA
ATP
ATP+KLA
NM_008894
polymerase (DNA directed), delta 2, regulatory subunit (Pold2), mRNA [NM_008894]
KLA
.77
.83
.69
.68
.59
.49
.57
ATP
1.05
1.09
.97
1.24
.89
.44
.43
KLA/ATP
.79
.78
.70
.84
.60
.41
.30
Pold3
KLA
ATP
ATP+KLA
NM_133692
polymerase (DNA-directed), delta 3, accessory subunit (Pold3), mRNA [NM_133692]
KLA
1.14
1.07
1.22
1.22
1.12
1.40
1.10
ATP
.99
.95
1.17
.89
1.46
1.74
1.55
KLA/ATP
1.01
1.08
1.54
1.28
1.86
2.34
2.11
Pold4
KLA
ATP
ATP+KLA
NM_027196
polymerase (DNA-directed), delta 4 (Pold4), mRNA [NM_027196]
KLA
.81
.88
.80
.78
.85
1.04
1.40
ATP
.97
1.07
1.12
1.37
1.19
.86
1.27
KLA/ATP
.85
.90
.89
1.07
.90
.94
1.62
Pole
KLA
ATP
ATP+KLA
AK086490
15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930032B21 product:DNA polymerase epsilon, full insert sequence. [AK086490]
KLA
1.00
1.00
1.04
.96
.94
.99
1.04
ATP
.97
.95
.91
.95
.97
1.06
.95
KLA/ATP
.96
.93
1.00
1.01
1.08
1.02
1.01
Pole
KLA
ATP
ATP+KLA
NM_011132
polymerase (DNA directed), epsilon (Pole), mRNA [NM_011132]
KLA
.50
.44
.38
.31
.25
.21
.17
ATP
1.12
1.03
1.28
.89
.68
.30
.16
KLA/ATP
.45
.44
.56
.38
.30
.21
.14
Pole2
KLA
ATP
ATP+KLA
NM_011133
polymerase (DNA directed), epsilon 2 (p59 subunit) (Pole2), mRNA [NM_011133]
KLA
.25
.24
.22
.21
.21
.37
.34
ATP
.93
.98
1.11
1.00
.36
.30
.35
KLA/ATP
.22
.22
.29
.30
.26
.28
.19
Pole3
KLA
ATP
ATP+KLA
BC034004
polymerase (DNA directed), epsilon 3 (p17 subunit), mRNA (cDNA clone IMAGE:5117478) [BC034004]
KLA
.69
.72
.63
.69
.68
.81
.61
ATP
.91
.86
1.29
.96
.81
.94
.51
KLA/ATP
.62
.54
.85
.64
.70
.75
.44
Pole3
KLA
ATP
ATP+KLA
NM_021498
polymerase (DNA directed), epsilon 3 (p17 subunit) (Pole3), mRNA [NM_021498]
KLA
1.14
1.14
1.23
1.36
1.18
1.15
1.01
ATP
1.02
.98
1.17
1.44
1.40
1.27
1.25
KLA/ATP
1.20
1.24
1.58
1.57
1.60
1.25
1.23
Pole4
KLA
ATP
ATP+KLA
NM_025882
polymerase (DNA-directed), epsilon 4 (p12 subunit) (Pole4), mRNA [NM_025882]
KLA
1.11
1.15
1.15
1.22
1.19
1.31
1.26
ATP
1.00
.99
1.36
1.32
1.34
1.19
.98
KLA/ATP
1.02
1.15
1.58
1.47
1.52
1.10
.85
Polg
KLA
ATP
ATP+KLA
NM_017462
polymerase (DNA directed), gamma (Polg), mRNA [NM_017462]
KLA
.67
.66
.76
.65
.85
.74
.84
ATP
1.01
.93
.57
.51
.55
.89
.97
KLA/ATP
.70
.67
.41
.41
.44
.69
.67
Polg2
KLA
ATP
ATP+KLA
NM_015810
polymerase (DNA directed), gamma 2, accessory subunit (Polg2), mRNA [NM_015810]
KLA
.56
.58
.61
.67
.66
.80
.63
ATP
.84
.78
1.12
4.24
1.38
.94
.72
KLA/ATP
.52
.54
1.36
4.68
2.77
2.45
.59
Polr1e
KLA
ATP
ATP+KLA
NM_022811
polymerase (RNA) I polypeptide E (Polr1e), mRNA [NM_022811]
KLA
1.01
1.06
.93
.81
.72
.80
1.37
ATP
1.04
1.10
1.09
1.06
.68
1.06
.85
KLA/ATP
1.15
1.13
.87
.96
.60
.72
.56
Polr2a
KLA
ATP
ATP+KLA
NM_009089
polymerase (RNA) II (DNA directed) polypeptide A (Polr2a), mRNA [NM_009089]
KLA
1.21
1.16
1.15
1.16
1.16
1.25
1.12
ATP
1.00
1.09
1.07
1.39
1.35
1.28
1.16
KLA/ATP
1.20
1.18
1.26
1.30
1.30
1.51
1.37
Polr2b
KLA
ATP
ATP+KLA
NM_153798
polymerase (RNA) II (DNA directed) polypeptide B (Polr2b), mRNA [NM_153798]
KLA
.91
.91
.92
.73
.77
.80
.83
ATP
1.09
1.18
.96
.80
.64
.75
.93
KLA/ATP
1.01
.98
.74
.74
.53
.72
.71
Polr2c
KLA
ATP
ATP+KLA
NM_009090
polymerase (RNA) II (DNA directed) polypeptide C (Polr2c), mRNA [NM_009090]
KLA
1.45
1.41
1.48
1.33
1.24
1.24
1.34
ATP
.97
1.07
1.01
1.06
1.09
1.27
1.13
KLA/ATP
1.48
1.46
1.34
1.46
1.27
1.50
1.26
Polr2d
KLA
ATP
ATP+KLA
NM_027101
polymerase (RNA) II (DNA directed) polypeptide D (Polr2d), transcript variant 2, mRNA [NM_027101]
KLA
.89
.90
.80
.87
.86
.94
.99
ATP
.95
.95
1.15
1.05
.93
1.45
.80
KLA/ATP
.81
.88
.99
.96
.99
1.33
.89
Polr2e
KLA
ATP
ATP+KLA
AK010567
ES cells cDNA, RIKEN full-length enriched library, clone:2410021N14 product:polymerase (RNA) II (DNA directed) polypeptide E, full insert sequence. [AK010567]
KLA
.67
.68
.68
.56
.58
.45
.67
ATP
1.14
1.18
1.05
1.26
.91
.63
.80
KLA/ATP
.80
.77
.71
.81
.75
.50
.49
Polr2e
KLA
ATP
ATP+KLA
NM_025554
polymerase (RNA) II (DNA directed) polypeptide E (Polr2e), mRNA [NM_025554]
KLA
.69
.74
.69
.61
.56
.49
.70
ATP
1.00
1.06
1.02
1.20
.88
.67
.73
KLA/ATP
.79
.76
.72
.80
.77
.55
.45
Polr2f
KLA
ATP
ATP+KLA
NM_027231
polymerase (RNA) II (DNA directed) polypeptide F (Polr2f), mRNA [NM_027231]
KLA
1.01
.99
.92
.94
.86
.78
.84
ATP
.94
1.00
1.18
1.34
1.14
.88
.91
KLA/ATP
.96
1.07
1.23
1.38
1.16
.96
.70
Polr2g
KLA
ATP
ATP+KLA
NM_026329
polymerase (RNA) II (DNA directed) polypeptide G (Polr2g), mRNA [NM_026329]
KLA
2.39
2.22
2.36
2.22
1.69
1.12
1.08
ATP
.93
.91
1.27
1.12
1.19
1.43
1.23
KLA/ATP
2.24
2.26
3.23
2.51
3.15
2.36
1.54
Polr2h
KLA
ATP
ATP+KLA
NM_145632
polymerase (RNA) II (DNA directed) polypeptide H (Polr2h), mRNA [NM_145632]
KLA
.80
.76
.66
.62
.73
.87
1.14
ATP
.90
.91
1.01
.99
1.10
1.32
.98
KLA/ATP
.68
.72
.69
.65
.90
1.01
.62
Polr2i
KLA
ATP
ATP+KLA
NM_027259
polymerase (RNA) II (DNA directed) polypeptide I (Polr2i), mRNA [NM_027259]
KLA
.67
.69
.68
.78
.80
.90
.99
ATP
.98
.88
1.10
.84
.77
1.13
1.17
KLA/ATP
.64
.68
.85
.70
.91
1.10
1.03
Polr2j
KLA
ATP
ATP+KLA
NM_011293
polymerase (RNA) II (DNA directed) polypeptide J (Polr2j), mRNA [NM_011293]
KLA
.96
.89
.88
1.01
.88
.92
.85
ATP
1.09
1.12
1.38
1.58
1.39
1.15
.89
KLA/ATP
1.05
1.05
1.46
1.33
1.51
1.25
.88
Polr2l
KLA
ATP
ATP+KLA
XM_888022
gb|PREDICTED: Mus musculus polymerase (RNA) II (DNA directed) polypeptide L (Polr2l), mRNA [XM_888022]
KLA
.82
.92
.85
.82
.77
.73
.88
ATP
.95
1.00
1.15
1.42
1.20
.91
.99
KLA/ATP
.86
.89
1.04
1.23
1.25
.91
.59
Polr3a
KLA
ATP
ATP+KLA
AK039440
adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330043C08 product:hypothetical protein, full insert sequence. [AK039440]
KLA
1.02
.94
.96
.97
1.13
.97
1.02
ATP
.71
.55
.59
.69
.88
.93
.94
KLA/ATP
.81
.65
.65
.80
.83
.88
.75
Polr3a
KLA
ATP
ATP+KLA
NM_001081247
polymerase (RNA) III (DNA directed) polypeptide A (Polr3a), mRNA [NM_001081247]
KLA
1.16
1.20
1.27
1.15
1.26
1.17
1.32
ATP
.98
1.08
1.07
.92
.80
.99
1.26
KLA/ATP
1.22
1.30
1.18
.99
.78
1.24
1.27
Polr3b
KLA
ATP
ATP+KLA
NM_027423
polymerase (RNA) III (DNA directed) polypeptide B (Polr3b), mRNA [NM_027423]
KLA
1.03
1.05
1.02
1.07
1.11
1.15
1.05
ATP
1.09
1.15
.96
.97
.73
.75
.93
KLA/ATP
1.04
1.12
1.00
1.00
.74
.75
.77
Polr3c
KLA
ATP
ATP+KLA
XM_131049
gb|PREDICTED: Mus musculus polymerase (RNA) III (DNA directed) polypeptide C, transcript variant 1 (Polr3c), mRNA [XM_131049]
KLA
2.33
2.34
2.59
2.37
2.10
1.82
1.42
ATP
1.02
.97
1.12
1.19
.99
1.10
1.14
KLA/ATP
2.34
2.54
2.70
2.54
2.18
1.75
1.88
Polr3d
KLA
ATP
ATP+KLA
NM_025945
polymerase (RNA) III (DNA directed) polypeptide D (Polr3d), mRNA [NM_025945]
KLA
1.08
1.08
.90
.88
.98
.99
1.60
ATP
.95
1.00
.94
.89
1.23
1.19
1.21
KLA/ATP
1.06
1.13
.88
.82
.68
.72
.55
Polr3f
KLA
ATP
ATP+KLA
NM_029763
polymerase (RNA) III (DNA directed) polypeptide F (Polr3f), mRNA [NM_029763]
KLA
1.10
1.09
1.09
.98
.95
1.00
1.08
ATP
1.07
1.06
.84
.69
.72
.94
1.06
KLA/ATP
1.13
1.08
.80
.71
.70
.92
.92
Polr3g
KLA
ATP
ATP+KLA
NM_001081176
polymerase (RNA) III (DNA directed) polypeptide G (Polr3g), mRNA [NM_001081176]
KLA
.51
.53
.43
.45
.41
.45
.57
ATP
.90
.84
.68
.55
.54
.64
.60
KLA/ATP
.51
.47
.46
.50
.48
.53
.46
Polr3gl
KLA
ATP
ATP+KLA
NM_027241
polymerase (RNA) III (DNA directed) polypeptide G like (Polr3gl), mRNA [NM_027241]
KLA
.60
.51
.54
.55
.57
.70
.53
ATP
.99
.86
1.08
.84
.48
.57
.69
KLA/ATP
.55
.49
.64
.50
.53
.57
.67
Polr3h
KLA
ATP
ATP+KLA
NM_030229
polymerase (RNA) III (DNA directed) polypeptide H (Polr3h), mRNA [NM_030229]
KLA
.89
.85
.75
.81
.76
.85
1.01
ATP
.93
.81
.86
.71
.70
.93
.83
KLA/ATP
.75
.78
.73
.70
.69
.76
.76
Polr3k
KLA
ATP
ATP+KLA
NM_025901
polymerase (RNA) III (DNA directed) polypeptide K (Polr3k), mRNA [NM_025901]
KLA
.72
.72
.66
.69
.63
.74
.85
ATP
.87
.84
1.14
.92
.64
.87
.72
KLA/ATP
.65
.71
.90
.74
.65
.53
.44
Pon1
KLA
ATP
ATP+KLA
NM_011134
paraoxonase 1 (Pon1), mRNA [NM_011134]
KLA
.91
.98
.94
.94
.95
1.01
1.01
ATP
1.06
.93
1.03
1.05
.96
1.05
1.05
KLA/ATP
.99
.98
.92
.98
.97
1.02
1.22
Pon2
KLA
ATP
ATP+KLA
AK018124
adult male medulla oblongata cDNA, RIKEN full-length enriched library, clone:6330405I24 product:unclassifiable, full insert sequence [AK018124]
KLA
1.00
.95
1.00
.98
.86
.73
.58
ATP
1.05
.96
1.23
.93
.88
.80
.44
KLA/ATP
.96
1.03
1.20
.84
.87
.64
.35
Pon2
KLA
ATP
ATP+KLA
NM_183308
paraoxonase 2 (Pon2), mRNA [NM_183308]
KLA
.91
.88
.94
.99
.91
.78
.90
ATP
1.06
1.02
.94
1.00
.94
.88
.89
KLA/ATP
.90
.97
.98
.95
.76
.74
1.03
Pon3
KLA
ATP
ATP+KLA
NM_173006
paraoxonase 3 (Pon3), mRNA [NM_173006]
KLA
.95
.93
.87
.88
.73
.63
1.01
ATP
1.01
.99
1.23
1.15
1.10
1.12
1.16
KLA/ATP
.89
.94
1.16
1.03
.89
.80
1.63
Ppap2a
KLA
ATP
ATP+KLA
NM_008903
phosphatidic acid phosphatase 2a (Ppap2a), transcript variant 2, mRNA [NM_008903]
KLA
2.62
2.86
4.01
5.61
7.84
10.88
16.35
ATP
1.01
1.02
1.09
1.28
1.27
2.38
1.44
KLA/ATP
2.78
2.78
2.99
3.43
2.85
3.59
6.59
Ppap2b
KLA
ATP
ATP+KLA
NM_080555
phosphatidic acid phosphatase type 2B (Ppap2b), mRNA [NM_080555]
KLA
2.73
2.72
2.65
2.39
1.07
1.48
3.26
ATP
.99
.97
1.60
2.76
18.64
27.23
9.19
KLA/ATP
2.69
2.80
4.36
4.20
14.33
15.32
17.91
Ppap2c
KLA
ATP
ATP+KLA
NM_015817
phosphatidic acid phosphatase type 2c (Ppap2c), mRNA [NM_015817]
KLA
.94
.88
.91
.79
.65
.46
.51
ATP
1.01
1.03
1.00
1.12
1.24
.90
.83
KLA/ATP
.95
.93
.87
.95
.79
.63
.43
Ppat
KLA
ATP
ATP+KLA
XM_896000
gb|PREDICTED: Mus musculus phosphoribosyl pyrophosphate amidotransferase, transcript variant 3 (Ppat), mRNA [XM_896000]
KLA
.54
.49
.44
.40
.36
.46
.60
ATP
.91
.96
1.03
.85
.83
.81
.67
KLA/ATP
.49
.50
.52
.49
.65
.63
.37
Ppcdc
KLA
ATP
ATP+KLA
NM_176831
phosphopantothenoylcysteine decarboxylase (Ppcdc), mRNA [NM_176831]
KLA
.52
.50
.46
.57
.63
.84
.95
ATP
.95
.81
.76
.61
.46
.55
.89
KLA/ATP
.47
.46
.47
.46
.46
.56
.99
Ppcs
KLA
ATP
ATP+KLA
NM_026494
phosphopantothenoylcysteine synthetase (Ppcs), mRNA [NM_026494]
KLA
.71
.66
.63
.72
.73
.93
1.01
ATP
.93
.81
.72
.49
.43
.94
1.07
KLA/ATP
.68
.67
.61
.47
.50
.97
.73
Ppox
KLA
ATP
ATP+KLA
NM_008911
protoporphyrinogen oxidase (Ppox), nuclear gene encoding mitochondrial protein, mRNA [NM_008911]
KLA
1.12
1.19
1.12
1.10
1.21
1.14
1.07
ATP
1.01
.86
.65
.67
.45
.71
1.09
KLA/ATP
1.28
1.00
.69
.77
.56
.69
1.08
Ppt1
KLA
ATP
ATP+KLA
AK148314
B16 F10Y cells cDNA, RIKEN full-length enriched library, clone:G370087F11 product:palmitoyl-protein thioesterase 1, full insert sequence. [AK148314]
KLA
.81
.79
.79
.90
.82
.88
1.24
ATP
.98
1.11
1.72
1.24
1.13
.95
1.91
KLA/ATP
.80
.85
1.14
.98
.93
.73
1.39
Ppt1
KLA
ATP
ATP+KLA
NM_008917
palmitoyl-protein thioesterase 1 (Ppt1), mRNA [NM_008917]
KLA
.88
.86
.86
.89
.78
.73
.81
ATP
1.05
1.02
1.17
1.10
.99
.76
.77
KLA/ATP
.83
.85
1.02
.91
.71
.59
.71
Ppt2
KLA
ATP
ATP+KLA
NM_019441
palmitoyl-protein thioesterase 2 (Ppt2), mRNA [NM_019441]
KLA
1.08
1.27
1.22
1.04
1.29
1.14
1.70
ATP
1.13
1.21
.63
.82
.60
.74
1.42
KLA/ATP
1.42
1.32
.63
1.02
.54
.85
2.24
Prdx6
KLA
ATP
ATP+KLA
AK081980
16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130091B17 product:peroxiredoxin 5, related sequence 3, full insert sequence [AK081980]
KLA
1.61
1.58
.92
.93
.93
1.08
1.24
ATP
2.61
2.91
4.18
6.45
12.41
12.74
3.19
KLA/ATP
2.79
4.31
7.52
6.17
5.64
6.93
5.25
Prdx6
KLA
ATP
ATP+KLA
NM_007453
peroxiredoxin 6 (Prdx6), mRNA [NM_007453]
KLA
1.33
1.40
1.49
1.32
1.28
1.04
.90
ATP
1.07
1.22
1.15
1.46
2.77
9.93
8.48
KLA/ATP
1.36
1.59
1.61
1.96
1.90
5.10
9.06
Prhoxnb
KLA
ATP
ATP+KLA
NM_001039678
parahox cluster neighbor (Prhoxnb), mRNA [NM_001039678]
KLA
.98
.97
1.01
.96
.96
.97
.97
ATP
.97
.97
.98
1.02
1.04
1.01
1.03
KLA/ATP
.99
1.05
1.01
1.01
1.00
.93
.96
Prim1
KLA
ATP
ATP+KLA
NM_008921
DNA primase, p49 subunit (Prim1), mRNA [NM_008921]
KLA
.28
.26
.22
.18
.14
.24
.28
ATP
.88
.80
1.35
.98
.50
.25
.26
KLA/ATP
.22
.22
.33
.23
.20
.16
.10
Prim2
KLA
ATP
ATP+KLA
NM_008922
DNA primase, p58 subunit (Prim2), mRNA [NM_008922]
KLA
.72
.68
.61
.54
.39
.52
.50
ATP
.88
.76
.77
.64
.39
.47
.44
KLA/ATP
.63
.59
.59
.44
.34
.46
.33
Prodh
KLA
ATP
ATP+KLA
NM_011172
proline dehydrogenase (Prodh), nuclear gene encoding mitochondrial protein, mRNA [NM_011172]
KLA
.78
.72
.60
.59
.44
.32
.27
ATP
.93
.97
1.11
1.02
.63
.44
.49
KLA/ATP
.73
.76
.74
.78
.56
.39
.27
Prodh2
KLA
ATP
ATP+KLA
NM_019546
proline dehydrogenase (oxidase) 2 (Prodh2), mRNA [NM_019546]
KLA
1.03
1.01
1.04
1.07
1.01
1.06
1.04
ATP
.96
1.01
1.00
1.00
.93
.98
1.00
KLA/ATP
.98
.99
1.09
1.03
1.00
.96
1.03
Prps1
KLA
ATP
ATP+KLA
NM_021463
phosphoribosyl pyrophosphate synthetase 1 (Prps1), mRNA [NM_021463]
KLA
.82
.83
.85
.70
.56
.42
.52
ATP
1.00
1.03
1.20
1.21
1.08
.67
.54
KLA/ATP
.85
.86
.90
.86
.68
.52
.42
Prps1l1
KLA
ATP
ATP+KLA
NM_029294
phosphoribosyl pyrophosphate synthetase 1-like 1 (Prps1l1), mRNA [NM_029294]
KLA
1.05
.97
.99
1.03
1.04
1.00
1.04
ATP
.99
.96
1.04
1.05
1.05
.99
1.07
KLA/ATP
.99
1.03
1.07
1.00
1.01
1.01
1.09
Prps2
KLA
ATP
ATP+KLA
NM_026662
phosphoribosyl pyrophosphate synthetase 2 (Prps2), mRNA [NM_026662]
KLA
.85
.85
.88
.76
.60
.45
.43
ATP
1.00
1.13
1.18
1.19
.79
.35
.37
KLA/ATP
.85
.93
.88
.83
.62
.38
.24
Psat1
KLA
ATP
ATP+KLA
NM_177420
phosphoserine aminotransferase 1 (Psat1), mRNA [NM_177420]
KLA
1.02
1.21
1.24
1.27
1.64
1.59
.38
ATP
1.02
1.01
1.04
1.17
1.27
1.09
.43
KLA/ATP
1.16
1.11
1.04
1.37
1.04
.70
.24
Psph
KLA
ATP
ATP+KLA
NM_133900
phosphoserine phosphatase (Psph), mRNA [NM_133900]
KLA
.94
.88
.76
.88
.65
.87
.75
ATP
.77
.61
.53
.35
1.23
1.85
.73
KLA/ATP
.71
.64
.54
.31
.46
.78
.61
Ptdss1
KLA
ATP
ATP+KLA
NM_008959
phosphatidylserine synthase 1 (Ptdss1), mRNA [NM_008959]
KLA
.88
.95
.96
.86
.88
.92
1.05
ATP
1.02
1.05
.90
1.08
.99
.93
1.17
KLA/ATP
.95
.93
.81
.85
.67
.83
1.10
Ptdss2
KLA
ATP
ATP+KLA
NM_013782
phosphatidylserine synthase 2 (Ptdss2), mRNA [NM_013782]
KLA
.95
.96
1.02
1.06
1.17
1.34
1.27
ATP
.90
.93
.92
1.04
.83
.86
1.34
KLA/ATP
.93
.96
.93
.90
.90
.96
1.42
Ptgds
KLA
ATP
ATP+KLA
NM_008963
prostaglandin D2 synthase (brain) (Ptgds), mRNA [NM_008963]
KLA
1.19
1.16
1.11
1.19
1.04
.98
.93
ATP
.99
.99
1.10
1.07
1.02
1.00
.97
KLA/ATP
1.18
1.18
1.31
1.39
1.09
.89
.90
Ptgds2
KLA
ATP
ATP+KLA
NM_019455
prostaglandin D2 synthase 2, hematopoietic (Ptgds2), mRNA [NM_019455]
KLA
.50
.48
.58
.52
.66
.57
.53
ATP
1.03
1.05
1.05
1.36
1.04
.32
.61
KLA/ATP
.52
.47
.50
.74
.73
.35
.42
Ptges
KLA
ATP
ATP+KLA
NM_022415
prostaglandin E synthase (Ptges), mRNA [NM_022415]
KLA
16.01
15.00
16.36
20.05
28.20
32.79
23.08
ATP
1.00
1.03
1.44
2.27
10.67
30.61
17.52
KLA/ATP
14.56
16.98
20.33
21.07
21.87
25.39
38.01
Ptges2
KLA
ATP
ATP+KLA
NM_133783
prostaglandin E synthase 2 (Ptges2), mRNA [NM_133783]
KLA
1.02
1.07
1.30
1.30
1.39
1.06
1.43
ATP
1.09
1.14
.97
1.09
.70
1.00
1.20
KLA/ATP
1.19
1.12
.93
1.13
.81
.97
1.37
Ptges3
KLA
ATP
ATP+KLA
NM_019766
prostaglandin E synthase 3 (cytosolic) (Ptges3), mRNA [NM_019766]
KLA
1.26
1.26
1.19
1.10
1.10
1.01
1.20
ATP
1.08
1.21
1.14
1.68
1.49
1.49
.65
KLA/ATP
1.31
1.49
1.19
1.74
1.34
1.12
.78
Ptgis
KLA
ATP
ATP+KLA
NM_008968
prostaglandin I2 (prostacyclin) synthase (Ptgis), mRNA [NM_008968]
KLA
1.05
1.07
.93
1.05
1.05
1.05
1.02
ATP
1.01
.98
1.01
1.04
1.02
.92
1.00
KLA/ATP
1.09
.99
.94
.99
.96
1.01
1.06
Ptgs1
KLA
ATP
ATP+KLA
NM_008969
prostaglandin-endoperoxide synthase 1 (Ptgs1), mRNA [NM_008969]
KLA
.74
.74
.76
.74
.61
.53
.18
ATP
1.01
1.05
1.29
1.14
.99
1.16
3.96
KLA/ATP
.77
.71
.88
.77
.75
.61
.40
Ptgs2
KLA
ATP
ATP+KLA
NM_011198
prostaglandin-endoperoxide synthase 2 (Ptgs2), mRNA [NM_011198]
KLA
181.04
220.88
218.58
132.79
103.05
22.69
18.02
ATP
2.47
9.45
52.13
208.62
271.22
306.11
6.86
KLA/ATP
233.39
387.29
617.86
###.##
608.44
290.80
112.22
Pts
KLA
ATP
ATP+KLA
NM_011220
6-pyruvoyl-tetrahydropterin synthase (Pts), mRNA [NM_011220]
KLA
1.12
1.20
1.22
1.18
1.22
1.30
1.00
ATP
.84
.77
1.06
.97
.88
.70
.69
KLA/ATP
.94
.95
1.32
1.08
1.11
.87
.84
Pycr2
KLA
ATP
ATP+KLA
NM_133705
pyrroline-5-carboxylate reductase family, member 2 (Pycr2), mRNA [NM_133705]
KLA
.59
.56
.56
.66
.62
.65
.80
ATP
.86
.74
.49
.43
.33
.56
.69
KLA/ATP
.53
.50
.41
.30
.29
.54
.52
Pycrl
KLA
ATP
ATP+KLA
AK004291
18-day embryo whole body cDNA, RIKEN full-length enriched library, clone:1110058B13 product:pyrroline-5-carboxylate reductase-like, full insert sequence. [AK004291]
KLA
.50
.57
.50
.50
.54
.66
.74
ATP
.98
.99
.97
1.09
.76
.48
.60
KLA/ATP
.58
.55
.48
.54
.59
.53
.44
Pycrl
KLA
ATP
ATP+KLA
NM_025412
pyrroline-5-carboxylate reductase-like (Pycrl), mRNA [NM_025412]
KLA
.66
.69
.67
.64
.64
.78
.89
ATP
.99
1.01
1.03
1.10
.78
.61
.69
KLA/ATP
.66
.69
.70
.69
.68
.63
.56
Pygb
KLA
ATP
ATP+KLA
NM_153781
brain glycogen phosphorylase (Pygb), mRNA [NM_153781]
KLA
.91
.83
.91
.78
.88
.87
.81
ATP
1.12
1.17
.92
1.03
.75
.51
.83
KLA/ATP
.92
.91
.81
.88
.67
.61
.63
Pygl
KLA
ATP
ATP+KLA
AK083075
12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530044G15 product:weakly similar to GLYCOGEN PHOSPHORYLASE (EC 2.4.1.1) (ALPHA-GLUCAN PHOSPHORYLASE) (STARCH PHOSPHORYLASE) [Mus musculus], full insert sequence [
KLA
.85
.87
.84
.91
.88
.84
.95
ATP
1.04
1.03
.99
1.07
.95
.80
.83
KLA/ATP
.88
.88
.95
.97
.98
.87
.76
Pygl
KLA
ATP
ATP+KLA
NM_133198
liver glycogen phosphorylase (Pygl), mRNA [NM_133198]
KLA
.79
.76
.73
.67
.52
.42
.66
ATP
1.01
.94
1.24
1.10
.92
.55
.44
KLA/ATP
.76
.81
.93
.81
.76
.45
.14
Pygm
KLA
ATP
ATP+KLA
NM_011224
muscle glycogen phosphorylase (Pygm), mRNA [NM_011224]
KLA
1.11
1.08
.97
1.00
1.09
1.13
1.19
ATP
1.02
.98
.97
2.09
1.91
1.71
1.11
KLA/ATP
1.15
1.06
.87
1.65
1.87
1.99
1.42
Qars
KLA
ATP
ATP+KLA
AK161817
13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030468K12 product:hypothetical protein, full insert sequence. [AK161817]
KLA
.86
.79
.83
.83
1.06
.97
.92
ATP
.94
.84
.70
.71
1.19
1.03
.94
KLA/ATP
.79
.73
.77
.73
1.06
.96
.90
Qars
KLA
ATP
ATP+KLA
NM_133794
glutaminyl-tRNA synthetase (Qars), mRNA [NM_133794]
KLA
.78
.80
.80
.70
.70
.73
.76
ATP
1.09
1.06
.92
.98
.86
.83
.80
KLA/ATP
.87
.84
.71
.71
.59
.78
.73
Qdpr
KLA
ATP
ATP+KLA
NM_024236
quinoid dihydropteridine reductase (Qdpr), mRNA [NM_024236]
KLA
.88
.92
.85
.73
.82
.57
.49
ATP
1.16
1.24
1.00
1.09
1.01
.58
.53
KLA/ATP
.86
.99
.90
.92
.70
.50
.25
Qprt
KLA
ATP
ATP+KLA
NM_133686
quinolinate phosphoribosyltransferase (Qprt), mRNA [NM_133686]
KLA
1.01
.99
.88
.93
1.07
.96
1.03
ATP
1.00
.95
1.04
.93
.98
1.05
.92
KLA/ATP
1.02
.97
.99
1.01
1.00
.94
.89
RP23-136
K12.4
KLA
ATP
ATP+KLA
NM_008916
putative phosphatase (Pps), mRNA [NM_008916]
KLA
1.35
1.47
1.81
1.90
2.21
2.28
1.37
ATP
1.00
1.04
1.03
1.11
.86
.77
1.25
KLA/ATP
1.45
1.56
1.59
1.74
1.57
1.45
2.55
Rdh10
KLA
ATP
ATP+KLA
NM_133832
retinol dehydrogenase 10 (all-trans) (Rdh10), mRNA [NM_133832]
KLA
.87
.88
.87
.75
.59
.46
.52
ATP
1.08
1.16
1.00
1.60
1.16
.96
.56
KLA/ATP
.90
.91
.84
1.31
1.09
.86
.69
Rdh11
KLA
ATP
ATP+KLA
AY039032
short-chain dehydrogenase/reductase (Psdr1) mRNA, complete cds. [AY039032]
KLA
.94
.90
.94
.87
.74
.68
.77
ATP
.91
.93
1.39
1.14
1.38
2.76
.84
KLA/ATP
.87
.90
1.20
.93
1.15
1.57
1.18
Rdh11
KLA
ATP
ATP+KLA
NM_021557
retinol dehydrogenase 11 (Rdh11), mRNA [NM_021557]
KLA
1.11
1.06
1.22
1.17
1.02
.87
1.00
ATP
1.11
1.06
1.48
1.56
1.69
2.35
1.27
KLA/ATP
1.22
1.21
1.37
1.51
1.44
1.47
1.83
Rdh12
KLA
ATP
ATP+KLA
NM_030017
retinol dehydrogenase 12 (Rdh12), mRNA [NM_030017]
KLA
1.52
1.36
1.48
1.52
1.49
1.57
1.11
ATP
.97
1.02
1.33
1.50
1.84
1.82
1.23
KLA/ATP
1.36
1.45
1.97
2.02
2.30
2.27
1.89
Rdh16
KLA
ATP
ATP+KLA
NM_009040
retinol dehydrogenase 16 (Rdh16), mRNA [NM_009040]
KLA
1.03
1.04
1.01
.98
.90
.98
.98
ATP
1.05
.96
1.04
1.04
.94
.98
.96
KLA/ATP
1.08
1.03
.99
.97
.72
.98
.94
Rev3l
KLA
ATP
ATP+KLA
NM_011264
REV3-like, catalytic subunit of DNA polymerase zeta RAD54 like (S. cerevisiae) (Rev3l), mRNA [NM_011264]
KLA
.38
.33
.34
.31
.36
.53
1.02
ATP
1.14
.97
1.14
1.03
1.41
1.09
1.27
KLA/ATP
.42
.36
.44
.51
1.81
1.08
1.39
Rfk
KLA
ATP
ATP+KLA
NM_019437
riboflavin kinase (Rfk), mRNA [NM_019437]
KLA
1.03
1.05
.97
.96
.86
.77
.86
ATP
1.05
1.20
1.16
1.43
1.21
1.23
1.24
KLA/ATP
1.04
1.09
.95
1.20
.91
.93
1.03
Rgn
KLA
ATP
ATP+KLA
NM_009060
regucalcin (Rgn), mRNA [NM_009060]
KLA
.99
.94
.99
.93
.97
1.00
1.04
ATP
.98
1.03
.95
.98
.95
.96
.91
KLA/ATP
.93
1.03
1.01
.98
.94
.93
.94
Rpe
KLA
ATP
ATP+KLA
NM_025683
ribulose-5-phosphate-3-epimerase (Rpe), mRNA [NM_025683]
KLA
2.06
2.10
2.39
2.33
2.29
2.01
1.45
ATP
1.01
1.14
1.25
1.29
.90
.80
.89
KLA/ATP
1.87
2.38
2.22
2.33
1.57
1.08
1.10
Rpn1
KLA
ATP
ATP+KLA
NM_133933
ribophorin I (Rpn1), mRNA [NM_133933]
KLA
.79
.80
.74
.71
.66
.66
.86
ATP
1.02
.96
1.08
.94
.93
.86
.96
KLA/ATP
.80
.84
.85
.74
.74
.69
.56
Rpn2
KLA
ATP
ATP+KLA
NM_019642
ribophorin II (Rpn2), mRNA [NM_019642]
KLA
1.06
1.03
1.13
.99
1.05
.92
.92
ATP
1.08
1.10
.95
.97
.87
.80
.82
KLA/ATP
1.10
1.10
1.00
1.03
.71
.67
.66
Rpo1-1
KLA
ATP
ATP+KLA
NM_009085
RNA polymerase 1-1 (Rpo1-1), mRNA [NM_009085]
KLA
.77
.81
.81
.91
.90
.68
.86
ATP
1.03
.92
.86
.94
2.06
1.70
.91
KLA/ATP
.82
.85
.86
.65
1.41
1.49
.92
Rpo1-2
KLA
ATP
ATP+KLA
AK052672
0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630020H17 product:RNA polymerase 1-2 (128 kDa subunit), full insert sequence. [AK052672]
KLA
1.03
.94
1.03
1.01
.97
.97
1.00
ATP
1.01
1.00
.99
.94
1.02
.94
1.00
KLA/ATP
1.04
.98
.97
.89
1.01
1.02
.93
Rpo1-2
KLA
ATP
ATP+KLA
NM_009086
RNA polymerase 1-2 (Rpo1-2), mRNA [NM_009086]
KLA
1.64
1.60
1.10
.82
.62
.63
.98
ATP
1.04
1.17
.99
.79
.50
.59
.91
KLA/ATP
1.21
1.54
1.15
.76
.37
.61
.50
Rpo1-3
KLA
ATP
ATP+KLA
NM_009087
RNA polymerase 1-3 (Rpo1-3), transcript variant 1, mRNA [NM_009087]
KLA
1.00
.98
.86
.90
.95
.76
.93
ATP
1.07
1.09
1.20
1.26
1.26
1.12
.99
KLA/ATP
.89
1.04
1.10
1.08
1.01
.71
.67
Rpo1-3
KLA
ATP
ATP+KLA
NM_181730
RNA polymerase 1-3 (Rpo1-3), transcript variant 2, mRNA [NM_181730]
KLA
1.06
1.17
1.07
1.08
.99
1.04
.98
ATP
.93
.97
1.12
1.27
1.36
1.31
.82
KLA/ATP
1.02
1.06
1.20
1.31
1.28
1.32
.90
Rpo1-4
KLA
ATP
ATP+KLA
NM_009088
RNA polymerase 1-4 (Rpo1-4), mRNA [NM_009088]
KLA
.75
.68
.58
.60
.46
.53
1.06
ATP
1.07
.98
1.22
1.00
.69
.74
.75
KLA/ATP
.68
.65
.76
.61
.45
.34
.49
Rrm1
KLA
ATP
ATP+KLA
AK049601
12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530001L22 product:ribonucleotide reductase M1, full insert sequence. [AK049601]
KLA
.99
.96
1.17
1.00
1.00
.88
.97
ATP
1.07
.98
.94
.96
.92
.86
.99
KLA/ATP
1.00
1.03
1.00
.96
1.02
1.00
.95
Rrm1
KLA
ATP
ATP+KLA
NM_009103
ribonucleotide reductase M1 (Rrm1), mRNA [NM_009103]
KLA
.47
.46
.38
.28
.18
.21
.17
ATP
.97
1.01
1.06
.97
.65
.27
.18
KLA/ATP
.46
.42
.39
.36
.23
.16
.11
Rrm2
KLA
ATP
ATP+KLA
NM_009104
ribonucleotide reductase M2 (Rrm2), mRNA [NM_009104]
KLA
.32
.27
.23
.17
.13
.13
.12
ATP
.98
1.00
1.17
1.28
.66
.20
.08
KLA/ATP
.28
.25
.30
.30
.23
.13
.08
Rrm2b
KLA
ATP
ATP+KLA
NM_199476
ribonucleotide reductase M2 B (TP53 inducible) (Rrm2b), mRNA [NM_199476]
KLA
.93
.90
.89
.95
.97
1.00
1.13
ATP
.96
.95
.95
.87
.75
.80
.90
KLA/ATP
.84
.85
.89
.84
.78
.78
.88
Sardh
KLA
ATP
ATP+KLA
NM_138665
sarcosine dehydrogenase (Sardh), mRNA [NM_138665]
KLA
.91
.92
.92
.95
.79
.75
.70
ATP
.98
.90
.98
.94
.75
.74
.67
KLA/ATP
.94
.92
.88
.89
.78
.73
.67
Sc4mol
KLA
ATP
ATP+KLA
NM_025436
sterol-C4-methyl oxidase-like (Sc4mol), mRNA [NM_025436]
KLA
.43
.37
.41
.44
.44
.41
.54
ATP
.95
.92
1.30
.92
.70
.47
1.36
KLA/ATP
.41
.37
.45
.38
.35
.23
.37
Sc5d
KLA
ATP
ATP+KLA
AK080673
10 days neonate cortex cDNA, RIKEN full-length enriched library, clone:A830073K23 product:unclassifiable, full insert sequence [AK080673]
KLA
.62
.56
.53
.46
.38
.29
.35
ATP
.87
.91
1.37
.86
.56
.43
.33
KLA/ATP
.54
.49
.72
.72
.72
.39
.20
Sc5d
KLA
ATP
ATP+KLA
NM_172769
sterol-C5-desaturase (fungal ERG3, delta-5-desaturase) homolog (S. cerevisae) (Sc5d), mRNA [NM_172769]
KLA
1.18
1.19
1.17
1.09
.95
.63
.70
ATP
.99
1.00
1.31
1.09
.84
1.04
1.51
KLA/ATP
1.09
1.08
1.30
1.20
1.05
.88
.76
Scly
KLA
ATP
ATP+KLA
NM_016717
selenocysteine lyase (Scly), mRNA [NM_016717]
KLA
1.01
.98
1.02
1.06
1.13
1.12
1.31
ATP
1.13
1.20
.97
1.14
.76
.60
1.20
KLA/ATP
1.18
1.16
.99
1.21
.76
.64
1.49
Scp2
KLA
ATP
ATP+KLA
NM_011327
sterol carrier protein 2, liver (Scp2), mRNA [NM_011327]
KLA
.88
.85
.85
.77
.71
.68
.66
ATP
1.03
1.13
1.25
1.38
1.10
.63
.47
KLA/ATP
.85
.88
.91
1.06
.83
.58
.38
Sdha
KLA
ATP
ATP+KLA
NM_023281
succinate dehydrogenase complex, subunit A, flavoprotein (Fp) (Sdha), nuclear gene encoding mitochondrial protein, mRNA [NM_023281]
KLA
.97
1.04
1.13
.96
.99
.90
1.09
ATP
1.09
1.20
.93
1.16
.88
.55
.94
KLA/ATP
1.12
1.16
.82
1.02
.65
.65
.78
Sdhb
KLA
ATP
ATP+KLA
NM_023374
succinate dehydrogenase complex, subunit B, iron sulfur (Ip) (Sdhb), mRNA [NM_023374]
KLA
.83
.83
.84
.90
.88
1.22
1.74
ATP
1.08
1.02
1.04
1.19
1.05
.63
.87
KLA/ATP
.86
.84
.89
.89
.95
.94
.95
Sdhc
KLA
ATP
ATP+KLA
NM_025321
succinate dehydrogenase complex, subunit C, integral membrane protein (Sdhc), nuclear gene encoding mitochondrial protein, mRNA [NM_025321]
KLA
.90
.95
1.00
.93
.95
.84
1.01
ATP
1.19
1.21
.98
1.38
1.06
.58
.88
KLA/ATP
1.07
1.18
.93
1.11
.90
.80
.75
Sdhd
KLA
ATP
ATP+KLA
NM_025848
succinate dehydrogenase complex, subunit D, integral membrane protein (Sdhd), nuclear gene encoding mitochondrial protein, mRNA [NM_025848]
KLA
.94
.92
.93
.92
.93
.92
1.07
ATP
.98
1.02
1.05
1.16
.96
.91
.94
KLA/ATP
.90
.98
.91
1.01
.94
1.06
1.01
Sds
KLA
ATP
ATP+KLA
NM_145565
serine dehydratase (Sds), mRNA [NM_145565]
KLA
1.04
1.04
1.02
1.03
1.07
1.05
.77
ATP
.93
.97
.91
.94
1.00
.94
1.00
KLA/ATP
.93
.95
1.05
.96
.98
.96
1.05
Sec1
KLA
ATP
ATP+KLA
NM_019934
secretory blood group 1 (Sec1), mRNA [NM_019934]
KLA
1.01
1.02
.90
1.00
1.02
1.02
1.05
ATP
.99
1.00
.98
1.04
1.00
1.02
1.03
KLA/ATP
1.02
1.04
1.01
.97
.97
1.01
1.13
Sephs1
KLA
ATP
ATP+KLA
NM_175400
selenophosphate synthetase 1 (Sephs1), mRNA [NM_175400]
KLA
.92
.97
.99
.96
.87
.77
.73
ATP
1.04
1.08
.95
.89
.70
.70
.55
KLA/ATP
.91
1.05
.85
.92
.75
.73
.46
Sephs2
KLA
ATP
ATP+KLA
NM_009266
selenophosphate synthetase 2 (Sephs2), mRNA [NM_009266]
KLA
.74
.81
.66
.57
.59
.85
1.22
ATP
1.00
1.11
.95
.90
.80
.65
.67
KLA/ATP
.73
.81
.61
.72
.58
.61
.65
Sgms1
KLA
ATP
ATP+KLA
NM_144792
sphingomyelin synthase 1 (Sgms1), mRNA [NM_144792]
KLA
.84
.84
.58
.94
1.49
.66
.71
ATP
.98
.97
1.57
1.85
1.32
1.60
.57
KLA/ATP
.82
.73
.90
.97
.67
.81
.55
Sgms2
KLA
ATP
ATP+KLA
NM_028943
sphingomyelin synthase 2 (Sgms2), mRNA [NM_028943]
KLA
1.21
1.19
1.18
1.03
.89
.92
1.42
ATP
1.00
.99
1.08
1.22
3.11
11.82
3.08
KLA/ATP
1.17
1.16
1.07
1.21
1.17
3.37
5.49
Sgpl1
KLA
ATP
ATP+KLA
NM_009163
sphingosine phosphate lyase 1 (Sgpl1), mRNA [NM_009163]
KLA
.89
.84
.89
.90
.84
.86
1.09
ATP
1.17
1.14
.75
.82
1.35
1.57
1.75
KLA/ATP
1.01
.97
.64
.82
1.08
1.45
1.97
Sgsh
KLA
ATP
ATP+KLA
NM_018822
N-sulfoglucosamine sulfohydrolase (sulfamidase) (Sgsh), mRNA [NM_018822]
KLA
.68
.66
.65
.65
.54
.61
.71
ATP
1.00
1.03
1.06
.98
.73
.59
.73
KLA/ATP
.72
.67
.69
.66
.52
.56
.57
Shmt1
KLA
ATP
ATP+KLA
NM_009171
serine hydroxymethyltransferase 1 (soluble) (Shmt1), mRNA [NM_009171]
KLA
.85
.89
.82
.83
.82
.88
.83
ATP
.93
.81
.85
.82
.85
.86
.72
KLA/ATP
.81
.83
.91
.86
.85
.86
.72
Shmt2
KLA
ATP
ATP+KLA
NM_028230
serine hydroxymethyltransferase 2 (mitochondrial) (Shmt2), nuclear gene encoding mitochondrial protein, mRNA [NM_028230]
KLA
.82
.90
.78
.63
.51
.39
.63
ATP
1.04
1.21
.97
1.44
1.32
.85
.64
KLA/ATP
.94
.92
.62
1.01
.59
.49
.32
Slc27a5
KLA
ATP
ATP+KLA
NM_009512
solute carrier family 27 (fatty acid transporter), member 5 (Slc27a5), mRNA [NM_009512]
KLA
.94
.95
.95
1.02
1.03
.97
1.02
ATP
1.03
.95
1.04
1.10
.97
.91
1.00
KLA/ATP
1.06
.96
.94
.99
1.04
1.01
1.04
Slc33a1
KLA
ATP
ATP+KLA
NM_015728
solute carrier family 33 (acetyl-CoA transporter), member 1 (Slc33a1), mRNA [NM_015728]
KLA
1.19
1.11
1.28
1.14
1.15
.93
.98
ATP
1.09
1.08
.68
.65
.44
.55
.82
KLA/ATP
1.15
1.11
.74
.74
.50
.52
.63
Smpd1
KLA
ATP
ATP+KLA
NM_011421
sphingomyelin phosphodiesterase 1, acid lysosomal (Smpd1), mRNA [NM_011421]
KLA
.68
.66
.67
.87
.91
1.01
1.11
ATP
1.04
1.02
1.06
1.03
1.02
1.30
1.73
KLA/ATP
.69
.68
.86
.71
.78
.99
1.64
Smpd2
KLA
ATP
ATP+KLA
NM_009213
sphingomyelin phosphodiesterase 2, neutral (Smpd2), mRNA [NM_009213]
KLA
.56
.61
.60
.55
.63
.74
.65
ATP
.94
.87
.63
.65
.65
.69
.82
KLA/ATP
.62
.59
.56
.47
.73
.79
.65
Smpd3
KLA
ATP
ATP+KLA
NM_021491
sphingomyelin phosphodiesterase 3, neutral (Smpd3), mRNA [NM_021491]
KLA
.58
.60
.50
.51
.40
.41
.48
ATP
1.08
1.03
.97
.91
.56
.42
.79
KLA/ATP
.57
.59
.58
.59
.47
.44
.56
Smpd4
KLA
ATP
ATP+KLA
AK164456
12 days embryo eyeball cDNA, RIKEN full-length enriched library, clone:D230040E22 product:similar to Hypothetical P-loop containing nucleotide triphosphate hydrolases structure containing protein [Mus musculus], full insert sequence [AK16
KLA
.90
.91
.87
.80
.81
.75
.75
ATP
1.01
1.10
1.04
.99
1.03
.84
.41
KLA/ATP
.93
.94
.83
.88
.84
.75
.35
Smpd4
KLA
ATP
ATP+KLA
NM_029945
sphingomyelin phosphodiesterase 4 (Smpd4), mRNA [NM_029945]
KLA
.98
.97
.97
.94
1.00
1.01
1.02
ATP
.97
1.06
.98
1.01
.77
.74
.93
KLA/ATP
.94
1.02
.87
1.01
.69
.71
.87
Sms
KLA
ATP
ATP+KLA
NM_009214
spermine synthase (Sms), mRNA [NM_009214]
KLA
1.18
1.13
1.09
1.03
.91
.68
.62
ATP
.99
1.03
.86
.77
.69
.49
.56
KLA/ATP
1.08
1.13
.92
.80
.62
.42
.32
Sord
KLA
ATP
ATP+KLA
NM_146126
sorbitol dehydrogenase (Sord), mRNA [NM_146126]
KLA
.59
.64
.61
.54
.45
.41
.37
ATP
1.09
1.19
.99
1.21
1.46
1.09
.74
KLA/ATP
.69
.69
.59
.66
1.06
1.06
.47
Spam1
KLA
ATP
ATP+KLA
NM_001079875
sperm adhesion molecule 1 (Spam1), transcript variant 1, mRNA [NM_001079875]
KLA
1.12
1.05
.98
1.05
1.02
1.03
1.07
ATP
.96
1.02
.85
.96
.97
1.14
1.09
KLA/ATP
.96
.95
1.03
1.01
.98
.92
1.03
Sphk1
KLA
ATP
ATP+KLA
NM_025367
sphingosine kinase 1 (Sphk1), transcript variant 2, mRNA [NM_025367]
KLA
2.61
2.50
2.04
1.71
1.19
.91
.74
ATP
.94
1.00
2.06
8.09
16.52
12.59
3.53
KLA/ATP
2.64
2.81
3.50
8.13
23.71
16.46
2.22
Sphk2
KLA
ATP
ATP+KLA
NM_020011
sphingosine kinase 2 (Sphk2), transcript variant 2, mRNA [NM_020011]
KLA
.64
.74
1.05
1.47
2.15
1.84
1.67
ATP
1.10
1.02
.57
.54
.49
1.29
2.15
KLA/ATP
.78
.64
.43
.56
.86
1.90
3.74
Spr
KLA
ATP
ATP+KLA
NM_011467
sepiapterin reductase (Spr), mRNA [NM_011467]
KLA
.62
.69
.58
.53
.44
.46
.72
ATP
.95
1.09
.91
1.02
.73
.52
.87
KLA/ATP
.68
.71
.65
.67
.54
.40
.46
Sptlc1
KLA
ATP
ATP+KLA
NM_009269
serine palmitoyltransferase, long chain base subunit 1 (Sptlc1), mRNA [NM_009269]
KLA
1.34
1.32
1.35
1.36
1.26
1.30
1.31
ATP
.98
1.04
1.06
1.00
.76
1.02
1.57
KLA/ATP
1.27
1.44
1.37
1.27
.91
1.12
1.57
Sptlc2
KLA
ATP
ATP+KLA
NM_011479
serine palmitoyltransferase, long chain base subunit 2 (Sptlc2), mRNA [NM_011479]
KLA
2.03
2.10
2.53
2.42
2.17
1.88
1.45
ATP
1.08
1.10
1.17
1.27
2.52
4.23
1.87
KLA/ATP
2.17
2.37
2.54
2.82
3.28
4.03
2.41
Sptlc3
KLA
ATP
ATP+KLA
NM_175467
serine palmitoyltransferase, long chain base subunit 3 (Sptlc3), mRNA [NM_175467]
KLA
1.22
1.31
1.26
1.25
1.20
1.17
1.12
ATP
.95
1.03
1.02
.94
1.16
1.40
1.32
KLA/ATP
1.11
1.18
1.28
1.30
1.20
1.22
1.31
Sqle
KLA
ATP
ATP+KLA
NM_009270
squalene epoxidase (Sqle), mRNA [NM_009270]
KLA
.41
.38
.35
.27
.26
.24
.42
ATP
1.00
1.02
1.10
.92
.83
.65
1.37
KLA/ATP
.43
.42
.32
.31
.26
.23
.31
Srm
KLA
ATP
ATP+KLA
NM_009272
spermidine synthase (Srm), mRNA [NM_009272]
KLA
.61
.68
.55
.41
.31
.32
.57
ATP
.95
1.06
.92
1.19
.94
.50
.61
KLA/ATP
.70
.65
.55
.59
.44
.26
.17
St3gal1
KLA
ATP
ATP+KLA
NM_009177
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (St3gal1), mRNA [NM_009177]
KLA
9.07
8.10
8.07
8.61
6.32
6.17
4.65
ATP
.97
.87
1.27
4.14
10.38
21.66
8.10
KLA/ATP
8.21
8.67
10.15
8.82
11.00
12.94
21.26
St3gal2
KLA
ATP
ATP+KLA
NM_009179
ST3 beta-galactoside alpha-2,3-sialyltransferase 2 (St3gal2), mRNA [NM_009179]
KLA
.70
.72
.72
.65
.58
.53
.65
ATP
.96
.96
.88
.76
.61
.60
1.17
KLA/ATP
.75
.71
.67
.63
.50
.47
.68
St3gal3
KLA
ATP
ATP+KLA
NM_009176
ST3 beta-galactoside alpha-2,3-sialyltransferase 3 (St3gal3), mRNA [NM_009176]
KLA
2.87
3.30
2.81
2.78
2.43
1.70
1.08
ATP
1.01
1.10
.89
1.11
.69
.91
.76
KLA/ATP
3.12
3.19
2.25
2.60
1.52
1.00
.98
St3gal4
KLA
ATP
ATP+KLA
NM_009178
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 (St3gal4), mRNA [NM_009178]
KLA
1.75
1.88
2.01
2.31
2.72
1.78
.99
ATP
.93
.96
1.01
1.14
.93
.92
.70
KLA/ATP
1.61
1.68
1.65
1.72
1.29
1.01
.95
St3gal5
KLA
ATP
ATP+KLA
NM_011375
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 (St3gal5), transcript variant 2, mRNA [NM_011375]
KLA
1.10
1.09
1.17
1.35
1.33
1.52
1.63
ATP
.91
.91
1.00
.84
.59
.29
.98
KLA/ATP
.97
1.08
1.24
.95
.88
.56
1.54
St3gal6
KLA
ATP
ATP+KLA
NM_018784
ST3 beta-galactoside alpha-2,3-sialyltransferase 6 (St3gal6), mRNA [NM_018784]
KLA
.95
.89
1.03
1.00
1.09
1.11
.75
ATP
.96
.95
1.35
1.11
.88
.47
.44
KLA/ATP
.88
.92
1.18
1.06
.98
.87
.71
St6gal1
KLA
ATP
ATP+KLA
NM_145933
beta galactoside alpha 2,6 sialyltransferase 1 (St6gal1), mRNA [NM_145933]
KLA
.46
.43
.38
.39
.27
.26
.23
ATP
.93
.84
.69
.57
.43
.38
.26
KLA/ATP
.46
.41
.40
.39
.35
.41
.32
St6gal2
KLA
ATP
ATP+KLA
AK129462
mRNA for mKIAA1877 protein [AK129462]
KLA
1.03
.98
1.02
.95
1.01
.99
.95
ATP
1.05
.99
1.01
1.03
.96
1.07
.97
KLA/ATP
1.00
.99
.98
1.04
.98
.98
1.04
St6gal2
KLA
ATP
ATP+KLA
NM_172829
beta galactoside alpha 2,6 sialyltransferase 2 (St6gal2), mRNA [NM_172829]
KLA
1.03
1.01
.99
1.10
1.08
1.05
1.00
ATP
.95
1.06
1.02
1.07
.99
1.06
1.10
KLA/ATP
.94
1.01
1.06
1.08
.99
1.00
1.06
St6galna
c1
KLA
ATP
ATP+KLA
NM_011371
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 (St6galnac1), mRNA [NM_011371]
KLA
1.05
.99
1.02
.95
.97
.98
.98
ATP
.96
1.02
1.04
.94
1.02
1.02
1.04
KLA/ATP
1.02
1.01
.98
.95
.99
.92
1.01
St6galna
c3
KLA
ATP
ATP+KLA
NM_011372
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 (St6galnac3), mRNA [NM_011372]
KLA
.99
.99
.97
1.00
1.02
1.02
.97
ATP
1.03
.94
1.01
1.00
.97
1.09
1.03
KLA/ATP
.96
.90
.98
1.01
1.00
1.01
.99
St6galna
c4
KLA
ATP
ATP+KLA
NM_011373
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 (St6galnac4), mRNA [NM_011373]
KLA
1.26
1.24
1.31
1.41
1.55
1.34
.98
ATP
1.04
1.02
1.00
1.57
4.04
2.62
1.71
KLA/ATP
1.41
1.29
1.17
1.68
3.23
3.18
1.50
St6galna
c5
KLA
ATP
ATP+KLA
NM_012028
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 (St6galnac5), mRNA [NM_012028]
KLA
1.03
1.06
1.04
1.01
1.01
.99
1.03
ATP
.99
.98
1.04
1.05
1.04
1.05
.98
KLA/ATP
.98
.96
1.05
1.04
1.05
1.05
1.02
St6galna
c6
KLA
ATP
ATP+KLA
AK035447
adult male urinary bladder cDNA, RIKEN full-length enriched library, clone:9530049M17 product:sialytransferase 7 ((alpha-N-acetylneuraminyl 2,3-betagalactosyl-1,3)-N-acetyl galactosaminide alpha-2,6-sialytransferase) F, full insert sequen
KLA
1.01
1.04
.90
.95
.98
.92
1.00
ATP
.94
.92
.91
1.41
1.24
1.11
1.26
KLA/ATP
.91
.95
.99
1.34
1.20
.98
1.19
St6galna
c6
KLA
ATP
ATP+KLA
NM_016973
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 (St6galnac6), transcript variant 1, mRNA [NM_016973]
KLA
.71
.71
.70
.64
.64
.65
.68
ATP
.98
1.01
.88
1.12
1.17
1.09
1.08
KLA/ATP
.71
.71
.71
1.05
1.38
.90
1.03
St8sia1
KLA
ATP
ATP+KLA
NM_011374
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 (St8sia1), mRNA [NM_011374]
KLA
.96
.94
.94
.99
.94
.93
.91
ATP
1.04
.99
1.05
1.02
.95
.93
.86
KLA/ATP
.93
.90
.98
.95
.94
.90
.87
St8sia5
KLA
ATP
ATP+KLA
NM_153124
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 (St8sia5), transcript variant 2, mRNA [NM_153124]
KLA
1.25
1.32
1.17
1.33
1.11
1.31
1.81
ATP
1.00
.94
1.28
1.48
2.83
2.97
1.73
KLA/ATP
1.27
1.24
1.49
1.47
2.95
3.30
2.99
St8sia5
KLA
ATP
ATP+KLA
X98014
gb|M.musculus mRNA for alpha-2,8-sialyltransferase. [X98014]
KLA
.97
1.08
1.01
.97
1.07
1.06
1.19
ATP
1.00
1.05
1.01
1.04
1.64
1.66
1.25
KLA/ATP
.96
.92
1.04
1.10
1.37
1.73
1.60
Stt3a
KLA
ATP
ATP+KLA
AK030363
adult male pituitary gland cDNA, RIKEN full-length enriched library, clone:5330402C17 product:OLIGOSACCHARYL TRANSFERASE STT3 SUBUNIT HOMOLOG (B5) (INTEGRAL MEMBRANE PROTEIN 1) homolog [Mus musculus], full insert sequence [AK030363]
KLA
1.23
1.24
1.18
1.17
1.00
1.05
1.09
ATP
.94
.96
1.28
.97
.87
.70
.70
KLA/ATP
1.13
1.24
1.34
.98
.91
.69
.53
Stt3a
KLA
ATP
ATP+KLA
NM_008408
STT3, subunit of the oligosaccharyltransferase complex, homolog A (S. cerevisiae) (Stt3a), mRNA [NM_008408]
KLA
1.21
1.29
1.21
1.07
1.07
.88
1.08
ATP
1.17
1.46
1.01
1.36
.92
.66
.90
KLA/ATP
1.24
1.45
.82
1.29
.62
.60
.62
Stt3b
KLA
ATP
ATP+KLA
NM_024222
STT3, subunit of the oligosaccharyltransferase complex, homolog B (S. cerevisiae) (Stt3b), mRNA [NM_024222]
KLA
.99
1.02
.94
.82
.70
.57
.92
ATP
1.11
1.19
.92
1.18
1.01
.82
1.06
KLA/ATP
1.10
1.22
.70
.85
.69
.64
.60
Sucla2
KLA
ATP
ATP+KLA
AK016060
adult male testis cDNA, RIKEN full-length enriched library, clone:4930547K18 product:unclassifiable, full insert sequence. [AK016060]
KLA
.92
1.07
.96
1.02
.97
.95
1.02
ATP
1.08
1.02
1.00
1.06
.92
1.01
.94
KLA/ATP
.94
1.04
1.04
.96
.94
.94
.90
Sucla2
KLA
ATP
ATP+KLA
NM_011506
succinate-Coenzyme A ligase, ADP-forming, beta subunit (Sucla2), nuclear gene encoding mitochondrial protein, mRNA [NM_011506]
KLA
1.10
1.02
1.00
1.06
.87
.81
.86
ATP
.98
.95
1.30
1.02
.93
.69
.72
KLA/ATP
.98
1.02
1.35
1.04
1.00
.61
.52
Suclg1
KLA
ATP
ATP+KLA
NM_019879
succinate-CoA ligase, GDP-forming, alpha subunit (Suclg1), mRNA [NM_019879]
KLA
.87
.88
.81
.81
.84
.79
.89
ATP
1.14
1.06
1.05
1.06
.87
.41
.81
KLA/ATP
.93
.92
.92
.92
.76
.49
.49
Suclg2
KLA
ATP
ATP+KLA
NM_011507
succinate-Coenzyme A ligase, GDP-forming, beta subunit (Suclg2), mRNA [NM_011507]
KLA
.99
1.07
1.08
.88
.74
.49
.67
ATP
1.00
1.14
1.15
1.44
.91
.37
.45
KLA/ATP
1.08
1.08
.94
1.18
.65
.40
.35
Synj1
KLA
ATP
ATP+KLA
AK080946
4 days neonate male adipose cDNA, RIKEN full-length enriched library, clone:B430216F19 product:SYNAPTOJANIN 1 (EC 3.1.3.56) (SYNAPTIC INOSITOL-1,4,5-TRISPHOSPHATE 5- PHOSPHATASE 1) homolog [Rattus norvegicus], full insert sequence. [AK080
KLA
2.98
2.90
3.08
3.32
2.29
1.91
1.44
ATP
.88
.86
1.58
1.20
1.53
2.26
1.97
KLA/ATP
2.79
3.22
4.30
2.74
2.82
2.28
2.35
Synj1
KLA
ATP
ATP+KLA
XM_001481287
gb|PREDICTED: Mus musculus synaptojanin 1 (Synj1), mRNA [XM_001481287]
KLA
3.23
3.00
3.78
3.44
2.82
2.78
1.56
ATP
.97
.86
1.21
.59
1.04
1.34
1.07
KLA/ATP
3.33
3.04
4.28
1.80
2.61
2.79
1.99
Synj2
KLA
ATP
ATP+KLA
AK014584
0 day neonate skin cDNA, RIKEN full-length enriched library, clone:4632417B14 product:synaptojanin 2, full insert sequence. [AK014584]
KLA
.87
.82
.75
.78
.71
.96
1.05
ATP
.95
1.11
1.78
1.18
.95
1.08
1.89
KLA/ATP
.68
.74
.89
.83
.73
.73
1.14
Synj2
KLA
ATP
ATP+KLA
NM_001113353
synaptojanin 2 (Synj2), transcript variant 1, mRNA [NM_001113353]
KLA
.45
.41
.40
.44
.48
.65
.72
ATP
1.06
1.04
1.10
.99
.60
.76
1.67
KLA/ATP
.44
.41
.45
.46
.46
.52
1.15
Synj2
KLA
ATP
ATP+KLA
NM_011523
synaptojanin 2 (Synj2), transcript variant 3, mRNA [NM_011523]
KLA
.62
.59
.54
.64
.49
.57
.57
ATP
.95
.90
.94
.78
.61
.60
.78
KLA/ATP
.56
.59
.63
.56
.56
.68
.59
Taldo1
KLA
ATP
ATP+KLA
NM_011528
transaldolase 1 (Taldo1), mRNA [NM_011528]
KLA
.82
.79
.79
.76
.63
.56
.56
ATP
.93
.96
1.02
.91
1.13
1.91
2.17
KLA/ATP
.77
.80
.86
.75
.94
1.33
1.43
Tat
KLA
ATP
ATP+KLA
NM_146214
tyrosine aminotransferase (Tat), nuclear gene encoding mitochondrial protein, mRNA [NM_146214]
KLA
1.13
1.09
1.19
1.17
1.14
1.19
1.10
ATP
.97
1.08
1.12
1.25
1.02
1.16
1.18
KLA/ATP
1.16
1.21
1.27
1.23
1.22
1.11
1.08
Tbxas1
KLA
ATP
ATP+KLA
AK048544
16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130072B09 product:thromboxane A synthase 1, platelet, full insert sequence. [AK048544]
KLA
.96
.96
1.09
1.03
.96
1.02
.96
ATP
1.02
.96
.99
.97
.94
.95
1.51
KLA/ATP
.97
.97
.95
.95
.92
.96
1.30
Tbxas1
KLA
ATP
ATP+KLA
NM_011539
thromboxane A synthase 1, platelet (Tbxas1), mRNA [NM_011539]
KLA
.62
.62
.66
.58
.64
.76
.74
ATP
1.12
1.08
.92
.94
.74
.42
.68
KLA/ATP
.69
.73
.61
.62
.42
.33
.51
Tcirg1
KLA
ATP
ATP+KLA
NM_016921
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein A3 (Tcirg1), mRNA [NM_016921]
KLA
1.32
1.42
1.49
1.38
1.94
2.26
1.98
ATP
1.01
1.16
.69
.96
1.24
1.32
2.03
KLA/ATP
1.50
1.58
.90
1.29
1.37
2.08
3.28
Tdo2
KLA
ATP
ATP+KLA
NM_019911
tryptophan 2,3-dioxygenase (Tdo2), mRNA [NM_019911]
KLA
.99
1.04
1.03
.98
1.08
1.01
1.02
ATP
.98
1.01
.99
.98
1.06
1.06
1.04
KLA/ATP
1.06
.95
1.06
1.02
1.02
1.00
.98
Tgds
KLA
ATP
ATP+KLA
NM_029578
TDP-glucose 4,6-dehydratase (Tgds), mRNA [NM_029578]
KLA
1.13
1.09
1.07
1.18
1.27
1.43
1.49
ATP
1.04
1.05
1.20
1.10
.63
1.05
1.46
KLA/ATP
1.06
1.15
1.27
1.18
.83
1.11
1.50
Th
KLA
ATP
ATP+KLA
NM_009377
tyrosine hydroxylase (Th), mRNA [NM_009377]
KLA
1.00
1.01
1.00
1.00
1.00
1.00
1.00
ATP
.98
1.01
1.00
1.00
1.00
.99
1.01
KLA/ATP
1.00
1.01
1.01
1.00
1.01
.98
1.02
Tha1
KLA
ATP
ATP+KLA
NM_027919
threonine aldolase 1 (Tha1), mRNA [NM_027919]
KLA
3.92
4.62
4.23
4.99
4.59
2.42
2.04
ATP
.98
.92
.78
.74
.78
1.21
1.03
KLA/ATP
4.35
4.64
3.33
2.80
1.63
1.41
1.50
Thtpa
KLA
ATP
ATP+KLA
NM_153083
thiamine triphosphatase (Thtpa), mRNA [NM_153083]
KLA
.57
.56
.52
.57
.53
.51
.52
ATP
.92
.86
.78
.59
.29
.64
.97
KLA/ATP
.52
.49
.43
.39
.30
.39
.55
Tk1
KLA
ATP
ATP+KLA
NM_009387
thymidine kinase 1 (Tk1), mRNA [NM_009387]
KLA
.36
.36
.31
.23
.18
.15
.14
ATP
1.04
1.13
.91
1.21
.52
.15
.09
KLA/ATP
.39
.35
.29
.35
.22
.14
.11
Tk2
KLA
ATP
ATP+KLA
NM_021028
thymidine kinase 2, mitochondrial (Tk2), nuclear gene encoding mitochondrial protein, mRNA [NM_021028]
KLA
.49
.53
.48
.66
.84
1.01
.86
ATP
1.07
1.02
.91
.96
.52
.41
.73
KLA/ATP
.51
.48
.44
.46
.44
.56
.75
Tkt
KLA
ATP
ATP+KLA
NM_009388
transketolase (Tkt), mRNA [NM_009388]
KLA
.97
1.00
.97
1.00
.90
.86
.90
ATP
.99
1.00
1.03
.97
.89
.83
.58
KLA/ATP
1.01
1.00
.97
.91
.80
.76
.51
Tktl1
KLA
ATP
ATP+KLA
NM_031379
transketolase-like 1 (Tktl1), mRNA [NM_031379]
KLA
1.07
1.01
.98
1.03
.97
.99
.93
ATP
1.02
1.02
.98
.91
.99
1.06
.95
KLA/ATP
.96
.98
.96
.99
1.05
.99
1.00
Tktl2
KLA
ATP
ATP+KLA
AK029871
adult male testis cDNA, RIKEN full-length enriched library, clone:4931419A11 product:TRANSKETOLASE (FRAGMENT) homolog [Mus musculus], full insert sequence [AK029871]
KLA
1.09
1.03
1.10
.98
1.03
.96
.94
ATP
.96
1.05
.99
1.00
.94
1.02
1.02
KLA/ATP
.95
.92
1.15
1.06
.99
.93
.98
Tktl2
KLA
ATP
ATP+KLA
NM_028927
transketolase-like 2 (Tktl2), mRNA [NM_028927]
KLA
1.02
.98
.98
.98
1.01
.97
.98
ATP
1.06
1.01
1.01
.99
.93
1.01
1.06
KLA/ATP
1.02
1.03
.98
.99
.96
1.00
.99
Tm7sf2
KLA
ATP
ATP+KLA
NM_028454
transmembrane 7 superfamily member 2 (Tm7sf2), mRNA [NM_028454]
KLA
.93
.90
.79
.88
.63
.52
.33
ATP
.84
.94
.97
1.03
.76
.60
.51
KLA/ATP
.82
.94
.90
.95
.67
.47
.27
Tph1
KLA
ATP
ATP+KLA
NM_009414
tryptophan hydroxylase 1 (Tph1), mRNA [NM_009414]
KLA
.99
1.02
1.03
1.03
1.01
1.00
1.03
ATP
1.07
1.04
1.01
1.02
.99
.98
.98
KLA/ATP
1.00
1.07
1.05
1.37
1.20
1.03
.99
Tph2
KLA
ATP
ATP+KLA
AY090565
neuronal tryptophan hydroxylase (Ntph) mRNA, complete cds [AY090565]
KLA
1.01
.98
.98
1.05
.96
.97
1.05
ATP
.94
1.04
.95
.93
.97
.91
.95
KLA/ATP
1.06
1.07
.99
.99
1.05
1.06
.98
Tpi1
KLA
ATP
ATP+KLA
NM_009415
triosephosphate isomerase 1 (Tpi1), mRNA [NM_009415]
KLA
.70
.79
.73
.61
.66
.67
1.32
ATP
1.04
1.22
.90
1.30
.95
.86
1.24
KLA/ATP
.84
.82
.55
.90
.66
.74
1.54
Tpk1
KLA
ATP
ATP+KLA
NM_013861
thiamine pyrophosphokinase (Tpk1), mRNA [NM_013861]
KLA
.97
.98
1.02
.93
.78
.75
.72
ATP
.98
1.14
1.09
1.10
.75
.44
.66
KLA/ATP
.97
1.03
.81
.91
.61
.53
.58
Tpo
KLA
ATP
ATP+KLA
NM_009417
thyroid peroxidase (Tpo), mRNA [NM_009417]
KLA
1.05
1.05
.87
1.01
1.00
1.03
1.04
ATP
1.03
.95
.99
1.02
1.00
1.00
.91
KLA/ATP
1.01
.99
1.01
1.01
.93
.96
.93
Trak2
KLA
ATP
ATP+KLA
NM_172406
trafficking protein, kinesin binding 2 (Trak2), mRNA [NM_172406]
KLA
.94
1.01
1.01
.90
.86
.85
.98
ATP
1.05
1.04
1.02
.95
1.07
1.14
1.01
KLA/ATP
1.04
.93
.84
.79
.80
.95
.93
Treh
KLA
ATP
ATP+KLA
NM_021481
trehalase (brush-border membrane glycoprotein) (Treh), mRNA [NM_021481]
KLA
.91
1.00
1.05
.95
1.03
1.04
1.09
ATP
1.00
1.05
1.11
1.06
1.07
.97
1.01
KLA/ATP
1.04
.98
.97
1.15
1.13
1.09
1.04
Trit1
KLA
ATP
ATP+KLA
NM_025873
tRNA isopentenyltransferase 1 (Trit1), mRNA [NM_025873]
KLA
1.13
1.23
1.21
1.12
1.05
1.08
1.37
ATP
1.06
1.12
.96
.82
.91
.83
1.07
KLA/ATP
1.20
1.36
1.15
1.00
.84
1.02
1.17
Tst
KLA
ATP
ATP+KLA
NM_009437
thiosulfate sulfurtransferase, mitochondrial (Tst), nuclear gene encoding mitochondrial protein, mRNA [NM_009437]
KLA
.85
.91
.84
.85
.76
.80
1.10
ATP
1.01
1.12
1.44
1.34
.90
.98
1.04
KLA/ATP
.84
.98
1.14
1.23
.97
.93
.99
Tsta3
KLA
ATP
ATP+KLA
NM_031201
tissue specific transplantation antigen P35B (Tsta3), mRNA [NM_031201]
KLA
1.02
1.05
1.08
1.10
1.15
1.34
1.35
ATP
.94
1.05
.99
1.14
.93
.96
1.14
KLA/ATP
1.09
1.11
1.02
1.21
1.08
1.13
1.51
Tusc3
KLA
ATP
ATP+KLA
BC003311
tumor suppressor candidate 3, mRNA (cDNA clone IMAGE:3154952), complete cds. [BC003311]
KLA
1.07
1.13
1.27
1.18
1.14
.99
.91
ATP
1.09
1.02
.96
1.10
.92
.82
1.13
KLA/ATP
1.17
1.25
.97
.96
.73
.71
.91
Tusc3
KLA
ATP
ATP+KLA
NM_030254
tumor suppressor candidate 3 (Tusc3), mRNA [NM_030254]
KLA
1.28
1.26
1.13
1.34
1.18
1.05
.79
ATP
.99
.91
1.18
.99
.84
1.14
1.04
KLA/ATP
1.00
1.11
1.42
1.06
.81
.84
.95
Twistnb
KLA
ATP
ATP+KLA
NM_172253
TWIST neighbor (Twistnb), mRNA [NM_172253]
KLA
1.30
1.25
1.07
.87
.82
.80
1.03
ATP
1.10
1.00
.92
.87
1.26
1.07
.94
KLA/ATP
1.29
1.21
1.09
.82
.79
.85
.59
Tymp
KLA
ATP
ATP+KLA
NM_138302
thymidine phosphorylase (Tymp), mRNA [NM_138302]
KLA
.41
.42
.37
.39
.51
.66
1.18
ATP
1.04
1.00
.86
1.08
1.04
1.25
1.40
KLA/ATP
.46
.43
.34
.49
.56
.79
.64
Tyms
KLA
ATP
ATP+KLA
NM_021288
thymidylate synthase (Tyms), mRNA [NM_021288]
KLA
.82
.81
.75
.71
.48
.30
.16
ATP
1.00
.94
1.32
1.26
.91
.52
.18
KLA/ATP
.77
.73
1.07
.96
.80
.38
.18
Tyms
KLA
ATP
ATP+KLA
X14489
gb|M.musculus thymidylate synthase (TS) gene exons 5 - 7. [X14489]
KLA
.87
.84
.91
.93
.93
.94
.77
ATP
.99
.93
.95
.91
.94
.83
.79
KLA/ATP
.87
.89
.92
.82
.85
.87
.85
Tyr
KLA
ATP
ATP+KLA
NM_011661
tyrosinase (Tyr), mRNA [NM_011661]
KLA
.99
1.02
.99
1.01
1.00
1.01
1.03
ATP
1.01
.98
.99
1.03
1.00
1.01
1.00
KLA/ATP
1.01
1.00
1.00
1.01
1.00
1.03
.98
Tyrp1
KLA
ATP
ATP+KLA
NM_031202
tyrosinase-related protein 1 (Tyrp1), mRNA [NM_031202]
KLA
.97
.98
1.01
.99
.99
.98
.97
ATP
1.01
.99
1.00
.97
.99
1.00
.98
KLA/ATP
.98
.99
1.01
.98
.98
.97
1.00
Uap1
KLA
ATP
ATP+KLA
NM_133806
UDP-N-acetylglucosamine pyrophosphorylase 1 (Uap1), mRNA [NM_133806]
KLA
1.24
1.12
1.16
.89
.68
.63
.80
ATP
1.23
1.30
1.14
1.56
1.37
.94
.98
KLA/ATP
1.31
1.37
1.08
1.53
.98
.79
.71
Uap1l1
KLA
ATP
ATP+KLA
BC043307
UDP-N-acteylglucosamine pyrophosphorylase 1-like 1, mRNA (cDNA clone IMAGE:5042946), partial cds [BC043307]
KLA
.74
.74
.70
.74
.71
.74
.78
ATP
.93
.96
1.11
1.38
1.45
1.06
.86
KLA/ATP
.76
.72
.71
1.18
1.19
1.01
.65
Uap1l1
KLA
ATP
ATP+KLA
NM_001033293
UDP-N-acteylglucosamine pyrophosphorylase 1-like 1 (Uap1l1), mRNA [NM_001033293]
KLA
.72
.78
.76
.62
.76
.63
.92
ATP
1.17
1.36
.78
1.25
.91
.56
1.59
KLA/ATP
.90
.92
.45
.84
.49
.45
.80
Uck1
KLA
ATP
ATP+KLA
NM_011675
uridine-cytidine kinase 1 (Uck1), mRNA [NM_011675]
KLA
.58
.60
.69
.76
.92
1.21
1.07
ATP
.88
.96
.87
.78
.85
1.54
1.20
KLA/ATP
.55
.59
.63
.62
.83
1.60
1.58
Uck2
KLA
ATP
ATP+KLA
BC004016
uridine-cytidine kinase 2, mRNA (cDNA clone IMAGE:3493906), partial cds [BC004016]
KLA
.64
.62
.54
.44
.28
.23
.17
ATP
.89
.94
1.31
1.78
2.23
2.61
.31
KLA/ATP
.58
.57
.64
.67
.72
.95
.40
Uck2
KLA
ATP
ATP+KLA
NM_030724
uridine-cytidine kinase 2 (Uck2), mRNA [NM_030724]
KLA
.95
.96
.77
.68
.37
.25
.10
ATP
.90
.94
1.56
1.98
2.14
5.67
1.10
KLA/ATP
.90
.93
1.09
1.15
.95
1.39
1.71
Uckl1
KLA
ATP
ATP+KLA
NM_026765
uridine-cytidine kinase 1-like 1 (Uckl1), mRNA [NM_026765]
KLA
.97
.94
.95
1.01
.99
1.20
1.40
ATP
.86
.85
.97
.84
.82
.65
1.12
KLA/ATP
.89
.85
1.00
.86
.95
.76
1.37
Ugcg
KLA
ATP
ATP+KLA
BC050828
UDP-glucose ceramide glucosyltransferase, mRNA (cDNA clone MGC:59317 IMAGE:6512920), complete cds [BC050828]
KLA
3.14
2.80
2.93
3.01
1.88
1.45
1.73
ATP
1.22
1.28
1.11
1.66
6.31
4.52
1.39
KLA/ATP
3.05
3.59
2.52
3.22
4.86
5.40
2.39
Ugcg
KLA
ATP
ATP+KLA
NM_011673
UDP-glucose ceramide glucosyltransferase (Ugcg), mRNA [NM_011673]
KLA
2.82
2.78
2.92
2.52
1.85
1.64
1.75
ATP
1.04
1.22
1.55
2.42
5.88
4.88
1.65
KLA/ATP
3.05
3.21
3.10
3.92
5.18
5.21
2.64
Ugdh
KLA
ATP
ATP+KLA
NM_009466
UDP-glucose dehydrogenase (Ugdh), mRNA [NM_009466]
KLA
1.04
1.06
.96
.95
1.09
1.54
1.30
ATP
.99
1.06
.89
.91
1.31
3.29
1.49
KLA/ATP
1.04
.98
.73
.85
1.38
2.91
1.59
Ugp2
KLA
ATP
ATP+KLA
NM_139297
UDP-glucose pyrophosphorylase 2 (Ugp2), mRNA [NM_139297]
KLA
.94
1.01
.95
.96
.88
1.01
1.02
ATP
.97
.98
1.03
.92
.94
1.19
.82
KLA/ATP
.93
.94
.85
.78
.82
1.20
.96
Ugt1a1
KLA
ATP
ATP+KLA
NM_201645
UDP glucuronosyltransferase 1 family, polypeptide A1 (Ugt1a1), mRNA [NM_201645]
KLA
.95
1.07
1.00
.99
.97
.98
1.02
ATP
1.08
.95
1.02
1.04
1.08
1.03
1.01
KLA/ATP
1.02
.95
.93
1.01
1.01
1.11
1.06
Ugt1a6b
KLA
ATP
ATP+KLA
NM_201410
UDP glucuronosyltransferase 1 family, polypeptide A6B (Ugt1a6b), mRNA [NM_201410]
KLA
.89
.86
.93
.93
.89
.86
.89
ATP
1.10
1.05
1.15
1.07
1.01
.99
1.24
KLA/ATP
.90
.94
1.02
.89
.87
.81
.92
Ugt1a9
KLA
ATP
ATP+KLA
NM_201644
UDP glucuronosyltransferase 1 family, polypeptide A9 (Ugt1a9), mRNA [NM_201644]
KLA
1.07
.96
.98
1.09
1.03
1.06
1.08
ATP
1.04
.94
1.01
1.07
1.05
1.02
1.06
KLA/ATP
1.05
1.00
.94
1.01
1.03
1.04
1.00
Ugt2a1
KLA
ATP
ATP+KLA
NM_053184
UDP glucuronosyltransferase 2 family, polypeptide A1 (Ugt2a1), mRNA [NM_053184]
KLA
1.01
1.03
.99
.99
.99
1.01
1.02
ATP
1.01
.93
1.04
1.03
1.02
1.01
1.03
KLA/ATP
1.04
1.01
1.01
1.02
1.01
1.02
1.00
Ugt2a3
KLA
ATP
ATP+KLA
NM_028094
UDP glucuronosyltransferase 2 family, polypeptide A3 (Ugt2a3), mRNA [NM_028094]
KLA
1.07
1.01
.97
1.05
1.01
.98
.99
ATP
.98
.96
1.04
1.06
.95
.94
1.01
KLA/ATP
1.02
1.00
.94
1.02
1.02
1.01
1.06
Ugt2b1
KLA
ATP
ATP+KLA
NM_152811
UDP glucuronosyltransferase 2 family, polypeptide B1 (Ugt2b1), mRNA [NM_152811]
KLA
1.08
1.01
.95
1.08
1.00
1.04
.97
ATP
1.03
1.14
1.01
1.00
1.01
1.05
1.13
KLA/ATP
1.05
.99
1.06
.98
1.03
.96
.98
Ugt2b34
KLA
ATP
ATP+KLA
NM_153598
UDP glucuronosyltransferase 2 family, polypeptide B34 (Ugt2b34), mRNA [NM_153598]
KLA
.98
1.08
.99
1.06
.97
1.05
1.03
ATP
1.06
1.04
.96
1.01
1.03
1.01
.99
KLA/ATP
1.09
.94
1.00
1.07
1.01
1.03
.97
Ugt2b35
KLA
ATP
ATP+KLA
NM_172881
UDP glucuronosyltransferase 2 family, polypeptide B35 (Ugt2b35), mRNA [NM_172881]
KLA
.99
1.02
.99
1.01
1.00
.96
1.01
ATP
.96
1.02
1.02
.96
.93
1.00
1.02
KLA/ATP
1.01
.99
1.04
1.00
.97
.93
.97
Ugt2b36
KLA
ATP
ATP+KLA
NM_001029867
UDP glucuronosyltransferase 2 family, polypeptide B36 (Ugt2b36), mRNA [NM_001029867]
KLA
.95
.95
1.00
1.00
1.03
1.02
.92
ATP
1.02
1.07
1.03
.95
1.01
.93
1.00
KLA/ATP
.99
1.05
.98
1.04
1.02
.98
.99
Ugt2b37
KLA
ATP
ATP+KLA
NM_053215
UDP glucuronosyltransferase 2 family, polypeptide B37 (Ugt2b37), mRNA [NM_053215]
KLA
1.02
1.06
1.04
1.05
1.00
1.05
1.03
ATP
1.01
1.03
1.08
1.01
1.05
1.02
1.05
KLA/ATP
1.01
.99
1.11
1.14
1.04
1.08
1.05
Ugt2b38
KLA
ATP
ATP+KLA
NM_133894
UDP glucuronosyltransferase 2 family, polypeptide B38 (Ugt2b38), mRNA [NM_133894]
KLA
1.00
.96
1.04
.99
1.10
.97
.99
ATP
1.02
1.04
1.03
.94
.96
.93
.99
KLA/ATP
.98
.97
1.00
.97
.98
1.04
1.02
Ugt2b5
KLA
ATP
ATP+KLA
NM_009467
UDP glucuronosyltransferase 2 family, polypeptide B5 (Ugt2b5), mRNA [NM_009467]
KLA
1.01
.99
1.09
.96
.97
.99
1.01
ATP
1.03
1.02
1.02
1.01
.97
.90
.94
KLA/ATP
.99
.99
.98
1.05
1.01
.93
.95
Ugt8a
KLA
ATP
ATP+KLA
NM_011674
UDP galactosyltransferase 8A (Ugt8a), mRNA [NM_011674]
KLA
1.02
1.04
1.04
1.00
.98
1.08
1.00
ATP
.98
1.02
1.01
1.02
1.00
1.07
1.07
KLA/ATP
.98
1.06
1.04
.94
1.02
.99
1.04
Umps
KLA
ATP
ATP+KLA
NM_009471
uridine monophosphate synthetase (Umps), mRNA [NM_009471]
KLA
.43
.42
.37
.41
.44
.66
.83
ATP
1.14
1.06
1.07
1.01
.89
.60
1.03
KLA/ATP
.44
.44
.46
.45
.60
.56
.79
Uox
KLA
ATP
ATP+KLA
NM_009474
urate oxidase (Uox), mRNA [NM_009474]
KLA
.98
.99
1.00
1.00
1.02
1.02
1.01
ATP
.99
.98
.98
1.05
1.02
1.01
1.05
KLA/ATP
1.02
1.00
1.02
1.04
1.02
.99
1.02
Upb1
KLA
ATP
ATP+KLA
NM_133995
ureidopropionase, beta (Upb1), mRNA [NM_133995]
KLA
1.22
1.30
1.23
1.20
1.25
1.21
1.15
ATP
1.06
1.13
1.16
1.14
1.01
1.57
1.24
KLA/ATP
1.23
1.24
1.29
1.26
1.18
1.91
2.90
Upp1
KLA
ATP
ATP+KLA
NM_009477
uridine phosphorylase 1 (Upp1), mRNA [NM_009477]
KLA
1.68
1.67
2.20
2.12
1.95
1.34
1.12
ATP
.96
1.07
1.02
1.03
1.04
1.25
1.12
KLA/ATP
1.72
1.64
1.49
1.49
1.47
1.44
1.32
Upp2
KLA
ATP
ATP+KLA
NM_029692
uridine phosphorylase 2 (Upp2), mRNA [NM_029692]
KLA
1.01
1.05
1.04
1.05
1.04
1.04
1.01
ATP
1.06
1.00
1.05
1.01
1.00
1.00
1.03
KLA/ATP
1.05
1.02
1.07
1.03
1.05
1.10
1.04
Uqcr
KLA
ATP
ATP+KLA
NM_025650
ubiquinol-cytochrome c reductase (6.4kD) subunit (Uqcr), mRNA [NM_025650]
KLA
.88
.78
.82
.91
.72
.69
.63
ATP
1.13
1.03
1.18
1.31
1.15
1.02
.78
KLA/ATP
.92
.91
1.05
1.08
1.03
.85
.61
Uqcrb
KLA
ATP
ATP+KLA
NM_026219
ubiquinol-cytochrome c reductase binding protein (Uqcrb), nuclear gene encoding mitochondrial protein, mRNA [NM_026219]
KLA
1.06
.95
.99
1.09
1.01
1.11
.98
ATP
1.08
.97
1.35
1.07
1.19
1.14
.99
KLA/ATP
1.05
.98
1.49
1.22
1.30
1.24
.92
Uqcrc1
KLA
ATP
ATP+KLA
NM_025407
ubiquinol-cytochrome c reductase core protein 1 (Uqcrc1), mRNA [NM_025407]
KLA
.90
.96
.94
.90
.89
.85
.92
ATP
.97
1.06
.95
1.10
.92
.73
.89
KLA/ATP
.94
.99
.89
1.01
.85
.78
.73
Uqcrc2
KLA
ATP
ATP+KLA
NM_025899
ubiquinol cytochrome c reductase core protein 2 (Uqcrc2), mRNA [NM_025899]
KLA
1.00
1.08
1.05
1.10
1.03
1.08
1.06
ATP
.91
.89
1.17
.95
.96
.88
.97
KLA/ATP
.95
.96
1.26
1.00
1.07
.97
.92
Uqcrfs1
KLA
ATP
ATP+KLA
NM_025710
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 (Uqcrfs1), mRNA [NM_025710]
KLA
1.21
1.17
1.22
1.37
1.08
.92
.87
ATP
.91
.87
1.28
1.14
.97
1.00
.82
KLA/ATP
1.04
1.07
1.52
1.35
1.17
.91
.77
Uqcrh
KLA
ATP
ATP+KLA
NM_025641
ubiquinol-cytochrome c reductase hinge protein (Uqcrh), mRNA [NM_025641]
KLA
.94
1.04
1.09
1.06
.95
.94
.90
ATP
.95
.90
1.19
1.06
1.10
1.18
.86
KLA/ATP
1.02
1.01
1.34
1.19
1.36
1.28
.90
Uqcrq
KLA
ATP
ATP+KLA
AK017907
adult male thymus cDNA, RIKEN full-length enriched library, clone:5830407L17 product:Ubiquinol-cytochrome c reductase binding protein, full insert sequence. [AK017907]
KLA
.95
.93
.98
1.02
1.07
1.14
1.21
ATP
.73
.82
.80
.99
1.08
.96
1.08
KLA/ATP
.81
.86
.85
.97
.94
1.02
.98
Uqcrq
KLA
ATP
ATP+KLA
NM_025352
ubiquinol-cytochrome c reductase, complex III subunit VII (Uqcrq), nuclear gene encoding mitochondrial protein, mRNA [NM_025352]
KLA
.97
.92
.86
.94
.89
1.02
1.25
ATP
.90
.84
1.11
1.04
1.07
1.00
.97
KLA/ATP
.83
.87
1.15
1.01
1.14
1.06
.89
Uroc1
KLA
ATP
ATP+KLA
NM_144940
urocanase domain containing 1 (Uroc1), mRNA [NM_144940]
KLA
.98
.97
.93
.99
1.01
.97
.99
ATP
.94
.94
1.07
1.08
1.03
.99
.99
KLA/ATP
.88
.97
1.00
1.02
1.00
.93
1.00
Urod
KLA
ATP
ATP+KLA
NM_009478
uroporphyrinogen decarboxylase (Urod), mRNA [NM_009478]
KLA
.78
.85
.76
.71
.60
.53
.61
ATP
.99
.94
1.19
1.13
.99
.97
1.27
KLA/ATP
.83
.89
1.02
.99
.97
.85
1.00
Uros
KLA
ATP
ATP+KLA
NM_009479
uroporphyrinogen III synthase (Uros), mRNA [NM_009479]
KLA
1.00
1.01
.98
.92
1.01
1.30
1.36
ATP
.98
.95
.95
.95
.69
.70
1.51
KLA/ATP
.95
.99
.91
.90
.82
.86
1.32
Wbscr17
KLA
ATP
ATP+KLA
NM_145218
Williams-Beuren syndrome chromosome region 17 homolog (human) (Wbscr17), mRNA [NM_145218]
KLA
.97
1.01
.99
.98
1.06
1.01
1.03
ATP
1.05
.95
1.01
1.08
1.01
1.05
1.01
KLA/ATP
1.04
1.00
.98
1.00
1.02
1.03
1.01
Xdh
KLA
ATP
ATP+KLA
NM_011723
xanthine dehydrogenase (Xdh), mRNA [NM_011723]
KLA
1.82
1.90
2.33
2.06
2.49
2.56
1.77
ATP
1.02
1.15
.98
1.10
1.06
1.02
1.42
KLA/ATP
2.00
2.00
2.02
2.11
1.27
1.56
1.92
Xylb
KLA
ATP
ATP+KLA
BC026406
xylulokinase homolog (H. influenzae), mRNA (cDNA clone IMAGE:4211747), partial cds. [BC026406]
KLA
.73
.71
.74
.69
.65
.60
.85
ATP
.99
.99
1.00
1.04
.80
.73
.99
KLA/ATP
.68
.75
.77
.91
.91
.78
.63
Xylb
KLA
ATP
ATP+KLA
NM_001033209
xylulokinase homolog (H. influenzae) (Xylb), mRNA [NM_001033209]
KLA
.68
.61
.65
.60
.48
.48
.68
ATP
1.08
.93
1.29
1.02
.83
.72
.97
KLA/ATP
.66
.61
.87
.82
1.07
.66
.57
Xylt1
KLA
ATP
ATP+KLA
AJ539164
mRNA for xylosyltransferase I (Xylt1 gene) [AJ539164]
KLA
1.45
1.45
1.17
1.46
1.28
1.39
1.06
ATP
1.02
1.09
1.29
1.22
1.25
1.39
1.12
KLA/ATP
1.37
1.48
1.52
1.66
1.35
1.52
1.31
Xylt2
KLA
ATP
ATP+KLA
NM_145828
xylosyltransferase II (Xylt2), mRNA [NM_145828]
KLA
.81
.84
.84
.92
1.54
2.09
2.23
ATP
1.11
1.13
.82
.75
.48
.65
2.19
KLA/ATP
.90
.90
.65
.63
.45
.68
3.07
Znrd1
KLA
ATP
ATP+KLA
NM_023162
zinc ribbon domain containing, 1 (Znrd1), mRNA [NM_023162]
KLA
1.04
1.12
1.28
1.43
1.67
1.76
1.39
ATP
1.01
1.08
1.13
1.34
.81
1.14
1.30
KLA/ATP
1.00
1.16
1.22
1.53
1.21
1.74
1.97